1	Journal	NNP	O	Journal	dep	7	SENT_1	[p1l7t162r213b212],
2	of	IN	O	of	_	0	SENT_1	[p1l238t161r293b212],
3	Clinical	JJ	O	clinical	amod	4	SENT_1	[p1l316t161r516b212],
4	Lipidology	NN	O	lipidology	prep_of	1	SENT_1	[p1l543t161r824b226],
5	(	CD	NUMBER	(	dep	7	SENT_1	[p1l854t161r1031b227],
6	2011	CD	DATE	2011	num	7	SENT_1	[p1l854t161r1031b227],
7	)	NN	O	)	_	0	SENT_1	[p1l854t161r1031b227],
8	5	CD	NUMBER	5	dep	7	SENT_1	[p1l1063t167r1108b220],
9	,	,	O	,	_	0	SENT_1	[p1l1063t167r1108b220],
10	91-96	CD	DATE	91-96	appos	8	SENT_1	[p1l1140t166r1303b212],

1	The	DT	O	the	det	3	SENT_2	[p1l7t382r255b509],
2	C3435T	NN	O	c3435t	nn	3	SENT_2	[p1l328t385r861b509],
3	polymorphism	NN	O	polymorphism	_	0	SENT_2	[p1l927t382r1949b542],
4	in	IN	O	in	dep	3	SENT_2	[p1l2022t382r2153b506],

1	Journalof	NNP	O	Journalof	_	0	SENT_3	[p1l1470t753r1939b869],
2	Clinical	JJ	O	clinical	amod	3	SENT_3	[p1l1487t869r1902b983],
3	Lipidology	NN	O	lipidology	dep	1	SENT_3	[p1l1487t1005r2093b1151],

1	ABCB1	NN	O	abcb1	nsubj	2	SENT_4	[p1l6t1364r467b1491],
2	influences	VBZ	O	influence	_	0	SENT_4	[p1l544t1361r1308b1491],
3	atorvastatin	NN	O	atorvastatin	nn	4	SENT_4	[p1l36t1529r457b1591],
4	efﬁcacy	NN	O	efﬁcacy	dobj	2	SENT_4	[p1l494t1529r764b1607],
5	and	CC	O	and	_	0	SENT_4	[p1l796t1529r917b1591],
6	muscle	NN	O	muscle	nn	7	SENT_4	[p1l953t1529r1192b1591],
7	symptoms	NNS	O	symptom	dobj	2	SENT_4	[p1l1226t1535r1580b1607],
8	in	IN	O	in	_	0	SENT_4	[p1l35t1628r98b1688],
9	a	DT	O	a	det	12	SENT_4	[p1l135t1646r169b1690],
10	high-risk	JJ	O	high-risk	amod	12	SENT_4	[p1l205t1628r521b1706],
11	vascular	JJ	O	vascular	amod	12	SENT_4	[p1l550t1628r838b1690],
12	cohort	NN	O	cohort	prep_in	2	SENT_4	[p1l868t1628r1092b1690],

1	Michel	NNP	PERSON	Michel	nn	3	SENT_5	[p1l37t1785r195b1829],
2	R.	NNP	PERSON	R.	nn	3	SENT_5	[p1l219t1787r261b1829],
3	Hoenig	NNP	PERSON	Hoenig	_	0	SENT_5	[p1l287t1785r470b1840],
4	,	,	O	,	_	0	SENT_5	[p1l287t1785r470b1840],
5	MBBS	NNP	O	MBBS	appos	3	SENT_5	[p1l497t1781r674b1836],
6	*	CD	NUMBER	*	num	5	SENT_5	[p1l497t1781r674b1836],
7	,	,	O	,	_	0	SENT_5	[p1l497t1781r674b1836],
8	Philip	NNP	PERSON	Philip	nn	10	SENT_5	[p1l700t1785r840b1840],
9	J.	NNP	PERSON	J.	nn	10	SENT_5	[p1l862t1787r902b1829],
10	Walker	NNP	PERSON	Walker	appos	3	SENT_5	[p1l926t1785r1109b1836],
11	,	,	O	,	_	0	SENT_5	[p1l926t1785r1109b1836],
12	MBBS	NNP	O	MBBS	appos	3	SENT_5	[p1l1135t1786r1280b1836],
13	,	,	O	,	_	0	SENT_5	[p1l1135t1786r1280b1836],
14	Christine	NNP	PERSON	Christine	nn	15	SENT_5	[p1l1305t1785r1525b1829],
15	Gurnsey	NNP	PERSON	Gurnsey	appos	3	SENT_5	[p1l1549t1786r1758b1840],
16	,	,	O	,	_	0	SENT_5	[p1l1549t1786r1758b1840],
17	Karen	NNP	PERSON	Karen	nn	18	SENT_5	[p1l1786t1786r1919b1829],
18	Beadle	NNP	PERSON	Beadle	appos	3	SENT_5	[p1l1947t1785r2122b1836],
19	,	,	O	,	_	0	SENT_5	[p1l1947t1785r2122b1836],
20	Leslie	NNP	PERSON	Leslie	nn	21	SENT_5	[p1l38t1851r178b1894],
21	Johnson	NNP	PERSON	Johnson	appos	3	SENT_5	[p1l199t1851r419b1901],
22	,	,	O	,	_	0	SENT_5	[p1l199t1851r419b1901],
23	PhD	NN	O	phd	appos	3	SENT_5	[p1l446t1851r536b1893],

1	Royal	NNP	LOCATION	Royal	nn	2	SENT_6	[p1l33t1976r131b2013],
2	Brisbane	NNP	LOCATION	Brisbane	_	0	SENT_6	[p1l142t1976r291b2005],
3	and	CC	O	and	_	0	SENT_6	[p1l305t1976r368b2005],
4	Women	NNP	O	Women	poss	6	SENT_6	[p1l381t1977r498b2005],
5	’s	POS	O	’s	_	0	SENT_6	[p1l505t1977r527b2005],
6	Hospital	NNP	O	Hospital	conj_and	2	SENT_6	[p1l539t1976r689b2013],
7	,	,	O	,	_	0	SENT_6	[p1l539t1976r689b2013],
8	University	NNP	ORGANIZATION	University	appos	6	SENT_6	[p1l709t1977r877b2013],
9	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l891t1976r928b2013],
10	Queensland	NNP	ORGANIZATION	Queensland	nn	11	SENT_6	[p1l936t1976r1134b2012],
11	Centre	NNP	ORGANIZATION	Centre	prep_of	2	SENT_6	[p1l1147t1977r1255b2005],
12	for	IN	ORGANIZATION	for	dep	2	SENT_6	[p1l1261t1976r1317b2013],
13	Clinical	JJ	ORGANIZATION	clinical	amod	14	SENT_6	[p1l1330t1976r1462b2005],
14	Research	NN	ORGANIZATION	research	pobj	12	SENT_6	[p1l1473t1976r1633b2010],
15	,	,	O	,	_	0	SENT_6	[p1l1473t1976r1633b2010],
16	Building	NN	O	building	appos	14	SENT_6	[p1l1649t1976r1792b2013],
17	71	CD	NUMBER	71	num	16	SENT_6	[p1l1808t1976r1852b2010],
18	,	,	O	,	_	0	SENT_6	[p1l1808t1976r1852b2010],
19	Herston	NNP	LOCATION	Herston	nn	20	SENT_6	[p1l1867t1977r2001b2005],
20	Qld	NNP	O	Qld	conj_and	14	SENT_6	[p1l2015t1976r2077b2012],
21	4029	CD	NUMBER	4029	dep	20	SENT_6	[p1l33t2025r122b2059],
22	,	,	O	,	_	0	SENT_6	[p1l33t2025r122b2059],
23	Australia	NNP	LOCATION	Australia	nn	26	SENT_6	[p1l136t2025r291b2054],
24	(	CD	NUMBER	(	num	26	SENT_6	[p1l305t2026r365b2061],
25	Dr	NNP	O	Dr	nn	26	SENT_6	[p1l305t2026r365b2061],
26	Hoenig	NNP	PERSON	Hoenig	conj_and	14	SENT_6	[p1l380t2025r528b2062],
27	)	NN	O	)	dep	26	SENT_6	[p1l380t2025r528b2062],
28	;	:	O	;	_	0	SENT_6	[p1l380t2025r528b2062],
29	Department	NNP	O	Department	conj_and	14	SENT_6	[p1l542t2026r741b2062],
30	of	IN	O	of	_	0	SENT_6	[p1l753t2025r791b2062],
31	Surgery	NNP	O	Surgery	prep_of	29	SENT_6	[p1l796t2026r930b2062],
32	,	,	O	,	_	0	SENT_6	[p1l796t2026r930b2062],
33	The	NNP	ORGANIZATION	The	nn	34	SENT_6	[p1l948t2025r1007b2054],
34	University	NNP	ORGANIZATION	University	conj_and	14	SENT_6	[p1l1023t2026r1192b2062],
35	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1205t2025r1243b2062],
36	Queensland	NNP	ORGANIZATION	Queensland	nn	38	SENT_6	[p1l1250t2025r1452b2061],
37	,	,	O	,	_	0	SENT_6	[p1l1250t2025r1452b2061],
38	Queensland	NNP	LOCATION	Queensland	prep_of	34	SENT_6	[p1l1470t2025r1672b2061],
39	,	,	O	,	_	0	SENT_6	[p1l1470t2025r1672b2061],
40	Australia	NNP	LOCATION	Australia	nn	43	SENT_6	[p1l1686t2025r1842b2054],
41	(	CD	NUMBER	(	num	43	SENT_6	[p1l1855t2026r1915b2061],
42	Dr	NNP	O	Dr	nn	43	SENT_6	[p1l1855t2026r1915b2061],
43	Walker	NNP	PERSON	Walker	conj_and	14	SENT_6	[p1l1934t2025r2072b2061],
44	)	NN	O	)	dep	43	SENT_6	[p1l1934t2025r2072b2061],
45	;	:	O	;	_	0	SENT_6	[p1l1934t2025r2072b2061],
46	and	CC	O	and	_	0	SENT_6	[p1l34t2074r97b2103],
47	Queensland	NNP	ORGANIZATION	Queensland	nn	50	SENT_6	[p1l111t2074r309b2110],
48	Health	NNP	ORGANIZATION	Health	nn	50	SENT_6	[p1l320t2074r433b2103],
49	Pathology	NNP	ORGANIZATION	Pathology	nn	50	SENT_6	[p1l447t2074r615b2111],
50	Service	NNP	ORGANIZATION	Service	conj_and	14	SENT_6	[p1l630t2074r758b2108],
51	,	,	O	,	_	0	SENT_6	[p1l630t2074r758b2108],
52	Royal	NNP	ORGANIZATION	Royal	nn	53	SENT_6	[p1l775t2074r873b2111],
53	Brisbane	NNP	ORGANIZATION	Brisbane	conj_and	50	SENT_6	[p1l886t2074r1035b2103],
54	and	CC	O	and	_	0	SENT_6	[p1l1050t2074r1113b2103],
55	Women	NNP	O	Women	poss	57	SENT_6	[p1l1128t2075r1245b2103],
56	’s	POS	O	’s	_	0	SENT_6	[p1l1253t2074r1275b2103],
57	Hospital	NNP	O	Hospital	conj_and	50	SENT_6	[p1l1288t2074r1438b2111],
58	,	,	O	,	_	0	SENT_6	[p1l1288t2074r1438b2111],
59	Queensland	NNP	LOCATION	Queensland	conj_and	14	SENT_6	[p1l1457t2074r1660b2110],
60	,	,	O	,	_	0	SENT_6	[p1l1457t2074r1660b2110],
61	Australia	NNP	LOCATION	Australia	nn	64	SENT_6	[p1l1675t2074r1831b2103],
62	(	CD	NUMBER	(	num	64	SENT_6	[p1l1847t2074r1906b2110],
63	Dr.	NNP	O	Dr.	nn	64	SENT_6	[p1l1847t2074r1906b2110],
64	Johnson	NNP	PERSON	Johnson	appos	59	SENT_6	[p1l1924t2074r2073b2108],
65	;	:	O	;	_	0	SENT_6	[p1l1924t2074r2073b2108],
66	and	CC	O	and	_	0	SENT_6	[p1l34t2123r97b2152],
67	C.	NNP	PERSON	C.	nn	68	SENT_6	[p1l112t2123r143b2152],
68	Gurnsey	NNP	PERSON	Gurnsey	pobj	12	SENT_6	[p1l163t2123r305b2160],
69	,	,	O	,	_	0	SENT_6	[p1l163t2123r305b2160],
70	and	CC	O	and	_	0	SENT_6	[p1l324t2123r387b2152],
71	K.	NNP	PERSON	K.	nn	72	SENT_6	[p1l400t2124r433b2152],
72	Beadle	NNP	PERSON	Beadle	conj_and	68	SENT_6	[p1l451t2123r580b2159],
73	)	IN	O	)	dep	2	SENT_6	[p1l451t2123r580b2159],

1	KEYWO	NNP	O	KEYWO	nn	2	SENT_7	[p1l82t2262r200b2292],
2	RDS	NNPS	O	RDS	_	0	SENT_7	[p1l205t2262r280b2292],
3	:	:	O	:	_	0	SENT_7	[p1l205t2262r280b2292],
4	ABCB	NN	O	abcb	dep	2	SENT_7	[p1l81t2311r180b2338],
5	1	CD	NUMBER	1	dep	4	SENT_7	[p1l186t2311r197b2337],
6	;	:	O	;	_	0	SENT_7	[p1l204t2319r209b2342],
7	Cholesterol	NNP	O	Cholesterol	dep	4	SENT_7	[p1l82t2356r262b2387],
8	;	:	O	;	_	0	SENT_7	[p1l82t2356r262b2387],
9	P-glycoprotein	NN	O	p-glycoprotein	dep	7	SENT_7	[p1l81t2400r312b2435],
10	;	:	O	;	_	0	SENT_7	[p1l81t2400r312b2435],
11	Pharmacogenomics	NNS	O	pharmacogenomic	dep	4	SENT_7	[p1l81t2447r382b2481],
12	;	:	O	;	_	0	SENT_7	[p1l81t2447r382b2481],
13	Statin	NN	O	statin	dep	11	SENT_7	[p1l82t2492r168b2519],

1	The	DT	O	the	det	3	SENT_8	[p1l84t3253r147b3283],
2	clinical	JJ	O	clinical	amod	3	SENT_8	[p1l163t3253r285b3283],
3	beneﬁt	NN	O	beneﬁt	nsubj	9	SENT_8	[p1l300t3253r413b3283],
4	of	IN	O	of	_	0	SENT_8	[p1l429t3253r465b3283],
5	statin	NN	O	statin	nn	6	SENT_8	[p1l479t3253r567b3283],
6	therapy	NN	O	therapy	prep_of	3	SENT_8	[p1l582t3253r706b3291],
7	is	VBZ	O	be	cop	9	SENT_8	[p1l722t3253r747b3283],
8	directly	RB	O	directly	advmod	9	SENT_8	[p1l764t3253r890b3291],
9	proportional	JJ	O	proportional	_	0	SENT_8	[p1l905t3262r1028b3291, p1l34t3303r128b3333],
10	to	TO	O	to	aux	11	SENT_8	[p1l148t3308r179b3333],
11	achieved	VBN	O	achieve	xcomp	9	SENT_8	[p1l201t3303r347b3333],
12	percent	NN	O	percent	nn	13	SENT_8	[p1l366t3307r488b3341],
13	reduction	NN	O	reduction	dobj	11	SENT_8	[p1l508t3303r665b3333],
14	in	IN	O	in	_	0	SENT_8	[p1l685t3303r716b3332],
15	low	JJ	O	low	amod	21	SENT_8	[p1l737t3303r931b3341],
16	—	NN	O	—	nn	21	SENT_8	[p1l737t3303r931b3341],
17	density	NN	O	density	nn	21	SENT_8	[p1l737t3303r931b3341],
18	lipoprotein	NN	O	lipoprotein	nn	21	SENT_8	[p1l951t3303r1027b3341, p1l33t3353r151b3391],
19	cholesterol	NN	O	cholesterol	nn	21	SENT_8	[p1l168t3353r350b3382],
20	(	NN	O	(	nn	21	SENT_8	[p1l368t3344r539b3389],
21	LDL	NN	O	ldl	prep_in	13	SENT_8	[p1l368t3344r539b3389],
22	.	.	O	.	_	0	SENT_8	[p1l368t3344r539b3389],

1	—	NN	O	—	_	0	SENT_9	[p1l368t3344r539b3389],
2	.	.	O	.	_	0	SENT_9	[p1l368t3344r539b3389],

1	C	NN	O	c	dep	3	SENT_10	[p1l368t3344r539b3389],
2	)	CD	NUMBER	)	num	3	SENT_10	[p1l368t3344r539b3389],
3	.1	CD	NUMBER	.1	_	0	SENT_10	[p1l368t3344r539b3389],
4	We	PRP	O	we	nsubj	7	SENT_10	[p1l557t3354r611b3382],
5	have	VBP	O	have	aux	7	SENT_10	[p1l628t3353r705b3382],
6	previously	RB	DATE	previously	advmod	7	SENT_10	[p1l721t3353r895b3391],
7	shown	VBN	O	show	rcmod	3	SENT_10	[p1l914t3353r1027b3388],
8	,	,	O	,	_	0	SENT_10	[p1l914t3353r1027b3388],

1	*	NN	O	*	_	0	SENT_11	[p1l84t3483r96b3497],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_11	[p1l109t3483r305b3513],
3	author	NN	O	author	dobj	2	SENT_11	[p1l316t3483r404b3506],
4	.	.	O	.	_	0	SENT_11	[p1l316t3483r404b3506],

1	E-mail	NN	O	e-mail	nn	2	SENT_12	[p1l83t3524r174b3548],
2	address	NN	O	address	_	0	SENT_12	[p1l186t3524r291b3548],
3	:	:	O	:	_	0	SENT_12	[p1l186t3524r291b3548],
4	drmhoenig@yahoo.com.au	NN	O	drmhoenig@yahoo.com.au	dep	2	SENT_12	[p1l305t3524r665b3554],
5	Submitted	VBN	O	submit	partmod	4	SENT_12	[p1l85t3566r220b3589],
6	September	NNP	DATE	September	tmod	5	SENT_12	[p1l235t3566r376b3596],
7	18	CD	DATE	18	num	6	SENT_12	[p1l393t3566r429b3593],
8	,	,	DATE	,	_	0	SENT_12	[p1l393t3566r429b3593],
9	2010	CD	DATE	2010	num	6	SENT_12	[p1l445t3566r517b3589],
10	.	.	O	.	_	0	SENT_12	[p1l445t3566r517b3589],

1	Accepted	JJ	O	accepted	_	0	SENT_13	[p1l533t3566r658b3596],
2	for	IN	O	for	_	0	SENT_13	[p1l673t3566r711b3589],
3	publication	NN	O	publication	prep_for	1	SENT_13	[p1l724t3566r874b3596],
4	January	NNP	DATE	January	tmod	3	SENT_13	[p1l888t3566r990b3596],
5	5	CD	DATE	5	num	4	SENT_13	[p1l1006t3566r1028b3593],
6	,	,	O	,	_	0	SENT_13	[p1l1006t3566r1028b3593],

1	OBJECTIVE	NN	O	objective	_	0	SENT_14	[p1l631t2259r805b2287],
2	:	:	O	:	_	0	SENT_14	[p1l631t2259r805b2287],
3	The	DT	O	the	det	5	SENT_14	[p1l829t2260r886b2286],
4	CC	NN	O	cc	nn	5	SENT_14	[p1l896t2260r944b2287],
5	genotype	NN	O	genotype	nsubjpass	14	SENT_14	[p1l955t2264r1090b2294],
6	of	IN	O	of	_	0	SENT_14	[p1l1101t2260r1133b2286],
7	the	DT	O	the	det	9	SENT_14	[p1l1141t2260r1185b2286],
8	C3435T	NN	O	c3435t	nn	9	SENT_14	[p1l1196t2260r1317b2287],
9	polymorphism	NN	O	polymorphism	prep_of	5	SENT_14	[p1l1326t2260r1544b2294],
10	in	IN	O	in	_	0	SENT_14	[p1l1554t2260r1582b2286],
11	ABCB	NNP	O	ABCB	prep_in	9	SENT_14	[p1l1589t2260r1700b2287],
12	]	CD	NUMBER	]	num	11	SENT_14	[p1l1589t2260r1700b2287],
13	is	VBZ	O	be	auxpass	14	SENT_14	[p1l1713t2260r1736b2286],
14	associated	VBN	O	associate	dep	1	SENT_14	[p1l1747t2260r1899b2286],
15	with	IN	O	with	_	0	SENT_14	[p1l1910t2260r1975b2286],
16	increased	VBN	O	increase	amod	18	SENT_14	[p1l1984t2260r2125b2286],
17	P-glycoprotein	NN	MISC	p-glycoprotein	nn	18	SENT_14	[p1l580t2305r802b2339],
18	expression	NN	O	expression	prep_with	14	SENT_14	[p1l809t2305r975b2339],
19	,	,	O	,	_	0	SENT_14	[p1l809t2305r975b2339],
20	reduced	VBD	O	reduce	rcmod	18	SENT_14	[p1l983t2305r1101b2331],
21	low	JJ	O	low	amod	22	SENT_14	[p1l1108t2305r1282b2339],
22	—	NN	O	—	iobj	20	SENT_14	[p1l1108t2305r1282b2339],
23	density	NN	O	density	nn	29	SENT_14	[p1l1108t2305r1282b2339],
24	lipoprotein	NN	O	lipoprotein	nn	29	SENT_14	[p1l1289t2305r1453b2339],
25	cholesterol	NN	O	cholesterol	nn	29	SENT_14	[p1l1460t2305r1623b2331],
26	(	CD	NUMBER	(	num	29	SENT_14	[p1l1631t2305r1763b2338],
27	LDL-C	NN	O	ldl-c	nn	29	SENT_14	[p1l1631t2305r1763b2338],
28	)	NN	O	)	nn	29	SENT_14	[p1l1631t2305r1763b2338],
29	response	NN	O	response	dobj	20	SENT_14	[p1l1770t2313r1900b2339],
30	to	TO	O	to	_	0	SENT_14	[p1l1907t2309r1935b2331],
31	atorvastatin	NN	O	atorvastatin	prep_to	29	SENT_14	[p1l1943t2305r2124b2336],
32	,	,	O	,	_	0	SENT_14	[p1l1943t2305r2124b2336],
33	and	CC	O	and	_	0	SENT_14	[p1l581t2350r633b2377],
34	a	DT	O	a	det	36	SENT_14	[p1l643t2358r659b2377],
35	reduced	VBN	O	reduce	amod	36	SENT_14	[p1l667t2350r785b2377],
36	area-under-the-curve	NN	O	area-under-the-curve	conj_and	29	SENT_14	[p1l796t2350r1107b2377],
37	in	IN	O	in	_	0	SENT_14	[p1l1117t2350r1145b2376],
38	pharmacokinetic	JJ	O	pharmacokinetic	amod	39	SENT_14	[p1l1154t2350r1403b2384],
39	studies	NNS	O	study	prep_in	36	SENT_14	[p1l1415t2350r1524b2377],
40	.	.	O	.	_	0	SENT_14	[p1l1415t2350r1524b2377],

1	We	PRP	O	we	nsubj	2	SENT_15	[p1l1535t2351r1583b2377],
2	sought	VBD	O	seek	_	0	SENT_15	[p1l1594t2350r1692b2384],
3	to	TO	O	to	aux	4	SENT_15	[p1l1701t2354r1729b2377],
4	assess	VB	O	assess	xcomp	2	SENT_15	[p1l1739t2358r1828b2377],
5	the	DT	O	the	det	6	SENT_15	[p1l1838t2350r1883b2377],
6	relationship	NN	O	relationship	dobj	4	SENT_15	[p1l1892t2350r2068b2384],
7	between	IN	O	between	_	0	SENT_15	[p1l2078t2350r2124b2377, p1l580t2399r669b2421],
8	1	CD	NUMBER	1	number	9	SENT_15	[p1l680t2395r706b2427],
9	)	CD	NUMBER	)	num	10	SENT_15	[p1l680t2395r706b2427],
10	genotype	NN	O	genotype	prep_between	6	SENT_15	[p1l716t2399r851b2429],
11	and	CC	O	and	_	0	SENT_15	[p1l860t2395r913b2421],
12	Atorvastatin	NN	O	atorvastatin	nn	13	SENT_15	[p1l921t2395r1104b2421],
13	efﬁcacy	NN	O	efﬁcacy	conj_and	10	SENT_15	[p1l1113t2395r1235b2429],
14	,	,	O	,	_	0	SENT_15	[p1l1113t2395r1235b2429],
15	independently	RB	O	independently	advmod	13	SENT_15	[p1l1245t2395r1456b2429],
16	of	IN	O	of	_	0	SENT_15	[p1l1465t2395r1497b2421],
17	variation	NN	O	variation	prep_of	6	SENT_15	[p1l1504t2395r1635b2421],
18	in	IN	O	in	_	0	SENT_15	[p1l1643t2395r1671b2421],
19	cholesterol	NN	O	cholesterol	nn	20	SENT_15	[p1l1680t2395r1843b2421],
20	metabolism	NN	O	metabolism	prep_in	17	SENT_15	[p1l1851t2395r2026b2421],
21	and	CC	O	and	_	0	SENT_15	[p1l2034t2395r2087b2421],
22	2	CD	NUMBER	2	number	23	SENT_15	[p1l2095t2395r2124b2427],
23	)	CD	NUMBER	)	prep_of	6	SENT_15	[p1l2095t2395r2124b2427],
24	genotype	NN	O	genotype	dep	23	SENT_15	[p1l580t2445r716b2475],
25	and	CC	O	and	_	0	SENT_15	[p1l727t2441r780b2467],
26	myalgia	NN	O	myalgium	conj_and	24	SENT_15	[p1l790t2441r917b2475],
27	.	.	O	.	_	0	SENT_15	[p1l790t2441r917b2475],

1	METHODS	NNS	O	method	_	0	SENT_16	[p1l632t2486r785b2513],
2	:	:	O	:	_	0	SENT_16	[p1l632t2486r785b2513],
3	High-risk	JJ	O	high-risk	amod	5	SENT_16	[p1l810t2486r952b2521],
4	vascular	JJ	O	vascular	amod	5	SENT_16	[p1l966t2487r1090b2513],
5	patients	NNS	O	patient	nsubjpass	9	SENT_16	[p1l1103t2486r1218b2521],
6	were	VBD	O	be	auxpass	7	SENT_16	[p1l1233t2495r1305b2513],
7	genotyped	VBN	O	genotype	dep	1	SENT_16	[p1l1319t2487r1474b2521],
8	and	CC	O	and	_	0	SENT_16	[p1l1489t2486r1542b2513],
9	treated	VBN	O	treat	dep	1	SENT_16	[p1l1555t2487r1657b2513],
10	with	IN	O	with	_	0	SENT_16	[p1l1671t2486r1737b2513],
11	atorvastatin	NN	O	atorvastatin	nn	13	SENT_16	[p1l1752t2486r1924b2513],
12	80	CD	NUMBER	80	num	13	SENT_16	[p1l1940t2487r1975b2513],
13	mg	NN	O	mg	prep_with	7	SENT_16	[p1l1989t2495r2036b2521],
14	for	IN	O	for	_	0	SENT_16	[p1l2050t2486r2093b2513],
15	6	CD	DURATION	6	num	16	SENT_16	[p1l2108t2486r2124b2513],
16	weeks	NNS	NUMBER	week	prep_for	13	SENT_16	[p1l580t2531r680b2557],
17	.	.	O	.	_	0	SENT_16	[p1l580t2531r680b2557],

1	The	DT	O	the	det	3	SENT_17	[p1l690t2531r747b2557],
2	lipid	NN	O	lipid	nn	3	SENT_17	[p1l756t2531r824b2565],
3	panel	NN	O	panel	nsubjpass	11	SENT_17	[p1l832t2531r912b2565],
4	and	CC	O	and	_	0	SENT_17	[p1l922t2531r974b2557],
5	percent	NN	O	percent	nn	7	SENT_17	[p1l982t2535r1092b2565],
6	LDL-C	NN	O	ldl-c	nn	7	SENT_17	[p1l1100t2531r1209b2558],
7	reduction	NN	O	reduction	conj_and	3	SENT_17	[p1l1218t2531r1359b2557],
8	with	IN	O	with	_	0	SENT_17	[p1l1367t2531r1433b2557],
9	atorvastatin	NN	O	atorvastatin	prep_with	3	SENT_17	[p1l1442t2531r1614b2557],
10	were	VBD	O	be	auxpass	11	SENT_17	[p1l1623t2540r1694b2557],
11	related	VBN	O	relate	_	0	SENT_17	[p1l1703t2531r1804b2557],
12	to	TO	O	to	_	0	SENT_17	[p1l1813t2535r1840b2557],
13	C3435T	NN	O	c3435t	nn	14	SENT_17	[p1l1850t2531r1971b2558],
14	genotype	NN	O	genotype	prep_to	11	SENT_17	[p1l1980t2535r2123b2565],
15	.	.	O	.	_	0	SENT_17	[p1l1980t2535r2123b2565],

1	Genotypes	NNS	O	genotype	nsubjpass	6	SENT_18	[p1l581t2576r738b2610],
2	and	CC	O	and	_	0	SENT_18	[p1l750t2576r802b2602],
3	allele	NN	O	allele	nn	4	SENT_18	[p1l813t2576r893b2603],
4	frequency	NN	O	frequency	conj_and	1	SENT_18	[p1l904t2576r1052b2610],
5	were	VBD	O	be	auxpass	6	SENT_18	[p1l1063t2584r1134b2602],
6	assessed	VBN	O	assess	conj_and	6	SENT_18	[p1l1145t2576r1270b2603],
7	in	IN	O	in	_	0	SENT_18	[p1l1280t2576r1309b2602],
8	patients	NNS	O	patient	prep_in	6	SENT_18	[p1l1319t2576r1434b2610],
9	with	IN	O	with	_	0	SENT_18	[p1l1445t2576r1511b2603],
10	and	CC	O	and	_	0	SENT_18	[p1l1522t2576r1574b2603],
11	without	IN	O	without	_	0	SENT_18	[p1l1584t2576r1698b2602],
12	myalgia	NN	O	myalgium	prep_without	6	SENT_18	[p1l1708t2576r1835b2610],
13	.	.	O	.	_	0	SENT_18	[p1l1708t2576r1835b2610],

1	RESULTS	NNS	O	result	_	0	SENT_19	[p1l632t2621r772b2648],
2	:	:	O	:	_	0	SENT_19	[p1l632t2621r772b2648],
3	A	DT	O	a	det	4	SENT_19	[p1l796t2622r822b2648],
4	total	NN	O	total	nsubjpass	12	SENT_19	[p1l829t2622r894b2648],
5	of	IN	O	of	_	0	SENT_19	[p1l902t2621r935b2648],
6	1	CD	NUMBER	1	number	7	SENT_19	[p1l943t2622r954b2648],
7	17	CD	NUMBER	17	num	8	SENT_19	[p1l962t2622r993b2648],
8	patients	NNS	O	patient	prep_of	4	SENT_19	[p1l1001t2621r1117b2656],
9	were	VBD	O	be	auxpass	10	SENT_19	[p1l1125t2630r1196b2648],
10	recruited	VBN	O	recruit	dep	1	SENT_19	[p1l1204t2621r1337b2648],
11	and	CC	O	and	_	0	SENT_19	[p1l1344t2622r1397b2648],
12	genotyped	VBN	O	genotype	conj_and	10	SENT_19	[p1l1404t2621r1566b2656],
13	.	.	O	.	_	0	SENT_19	[p1l1404t2621r1566b2656],

1	Of	IN	O	of	_	0	SENT_20	[p1l1576t2621r1616b2648],
2	these	DT	O	these	prep_of	5	SENT_20	[p1l1621t2621r1705b2653],
3	,	,	O	,	_	0	SENT_20	[p1l1621t2621r1705b2653],
4	98	CD	NUMBER	98	nsubj	5	SENT_20	[p1l1714t2622r1749b2648],
5	completed	VBD	O	complete	_	0	SENT_20	[p1l1758t2621r1913b2656],
6	the	DT	O	the	det	7	SENT_20	[p1l1920t2621r1965b2648],
7	study	NN	O	study	dobj	5	SENT_20	[p1l1973t2621r2052b2656],
8	with	IN	O	with	_	0	SENT_20	[p1l2060t2621r2125b2648],
9	adequate	JJ	O	adequate	amod	11	SENT_20	[p1l581t2667r712b2701],
10	atorvastatin	NN	O	atorvastatin	nn	11	SENT_20	[p1l722t2667r894b2693],
11	adherence	NN	O	adherence	prep_with	5	SENT_20	[p1l903t2667r1061b2698],
12	,	,	O	,	_	0	SENT_20	[p1l903t2667r1061b2698],
13	and	CC	O	and	_	0	SENT_20	[p1l1072t2667r1124b2693],
14	10	CD	NUMBER	10	nsubj	15	SENT_20	[p1l1136t2667r1169b2694],
15	reported	VBD	O	report	conj_and	5	SENT_20	[p1l1177t2667r1301b2701],
16	myalgia	NN	O	myalgium	dobj	15	SENT_20	[p1l1309t2667r1437b2701],
17	.	.	O	.	_	0	SENT_20	[p1l1309t2667r1437b2701],

1	T	NN	O	t	nn	5	SENT_21	[p1l1447t2667r1469b2693],
2	and	CC	O	and	_	0	SENT_21	[p1l1475t2667r1528b2693],
3	C	NN	O	c	conj_and	1	SENT_21	[p1l1536t2667r1559b2693],
4	allele	NN	O	allele	nn	5	SENT_21	[p1l1569t2667r1648b2693],
5	frequencies	NNS	O	frequency	nsubj	7	SENT_21	[p1l1657t2667r1828b2701],
6	were	VBD	O	be	cop	7	SENT_21	[p1l1838t2675r1909b2693],
7	0.63	CD	NUMBER	0.63	_	0	SENT_21	[p1l1917t2667r1980b2694],
8	and	CC	O	and	_	0	SENT_21	[p1l1990t2667r2043b2693],
9	0.37	CD	NUMBER	0.37	conj_and	7	SENT_21	[p1l2051t2667r2124b2698],
10	,	,	O	,	_	0	SENT_21	[p1l2051t2667r2124b2698],
11	respectively	RB	O	respectively	advmod	7	SENT_21	[p1l580t2712r764b2746],
12	.	.	O	.	_	0	SENT_21	[p1l580t2712r764b2746],

1	A	DT	O	a	det	3	SENT_22	[p1l774t2712r801b2738],
2	6-week	JJ	DURATION	6-week	amod	3	SENT_22	[p1l809t2712r918b2739],
3	course	NN	O	course	_	0	SENT_22	[p1l926t2720r1022b2739],
4	of	IN	O	of	_	0	SENT_22	[p1l1031t2712r1063b2738],
5	atorvastatin	NN	O	atorvastatin	prep_of	3	SENT_22	[p1l1070t2712r1242b2739],
6	(	CD	NUMBER	(	num	5	SENT_22	[p1l1252t2712r1299b2744],
7	80	CD	NUMBER	80	num	9	SENT_22	[p1l1252t2712r1299b2744],
8	mg/day	JJ	O	mg/day	amod	9	SENT_22	[p1l1308t2712r1430b2746],
9	)	NN	O	)	nsubj	10	SENT_22	[p1l1308t2712r1430b2746],
10	reduced	VBD	O	reduce	rcmod	3	SENT_22	[p1l1439t2712r1557b2738],
11	LDL-C	NN	O	ldl-c	dobj	10	SENT_22	[p1l1565t2712r1674b2739],
12	by	IN	O	by	_	0	SENT_22	[p1l1682t2712r1719b2746],
13	58	CD	PERCENT	58	num	14	SENT_22	[p1l1728t2712r1793b2739],
14	%	NN	PERCENT	%	prep_by	10	SENT_22	[p1l1728t2712r1793b2739],
15	i	FW	O	i	dep	3	SENT_22	[p1l1807t2714r1830b2737],
16	11	CD	PERCENT	11	number	17	SENT_22	[p1l1845t2712r1908b2739],
17	%	NN	PERCENT	%	amod	15	SENT_22	[p1l1845t2712r1908b2739],
18	(	CD	NUMBER	(	num	19	SENT_22	[p1l1918t2712r2010b2745],
19	mean	NN	O	mean	dep	15	SENT_22	[p1l1918t2712r2010b2745],
20	:	:	O	:	_	0	SENT_22	[p1l2022t2714r2045b2737],
21	SD	NN	O	sd	dep	3	SENT_22	[p1l2058t2712r2123b2745],
22	)	NN	O	)	dep	21	SENT_22	[p1l2058t2712r2123b2745],
23	.	.	O	.	_	0	SENT_22	[p1l2058t2712r2123b2745],

1	Patients	NNS	O	patient	nsubj	6	SENT_23	[p1l580t2757r696b2783],
2	with	IN	O	with	_	0	SENT_23	[p1l706t2757r771b2783],
3	the	DT	O	the	det	5	SENT_23	[p1l779t2757r824b2783],
4	CC	NN	O	cc	nn	5	SENT_23	[p1l833t2757r881b2783],
5	genotype	NN	O	genotype	prep_with	1	SENT_23	[p1l890t2761r1025b2791],
6	showed	VBD	O	show	_	0	SENT_23	[p1l1035t2757r1147b2783],
7	less	JJR	O	less	amod	9	SENT_23	[p1l1155t2757r1209b2783],
8	LDL-C	NN	O	ldl-c	nn	9	SENT_23	[p1l1218t2757r1326b2783],
9	reduction	NN	O	reduction	dobj	6	SENT_23	[p1l1335t2757r1476b2783],
10	with	IN	O	with	_	0	SENT_23	[p1l1485t2757r1550b2783],
11	atorvastatin	NN	O	atorvastatin	prep_with	6	SENT_23	[p1l1559t2757r1731b2783],
12	compared	VBN	O	compare	_	0	SENT_23	[p1l1740t2757r1887b2791],
13	with	IN	O	with	prepc_compared_with	11	SENT_23	[p1l1895t2757r1960b2783],
14	the	DT	O	the	det	15	SENT_23	[p1l1968t2757r2013b2783],
15	TT	NN	O	tt	dep	11	SENT_23	[p1l2022t2757r2100b2783],
16	/	:	O	/	punct	15	SENT_23	[p1l2022t2757r2100b2783],
17	'	''	O	'	_	0	SENT_23	[p1l2022t2757r2100b2783],
18	T	NN	O	t	nn	20	SENT_23	[p1l2022t2757r2100b2783],
19	C	NN	O	c	nn	20	SENT_23	[p1l2101t2757r2124b2783],
20	genotype	NN	O	genotype	dep	11	SENT_23	[p1l580t2805r716b2835],
21	(	CD	PERCENT	(	num	23	SENT_23	[p1l727t2801r804b2833],
22	53	CD	PERCENT	53	num	23	SENT_23	[p1l727t2801r804b2833],
23	%	NN	PERCENT	%	nsubj	46	SENT_23	[p1l727t2801r804b2833],
24	vs	CC	O	vs	_	0	SENT_23	[p1l815t2809r847b2827],
25	59	CD	PERCENT	59	num	26	SENT_23	[p1l857t2801r932b2832],
26	%	NN	PERCENT	%	nsubj	46	SENT_23	[p1l857t2801r932b2832],
27	,	,	O	,	_	0	SENT_23	[p1l857t2801r932b2832],
28	respectively	RB	O	respectively	advmod	26	SENT_23	[p1l943t2801r1128b2835],
29	,	,	O	,	_	0	SENT_23	[p1l943t2801r1128b2835],
30	P	NN	O	p	nsubj	46	SENT_23	[p1l1138t2802r1161b2827],
31	=	JJ	O	=	amod	30	SENT_23	[p1l1174t2810r1197b2819],
32	.034	CD	NUMBER	.034	num	33	SENT_23	[p1l1208t2801r1291b2833],
33	)	NN	O	)	tmod	31	SENT_23	[p1l1208t2801r1291b2833],
34	,	,	O	,	_	0	SENT_23	[p1l1208t2801r1291b2833],
35	and	CC	O	and	_	0	SENT_23	[p1l1302t2801r1355b2827],
36	this	DT	O	this	det	37	SENT_23	[p1l1364t2801r1417b2827],
37	ﬁnding	NN	O	ﬁnding	tmod	31	SENT_23	[p1l1427t2801r1531b2835],
38	was	VBD	O	be	cop	46	SENT_23	[p1l1541t2809r1597b2827],
39	independent	JJ	O	independent	amod	46	SENT_23	[p1l1608t2801r1790b2835],
40	of	IN	O	of	_	0	SENT_23	[p1l1800t2801r1832b2827],
41	variation	NN	O	variation	prep_of	39	SENT_23	[p1l1839t2801r1971b2827],
42	in	IN	O	in	_	0	SENT_23	[p1l1980t2801r2008b2827],
43	cholesterol	NN	O	cholesterol	nn	44	SENT_23	[p1l2018t2801r2124b2827, p1l580t2846r648b2872],
44	metabolism	NN	O	metabolism	prep_in	41	SENT_23	[p1l664t2846r838b2872],
45	(	CD	NUMBER	(	num	44	SENT_23	[p1l855t2846r889b2878],
46	P	NN	O	p	rcmod	20	SENT_23	[p1l855t2846r889b2878],
47	=	JJ	O	=	amod	46	SENT_23	[p1l908t2855r931b2864],
48	.045	CD	NUMBER	.045	tmod	47	SENT_23	[p1l948t2846r1009b2872],
49	after	IN	O	after	_	0	SENT_23	[p1l1027t2846r1095b2872],
50	correction	NN	O	correction	prep_after	46	SENT_23	[p1l1111t2846r1262b2872],
51	for	IN	O	for	_	0	SENT_23	[p1l1278t2846r1321b2872],
52	desmosterol	NN	O	desmosterol	nn	56	SENT_23	[p1l1336t2846r1516b2872],
53	and	CC	O	and	_	0	SENT_23	[p1l1533t2846r1585b2872],
54	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	conj_and	52	SENT_23	[p1l1601t2846r1945b2872],
55	ratio	NN	O	ratio	nn	56	SENT_23	[p1l1961t2846r2050b2878],
56	)	NN	O	)	prep_for	50	SENT_23	[p1l1961t2846r2050b2878],
57	.	.	O	.	_	0	SENT_23	[p1l1961t2846r2050b2878],

1	The	DT	O	the	det	3	SENT_24	[p1l2067t2846r2124b2872],
2	T	NN	O	t	nn	3	SENT_24	[p1l580t2892r602b2917],
3	allele	NN	O	allele	nsubj	6	SENT_24	[p1l612t2891r692b2917],
4	was	VBD	O	be	cop	6	SENT_24	[p1l704t2899r760b2917],
5	more	RBR	O	more	advmod	6	SENT_24	[p1l772t2899r848b2917],
6	frequent	JJ	O	frequent	_	0	SENT_24	[p1l861t2891r985b2925],
7	in	IN	O	in	_	0	SENT_24	[p1l996t2891r1025b2917],
8	patients	NNS	O	patient	prep_in	6	SENT_24	[p1l1036t2891r1152b2925],
9	with	IN	O	with	_	0	SENT_24	[p1l1164t2891r1230b2917],
10	myalgia	NN	O	myalgium	prep_with	8	SENT_24	[p1l1242t2891r1362b2925],
11	than	IN	O	than	_	0	SENT_24	[p1l1374t2891r1438b2917],
12	those	DT	O	those	prep_than	6	SENT_24	[p1l1449t2891r1527b2917],
13	without	IN	O	without	_	0	SENT_24	[p1l1539t2891r1653b2917],
14	(	CD	NUMBER	(	num	15	SENT_24	[p1l1665t2891r1741b2923],
15	0.80	CD	NUMBER	0.80	prep_without	12	SENT_24	[p1l1665t2891r1741b2923],
16	vs	CC	O	vs	_	0	SENT_24	[p1l1753t2899r1784b2917],
17	0.62	CD	NUMBER	0.62	num	18	SENT_24	[p1l1797t2891r1873b2923],
18	)	NN	O	)	conj_vs	12	SENT_24	[p1l1797t2891r1873b2923],
19	and	CC	O	and	_	0	SENT_24	[p1l1887t2891r1939b2917],
20	the	DT	O	the	det	22	SENT_24	[p1l1951t2891r1996b2917],
21	C	NN	O	c	nn	22	SENT_24	[p1l2008t2891r2031b2917],
22	allele	NN	O	allele	conj_vs	12	SENT_24	[p1l2045t2891r2124b2917],
23	less	RBR	O	less	advmod	24	SENT_24	[p1l580t2935r634b2961],
24	frequent	JJ	O	frequent	amod	22	SENT_24	[p1l645t2935r770b2969],
25	(	NN	O	(	dep	12	SENT_24	[p1l781t2935r856b2967],
26	0.20	CD	NUMBER	0.20	num	25	SENT_24	[p1l781t2935r856b2967],
27	vs	CC	O	vs	_	0	SENT_24	[p1l867t2943r898b2961],
28	0.38	CD	NUMBER	0.38	dep	12	SENT_24	[p1l909t2935r981b2966],
29	,	,	O	,	_	0	SENT_24	[p1l909t2935r981b2966],
30	P	NN	O	p	appos	12	SENT_24	[p1l993t2936r1015b2961],
31	=	JJ	O	=	amod	33	SENT_24	[p1l1029t2944r1052b2953],
32	.043	CD	NUMBER	.043	tmod	31	SENT_24	[p1l1064t2935r1146b2967],
33	)	NN	O	)	dep	30	SENT_24	[p1l1064t2935r1146b2967],
34	.	.	O	.	_	0	SENT_24	[p1l1064t2935r1146b2967],

1	CONCLUSION	NN	O	conclusion	_	0	SENT_25	[p1l631t2979r841b3007],
2	:	:	O	:	_	0	SENT_25	[p1l631t2979r841b3007],
3	In	IN	O	in	ccomp	20	SENT_25	[p1l865t2981r895b3006],
4	patients	NNS	O	patient	pobj	3	SENT_25	[p1l903t2980r1018b3014],
5	treated	VBN	O	treat	partmod	4	SENT_25	[p1l1027t2980r1128b3006],
6	with	IN	O	with	_	0	SENT_25	[p1l1137t2980r1202b3006],
7	atorvastatin	NN	O	atorvastatin	prep_with	5	SENT_25	[p1l1210t2980r1391b3011],
8	,	,	O	,	_	0	SENT_25	[p1l1210t2980r1391b3011],
9	the	DT	O	the	det	11	SENT_25	[p1l1400t2980r1445b3006],
10	CC	NN	O	cc	nn	11	SENT_25	[p1l1454t2980r1502b3007],
11	genotype	NN	O	genotype	nsubjpass	20	SENT_25	[p1l1511t2984r1646b3014],
12	at	IN	O	at	_	0	SENT_25	[p1l1655t2984r1681b3006],
13	the	DT	O	the	det	15	SENT_25	[p1l1689t2980r1733b3006],
14	C3435T	NN	O	c3435t	nn	15	SENT_25	[p1l1742t2980r1863b3007],
15	polymorphism	NN	O	polymorphism	prep_at	11	SENT_25	[p1l1871t2980r2089b3014],
16	in	IN	O	in	_	0	SENT_25	[p1l2097t2980r2125b3006],
17	ABCB	NNP	O	ABCB	prep_in	15	SENT_25	[p1l578t3025r689b3051],
18	]	CD	NUMBER	]	num	17	SENT_25	[p1l578t3025r689b3051],
19	is	VBZ	O	be	auxpass	20	SENT_25	[p1l704t3025r727b3051],
20	associated	VBN	O	associate	dep	1	SENT_25	[p1l741t3025r893b3051],
21	with	IN	O	with	_	0	SENT_25	[p1l906t3025r971b3051],
22	reduced	VBN	O	reduce	amod	24	SENT_25	[p1l983t3025r1102b3051],
23	atorvastatin	NN	O	atorvastatin	nn	24	SENT_25	[p1l1115t3025r1287b3051],
24	efﬁcacy	NN	O	efﬁcacy	prep_with	20	SENT_25	[p1l1300t3025r1417b3059],
25	independently	RB	O	independently	advmod	24	SENT_25	[p1l1429t3025r1640b3059],
26	of	IN	O	of	_	0	SENT_25	[p1l1654t3025r1686b3051],
27	cholesterol	NN	O	cholesterol	nn	28	SENT_25	[p1l1696t3025r1859b3051],
28	metabolism	NN	O	metabolism	prep_of	24	SENT_25	[p1l1872t3025r2053b3051],
29	.	.	O	.	_	0	SENT_25	[p1l1872t3025r2053b3051],

1	The	DT	O	the	det	3	SENT_26	[p1l2067t3025r2124b3051],
2	T	NN	O	t	nn	3	SENT_26	[p1l580t3070r602b3095],
3	allele	NN	O	allele	nsubj	12	SENT_26	[p1l610t3069r690b3095],
4	is	VBZ	O	be	cop	6	SENT_26	[p1l700t3069r724b3095],
5	more	RBR	O	more	advmod	6	SENT_26	[p1l735t3077r810b3095],
6	frequent	JJ	O	frequent	_	0	SENT_26	[p1l821t3069r946b3103],
7	and	CC	O	and	_	0	SENT_26	[p1l956t3069r1009b3095],
8	the	DT	O	the	det	10	SENT_26	[p1l1019t3069r1063b3095],
9	C	NN	O	c	nn	10	SENT_26	[p1l1075t3069r1097b3095],
10	allele	NN	O	allele	dep	12	SENT_26	[p1l1109t3069r1189b3095],
11	less	RBR	O	less	advmod	12	SENT_26	[p1l1200t3069r1254b3095],
12	frequent	JJ	O	frequent	conj_and	6	SENT_26	[p1l1265t3069r1389b3103],
13	in	IN	O	in	_	0	SENT_26	[p1l1399t3069r1427b3095],
14	patients	NNS	O	patient	prep_in	6	SENT_26	[p1l1437t3069r1552b3103],
15	with	IN	O	with	_	0	SENT_26	[p1l1564t3069r1629b3095],
16	myalgia	NN	O	myalgium	prep_with	14	SENT_26	[p1l1639t3069r1767b3103],
17	.	.	O	.	_	0	SENT_26	[p1l1639t3069r1767b3103],

1	©	RB	O	©	advmod	2	SENT_27	[p1l581t3114r607b3141],
2	2011	CD	DATE	2011	_	0	SENT_27	[p1l623t3114r693b3141],
3	National	NNP	ORGANIZATION	National	nn	5	SENT_27	[p1l709t3114r837b3140],
4	Lipid	NNP	ORGANIZATION	Lipid	nn	5	SENT_27	[p1l851t3114r931b3148],
5	Association	NNP	ORGANIZATION	Association	dep	2	SENT_27	[p1l944t3114r1128b3141],
6	.	.	O	.	_	0	SENT_27	[p1l944t3114r1128b3141],

1	All	DT	O	all	det	2	SENT_28	[p1l1143t3114r1190b3140],
2	rights	NNS	O	rights	nsubj	3	SENT_28	[p1l1203t3114r1287b3148],
3	reserved	VBN	O	reserve	_	0	SENT_28	[p1l1301t3114r1434b3141],
4	.	.	O	.	_	0	SENT_28	[p1l1301t3114r1434b3141],

1	in	IN	O	in	_	0	SENT_29	[p1l1130t3253r1161b3282],
2	a	DT	O	a	det	4	SENT_29	[p1l1176t3262r1193b3283],
3	prospective	JJ	O	prospective	amod	4	SENT_29	[p1l1207t3253r1397b3291],
4	study	NN	O	study	pobj	1	SENT_29	[p1l1413t3253r1506b3291],
5	,	,	O	,	_	0	SENT_29	[p1l1413t3253r1506b3291],
6	that	WDT	O	that	dobj	11	SENT_29	[p1l1522t3253r1584b3283],
7	markers	NNS	O	marker	nsubj	11	SENT_29	[p1l1598t3253r1730b3283],
8	of	IN	O	of	_	0	SENT_29	[p1l1746t3253r1781b3283],
9	cholesterol	NN	O	cholesterol	nn	10	SENT_29	[p1l1793t3253r1975b3283],
10	metabolism	NN	O	metabolism	prep_of	7	SENT_29	[p1l1989t3253r2124b3283, p1l1130t3303r1201b3333],
11	predict	VBP	O	predict	rcmod	4	SENT_29	[p1l1214t3303r1330b3341],
12	the	DT	O	the	det	14	SENT_29	[p1l1344t3303r1394b3332],
13	LDL-C	NN	O	ldl-c	nn	14	SENT_29	[p1l1408t3303r1529b3333],
14	response	NN	O	response	dobj	11	SENT_29	[p1l1544t3312r1688b3341],
15	to	TO	O	to	_	0	SENT_29	[p1l1703t3308r1734b3333],
16	atorvastatin	NN	O	atorvastatin	prep_to	11	SENT_29	[p1l1749t3303r1950b3333],
17	.	.	O	.	_	0	SENT_29	[p1l1749t3303r1950b3333],

1	Cholesta	NNP	O	Cholesta	nn	3	SENT_30	[p1l1967t3303r2124b3333],
2	—	CD	NUMBER	—	num	3	SENT_30	[p1l1967t3303r2124b3333],
3	nol	NN	O	nol	nsubj	11	SENT_30	[p1l1130t3353r1191b3388],
4	,	,	O	,	_	0	SENT_30	[p1l1130t3353r1191b3388],
5	a	DT	O	a	det	6	SENT_30	[p1l1212t3362r1229b3382],
6	marker	NN	O	marker	appos	3	SENT_30	[p1l1248t3353r1365b3382],
7	of	IN	O	of	_	0	SENT_30	[p1l1384t3353r1420b3382],
8	cholesterol	NN	O	cholesterol	nn	9	SENT_30	[p1l1436t3353r1618b3382],
9	absorption	NN	O	absorption	prep_of	6	SENT_30	[p1l1638t3353r1821b3391],
10	,	,	O	,	_	0	SENT_30	[p1l1638t3353r1821b3391],
11	expressed	VBN	O	express	_	0	SENT_30	[p1l1841t3353r2004b3391],
12	as	IN	O	as	_	0	SENT_30	[p1l2023t3362r2055b3382],
13	the	DT	O	the	det	15	SENT_30	[p1l2075t3353r2124b3382],
14	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	nn	15	SENT_30	[p1l1130t3402r1513b3431],
15	ratio	NN	O	ratio	prep_as	11	SENT_30	[p1l1525t3402r1609b3436],
16	,	,	O	,	_	0	SENT_30	[p1l1525t3402r1609b3436],
17	and	CC	O	and	_	0	SENT_30	[p1l1623t3402r1682b3431],
18	desmosterol	NN	O	desmosterol	nsubj	25	SENT_30	[p1l1693t3402r1901b3436],
19	,	,	O	,	_	0	SENT_30	[p1l1693t3402r1901b3436],
20	a	DT	O	a	det	23	SENT_30	[p1l1915t3411r1932b3431],
21	cholesterol	NN	O	cholesterol	nn	23	SENT_30	[p1l1943t3402r2124b3431],
22	synthesis	NN	O	synthesis	nn	23	SENT_30	[p1l1131t3452r1280b3490],
23	marker	NN	O	marker	appos	18	SENT_30	[p1l1295t3452r1420b3486],
24	,	,	O	,	_	0	SENT_30	[p1l1295t3452r1420b3486],
25	emerged	VBD	O	emerge	conj_and	11	SENT_30	[p1l1437t3452r1579b3490],
26	as	RB	O	as	advmod	27	SENT_30	[p1l1594t3461r1626b3481],
27	important	JJ	O	important	amod	31	SENT_30	[p1l1641t3452r1802b3490],
28	negative	JJ	O	negative	amod	31	SENT_30	[p1l1816t3452r1955b3490],
29	and	CC	O	and	_	0	SENT_30	[p1l1970t3452r2029b3481],
30	positive	JJ	O	positive	conj_and	28	SENT_30	[p1l2042t3452r2124b3490, p1l1130t3502r1190b3531],
31	predictors	NNS	O	predictor	dobj	25	SENT_30	[p1l1204t3502r1369b3539],
32	respectively	RB	O	respectively	advmod	25	SENT_30	[p1l1385t3502r1584b3539],
33	of	IN	O	of	_	0	SENT_30	[p1l1600t3502r1636b3531],
34	LDL-C	NN	O	ldl-c	nn	35	SENT_30	[p1l1647t3502r1768b3531],
35	response	NN	O	response	prep_of	25	SENT_30	[p1l1783t3493r1954b3539],
36	?	.	O	?	_	0	SENT_30	[p1l1783t3493r1954b3539],

1	Although	IN	O	although	mark	10	SENT_31	[p1l1969t3502r2125b3539],
2	the	DT	O	the	det	3	SENT_31	[p1l1130t3552r1179b3580],
3	amount	NN	O	amount	nsubj	10	SENT_31	[p1l1206t3556r1330b3581],
4	of	IN	O	of	_	0	SENT_31	[p1l1356t3551r1391b3580],
5	variability	NN	O	variability	prep_of	3	SENT_31	[p1l1414t3551r1584b3589],
6	predicted	VBN	O	predict	partmod	5	SENT_31	[p1l1609t3551r1765b3589],
7	with	IN	O	with	_	0	SENT_31	[p1l1790t3551r1863b3581],
8	this	DT	O	this	det	9	SENT_31	[p1l1888t3551r1947b3580],
9	approach	NN	O	approach	prep_with	6	SENT_31	[p1l1974t3551r2125b3589],
10	exceeds	VBZ	O	exceed	_	0	SENT_31	[p1l1130t3601r1260b3630],
11	that	IN	O	that	complm	13	SENT_31	[p1l1277t3601r1339b3630],
12	previously	RB	DATE	previously	advmod	13	SENT_31	[p1l1355t3601r1529b3639],
13	reported	VBN	O	report	ccomp	10	SENT_31	[p1l1546t3601r1685b3639],
14	with	IN	O	with	_	0	SENT_31	[p1l1702t3601r1774b3630],
15	pharmacogenomics	NNS	O	pharmacogenomic	prep_with	13	SENT_31	[p1l1791t3601r2123b3639],
16	,	,	O	,	_	0	SENT_31	[p1l1791t3601r2123b3639],

1	1933-2874	CD	DATE	1933-2874	nsubj	5	SENT_32	[p1l37t3714r203b3745],
2	/	:	O	/	punct	3	SENT_32	[p1l37t3714r203b3745],
3	$	$	MONEY	$	dep	1	SENT_32	[p1l37t3714r203b3745],
4	-	:	O	-	_	0	SENT_32	[p1l217t3729r225b3732],
5	see	VB	O	see	_	0	SENT_32	[p1l239t3722r278b3739],
6	front	JJ	O	front	amod	7	SENT_32	[p1l291t3714r362b3739],
7	matter	NN	O	matter	dobj	5	SENT_32	[p1l373t3718r466b3739],
8	©	CD	NUMBER	©	num	12	SENT_32	[p1l479t3715r502b3739],
9	2011	CD	DATE	2011	num	12	SENT_32	[p1l515t3715r577b3739],
10	National	NNP	ORGANIZATION	National	nn	12	SENT_32	[p1l592t3714r717b3739],
11	Lipid	NNP	ORGANIZATION	Lipid	nn	12	SENT_32	[p1l730t3714r805b3745],
12	Association	NNP	ORGANIZATION	Association	dep	7	SENT_32	[p1l817t3714r989b3739],
13	.	.	O	.	_	0	SENT_32	[p1l817t3714r989b3739],

1	All	DT	O	all	det	2	SENT_33	[p1l1003t3714r1045b3738],
2	rights	NNS	O	rights	nsubj	3	SENT_33	[p1l1058t3714r1136b3745],
3	reserved	VBN	O	reserve	_	0	SENT_33	[p1l1149t3714r1271b3739],
4	.	.	O	.	_	0	SENT_33	[p1l1149t3714r1271b3739],

1	doi	FW	O	doi	_	0	SENT_34	[p1l34t3755r446b3786],
2	:	:	O	:	_	0	SENT_34	[p1l34t3755r446b3786],
3	l0	NN	O	l0	dep	1	SENT_34	[p1l34t3755r446b3786],
4	.	.	O	.	_	0	SENT_34	[p1l34t3755r446b3786],

1	l016/j	NN	O	l016/j	_	0	SENT_35	[p1l34t3755r446b3786],
2	.	.	O	.	_	0	SENT_35	[p1l34t3755r446b3786],

1	jacl	NN	O	jacl	_	0	SENT_36	[p1l34t3755r446b3786],
2	.2011.01.001	CD	NUMBER	.2011.01.001	num	1	SENT_36	[p1l34t3755r446b3786],

1	92	CD	NUMBER	92	_	0	SENT_37	[p2l35t61r72b89],
2	Journal	NNP	O	Journal	dep	1	SENT_37	[p2l1207t58r1332b89],
3	of	IN	O	of	_	0	SENT_37	[p2l1347t58r1381b89],
4	Clinical	JJ	O	clinical	amod	5	SENT_37	[p2l1395t58r1516b89],
5	Lipidology	NNP	O	Lipidology	prep_of	2	SENT_37	[p2l1533t58r1714b97],
6	,	,	O	,	_	0	SENT_37	[p2l1533t58r1714b97],
7	Vol	NNP	O	Vol	appos	5	SENT_37	[p2l1732t58r1784b89],
8	5	CD	NUMBER	5	num	7	SENT_37	[p2l1800t61r1827b94],
9	,	,	O	,	_	0	SENT_37	[p2l1800t61r1827b94],
10	No	DT	O	no	det	11	SENT_37	[p2l1847t60r1886b89],
11	2	CD	NUMBER	2	appos	7	SENT_37	[p2l1905t61r1932b93],
12	,	,	O	,	_	0	SENT_37	[p2l1905t61r1932b93],
13	April	NNP	DATE	April	tmod	7	SENT_37	[p2l1950t58r2029b97],
14	2011	CD	DATE	2011	num	13	SENT_37	[p2l2045t61r2122b89],

1	a	DT	O	a	det	2	SENT_38	[p2l14t230r50b273],
2	limitation	NN	O	limitation	nsubj	6	SENT_38	[p2l89t211r436b273],
3	of	IN	O	of	_	0	SENT_38	[p2l476t211r553b273],
4	this	DT	O	this	det	5	SENT_38	[p2l586t211r711b273],
5	approach	NN	O	approach	prep_of	2	SENT_38	[p2l755t211r1079b292],
6	is	VBZ	O	be	ccomp	25	SENT_38	[p2l1118t211r1173b273],
7	that	IN	O	that	complm	11	SENT_38	[p2l1214t211r1348b273],
8	it	PRP	O	it	nsubj	11	SENT_38	[p2l1386t211r1435b273],
9	does	VBZ	O	do	aux	11	SENT_38	[p2l1474t211r1632b273],
10	not	RB	O	not	neg	11	SENT_38	[p2l1673t220r1787b273],
11	take	VB	O	take	ccomp	6	SENT_38	[p2l1825t211r1971b273],
12	into	IN	O	into	_	0	SENT_38	[p2l2011t210r2147b273],
13	account	NN	O	account	nn	15	SENT_38	[p2l14t328r290b381],
14	genetic	JJ	O	genetic	amod	15	SENT_38	[p2l324t318r577b399],
15	variation	NN	O	variation	prep_into	11	SENT_38	[p2l613t318r928b381],
16	in	IN	O	in	_	0	SENT_38	[p2l962t318r1029b380],
17	drug	NN	O	drug	nn	18	SENT_38	[p2l1063t318r1222b399],
18	metabolism	NN	O	metabolism	prep_in	15	SENT_38	[p2l1258t318r1674b381],
19	and	CC	O	and	_	0	SENT_38	[p2l1709t318r1835b381],
20	disposition	NN	O	disposition	nn	21	SENT_38	[p2l1869t318r2146b399, p2l11t405r202b487],
21	.3	NN	NUMBER	.3	conj_and	18	SENT_38	[p2l1869t318r2146b399, p2l11t405r202b487],
22	Hence	RB	O	hence	advmod	11	SENT_38	[p2l237t426r482b498],
23	,	,	O	,	_	0	SENT_38	[p2l237t426r482b498],
24	we	PRP	O	we	nsubj	25	SENT_38	[p2l518t444r618b487],
25	sought	VBD	O	seek	_	0	SENT_38	[p2l654t424r887b505],
26	to	TO	O	to	aux	27	SENT_38	[p2l918t434r984b487],
27	determine	VB	O	determine	xcomp	25	SENT_38	[p2l1018t424r1373b487],
28	whether	IN	O	whether	complm	34	SENT_38	[p2l1404t424r1692b487],
29	genetic	JJ	O	genetic	amod	30	SENT_38	[p2l1722t424r1975b505],
30	variation	NN	O	variation	nsubjpass	34	SENT_38	[p2l2010t444r2146b487, p2l12t532r214b594],
31	in	IN	O	in	_	0	SENT_38	[p2l262t532r329b594],
32	ABCBI	NNP	ORGANIZATION	ABCBI	prep_in	30	SENT_38	[p2l372t532r636b595],
33	is	VBZ	O	be	auxpass	34	SENT_38	[p2l692t532r747b594],
34	associated	VBN	O	associate	ccomp	27	SENT_38	[p2l798t532r1163b594],
35	with	IN	O	with	_	0	SENT_38	[p2l1211t532r1367b595],
36	LDL	NN	O	ldl	prep_with	34	SENT_38	[p2l1414t532r1674b595],
37	.	.	O	.	_	0	SENT_38	[p2l1414t532r1674b595],

1	—	NN	O	—	_	0	SENT_39	[p2l1414t532r1674b595],
2	.	.	O	.	_	0	SENT_39	[p2l1414t532r1674b595],

1	C	NN	O	c	nn	2	SENT_40	[p2l1414t532r1674b595],
2	response	NN	O	response	_	0	SENT_40	[p2l1722t551r2032b613],
3	to	TO	O	to	_	0	SENT_40	[p2l2081t541r2147b594],
4	atorvastatin	NN	O	atorvastatin	prep_to	2	SENT_40	[p2l14t639r426b702],
5	independently	RB	O	independently	advmod	2	SENT_40	[p2l479t639r984b720],
6	of	IN	O	of	_	0	SENT_40	[p2l1040t639r1116b702],
7	the	DT	O	the	det	9	SENT_40	[p2l1163t639r1270b702],
8	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	nn	9	SENT_40	[p2l1325t639r2147b702],
9	ratio	NN	O	ratio	prep_of	2	SENT_40	[p2l11t745r173b806],
10	and	CC	O	and	_	0	SENT_40	[p2l209t745r334b806],
11	desmosterol	NN	O	desmosterol	conj_and	9	SENT_40	[p2l366t745r813b806],
12	.	.	O	.	_	0	SENT_40	[p2l366t745r813b806],

1	The	DT	O	the	det	6	SENT_41	[p2l119t852r255b915],
2	ABCBI	NNP	O	ABCBI	nn	6	SENT_41	[p2l315t853r580b916],
3	(	CD	NUMBER	(	num	6	SENT_41	[p2l656t853r945b930],
4	MDRI	NN	O	mdrus	nn	6	SENT_41	[p2l656t853r945b930],
5	)	NN	O	)	nn	6	SENT_41	[p2l656t853r945b930],
6	gene	NN	O	gene	nsubj	7	SENT_41	[p2l1015t872r1179b933],
7	encodes	VBZ	O	encode	_	0	SENT_41	[p2l1246t852r1529b915],
8	P	NN	O	p	nn	10	SENT_41	[p2l1597t852r2145b933],
9	—	CD	NUMBER	—	num	10	SENT_41	[p2l1597t852r2145b933],
10	glycoprotein	NN	O	glycoprotein	dobj	7	SENT_41	[p2l1597t852r2145b933],
11	,	,	O	,	_	0	SENT_41	[p2l1597t852r2145b933],
12	which	WDT	O	which	nsubj	13	SENT_41	[p2l13t959r229b1022],
13	plays	VBZ	O	play	rcmod	10	SENT_41	[p2l257t959r442b1040],
14	an	DT	O	a	det	16	SENT_41	[p2l475t979r556b1022],
15	important	JJ	O	important	amod	16	SENT_41	[p2l586t959r932b1040],
16	role	NN	O	role	dobj	13	SENT_41	[p2l960t959r1097b1022],
17	in	IN	O	in	_	0	SENT_41	[p2l1128t959r1195b1021],
18	drug	NN	O	drug	nn	19	SENT_41	[p2l1225t959r1384b1040],
19	disposition	NN	O	disposition	prep_in	16	SENT_41	[p2l1416t959r1805b1040],
20	by	IN	O	by	_	0	SENT_41	[p2l1833t959r1920b1040],
21	ejecting	VBG	O	eject	prepc_by	13	SENT_41	[p2l1952t959r2146b1040, p2l12t1066r123b1147],
22	substrates	NNS	O	substrate	dobj	21	SENT_41	[p2l170t1066r515b1128],
23	from	IN	O	from	_	0	SENT_41	[p2l560t1066r732b1128],
24	the	DT	O	the	det	25	SENT_41	[p2l774t1066r880b1128],
25	cytoplasm	NN	O	cytoplasm	prep_from	21	SENT_41	[p2l925t1066r1307b1147],
26	.	.	O	.	_	0	SENT_41	[p2l925t1066r1307b1147],

1	This	DT	O	this	dep	164	SENT_42	[p2l1354t1066r1509b1128],
2	protein	NN	O	protein	dep	164	SENT_42	[p2l1553t1066r1805b1147],
3	serves	VBZ	O	serve	dep	164	SENT_42	[p2l1851t1085r2066b1128],
4	a	DT	O	a	dep	164	SENT_42	[p2l2113t1085r2150b1128],
5	protective	JJ	O	protective	dep	164	SENT_42	[p2l11t1173r366b1254],
6	function	NN	O	function	dep	164	SENT_42	[p2l396t1173r691b1236],
7	against	IN	O	against	dep	164	SENT_42	[p2l722t1173r972b1254],
8	xenobiotics	NNS	O	xenobiotic	dep	164	SENT_42	[p2l1001t1173r1430b1247],
9	,	,	O	,	_	0	SENT_42	[p2l1001t1173r1430b1247],
10	limiting	VBG	O	limit	dep	164	SENT_42	[p2l1462t1173r1743b1254],
11	absorption	NN	O	absorption	dep	164	SENT_42	[p2l1775t1173r2149b1254],
12	from	IN	O	from	dep	164	SENT_42	[p2l12t1280r184b1343],
13	the	DT	O	the	dep	164	SENT_42	[p2l224t1280r330b1343],
14	gastrointestinal	JJ	O	gastrointestinal	dep	164	SENT_42	[p2l372t1280r915b1361],
15	tracts	NNS	O	tract	dep	164	SENT_42	[p2l956t1290r1146b1343],
16	and	CC	O	and	dep	164	SENT_42	[p2l1190t1280r1316b1343],
17	promoting	VBG	O	promote	dep	164	SENT_42	[p2l1354t1280r1724b1361],
18	efﬂux	NN	O	efﬂux	dep	164	SENT_42	[p2l1766t1280r1971b1343],
19	into	IN	O	into	dep	164	SENT_42	[p2l2012t1280r2148b1343],
20	bile	NN	O	bile	dep	164	SENT_42	[p2l11t1386r143b1449],
21	and	CC	O	and	dep	164	SENT_42	[p2l176t1386r302b1449],
22	urine	NN	O	urine	dep	164	SENT_42	[p2l330t1367r568b1449],
23	.4	NN	NUMBER	.4	dep	164	SENT_42	[p2l330t1367r568b1449],
24	Hence	RB	O	hence	dep	164	SENT_42	[p2l597t1388r842b1460],
25	,	,	O	,	_	0	SENT_42	[p2l597t1388r842b1460],
26	P	NN	O	p	dep	164	SENT_42	[p2l875t1386r1405b1467],
27	—	CD	NUMBER	—	dep	164	SENT_42	[p2l875t1386r1405b1467],
28	glycoprotein	NN	O	glycoprotein	dep	164	SENT_42	[p2l875t1386r1405b1467],
29	determines	VBZ	O	determine	dep	164	SENT_42	[p2l1436t1386r1823b1448],
30	the	DT	O	the	dep	164	SENT_42	[p2l1855t1386r1962b1448],
31	concentration	NN	O	concentration	dep	164	SENT_42	[p2l1993t1406r2146b1448, p2l13t1494r369b1557],
32	of	IN	O	of	dep	164	SENT_42	[p2l393t1494r470b1557],
33	drugs	NNS	O	drug	dep	164	SENT_42	[p2l489t1494r681b1575],
34	that	WDT	O	that	dep	164	SENT_42	[p2l707t1494r840b1557],
35	reach	VBP	O	reach	dep	164	SENT_42	[p2l861t1494r1055b1557],
36	target	NN	O	target	dep	164	SENT_42	[p2l1078t1504r1280b1575],
37	tissues	NNS	O	tissue	dep	164	SENT_42	[p2l1302t1494r1557b1568],
38	,	,	O	,	_	0	SENT_42	[p2l1302t1494r1557b1568],
39	and	CC	O	and	dep	164	SENT_42	[p2l1586t1494r1711b1557],
40	atorvastatin	NN	O	atorvastatin	dep	164	SENT_42	[p2l1736t1494r2148b1557],
41	is	VBZ	O	be	dep	164	SENT_42	[p2l12t1600r67b1662],
42	among	IN	O	among	dep	164	SENT_42	[p2l97t1620r336b1681],
43	its	PRP$	O	its	dep	164	SENT_42	[p2l362t1600r443b1662],
44	substrates	NNS	O	substrate	dep	164	SENT_42	[p2l474t1581r874b1662],
45	.5	CD	NUMBER	.5	dep	164	SENT_42	[p2l474t1581r874b1662],
46	The	DT	O	the	dep	164	SENT_42	[p2l902t1600r1039b1662],
47	synonymous	JJ	O	synonymous	dep	164	SENT_42	[p2l1069t1620r1512b1681],
48	single	JJ	O	single	dep	164	SENT_42	[p2l1543t1600r1750b1681],
49	nucleotide	NN	O	nucleotide	dep	164	SENT_42	[p2l1777t1600r2148b1662],
50	polymorphism	NN	O	polymorphism	dep	164	SENT_42	[p2l11t1708r532b1789],
51	C3435T	NN	O	c3435t	dep	164	SENT_42	[p2l564t1708r853b1771],
52	(	CD	NUMBER	(	dep	164	SENT_42	[p2l887t1708r1279b1786],
53	Ilell45Ile	NN	O	ilell45ile	dep	164	SENT_42	[p2l887t1708r1279b1786],
54	or	CC	O	or	dep	164	SENT_42	[p2l1312t1728r1385b1771],
55	Rsl045642	NN	O	rsl045642	dep	164	SENT_42	[p2l1415t1708r1845b1785],
56	)	NN	O	)	dep	164	SENT_42	[p2l1415t1708r1845b1785],
57	in	IN	O	in	dep	164	SENT_42	[p2l1880t1708r1947b1770],
58	exon	NN	O	exon	dep	164	SENT_42	[p2l1979t1728r2149b1771],
59	26	CD	NUMBER	26	dep	164	SENT_42	[p2l13t1815r97b1878],
60	is	VBZ	O	be	dep	164	SENT_42	[p2l140t1815r195b1878],
61	the	DT	O	the	dep	164	SENT_42	[p2l237t1815r344b1878],
62	best	JJS	O	best	dep	164	SENT_42	[p2l385t1815r817b1878],
63	—	NN	O	—	dep	164	SENT_42	[p2l385t1815r817b1878],
64	studied	VBN	O	study	dep	164	SENT_42	[p2l385t1815r817b1878],
65	single	JJ	O	single	dep	164	SENT_42	[p2l859t1815r1067b1896],
66	nucleotide	NN	O	nucleotide	dep	164	SENT_42	[p2l1109t1815r1479b1878],
67	polymorphism	NN	O	polymorphism	dep	164	SENT_42	[p2l1520t1815r2041b1896],
68	in	IN	O	in	dep	164	SENT_42	[p2l2081t1815r2149b1877],
69	ABCBI	NNP	ORGANIZATION	ABCBI	dep	164	SENT_42	[p2l6t1922r271b1985],
70	and	CC	O	and	dep	164	SENT_42	[p2l322t1922r447b1984],
71	has	VBZ	O	have	dep	164	SENT_42	[p2l488t1922r603b1984],
72	been	VBN	O	be	dep	164	SENT_42	[p2l646t1922r813b1984],
73	associated	VBN	O	associate	dep	164	SENT_42	[p2l857t1922r1221b1984],
74	with	IN	O	with	dep	164	SENT_42	[p2l1263t1922r1419b1985],
75	altered	JJ	O	altered	dep	164	SENT_42	[p2l1463t1922r1703b1984],
76	protein	NN	O	protein	dep	164	SENT_42	[p2l1743t1922r1996b2003],
77	expression	NN	O	expression	dep	164	SENT_42	[p2l2038t1941r2146b1984, p2l11t2028r307b2109],
78	and	CC	O	and	dep	164	SENT_42	[p2l343t2029r468b2091],
79	function	NN	O	function	dep	164	SENT_42	[p2l502t2009r905b2103],
80	;	:	O	;	_	0	SENT_42	[p2l502t2009r905b2103],
81	4	CD	NUMBER	4	dep	164	SENT_42	[p2l502t2009r905b2103],
82	’	CD	NUMBER	’	dep	164	SENT_42	[p2l502t2009r905b2103],
83	6	CD	NUMBER	6	dep	164	SENT_42	[p2l502t2009r905b2103],
84	the	DT	O	the	dep	164	SENT_42	[p2l940t2029r1046b2091],
85	TT	NN	O	tt	dep	164	SENT_42	[p2l1081t2030r1188b2090],
86	genotype	NN	O	genotype	dep	164	SENT_42	[p2l1223t2038r1546b2109],
87	is	VBZ	O	be	dep	164	SENT_42	[p2l1581t2028r1636b2091],
88	characterized	VBN	O	characterize	dep	164	SENT_42	[p2l1673t2028r2149b2091],
89	by	IN	O	by	dep	164	SENT_42	[p2l11t2136r98b2217],
90	50	CD	PERCENT	50	dep	164	SENT_42	[p2l149t2136r305b2199],
91	%	NN	PERCENT	%	dep	164	SENT_42	[p2l149t2136r305b2199],
92	lower	JJR	O	lower	dep	164	SENT_42	[p2l358t2136r558b2199],
93	P	NN	O	p	dep	164	SENT_42	[p2l605t2136r1135b2217],
94	—	CD	NUMBER	—	dep	164	SENT_42	[p2l605t2136r1135b2217],
95	glycoprotein	NN	O	glycoprotein	dep	164	SENT_42	[p2l605t2136r1135b2217],
96	levels	NNS	O	level	dep	164	SENT_42	[p2l1183t2136r1386b2199],
97	compared	VBN	O	compare	dep	164	SENT_42	[p2l1437t2136r1788b2217],
98	with	IN	O	with	dep	164	SENT_42	[p2l1836t2136r1992b2199],
99	the	DT	O	the	dep	164	SENT_42	[p2l2040t2136r2147b2199],
100	CC	NN	O	cc	dep	164	SENT_42	[p2l13t2242r127b2305],
101	genotype	NN	O	genotype	dep	164	SENT_42	[p2l160t2224r539b2323],
102	.7	CD	NUMBER	.7	dep	164	SENT_42	[p2l160t2224r539b2323],
103	Functionally	RB	O	functionally	dep	164	SENT_42	[p2l572t2242r1036b2323],
104	,	,	O	,	_	0	SENT_42	[p2l572t2242r1036b2323],
105	the	DT	O	the	dep	164	SENT_42	[p2l1070t2242r1176b2304],
106	TT	NN	O	tt	dep	164	SENT_42	[p2l1208t2244r1315b2304],
107	genotype	NN	O	genotype	dep	164	SENT_42	[p2l1347t2252r1670b2323],
108	has	VBZ	O	have	dep	164	SENT_42	[p2l1702t2242r1817b2304],
109	been	VBN	O	be	dep	164	SENT_42	[p2l1848t2242r2016b2304],
110	associated	VBN	O	associate	dep	164	SENT_42	[p2l2049t2262r2146b2304, p2l15t2350r304b2413],
111	with	IN	O	with	dep	164	SENT_42	[p2l332t2350r488b2413],
112	a	DT	O	a	dep	164	SENT_42	[p2l518t2370r555b2413],
113	55	CD	PERCENT	55	dep	164	SENT_42	[p2l583t2350r738b2413],
114	%	NN	PERCENT	%	dep	164	SENT_42	[p2l583t2350r738b2413],
115	larger	JJR	O	larger	dep	164	SENT_42	[p2l771t2350r979b2431],
116	area	NN	O	area	dep	164	SENT_42	[p2l1006t2370r1152b2413],
117	under	IN	O	under	dep	164	SENT_42	[p2l1179t2350r1382b2413],
118	the	DT	O	the	dep	164	SENT_42	[p2l1409t2350r1515b2413],
119	curve	NN	O	curve	dep	164	SENT_42	[p2l1544t2370r1739b2413],
120	and	CC	O	and	dep	164	SENT_42	[p2l1769t2350r1894b2413],
121	a	DT	O	a	dep	164	SENT_42	[p2l1924t2370r1960b2413],
122	24	CD	PERCENT	24	dep	164	SENT_42	[p2l1989t2351r2144b2413],
123	%	NN	PERCENT	%	dep	164	SENT_42	[p2l1989t2351r2144b2413],
124	longer	JJR	O	longer	dep	164	SENT_42	[p2l12t2456r240b2537],
125	atorvastatin	NN	O	atorvastatin	dep	164	SENT_42	[p2l280t2455r692b2518],
126	half-life	NN	O	half-life	dep	164	SENT_42	[p2l731t2456r1018b2518],
127	compared	VBN	O	compare	dep	164	SENT_42	[p2l1058t2456r1409b2537],
128	with	IN	O	with	dep	164	SENT_42	[p2l1449t2456r1605b2518],
129	the	DT	O	the	dep	164	SENT_42	[p2l1644t2456r1751b2518],
130	CC	NN	O	cc	dep	164	SENT_42	[p2l1792t2456r1905b2519],
131	genotype	NN	O	genotype	dep	164	SENT_42	[p2l1948t2475r2146b2537, p2l12t2573r163b2644],
132	in	IN	O	in	dep	164	SENT_42	[p2l194t2563r261b2625],
133	pharmacokinetic	JJ	O	pharmacokinetic	dep	164	SENT_42	[p2l289t2563r883b2644],
134	studies	NNS	O	study	dep	164	SENT_42	[p2l918t2545r1215b2626],
135	.8	CD	NUMBER	.8	dep	164	SENT_42	[p2l918t2545r1215b2626],
136	Because	IN	O	because	dep	164	SENT_42	[p2l1247t2565r1541b2626],
137	statin	NN	O	statin	dep	164	SENT_42	[p2l1574t2563r1763b2626],
138	myopathy	NN	O	myopathy	dep	164	SENT_42	[p2l1793t2564r2148b2644],
139	is	VBZ	O	be	dep	164	SENT_42	[p2l12t2670r67b2733],
140	related	VBN	O	relate	dep	164	SENT_42	[p2l102t2670r345b2733],
141	to	TO	O	to	dep	164	SENT_42	[p2l379t2680r445b2733],
142	the	DT	O	the	dep	164	SENT_42	[p2l479t2670r586b2733],
143	concentration	NN	O	concentration	dep	164	SENT_42	[p2l622t2670r1107b2733],
144	of	IN	O	of	dep	164	SENT_42	[p2l1142t2670r1219b2733],
145	the	DT	O	the	dep	164	SENT_42	[p2l1247t2670r1353b2733],
146	offending	VBG	O	offend	dep	164	SENT_42	[p2l1389t2670r1730b2751],
147	statin	NN	O	statin	dep	164	SENT_42	[p2l1768t2651r2012b2744],
148	,9	CD	NUMBER	,9	dep	164	SENT_42	[p2l1768t2651r2012b2744],
149	we	PRP	O	we	dep	164	SENT_42	[p2l2047t2690r2147b2733],
150	hypothesized	VBD	O	hypothesize	dep	164	SENT_42	[p2l11t2777r482b2858],
151	that	IN	O	that	dep	164	SENT_42	[p2l521t2777r655b2839],
152	patients	NNS	O	patient	dep	164	SENT_42	[p2l693t2777r969b2858],
153	with	IN	O	with	dep	164	SENT_42	[p2l1011t2777r1166b2839],
154	muscle	NN	O	muscle	dep	164	SENT_42	[p2l1206t2777r1456b2839],
155	complaints	NNS	O	complaint	dep	164	SENT_42	[p2l1498t2777r1887b2858],
156	would	MD	O	would	dep	164	SENT_42	[p2l1928t2777r2149b2839],
157	have	VB	O	have	dep	164	SENT_42	[p2l11t2885r177b2948],
158	an	DT	O	a	dep	164	SENT_42	[p2l215t2905r296b2948],
159	increased	VBN	O	increase	dep	164	SENT_42	[p2l331t2885r667b2948],
160	frequency	NN	O	frequency	dep	164	SENT_42	[p2l704t2885r1058b2966],
161	of	IN	O	of	dep	164	SENT_42	[p2l1095t2885r1172b2948],
162	the	DT	O	the	dep	164	SENT_42	[p2l1202t2885r1308b2948],
163	T	NN	O	t	dep	164	SENT_42	[p2l1345t2887r1397b2947],
164	allele	NN	O	allele	_	0	SENT_42	[p2l1429t2885r1637b2948],
165	.	.	O	.	_	0	SENT_42	[p2l1429t2885r1637b2948],

1	With	IN	O	with	mark	2	SENT_43	[p2l1677t2885r1852b2948],
2	regards	VBZ	O	regard	advcl	10	SENT_43	[p2l1888t2885r2146b2966],
3	to	TO	O	to	_	0	SENT_43	[p2l12t3002r78b3055],
4	efﬁcacy	NN	O	efﬁcacy	prep_to	2	SENT_43	[p2l125t2992r418b3073],
5	,	,	O	,	_	0	SENT_43	[p2l125t2992r418b3073],
6	the	DT	O	the	det	8	SENT_43	[p2l466t2992r573b3055],
7	CC	NN	O	cc	nn	8	SENT_43	[p2l620t2993r733b3055],
8	genotype	NN	O	genotype	nsubjpass	10	SENT_43	[p2l781t3002r1105b3073],
9	is	VBZ	O	be	auxpass	10	SENT_43	[p2l1150t2992r1205b3055],
10	associated	VBN	O	associate	_	0	SENT_43	[p2l1254t2992r1619b3055],
11	with	IN	O	with	_	0	SENT_43	[p2l1663t2992r1819b3055],
12	a	DT	O	a	det	15	SENT_43	[p2l1867t3012r1903b3055],
13	lesser	JJR	O	lesser	amod	15	SENT_43	[p2l1947t2992r2149b3055],
14	percent	NN	O	percent	nn	15	SENT_43	[p2l11t3108r275b3180],
15	reduction	NN	O	reduction	prep_with	10	SENT_43	[p2l323t3099r660b3161],
16	in	IN	O	in	_	0	SENT_43	[p2l710t3099r778b3161],
17	LDL	NN	O	ldl	prep_in	15	SENT_43	[p2l827t3099r1087b3162],
18	.	.	O	.	_	0	SENT_43	[p2l827t3099r1087b3162],

1	—	NN	O	—	_	0	SENT_44	[p2l827t3099r1087b3162],
2	.	.	O	.	_	0	SENT_44	[p2l827t3099r1087b3162],

1	C	NN	O	c	_	0	SENT_45	[p2l827t3099r1087b3162],
2	in	IN	O	in	_	0	SENT_45	[p2l1139t3099r1206b3161],
3	response	NN	O	response	prep_in	1	SENT_45	[p2l1255t3118r1566b3180],
4	to	TO	O	to	_	0	SENT_45	[p2l1616t3108r1683b3161],
5	atorvastatin	NN	O	atorvastatin	prep_to	1	SENT_45	[p2l1736t3099r2148b3162],
6	compared	VBN	O	compare	_	0	SENT_45	[p2l13t3204r364b3285],
7	with	IN	O	with	prepc_compared_with	1	SENT_45	[p2l399t3204r555b3266],
8	the	DT	O	the	det	10	SENT_45	[p2l590t3204r696b3266],
9	TT/TC	NN	O	tt/tc	nn	10	SENT_45	[p2l732t3204r978b3267],
10	genotype	NN	O	genotype	pobj	1	SENT_45	[p2l1015t3184r1429b3285],
11	.	.	O	.	_	0	SENT_45	[p2l1015t3184r1429b3285],

1	”	NN	O	”	nsubj	17	SENT_46	[p2l1015t3184r1429b3285],
2	The	DT	O	the	det	4	SENT_46	[p2l1465t3204r1600b3266],
3	C3435T	NN	O	c3435t	nn	4	SENT_46	[p2l1637t3203r1927b3266],
4	polymorphism	NN	O	polymorphism	nsubj	8	SENT_46	[p2l1961t3203r2145b3284, p2l12t3311r373b3392],
5	in	IN	O	in	_	0	SENT_46	[p2l421t3311r488b3372],
6	ABCBI	NNP	ORGANIZATION	ABCBI	prep_in	4	SENT_46	[p2l531t3311r795b3374],
7	is	VBZ	O	be	cop	8	SENT_46	[p2l851t3311r906b3373],
8	common	JJ	O	common	rcmod	1	SENT_46	[p2l957t3330r1267b3373],
9	with	IN	O	with	_	0	SENT_46	[p2l1316t3311r1472b3373],
10	the	DT	O	the	det	13	SENT_46	[p2l1520t3311r1626b3373],
11	C	NN	O	c	nn	13	SENT_46	[p2l1676t3311r1730b3374],
12	allele	NN	O	allele	nn	13	SENT_46	[p2l1783t3311r1973b3373],
13	frequency	NN	O	frequency	prep_with	8	SENT_46	[p2l2022t3311r2146b3373, p2l12t3439r267b3499],
14	of	IN	O	of	_	0	SENT_46	[p2l305t3418r382b3481],
15	0.4-0	CD	NUMBER	0.4-0	num	16	SENT_46	[p2l414t3418r677b3481],
16	.6	CD	NUMBER	.6	prep_of	13	SENT_46	[p2l414t3418r677b3481],
17	reported	VBN	O	report	_	0	SENT_46	[p2l715t3419r1012b3499],
18	in	IN	O	in	_	0	SENT_46	[p2l1049t3418r1117b3480],
19	white	JJ	O	white	amod	20	SENT_46	[p2l1154t3418r1349b3481],
20	subjects	NNS	O	subject	prep_in	17	SENT_46	[p2l1391t3400r1734b3499],
21	“	JJ	O	“	amod	20	SENT_46	[p2l1391t3400r1734b3499],
22	and	CC	O	and	_	0	SENT_46	[p2l1779t3419r1905b3481],
23	hence	RB	O	hence	advmod	24	SENT_46	[p2l1941t3418r2147b3481],
24	suitable	JJ	O	suitable	conj_and	21	SENT_46	[p2l15t3526r288b3589],
25	for	IN	O	for	_	0	SENT_46	[p2l321t3526r424b3589],
26	further	JJ	O	further	amod	27	SENT_46	[p2l455t3526r697b3589],
27	study	NN	O	study	prep_for	17	SENT_46	[p2l731t3526r918b3607],
28	in	IN	O	in	_	0	SENT_46	[p2l951t3526r1018b3588],
29	this	DT	O	this	det	31	SENT_46	[p2l1050t3526r1176b3589],
30	small	JJ	O	small	amod	31	SENT_46	[p2l1213t3526r1401b3589],
31	cohort	NN	O	cohort	prep_in	17	SENT_46	[p2l1435t3526r1678b3589],
32	.	.	O	.	_	0	SENT_46	[p2l1435t3526r1678b3589],

1	Methods	NNS	O	method	_	0	SENT_47	[p3l18t88r392b168],

1	Ethics	NNS	O	ethic	_	0	SENT_48	[p3l18t330r259b402],
2	approval	NN	O	approval	dep	1	SENT_48	[p3l298t330r654b421],

1	This	DT	O	this	det	2	SENT_49	[p3l119t553r274b616],
2	study	NN	O	study	nsubjpass	4	SENT_49	[p3l320t553r508b634],
3	is	VBZ	O	be	auxpass	4	SENT_49	[p3l550t553r605b616],
4	approved	VBN	O	approve	_	0	SENT_49	[p3l651t553r978b634],
5	by	IN	O	by	_	0	SENT_49	[p3l1018t553r1105b634],
6	the	DT	O	the	det	9	SENT_49	[p3l1148t553r1254b616],
7	RBWH	NN	ORGANIZATION	rbwh	nn	9	SENT_49	[p3l1297t555r1562b616],
8	research	NN	O	research	nn	9	SENT_49	[p3l1603t553r1901b616],
9	ethics	NNS	O	ethic	agent	4	SENT_49	[p3l1942t553r2146b616],
10	committee	NN	O	committee	nn	13	SENT_49	[p3l13t660r388b723],
11	(	CD	NUMBER	(	num	13	SENT_49	[p3l415t660r890b737],
12	2005/006A	NN	O	2005/006a	nn	13	SENT_49	[p3l415t660r890b737],
13	)	NN	O	)	dep	9	SENT_49	[p3l415t660r890b737],
14	,	,	O	,	_	0	SENT_49	[p3l415t660r890b737],
15	and	CC	O	and	_	0	SENT_49	[p3l919t660r1045b723],
16	all	DT	O	all	det	18	SENT_49	[p3l1070t660r1155b723],
17	study	NN	O	study	nn	18	SENT_49	[p3l1182t660r1370b741],
18	participants	NNS	O	participant	nsubj	19	SENT_49	[p3l1393t660r1808b741],
19	provided	VBD	O	provide	conj_and	4	SENT_49	[p3l1833t660r2150b741],
20	informed	VBN	O	inform	amod	21	SENT_49	[p3l12t765r338b827],
21	consent	NN	O	consent	dobj	19	SENT_49	[p3l371t774r659b827],
22	.	.	O	.	_	0	SENT_49	[p3l371t774r659b827],

1	Study	NNP	O	Study	_	0	SENT_50	[p3l13t968r244b1060],
2	population	NN	O	population	dep	1	SENT_50	[p3l283t968r728b1060],

1	We	PRP	O	we	nsubj	2	SENT_51	[p3l118t1194r234b1255],
2	recruited	VBD	O	recruit	_	0	SENT_51	[p3l255t1192r574b1255],
3	patients	NNS	O	patient	dobj	2	SENT_51	[p3l593t1192r868b1273],
4	with	IN	O	with	_	0	SENT_51	[p3l893t1192r1049b1255],
5	coronary	JJ	O	coronary	amod	7	SENT_51	[p3l1072t1212r1385b1273],
6	artery	NN	O	artery	nn	7	SENT_51	[p3l1410t1202r1614b1273],
7	disease	NN	O	disease	prep_with	3	SENT_51	[p3l1638t1192r1912b1266],
8	,	,	O	,	_	0	SENT_51	[p3l1638t1192r1912b1266],
9	ische	NN	O	ische	nn	10	SENT_51	[p3l1937t1192r2145b1255],
10	—	NN	O	—	conj_or	3	SENT_51	[p3l1937t1192r2145b1255],
11	mic	JJ	O	mic	amod	12	SENT_51	[p3l12t1299r142b1361],
12	stroke	NN	O	stroke	dep	10	SENT_51	[p3l187t1299r419b1373],
13	,	,	O	,	_	0	SENT_51	[p3l187t1299r419b1373],
14	or	CC	O	or	_	0	SENT_51	[p3l463t1318r536b1361],
15	coronary	JJ	O	coronary	amod	18	SENT_51	[p3l575t1318r888b1380],
16	artery	NN	O	artery	nn	18	SENT_51	[p3l931t1308r1134b1380],
17	disease	NN	O	disease	nn	18	SENT_51	[p3l1176t1299r1430b1361],
18	risk	NN	O	risk	conj_or	3	SENT_51	[p3l1470t1299r2035b1380],
19	—	CD	NUMBER	—	num	20	SENT_51	[p3l1470t1299r2035b1380],
20	equivalents	NNS	O	equivalent	npadvmod	21	SENT_51	[p3l1470t1299r2035b1380],
21	as	IN	O	as	advmod	22	SENT_51	[p3l2079t1318r2147b1361],
22	outlined	VBN	O	outline	partmod	18	SENT_51	[p3l13t1406r304b1469],
23	in	IN	O	in	_	0	SENT_51	[p3l322t1406r389b1468],
24	the	DT	O	the	det	27	SENT_51	[p3l407t1406r513b1469],
25	Adult	NN	O	adult	nn	27	SENT_51	[p3l533t1406r735b1469],
26	Treatment	NN	O	treatment	nn	27	SENT_51	[p3l752t1408r1116b1469],
27	Panel	NN	O	panel	prep_in	22	SENT_51	[p3l1134t1406r1329b1469],
28	III	CD	NUMBER	iii	number	29	SENT_51	[p3l1348t1408r1434b1468],
29	(	CD	NUMBER	(	num	30	SENT_51	[p3l1455t1407r1640b1484],
30	ATP	NN	O	atp	dep	27	SENT_51	[p3l1455t1407r1640b1484],
31	III	CD	NUMBER	iii	number	32	SENT_51	[p3l1658t1407r1771b1484],
32	)	CD	NUMBER	)	num	33	SENT_51	[p3l1658t1407r1771b1484],
33	report	NN	O	report	dep	27	SENT_51	[p3l1791t1416r2005b1487],
34	and	CC	O	and	_	0	SENT_51	[p3l2023t1406r2149b1469],
35	as	IN	O	as	amod	36	SENT_51	[p3l14t1534r82b1577],
36	previously	RB	DATE	previously	conj_and	27	SENT_51	[p3l109t1514r483b1595],
37	described	VBN	O	describe	partmod	36	SENT_51	[p3l511t1495r906b1577],
38	.2	NN	NUMBER	.2	dobj	37	SENT_51	[p3l511t1495r906b1577],
39	We	PRP	O	we	nsubj	40	SENT_51	[p3l931t1516r1047b1577],
40	excluded	VBD	O	exclude	rcmod	38	SENT_51	[p3l1075t1514r1395b1577],
41	patients	NNS	O	patient	dobj	40	SENT_51	[p3l1420t1514r1695b1595],
42	treated	VBN	O	treat	partmod	41	SENT_51	[p3l1723t1514r1966b1577],
43	with	IN	O	with	_	0	SENT_51	[p3l1992t1514r2148b1577],
44	statin	NN	O	statin	nn	46	SENT_51	[p3l15t1621r223b1695],
45	,	,	O	,	_	0	SENT_51	[p3l15t1621r223b1695],
46	ezetimibe	NN	O	ezetimibe	prep_with	42	SENT_51	[p3l245t1621r609b1695],
47	,	,	O	,	_	0	SENT_51	[p3l245t1621r609b1695],
48	or	CC	O	or	_	0	SENT_51	[p3l633t1641r705b1684],
49	stanol/sterol	NN	O	stanol/sterol	nn	50	SENT_51	[p3l723t1621r1156b1684],
50	spreads	NNS	O	spread	prep_with	42	SENT_51	[p3l1177t1621r1437b1702],
51	at	IN	O	at	_	0	SENT_51	[p3l1458t1631r1521b1684],
52	baseline	NN	O	baseline	prep_at	42	SENT_51	[p3l1536t1621r1846b1684],
53	.	.	O	.	_	0	SENT_51	[p3l1536t1621r1846b1684],

1	Further	RB	O	further	advmod	4	SENT_52	[p3l1868t1621r2145b1695],
2	,	,	O	,	_	0	SENT_52	[p3l1868t1621r2145b1695],
3	we	PRP	O	we	nsubj	4	SENT_52	[p3l12t1748r112b1791],
4	excluded	VBD	O	exclude	_	0	SENT_52	[p3l140t1728r460b1791],
5	patients	NNS	O	patient	dobj	4	SENT_52	[p3l483t1728r758b1809],
6	treated	VBN	O	treat	partmod	5	SENT_52	[p3l785t1728r1028b1791],
7	with	IN	O	with	_	0	SENT_52	[p3l1053t1728r1209b1791],
8	cyclosporine	NN	O	cyclosporine	prep_with	6	SENT_52	[p3l1235t1728r1706b1809],
9	,	,	O	,	_	0	SENT_52	[p3l1235t1728r1706b1809],
10	macrolides	NNS	O	macrolide	prep_with	6	SENT_52	[p3l1735t1728r2145b1802],
11	,	,	O	,	_	0	SENT_52	[p3l1735t1728r2145b1802],
12	azole	JJ	O	azole	amod	14	SENT_52	[p3l14t1834r646b1915],
13	—	NN	O	—	nn	14	SENT_52	[p3l14t1834r646b1915],
14	antifungals	NNS	O	antifungal	prep_with	6	SENT_52	[p3l14t1834r646b1915],
15	,	,	O	,	_	0	SENT_52	[p3l14t1834r646b1915],
16	gemﬁbrozil	NN	O	gemﬁbrozil	prep_with	6	SENT_52	[p3l690t1834r1118b1915],
17	,	,	O	,	_	0	SENT_52	[p3l690t1834r1118b1915],
18	fenoﬁbrate	NN	O	fenoﬁbrate	prep_with	6	SENT_52	[p3l1162t1834r1565b1908],
19	,	,	O	,	_	0	SENT_52	[p3l1162t1834r1565b1908],
20	diltiazem	NN	O	diltiazem	prep_with	6	SENT_52	[p3l1609t1834r1959b1908],
21	,	,	O	,	_	0	SENT_52	[p3l1609t1834r1959b1908],
22	protease	NN	O	protease	nn	23	SENT_52	[p3l2001t1853r2146b1915, p3l12t1952r189b2005],
23	inhibitors	NNS	O	inhibitor	prep_with	6	SENT_52	[p3l234t1942r592b2016],
24	,	,	O	,	_	0	SENT_52	[p3l234t1942r592b2016],
25	or	CC	O	or	_	0	SENT_52	[p3l641t1962r714b2005],
26	patients	NNS	O	patient	prep_with	6	SENT_52	[p3l755t1942r1031b2023],
27	consuming	VBG	O	consume	xcomp	6	SENT_52	[p3l1078t1942r1466b2023],
28	large	JJ	O	large	amod	29	SENT_52	[p3l1512t1942r1687b2023],
29	amounts	NNS	O	amount	dobj	27	SENT_52	[p3l1734t1952r2030b2005],
30	of	IN	O	of	_	0	SENT_52	[p3l2078t1942r2154b2005],
31	grapefruit	NN	O	grapefruit	nn	32	SENT_52	[p3l13t2049r364b2130],
32	juice	NN	O	juice	prep_of	29	SENT_52	[p3l394t2049r591b2130],
33	.	.	O	.	_	0	SENT_52	[p3l394t2049r591b2130],

1	Patients	NNS	O	patient	nsubjpass	18	SENT_53	[p3l634t2049r913b2112],
2	with	IN	O	with	_	0	SENT_53	[p3l954t2049r1110b2112],
3	liver	NN	O	liver	nn	4	SENT_53	[p3l1148t2049r1309b2112],
4	disease	NN	O	disease	prep_with	1	SENT_53	[p3l1347t2049r1620b2123],
5	,	,	O	,	_	0	SENT_53	[p3l1347t2049r1620b2123],
6	skeletal	JJ	O	skeletal	amod	8	SENT_53	[p3l1665t2049r1933b2112],
7	muscle	NN	O	muscle	nn	8	SENT_53	[p3l1972t2069r2146b2112, p3l13t2156r114b2218],
8	disease	NN	O	disease	conj_or	4	SENT_53	[p3l161t2156r435b2230],
9	,	,	O	,	_	0	SENT_53	[p3l161t2156r435b2230],
10	untreated	JJ	O	untreated	amod	11	SENT_53	[p3l483t2156r815b2218],
11	hypothyroidism	NN	O	hypothyroidism	conj_or	4	SENT_53	[p3l859t2156r1443b2237],
12	,	,	O	,	_	0	SENT_53	[p3l859t2156r1443b2237],
13	or	CC	O	or	_	0	SENT_53	[p3l1493t2175r1565b2218],
14	premenopausal	JJ	O	premenopausal	amod	15	SENT_53	[p3l1607t2156r2148b2237],
15	women	NNS	O	woman	prep_with	1	SENT_53	[p3l12t2281r273b2324],
16	also	RB	O	also	advmod	18	SENT_53	[p3l305t2262r444b2324],
17	were	VBD	O	be	auxpass	18	SENT_53	[p3l474t2281r644b2324],
18	considered	VBN	O	consider	_	0	SENT_53	[p3l677t2262r1062b2324],
19	ineligible	JJ	O	ineligible	acomp	18	SENT_53	[p3l1092t2261r1446b2343],
20	.	.	O	.	_	0	SENT_53	[p3l1092t2261r1446b2343],

1	At	IN	O	at	_	0	SENT_54	[p3l1482t2262r1569b2324],
2	the	DT	O	the	det	4	SENT_54	[p3l1599t2262r1705b2324],
3	recruitment	NN	O	recruitment	nn	4	SENT_54	[p3l1736t2262r2149b2324],
4	interview	NN	O	interview	prep_at	9	SENT_54	[p3l12t2370r359b2444],
5	,	,	O	,	_	0	SENT_54	[p3l12t2370r359b2444],
6	baseline	NN	O	baseline	nn	7	SENT_54	[p3l408t2370r700b2433],
7	data	NNS	O	datum	nsubjpass	9	SENT_54	[p3l747t2370r894b2433],
8	were	VBD	O	be	auxpass	9	SENT_54	[p3l939t2390r1109b2433],
9	collected	VBN	O	collect	_	0	SENT_54	[p3l1156t2370r1496b2444],
10	,	,	O	,	_	0	SENT_54	[p3l1156t2370r1496b2444],
11	and	CC	O	and	_	0	SENT_54	[p3l1548t2370r1673b2433],
12	the	DT	O	the	det	13	SENT_54	[p3l1719t2370r1825b2433],
13	patients	NNS	O	patient	nsubjpass	15	SENT_54	[p3l1871t2370r2146b2451],
14	were	VBD	O	be	auxpass	15	SENT_54	[p3l12t2497r183b2540],
15	instructed	VBN	O	instruct	conj_and	9	SENT_54	[p3l209t2477r560b2540],
16	to	TO	O	to	aux	17	SENT_54	[p3l585t2487r651b2540],
17	take	VB	O	take	xcomp	15	SENT_54	[p3l677t2477r824b2540],
18	atorvastatin	NN	O	atorvastatin	dobj	17	SENT_54	[p3l852t2477r1264b2540],
19	80	CD	NUMBER	80	num	22	SENT_54	[p3l1293t2478r1376b2540],
20	mg/day	JJ	O	mg/day	amod	22	SENT_54	[p3l1402t2477r1667b2558],
21	(	NN	O	(	nn	22	SENT_54	[p3l1696t2477r1945b2555],
22	Pﬁzer	NN	O	pﬁzer	dep	18	SENT_54	[p3l1696t2477r1945b2555],
23	,	,	O	,	_	0	SENT_54	[p3l1696t2477r1945b2555],
24	West	NNP	LOCATION	West	nn	25	SENT_54	[p3l1972t2479r2149b2540],
25	Ryde	NNP	LOCATION	Ryde	appos	18	SENT_54	[p3l8t2584r213b2665],
26	,	,	O	,	_	0	SENT_54	[p3l8t2584r213b2665],
27	Australia	NNP	LOCATION	Australia	appos	25	SENT_54	[p3l248t2584r601b2661],
28	)	CD	NUMBER	)	num	27	SENT_54	[p3l248t2584r601b2661],
29	with	IN	O	with	_	0	SENT_54	[p3l637t2584r793b2647],
30	follow	VB	O	follow	prepc_with	17	SENT_54	[p3l825t2584r1172b2665],
31	—	CD	NUMBER	—	npadvmod	32	SENT_54	[p3l825t2584r1172b2665],
32	up	IN	O	up	advmod	33	SENT_54	[p3l825t2584r1172b2665],
33	arranged	VBN	O	arrange	dep	30	SENT_54	[p3l1207t2584r1517b2665],
34	for	IN	O	for	_	0	SENT_54	[p3l1549t2584r1652b2646],
35	6	CD	DURATION	6	num	36	SENT_54	[p3l1684t2584r1723b2647],
36	weeks	NNS	NUMBER	week	prep_for	33	SENT_54	[p3l1756t2584r1995b2646],
37	.	.	O	.	_	0	SENT_54	[p3l1756t2584r1995b2646],

1	We	PRP	O	we	nsubj	2	SENT_55	[p3l2030t2585r2146b2646],
2	did	VBD	O	do	_	0	SENT_55	[p3l9t2690r120b2752],
3	not	RB	O	not	neg	4	SENT_55	[p3l152t2699r265b2752],
4	routine	JJ	O	routine	acomp	2	SENT_55	[p3l295t2690r547b2752],
5	measure	NN	O	measure	nn	7	SENT_55	[p3l581t2709r876b2752],
6	creatine	NN	O	creatine	nn	7	SENT_55	[p3l911t2689r1191b2752],
7	phosphokinase	NN	O	phosphokinase	dep	4	SENT_55	[p3l1224t2690r1752b2771],
8	in	IN	O	in	_	0	SENT_55	[p3l1786t2690r1854b2751],
9	asymptomatic	JJ	O	asymptomatic	amod	10	SENT_55	[p3l1888t2709r2144b2771, p3l8t2798r273b2861],
10	patients	NNS	O	patient	prep_in	7	SENT_55	[p3l304t2798r580b2879],
11	and	CC	O	and	_	0	SENT_55	[p3l614t2798r739b2861],
12	only	RB	O	only	advmod	13	SENT_55	[p3l771t2798r925b2879],
13	undertook	VBD	O	undertake	conj_and	2	SENT_55	[p3l956t2798r1319b2861],
14	such	JJ	O	such	amod	15	SENT_55	[p3l1350t2798r1509b2861],
15	measurements	NNS	O	measurement	dobj	13	SENT_55	[p3l1539t2808r2048b2861],
16	in	IN	O	in	_	0	SENT_55	[p3l2080t2798r2147b2860],
17	patients	NNS	O	patient	prep_in	13	SENT_55	[p3l7t2906r282b2987],
18	with	IN	O	with	_	0	SENT_55	[p3l310t2906r466b2969],
19	symptoms	NNS	O	symptom	prep_with	17	SENT_55	[p3l494t2887r946b2987],
20	.	.	O	.	_	0	SENT_55	[p3l494t2887r946b2987],

1	”	NN	O	”	_	0	SENT_56	[p3l494t2887r946b2987],

1	Data	NNS	O	datum	_	0	SENT_57	[p3l14t3113r192b3182],
2	collection	NN	O	collection	dep	1	SENT_57	[p3l232t3109r634b3182],

1	Patient	NN	O	patient	nn	3	SENT_58	[p3l115t3333r362b3396],
2	demographic	JJ	O	demographic	amod	3	SENT_58	[p3l407t3333r870b3414],
3	information	NN	O	information	nsubjpass	5	SENT_58	[p3l917t3333r1338b3396],
4	was	VBD	O	be	auxpass	5	SENT_58	[p3l1384t3353r1518b3396],
5	collected	VBN	O	collect	_	0	SENT_58	[p3l1565t3333r1888b3396],
6	at	IN	O	at	_	0	SENT_58	[p3l1934t3343r1996b3396],
7	the	DT	O	the	det	9	SENT_58	[p3l2040t3333r2146b3396],
8	recruitment	NN	O	recruitment	nn	9	SENT_58	[p3l7t3439r420b3501],
9	interview	NN	O	interview	prep_at	5	SENT_58	[p3l478t3439r825b3512],
10	,	,	O	,	_	0	SENT_58	[p3l478t3439r825b3512],
11	and	CC	O	and	_	0	SENT_58	[p3l889t3439r1015b3501],
12	fasting	VBG	O	fast	amod	14	SENT_58	[p3l1073t3439r1312b3520],
13	blood	NN	O	blood	nn	14	SENT_58	[p3l1370t3439r1574b3501],
14	samples	NNS	O	sample	nsubjpass	16	SENT_58	[p3l1634t3439r1916b3520],
15	were	VBD	O	be	auxpass	16	SENT_58	[p3l1976t3458r2146b3501],
16	analyzed	VBN	O	analyze	conj_and	5	SENT_58	[p3l10t3547r324b3628],
17	for	IN	O	for	_	0	SENT_58	[p3l364t3547r467b3610],
18	baseline	NN	O	baseline	nn	19	SENT_58	[p3l505t3547r796b3610],
19	lipids	NNS	O	lipid	prep_for	16	SENT_58	[p3l837t3547r1031b3628],
20	and	CC	O	and	_	0	SENT_58	[p3l1075t3547r1200b3610],
21	cholestanol	NN	O	cholestanol	nn	25	SENT_58	[p3l1240t3547r1644b3610],
22	and	CC	O	and	_	0	SENT_58	[p3l1687t3547r1813b3610],
23	desmos	NN	O	desmo	nn	25	SENT_58	[p3l1852t3547r2145b3610],
24	—	NN	O	—	nn	25	SENT_58	[p3l1852t3547r2145b3610],
25	terol	NN	O	terol	prep_for	16	SENT_58	[p3l8t3654r187b3717],
26	.	.	O	.	_	0	SENT_58	[p3l8t3654r187b3717],

1	Follow-up	JJ	O	follow-up	nsubj	4	SENT_59	[p3l236t3654r603b3735],
2	was	VBD	O	be	cop	4	SENT_59	[p3l649t3674r782b3717],
3	6	CD	DURATION	6	num	4	SENT_59	[p3l831t3654r870b3717],
4	weeks	NNS	NUMBER	week	_	0	SENT_59	[p3l916t3654r1135b3717],
5	after	IN	O	after	_	0	SENT_59	[p3l1183t3654r1345b3717],
6	recruitment	NN	O	recruitment	prep_after	4	SENT_59	[p3l1387t3654r1817b3717],
7	.	.	O	.	_	0	SENT_59	[p3l1387t3654r1817b3717],

1	Patients	NNS	O	patient	nsubj	2	SENT_60	[p3l1867t3654r2145b3717],
2	gave	VBD	O	give	_	0	SENT_60	[p4l9t39r172b101],
3	a	DT	O	a	det	5	SENT_60	[p4l212t39r249b82],
4	further	JJ	O	further	amod	5	SENT_60	[p4l286t20r528b82],
5	fasting	NN	O	fasting	iobj	2	SENT_60	[p4l565t20r805b101],
6	blood	NN	O	blood	nn	7	SENT_60	[p4l842t20r1046b82],
7	test	NN	O	test	dobj	2	SENT_60	[p4l1083t29r1206b82],
8	for	IN	O	for	_	0	SENT_60	[p4l1243t20r1346b82],
9	fasting	VBG	O	fast	amod	10	SENT_60	[p4l1382t20r1622b101],
10	lipids	NNS	O	lipid	prep_for	7	SENT_60	[p4l1662t20r1856b101],
11	and	CC	O	and	_	0	SENT_60	[p4l1897t20r2023b82],
12	Creactive	JJ	O	creactive	amod	13	SENT_60	[p4l2061t20r2144b83, p4l7t126r287b188],
13	protein	NN	O	protein	prep_for	7	SENT_60	[p4l317t126r588b207],
14	.	.	O	.	_	0	SENT_60	[p4l317t126r588b207],

1	Patients	NNS	O	patient	nsubjpass	15	SENT_61	[p4l623t126r902b188],
2	with	IN	O	with	_	0	SENT_61	[p4l935t126r1091b188],
3	>	JJR	O	>	prep_with	1	SENT_61	[p4l1128t126r1237b187],
4	4	CD	DURATION	4	num	5	SENT_61	[p4l1128t126r1237b187],
5	days	NNS	NUMBER	day	tmod	3	SENT_61	[p4l1270t126r1429b207],
6	of	IN	O	of	_	0	SENT_61	[p4l1463t126r1539b188],
7	tablets	NNS	O	tablet	prep_of	3	SENT_61	[p4l1564t126r1795b188],
8	left	VBN	O	leave	partmod	7	SENT_61	[p4l1827t126r1946b188],
9	were	VBD	O	be	auxpass	10	SENT_61	[p4l1976t145r2146b188],
10	deemed	VBN	O	deem	_	0	SENT_61	[p4l8t233r285b295],
11	nonadherent	JJ	O	nonadherent	acomp	10	SENT_61	[p4l315t233r757b295],
12	and	CC	O	and	_	0	SENT_61	[p4l789t233r914b295],
13	were	VBD	O	be	auxpass	15	SENT_61	[p4l945t252r1115b295],
14	not	RB	O	not	neg	15	SENT_61	[p4l1147t242r1260b295],
15	included	VBN	O	include	conj_and	10	SENT_61	[p4l1289t233r1597b295],
16	in	IN	O	in	_	0	SENT_61	[p4l1627t233r1694b294],
17	the	DT	O	the	det	20	SENT_61	[p4l1725t233r1832b295],
18	atorvastatin	NN	O	atorvastatin	nn	20	SENT_61	[p4l1865t242r2144b295, p4l7t339r165b402],
19	efﬁcacy	NN	O	efﬁcacy	nn	20	SENT_61	[p4l198t339r478b420],
20	analysis	NN	O	analysis	prep_in	15	SENT_61	[p4l512t339r795b420],
21	as	IN	O	as	_	0	SENT_61	[p4l831t360r899b402],
22	previously	RB	DATE	previously	advmod	23	SENT_61	[p4l932t339r1306b420],
23	described	VBN	O	describe	amod	24	SENT_61	[p4l1340t321r1736b402],
24	.2	NN	NUMBER	.2	prep_as	15	SENT_61	[p4l1340t321r1736b402],

1	Laboratory	NNP	O	Laboratory	_	0	SENT_62	[p4l15t543r457b635],
2	methodology	NN	O	methodology	dep	1	SENT_62	[p4l496t543r1034b635],

1	Fasting	VBG	O	fast	csubjpass	5	SENT_63	[p4l114t767r373b848],
2	lipid	NN	O	lipid	nn	3	SENT_63	[p4l433t767r595b848],
3	proﬁle	NN	O	proﬁle	dobj	1	SENT_63	[p4l651t767r882b848],
4	was	VBD	O	be	auxpass	5	SENT_63	[p4l939t787r1073b830],
5	determined	VBN	O	determine	_	0	SENT_63	[p4l1134t767r1535b830],
6	by	IN	O	by	_	0	SENT_63	[p4l1591t767r1678b848],
7	the	DT	O	the	det	8	SENT_63	[p4l1736t767r1842b830],
8	use	NN	O	use	agent	5	SENT_63	[p4l1900t787r2016b830],
9	of	IN	O	of	_	0	SENT_63	[p4l2076t767r2153b830],
10	standard	JJ	O	standard	amod	12	SENT_63	[p4l11t874r309b936],
11	hospital	NN	O	hospital	nn	12	SENT_63	[p4l369t874r651b955],
12	methods	NNS	O	method	prep_of	8	SENT_63	[p4l713t874r1033b948],
13	,	,	O	,	_	0	SENT_63	[p4l713t874r1033b948],
14	and	CC	O	and	_	0	SENT_63	[p4l1099t874r1225b936],
15	LDL	NN	O	ldl	agent	5	SENT_63	[p4l1284t874r1545b937],
16	.	.	O	.	_	0	SENT_63	[p4l1284t874r1545b937],

1	—	NN	O	—	_	0	SENT_64	[p4l1284t874r1545b937],
2	.	.	O	.	_	0	SENT_64	[p4l1284t874r1545b937],

1	C	NN	O	c	nsubjpass	4	SENT_65	[p4l1284t874r1545b937],
2	was	VBD	O	be	auxpass	4	SENT_65	[p4l1608t893r1742b936],
3	indirectly	RB	O	indirectly	advmod	4	SENT_65	[p4l1805t874r2146b955],
4	measured	VBN	O	measure	_	0	SENT_65	[p4l8t980r349b1042],
5	with	IN	O	with	_	0	SENT_65	[p4l398t980r555b1042],
6	the	DT	O	the	det	8	SENT_65	[p4l604t980r710b1042],
7	Friedewald	NN	MISC	friedewald	nn	8	SENT_65	[p4l759t980r1159b1042],
8	method	NN	O	method	prep_with	4	SENT_65	[p4l1208t980r1491b1042],
9	.	.	O	.	_	0	SENT_65	[p4l1208t980r1491b1042],

1	Cholestanol	NNP	O	Cholestanol	nsubjpass	5	SENT_66	[p4l1546t980r1970b1042],
2	and	CC	O	and	_	0	SENT_66	[p4l2022t980r2148b1042],
3	desmosterol	NN	O	desmosterol	nsubjpass	5	SENT_66	[p4l9t1086r437b1148],
4	were	VBD	O	be	auxpass	5	SENT_66	[p4l474t1105r644b1148],
5	assayed	VBN	O	assay	_	0	SENT_66	[p4l682t1086r956b1167],
6	by	IN	O	by	_	0	SENT_66	[p4l990t1086r1077b1167],
7	the	DT	O	the	det	8	SENT_66	[p4l1113t1086r1219b1148],
8	use	NN	O	use	agent	5	SENT_66	[p4l1255t1105r1371b1148],
9	of	IN	O	of	_	0	SENT_66	[p4l1409t1086r1485b1148],
10	gas	NN	O	gas	nn	12	SENT_66	[p4l1515t1105r1629b1167],
11	chromatography/mass	NN	O	chromatography/mass	nn	12	SENT_66	[p4l1667t1086r2144b1167, p4l7t1193r342b1274],
12	spectrometry	NN	O	spectrometry	prep_of	8	SENT_66	[p4l379t1203r840b1274],
13	as	IN	O	as	_	0	SENT_66	[p4l876t1214r944b1256],
14	previously	RB	DATE	previously	advmod	15	SENT_66	[p4l977t1193r1351b1274],
15	described	VBN	O	describe	amod	16	SENT_66	[p4l1385t1175r1781b1256],
16	.2	NN	NUMBER	.2	prep_as	5	SENT_66	[p4l1385t1175r1781b1256],

1	Genotyping	VBG	O	genotype	_	0	SENT_67	[p4l11t1397r483b1489],

1	Genotyping	VBG	O	genotype	csubjpass	8	SENT_68	[p4l116t1621r534b1702],
2	the	DT	O	the	det	4	SENT_68	[p4l572t1621r679b1684],
3	C3435T	NN	O	c3435t	nn	4	SENT_68	[p4l718t1621r1007b1684],
4	polymorphism	NN	O	polymorphism	dobj	1	SENT_68	[p4l1044t1621r1566b1702],
5	in	IN	O	in	_	0	SENT_68	[p4l1603t1621r1670b1683],
6	ABCBI	NNP	ORGANIZATION	ABCBI	prep_in	1	SENT_68	[p4l1701t1622r1966b1684],
7	was	VBD	O	be	auxpass	8	SENT_68	[p4l2011t1641r2145b1684],
8	undertaken	VBN	O	undertake	_	0	SENT_68	[p4l7t1728r404b1790],
9	by	IN	O	by	_	0	SENT_68	[p4l430t1728r518b1809],
10	use	NN	O	use	agent	8	SENT_68	[p4l545t1747r661b1790],
11	of	IN	O	of	_	0	SENT_68	[p4l691t1728r768b1790],
12	the	DT	O	the	det	15	SENT_68	[p4l789t1728r896b1790],
13	Sequenom	NNP	O	Sequenom	nn	15	SENT_68	[p4l927t1728r1301b1809],
14	iPLEX	NNP	O	iPLEX	nn	15	SENT_68	[p4l1328t1728r1574b1790],
15	protocol	NN	O	protocol	prep_of	10	SENT_68	[p4l1600t1728r1897b1809],
16	on	IN	O	on	_	0	SENT_68	[p4l1926t1747r2012b1790],
17	the	DT	O	the	det	20	SENT_68	[p4l2040t1728r2146b1790],
18	Sequenom	NNP	ORGANIZATION	Sequenom	nn	20	SENT_68	[p4l10t1835r384b1915],
19	MassArray	NNP	O	MassArray	nn	20	SENT_68	[p4l425t1835r819b1915],
20	platform	NN	O	platform	prep_on	8	SENT_68	[p4l860t1834r1169b1915],
21	as	IN	O	as	mark	23	SENT_68	[p4l1211t1855r1279b1897],
22	previously	RB	DATE	previously	advmod	23	SENT_68	[p4l1322t1834r1696b1915],
23	described	VBN	O	describe	advcl	8	SENT_68	[p4l1739t1815r2144b1897],
24	”	NN	O	”	dobj	23	SENT_68	[p4l1739t1815r2144b1897],
25	on	IN	O	on	_	0	SENT_68	[p4l9t1960r94b2003],
26	1	CD	NUMBER	1	num	27	SENT_68	[p4l140t1941r166b2002],
27	ng	NN	O	ng	prep_on	23	SENT_68	[p4l212t1960r298b2022],
28	of	IN	O	of	_	0	SENT_68	[p4l338t1941r415b2003],
29	genomic	JJ	O	genomic	amod	30	SENT_68	[p4l448t1941r751b2022],
30	DNA	NN	O	dna	prep_of	27	SENT_68	[p4l791t1941r979b2003],
31	extracted	VBN	O	extract	partmod	30	SENT_68	[p4l1018t1941r1344b2003],
32	from	IN	O	from	_	0	SENT_68	[p4l1382t1941r1553b2003],
33	leukocytes	NNS	O	leukocyte	prep_from	31	SENT_68	[p4l1591t1941r1969b2022],
34	at	IN	O	at	_	0	SENT_68	[p4l2011t1950r2073b2003],
35	a	DT	O	a	det	39	SENT_68	[p4l2111t1960r2148b2003],
36	University	NNP	ORGANIZATION	University	dep	39	SENT_68	[p4l8t2049r380b2130],
37	of	IN	ORGANIZATION	of	_	0	SENT_68	[p4l407t2049r483b2112],
38	Sydney	NNP	ORGANIZATION	Sydney	prep_of	36	SENT_68	[p4l504t2049r767b2130],
39	facility	NN	O	facility	prep_at	33	SENT_68	[p4l792t2049r1056b2130],
40	.	.	O	.	_	0	SENT_68	[p4l792t2049r1056b2130],

1	Statistical	JJ	O	statistical	amod	2	SENT_69	[p4l9t2253r432b2326],
2	methods	NNS	O	method	_	0	SENT_69	[p4l469t2253r821b2326],

1	The	DT	O	the	det	2	SENT_70	[p4l115t2477r251b2540],
2	distribution	NN	O	distribution	nsubjpass	6	SENT_70	[p4l279t2477r688b2540],
3	of	IN	O	of	_	0	SENT_70	[p4l716t2477r792b2540],
4	genotypes	NNS	O	genotype	prep_of	2	SENT_70	[p4l814t2487r1172b2558],
5	was	VBD	O	be	auxpass	6	SENT_70	[p4l1200t2497r1334b2540],
6	assessed	VBN	O	assess	_	0	SENT_70	[p4l1364t2477r1663b2540],
7	for	IN	O	for	_	0	SENT_70	[p4l1689t2477r1792b2540],
8	deviation	NN	O	deviation	prep_for	6	SENT_70	[p4l1818t2477r2147b2540],
9	from	IN	O	from	_	0	SENT_70	[p4l8t2584r180b2646],
10	the	DT	O	the	det	11	SENT_70	[p4l220t2584r326b2646],
11	Hardy	NNP	PERSON	Hardy	prep_from	6	SENT_70	[p4l368t2584r965b2665],
12	.	.	O	.	_	0	SENT_70	[p4l368t2584r965b2665],

1	—	NN	O	—	_	0	SENT_71	[p4l368t2584r965b2665],
2	.	.	O	.	_	0	SENT_71	[p4l368t2584r965b2665],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_72	[p4l368t2584r965b2665],
2	equilibrium	NN	O	equilibrium	_	0	SENT_72	[p4l1007t2584r1423b2665],
3	by	IN	O	by	_	0	SENT_72	[p4l1463t2584r1550b2665],
4	use	NN	O	use	prep_by	2	SENT_72	[p4l1591t2603r1707b2646],
5	of	IN	O	of	_	0	SENT_72	[p4l1750t2584r1826b2646],
6	the	DT	O	the	det	8	SENT_72	[p4l1861t2584r1968b2646],
7	chisquare	JJ	O	chisquare	amod	8	SENT_72	[p4l2011t2584r2144b2646, p4l11t2711r237b2772],
8	test	NN	O	test	prep_of	2	SENT_72	[p4l288t2701r429b2754],
9	.	.	O	.	_	0	SENT_72	[p4l288t2701r429b2754],

1	To	TO	O	to	aux	2	SENT_73	[p4l484t2693r573b2754],
2	compare	VB	O	compare	csubjpass	13	SENT_73	[p4l625t2711r930b2772],
3	variables	NNS	O	variable	dobj	2	SENT_73	[p4l979t2691r1297b2754],
4	in	IN	O	in	_	0	SENT_73	[p4l1349t2691r1416b2753],
5	different	JJ	O	different	amod	7	SENT_73	[p4l1467t2691r1772b2754],
6	genotype	NN	O	genotype	nn	7	SENT_73	[p4l1822t2701r2146b2772],
7	groups	NNS	O	group	prep_in	2	SENT_73	[p4l9t2816r267b2878],
8	,	,	O	,	_	0	SENT_73	[p4l9t2816r267b2878],
9	normally	RB	O	normally	advmod	10	SENT_73	[p4l299t2797r621b2878],
10	distributed	VBN	O	distribute	partmod	7	SENT_73	[p4l652t2797r1032b2859],
11	variables	NNS	O	variable	dobj	10	SENT_73	[p4l1060t2797r1378b2859],
12	were	VBD	O	be	auxpass	13	SENT_73	[p4l1409t2816r1579b2859],
13	compared	VBN	O	compare	_	0	SENT_73	[p4l1611t2797r1962b2878],
14	with	IN	O	with	_	0	SENT_73	[p4l1991t2797r2148b2859],
15	analysis	NN	O	analysis	prep_with	13	SENT_73	[p4l10t2905r291b2986],
16	of	IN	O	of	_	0	SENT_73	[p4l338t2905r415b2968],
17	variance	NN	O	variance	prep_of	15	SENT_73	[p4l453t2905r752b2968],
18	or	CC	O	or	_	0	SENT_73	[p4l797t2925r870b2968],
19	the	DT	O	the	det	20	SENT_73	[p4l912t2905r1018b2968],
20	Student	NN	O	student	poss	24	SENT_73	[p4l1065t2905r1392b2968],
21	’s	POS	O	’s	_	0	SENT_73	[p4l1065t2905r1392b2968],
22	2	CD	NUMBER	2	number	23	SENT_73	[p4l1439t2918r1463b2968],
23	‘	CD	NUMBER	‘	num	24	SENT_73	[p4l1439t2918r1463b2968],
24	test	NN	O	test	conj_or	15	SENT_73	[p4l1503t2915r1626b2968],
25	and	CC	O	and	_	0	SENT_73	[p4l1671t2905r1796b2968],
26	with	IN	O	with	_	0	SENT_73	[p4l1840t2905r1997b2968],
27	the	DT	O	the	det	28	SENT_73	[p4l2040t2905r2146b2968],
28	Kruskal	NNP	PERSON	Kruskal	conj_and	15	SENT_73	[p4l9t3012r544b3075],
29	.	.	O	.	_	0	SENT_73	[p4l9t3012r544b3075],

1	—	NN	O	—	_	0	SENT_74	[p4l9t3012r544b3075],
2	.	.	O	.	_	0	SENT_74	[p4l9t3012r544b3075],

1	Wallis	NNP	PERSON	Wallis	_	0	SENT_75	[p4l9t3012r544b3075],
2	or	CC	O	or	_	0	SENT_75	[p4l583t3032r655b3075],
3	Mann	NNP	PERSON	Mann	conj_or	1	SENT_75	[p4l689t3012r1233b3093],
4	.	.	O	.	_	0	SENT_75	[p4l689t3012r1233b3093],

1	—	NN	O	—	_	0	SENT_76	[p4l689t3012r1233b3093],
2	.	.	O	.	_	0	SENT_76	[p4l689t3012r1233b3093],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_77	[p4l689t3012r1233b3093],
2	U	NNP	O	U	nsubj	3	SENT_77	[p4l1277t3014r1336b3075],
3	test	NN	O	test	_	0	SENT_77	[p4l1366t3021r1490b3075],
4	for	IN	O	for	_	0	SENT_77	[p4l1525t3012r1628b3075],
5	non	JJ	O	non	amod	6	SENT_77	[p4l1661t3012r2146b3093],
6	—	NN	O	—	prep_for	3	SENT_77	[p4l1661t3012r2146b3093],
7	normally	RB	O	normally	advmod	8	SENT_77	[p4l1661t3012r2146b3093],
8	distributed	VBN	O	distribute	partmod	6	SENT_77	[p4l9t3119r389b3181],
9	variables	NNS	O	variable	dobj	8	SENT_77	[p4l422t3119r759b3181],
10	.	.	O	.	_	0	SENT_77	[p4l422t3119r759b3181],

1	In	IN	O	in	_	0	SENT_78	[p4l798t3120r869b3181],
2	assessing	VBG	O	assess	pcomp	1	SENT_78	[p4l906t3119r1233b3200],
3	the	DT	O	the	det	4	SENT_78	[p4l1267t3119r1374b3181],
4	independence	NN	O	independence	dobj	2	SENT_78	[p4l1409t3119r1899b3200],
5	of	IN	O	of	_	0	SENT_78	[p4l1935t3119r2012b3181],
6	the	DT	O	the	det	7	SENT_78	[p4l2040t3119r2146b3181],
7	association	NN	O	association	prep_of	4	SENT_78	[p4l10t3225r404b3287],
8	of	IN	O	of	_	0	SENT_78	[p4l434t3225r510b3287],
9	C3435T	NN	O	c3435t	nn	10	SENT_78	[p4l536t3224r824b3288],
10	genotype	NN	O	genotype	prep_of	7	SENT_78	[p4l855t3234r1180b3306],
11	and	CC	O	and	_	0	SENT_78	[p4l1212t3225r1338b3287],
12	LDL	NN	O	ldl	prep_of	7	SENT_78	[p4l1366t3225r1626b3288],
13	.	.	O	.	_	0	SENT_78	[p4l1366t3225r1626b3288],

1	—	NN	O	—	_	0	SENT_79	[p4l1366t3225r1626b3288],
2	.	.	O	.	_	0	SENT_79	[p4l1366t3225r1626b3288],

1	C	NN	O	c	nn	2	SENT_80	[p4l1366t3225r1626b3288],
2	reduction	NN	O	reduction	nsubj	5	SENT_80	[p4l1656t3225r2012b3298],
3	,	,	O	,	_	0	SENT_80	[p4l1656t3225r2012b3298],
4	we	PRP	O	we	nsubj	5	SENT_80	[p4l2046t3244r2146b3287],
5	used	VBD	O	use	_	0	SENT_80	[p4l7t3333r170b3396],
6	a	DT	O	a	det	9	SENT_80	[p4l204t3353r240b3396],
7	multivariate	JJ	O	multivariate	amod	9	SENT_80	[p4l272t3333r700b3396],
8	regression	NN	O	regression	nn	9	SENT_80	[p4l733t3333r1098b3414],
9	model	NN	O	model	dobj	5	SENT_80	[p4l1131t3333r1352b3396],
10	with	IN	O	with	_	0	SENT_80	[p4l1386t3333r1542b3396],
11	the	DT	O	the	det	14	SENT_80	[p4l1575t3333r1681b3396],
12	cholestanoll	NN	O	cholestanoll	nn	14	SENT_80	[p4l1716t3333r2150b3396],
13	cholesterol	NN	O	cholesterol	nn	14	SENT_80	[p4l9t3439r398b3501],
14	ratio	NN	O	ratio	prep_with	5	SENT_80	[p4l416t3439r578b3501],
15	and	CC	O	and	_	0	SENT_80	[p4l599t3439r725b3501],
16	desmosterol	NN	O	desmosterol	prep_with	5	SENT_80	[p4l743t3439r1172b3501],
17	as	IN	O	as	_	0	SENT_80	[p4l1193t3459r1261b3501],
18	covariates	NNS	O	covariate	prep_as	5	SENT_80	[p4l1282t3439r1657b3501],
19	.	.	O	.	_	0	SENT_80	[p4l1282t3439r1657b3501],

1	In	IN	O	in	_	0	SENT_81	[p4l1680t3441r1752b3500],
2	the	DT	O	the	det	5	SENT_81	[p4l1770t3439r1877b3501],
3	muscle	NN	O	muscle	nn	5	SENT_81	[p4l1896t3439r2146b3501],
4	symptoms	NNS	O	symptom	nn	5	SENT_81	[p4l11t3554r371b3626],
5	analysis	NN	O	analysis	prep_in	12	SENT_81	[p4l393t3545r697b3626],
6	,	,	O	,	_	0	SENT_81	[p4l393t3545r697b3626],
7	the	DT	O	the	det	10	SENT_81	[p4l719t3545r825b3607],
8	Fisher	NNP	PERSON	Fisher	nn	10	SENT_81	[p4l844t3545r1068b3607],
9	exact	JJ	O	exact	amod	10	SENT_81	[p4l1085t3554r1273b3607],
10	test	NN	O	test	nsubjpass	12	SENT_81	[p4l1290t3554r1413b3607],
11	was	VBD	O	be	auxpass	12	SENT_81	[p4l1431t3564r1565b3607],
12	used	VBN	O	use	_	0	SENT_81	[p4l1585t3545r1748b3607],
13	in	IN	O	in	_	0	SENT_81	[p4l1766t3545r1833b3607],
14	comparing	VBG	O	compare	prepc_in	12	SENT_81	[p4l1853t3564r2146b3626, p4l8t3653r119b3734],
15	genotype	NN	O	genotype	nn	18	SENT_81	[p4l144t3662r468b3734],
16	or	CC	O	or	_	0	SENT_81	[p4l494t3672r566b3715],
17	allele	NN	O	allele	nn	18	SENT_81	[p4l590t3653r780b3715],
18	frequencies	NNS	O	frequency	dobj	14	SENT_81	[p4l805t3653r1214b3734],
19	in	IN	O	in	_	0	SENT_81	[p4l1239t3653r1306b3715],
20	patients	NNS	O	patient	prep_in	14	SENT_81	[p4l1329t3653r1605b3734],
21	with	IN	O	with	prep	14	SENT_81	[p4l1631t3653r1787b3715],
22	and	CC	O	and	_	0	SENT_81	[p4l1812t3653r1938b3715],
23	without	IN	O	without	conj_and	21	SENT_81	[p4l1961t3653r2144b3716, p5l9t29r121b82],

1	muscle	NN	O	muscle	nn	2	SENT_82	[p5l155t20r406b82],
2	symptoms	NNS	O	symptom	_	0	SENT_82	[p5l446t29r825b101],
3	.	.	O	.	_	0	SENT_82	[p5l446t29r825b101],

1	All	DT	O	all	det	2	SENT_83	[p5l867t20r978b81],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_83	[p5l1016t20r1313b101],
3	were	VBD	O	be	auxpass	4	SENT_83	[p5l1352t39r1521b83],
4	undertaken	VBN	O	undertake	_	0	SENT_83	[p5l1558t20r1954b82],
5	with	IN	O	with	_	0	SENT_83	[p5l1990t20r2147b82],
6	statistics	NNS	O	statistics	nn	7	SENT_83	[p5l11t128r312b191],
7	software	NN	O	software	prep_with	4	SENT_83	[p5l342t128r644b191],
8	(	CD	NUMBER	(	num	9	SENT_83	[p5l673t129r890b206],
9	SPSS	NNP	ORGANIZATION	SPSS	dep	7	SENT_83	[p5l673t129r890b206],
10	16	CD	NUMBER	16	num	9	SENT_83	[p5l928t128r1027b202],
11	;	:	O	;	_	0	SENT_83	[p5l928t128r1027b202],
12	SPSS	NNP	ORGANIZATION	SPSS	nn	18	SENT_83	[p5l1058t129r1247b191],
13	Institute	NNP	ORGANIZATION	Institute	nn	18	SENT_83	[p5l1276t128r1587b202],
14	,	,	O	,	_	0	SENT_83	[p5l1276t128r1587b202],
15	Cary	NNP	PERSON	Cary	appos	18	SENT_83	[p5l1616t129r1800b209],
16	,	,	O	,	_	0	SENT_83	[p5l1616t129r1800b209],
17	NC	NNP	O	NC	appos	18	SENT_83	[p5l1828t129r1997b206],
18	)	NNP	O	)	dep	7	SENT_83	[p5l1828t129r1997b206],
19	.	.	O	.	_	0	SENT_83	[p5l1828t129r1997b206],

1	Results	NNS	O	result	_	0	SENT_84	[p5l15t370r336b450],

1	Study	NNP	O	Study	_	0	SENT_85	[p5l9t612r240b703],
2	population	NN	O	population	dep	1	SENT_85	[p5l280t612r725b703],
3	and	CC	O	and	_	0	SENT_85	[p5l767t612r911b684],
4	allele	NN	O	allele	nn	5	SENT_85	[p5l951t612r1176b684],
5	frequency	NN	O	frequency	dep	1	SENT_85	[p5l1213t612r1626b703],

1	We	PRP	O	we	nsubj	2	SENT_86	[p5l114t836r230b897],
2	enrolled	VBD	O	enrol	_	0	SENT_86	[p5l281t835r573b897],
3	154	CD	NUMBER	154	num	4	SENT_86	[p5l631t835r753b898],
4	patients	NNS	O	patient	dobj	2	SENT_86	[p5l802t835r1079b916],
5	in	IN	O	in	_	0	SENT_86	[p5l1131t835r1198b897],
6	this	DT	O	this	det	7	SENT_86	[p5l1248t835r1373b897],
7	study	NN	O	study	prep_in	2	SENT_86	[p5l1428t835r1628b916],
8	.	.	O	.	_	0	SENT_86	[p5l1428t835r1628b916],

1	This	DT	O	this	det	3	SENT_87	[p5l1683t835r1838b897],
2	genetic	JJ	O	genetic	amod	3	SENT_87	[p5l1891t835r2145b916],
3	substudy	NN	O	substudy	nsubjpass	5	SENT_87	[p5l11t942r321b1023],
4	was	VBD	O	be	auxpass	5	SENT_87	[p5l358t961r492b1004],
5	added	VBN	O	add	_	0	SENT_87	[p5l532t941r742b1004],
6	retrospectively	RB	O	retrospectively	advmod	5	SENT_87	[p5l776t942r1305b1023],
7	and	CC	O	and	_	0	SENT_87	[p5l1342t942r1468b1004],
8	consent	NN	O	consent	nsubjpass	12	SENT_87	[p5l1504t951r1775b1004],
9	for	IN	O	for	_	0	SENT_87	[p5l1810t942r1912b1004],
10	genotyping	VBG	O	genotype	prep_for	8	SENT_87	[p5l1947t961r2144b1023, p5l8t1049r233b1130],
11	was	VBD	O	be	auxpass	12	SENT_87	[p5l264t1069r397b1112],
12	obtained	VBN	O	obtain	conj_and	5	SENT_87	[p5l429t1049r736b1112],
13	from	IN	O	from	_	0	SENT_87	[p5l765t1049r936b1112],
14	122	CD	NUMBER	122	num	15	SENT_87	[p5l973t1050r1095b1111],
15	patients	NNS	O	patient	prep_from	12	SENT_87	[p5l1124t1049r1419b1130],
16	.	.	O	.	_	0	SENT_87	[p5l1124t1049r1419b1130],

1	Of	IN	O	of	_	0	SENT_88	[p5l1455t1049r1550b1112],
2	the	DT	O	the	det	4	SENT_88	[p5l1573t1049r1680b1112],
3	122	CD	NUMBER	122	num	4	SENT_88	[p5l1718t1050r1840b1111],
4	patients	NNS	O	patient	pobj	1	SENT_88	[p5l1869t1049r2145b1130],

1	Hoenig	NNP	PERSON	Hoenig	_	0	SENT_89	[p5l37t1205r151b1244],
2	et	FW	O	et	nn	5	SENT_89	[p5l168t1208r200b1236],
3	al	FW	O	al	nn	5	SENT_89	[p5l216t1205r245b1236],
4	C3435T	NN	O	c3435t	nn	5	SENT_89	[p5l292t1206r410b1236],
5	polymorphism	NN	O	polymorphism	dep	1	SENT_89	[p5l427t1205r656b1244],
6	in	IN	O	in	_	0	SENT_89	[p5l674t1205r703b1236],
7	ABCB1	NN	O	abcb1	nn	10	SENT_89	[p5l722t1206r827b1236],
8	and	CC	O	and	_	0	SENT_89	[p5l845t1205r902b1236],
9	atorvastatin	NN	O	atorvastatin	nn	10	SENT_89	[p5l920t1205r1118b1236],
10	efﬁcacy	NN	O	efﬁcacy	prep_in	5	SENT_89	[p5l1137t1205r1263b1244],
11	93	CD	NUMBER	93	dep	1	SENT_89	[p5l2086t1208r2123b1236],

1	who	WP	O	who	nsubj	2	SENT_90	[p5l9t1358r158b1420],
2	provided	VBD	O	provide	dep	12	SENT_90	[p5l228t1358r546b1439],
3	consent	NN	O	consent	dobj	2	SENT_90	[p5l616t1367r906b1432],
4	,	,	O	,	_	0	SENT_90	[p5l616t1367r906b1432],
5	117	CD	PERCENT	117	number	6	SENT_90	[p5l988t1358r1108b1420],
6	(	CD	PERCENT	(	nsubjpass	12	SENT_90	[p5l1184t1358r1400b1435],
7	96	CD	PERCENT	96	num	8	SENT_90	[p5l1184t1358r1400b1435],
8	%	NN	PERCENT	%	dep	6	SENT_90	[p5l1184t1358r1400b1435],
9	)	CD	NUMBER	)	dep	6	SENT_90	[p5l1184t1358r1400b1435],
10	were	VBD	O	be	auxpass	12	SENT_90	[p5l1473t1377r1643b1420],
11	successfully	RB	O	successfully	advmod	12	SENT_90	[p5l1718t1358r2150b1439],
12	genotyped	VBN	O	genotype	_	0	SENT_90	[p5l9t1465r380b1546],
13	for	IN	O	for	_	0	SENT_90	[p5l423t1465r526b1528],
14	the	DT	O	the	det	16	SENT_90	[p5l567t1466r674b1528],
15	C3435T	NN	O	c3435t	nn	16	SENT_90	[p5l719t1465r1009b1528],
16	polymorphism	NN	O	polymorphism	prep_for	12	SENT_90	[p5l1050t1465r1590b1546],
17	.	.	O	.	_	0	SENT_90	[p5l1050t1465r1590b1546],

1	As	IN	O	as	mark	3	SENT_91	[p5l1637t1466r1732b1528],
2	previously	RB	DATE	previously	advmod	3	SENT_91	[p5l1775t1465r2150b1546],
3	reported	VBN	O	report	advcl	6	SENT_91	[p5l7t1571r324b1652],
4	,	,	O	,	_	0	SENT_91	[p5l7t1571r324b1652],
5	there	EX	O	there	expl	6	SENT_91	[p5l360t1571r538b1634],
6	were	VBD	O	be	_	0	SENT_91	[p5l571t1591r741b1634],
7	12	CD	NUMBER	12	num	8	SENT_91	[p5l784t1572r862b1633],
8	reports	NNS	O	report	nsubj	6	SENT_91	[p5l895t1581r1141b1652],
9	of	IN	O	of	_	0	SENT_91	[p5l1178t1571r1254b1634],
10	myalgia	NN	O	myalgium	prep_of	8	SENT_91	[p5l1282t1571r1571b1652],
11	in	IN	O	in	_	0	SENT_91	[p5l1604t1571r1671b1633],
12	this	DT	O	this	det	13	SENT_91	[p5l1704t1571r1829b1634],
13	cohortz	NN	O	cohortz	prep_in	10	SENT_91	[p5l1866t1552r2147b1645],
14	;	:	O	;	_	0	SENT_91	[p5l1866t1552r2147b1645],
15	10	CD	NUMBER	10	nsubj	18	SENT_91	[p5l17t1679r94b1742],
16	of	IN	O	of	_	0	SENT_91	[p5l164t1679r241b1741],
17	these	DT	O	these	prep_of	15	SENT_91	[p5l303t1679r483b1741],
18	were	VBD	O	be	parataxis	6	SENT_91	[p5l552t1698r721b1742],
19	among	IN	O	among	_	0	SENT_91	[p5l793t1698r1031b1760],
20	the	DT	O	the	prep_among	18	SENT_91	[p5l1100t1679r1207b1741],
21	successfully	RB	O	successfully	advmod	22	SENT_91	[p5l1278t1679r1710b1760],
22	genotyped	VBN	O	genotype	partmod	20	SENT_91	[p5l1780t1679r2151b1760],
23	patients	NNS	O	patient	dobj	22	SENT_91	[p5l7t1786r302b1867],
24	.	.	O	.	_	0	SENT_91	[p5l7t1786r302b1867],

1	For	IN	O	for	_	0	SENT_92	[p5l349t1788r472b1849],
2	the	DT	O	the	det	5	SENT_92	[p5l512t1786r619b1849],
3	atorvastatin	NN	O	atorvastatin	nn	5	SENT_92	[p5l664t1786r1076b1849],
4	efﬁcacy	NN	O	efﬁcacy	nn	5	SENT_92	[p5l1120t1786r1400b1867],
5	analysis	NN	O	analysis	prep_for	46	SENT_92	[p5l1444t1786r1747b1867],
6	,	,	O	,	_	0	SENT_92	[p5l1444t1786r1747b1867],
7	the	DT	O	the	det	10	SENT_92	[p5l1793t1786r1900b1849],
8	initial	JJ	O	initial	amod	10	SENT_92	[p5l1942t1786r2150b1849],
9	patient	NN	O	patient	nn	10	SENT_92	[p5l7t1893r252b1974],
10	subset	NN	O	subset	nsubj	14	SENT_92	[p5l286t1893r504b1955],
11	is	VBZ	O	be	cop	14	SENT_92	[p5l535t1893r590b1955],
12	the	DT	O	the	det	14	SENT_92	[p5l623t1893r730b1955],
13	118	CD	NUMBER	118	num	14	SENT_92	[p5l770t1893r890b1955],
14	patients	NNS	O	patient	dep	46	SENT_92	[p5l924t1893r1200b1974],
15	who	WP	O	who	nsubj	16	SENT_92	[p5l1234t1893r1384b1955],
16	completed	VBD	O	complete	rcmod	14	SENT_92	[p5l1417t1893r1790b1974],
17	the	DT	O	the	det	18	SENT_92	[p5l1820t1893r1927b1955],
18	study	NN	O	study	dobj	16	SENT_92	[p5l1962t1893r2150b1974],
19	and	CC	O	and	_	0	SENT_92	[p5l10t2000r136b2063],
20	were	VBD	O	be	cop	21	SENT_92	[p5l179t2020r350b2063],
21	compliant	JJ	O	compliant	rcmod	14	SENT_92	[p5l396t2000r753b2081],
22	with	IN	O	with	_	0	SENT_92	[p5l797t2000r953b2063],
23	the	DT	O	the	det	25	SENT_92	[p5l996t2001r1103b2063],
24	study	NN	O	study	nn	25	SENT_92	[p5l1151t2001r1339b2081],
25	medication	NN	O	medication	prep_with	21	SENT_92	[p5l1383t2000r1781b2063],
26	as	IN	O	as	_	0	SENT_92	[p5l1827t2020r1895b2063],
27	previously	RB	DATE	previously	advmod	28	SENT_92	[p5l1940t2000r2148b2081, p5l9t2106r199b2187],
28	reported	VBN	O	report	amod	29	SENT_92	[p5l244t2087r597b2187],
29	.2	NN	NUMBER	.2	prep_as	21	SENT_92	[p5l244t2087r597b2187],
30	Of	IN	O	of	_	0	SENT_92	[p5l643t2106r739b2169],
31	the	DT	O	the	det	33	SENT_92	[p5l778t2106r885b2169],
32	118	CD	NUMBER	118	num	33	SENT_92	[p5l939t2107r1059b2169],
33	patients	NNS	O	patient	prep_of	46	SENT_92	[p5l1106t2106r1383b2187],
34	who	WP	O	who	nsubj	35	SENT_92	[p5l1430t2106r1580b2169],
35	completed	VBD	O	complete	rcmod	33	SENT_92	[p5l1626t2106r1999b2187],
36	the	DT	O	the	det	37	SENT_92	[p5l2043t2106r2150b2169],
37	study	NN	O	study	dobj	35	SENT_92	[p5l11t2214r199b2295],
38	and	CC	O	and	_	0	SENT_92	[p5l232t2214r358b2276],
39	adhered	VBD	O	adhere	rcmod	33	SENT_92	[p5l390t2214r671b2276],
40	to	TO	O	to	_	0	SENT_92	[p5l701t2223r768b2276],
41	the	DT	O	the	det	43	SENT_92	[p5l800t2214r907b2276],
42	drug	NN	O	drug	nn	43	SENT_92	[p5l939t2214r1099b2295],
43	regimen	NN	O	regimen	prep_to	39	SENT_92	[p5l1131t2214r1442b2295],
44	,	,	O	,	_	0	SENT_92	[p5l1131t2214r1442b2295],
45	102	CD	NUMBER	102	nsubj	46	SENT_92	[p5l1485t2214r1607b2276],
46	gave	VBD	O	give	_	0	SENT_92	[p5l1640t2233r1803b2295],
47	provided	VBN	O	provide	dep	46	SENT_92	[p5l1834t2214r2152b2295],
48	consent	NN	O	consent	dobj	47	SENT_92	[p5l9t2331r281b2384],
49	for	IN	O	for	_	0	SENT_92	[p5l310t2321r413b2384],
50	this	DT	O	this	det	52	SENT_92	[p5l442t2321r567b2384],
51	genetic	JJ	O	genetic	amod	52	SENT_92	[p5l600t2321r855b2402],
52	substudy	NN	O	substudy	prep_for	48	SENT_92	[p5l890t2321r1215b2402],
53	,	,	O	,	_	0	SENT_92	[p5l890t2321r1215b2402],
54	and	CC	O	and	_	0	SENT_92	[p5l1251t2321r1377b2384],
55	genotyping	NN	O	genotyping	nsubj	57	SENT_92	[p5l1407t2321r1806b2402],
56	was	VBD	O	be	cop	57	SENT_92	[p5l1838t2341r1972b2384],
57	successful	JJ	O	successful	conj_and	46	SENT_92	[p5l2007t2341r2148b2384, p5l9t2428r253b2491],
58	in	IN	O	in	_	0	SENT_92	[p5l278t2428r346b2490],
59	98	CD	PERCENT	98	number	60	SENT_92	[p5l371t2429r453b2492],
60	(	CD	PERCENT	(	amod	63	SENT_92	[p5l483t2428r699b2505],
61	96	CD	PERCENT	96	num	62	SENT_92	[p5l483t2428r699b2505],
62	%	NN	PERCENT	%	dep	60	SENT_92	[p5l483t2428r699b2505],
63	)	CD	NUMBER	)	prep_in	57	SENT_92	[p5l483t2428r699b2505],
64	of	IN	O	of	_	0	SENT_92	[p5l727t2428r803b2491],
65	these	DT	O	these	det	66	SENT_92	[p5l821t2428r1002b2491],
66	patients	NNS	O	patient	prep_of	63	SENT_92	[p5l1026t2428r1322b2509],
67	.	.	O	.	_	0	SENT_92	[p5l1026t2428r1322b2509],

1	Hence	RB	O	hence	advmod	4	SENT_93	[p5l1351t2430r1597b2502],
2	,	,	O	,	_	0	SENT_93	[p5l1351t2430r1597b2502],
3	there	EX	O	there	expl	4	SENT_93	[p5l1624t2428r1800b2491],
4	were	VBD	O	be	_	0	SENT_93	[p5l1824t2448r1994b2491],
5	117	CD	NUMBER	117	num	6	SENT_93	[p5l2028t2429r2148b2490],
6	patients	NNS	O	patient	nsubj	4	SENT_93	[p5l7t2535r283b2616],
7	in	IN	O	in	_	0	SENT_93	[p5l313t2535r380b2597],
8	the	DT	O	the	det	10	SENT_93	[p5l406t2535r513b2597],
9	myalgia	NN	O	myalgium	nn	10	SENT_93	[p5l541t2535r830b2616],
10	analysis	NN	O	analysis	prep_in	6	SENT_93	[p5l857t2535r1140b2616],
11	and	CC	O	and	_	0	SENT_93	[p5l1171t2535r1297b2597],
12	98	CD	NUMBER	98	nsubj	4	SENT_93	[p5l1324t2535r1406b2598],
13	in	IN	O	in	_	0	SENT_93	[p5l1437t2535r1504b2597],
14	the	DT	O	the	det	16	SENT_93	[p5l1531t2535r1638b2597],
15	efﬁcacy	NN	O	efﬁcacy	nn	16	SENT_93	[p5l1666t2535r1946b2616],
16	analysis	NN	O	analysis	prep_in	12	SENT_93	[p5l1975t2535r2149b2597, p5l8t2642r162b2723],
17	.	.	O	.	_	0	SENT_93	[p5l1975t2535r2149b2597, p5l8t2642r162b2723],

1	The	DT	O	the	det	2	SENT_94	[p5l194t2642r330b2704],
2	genotypes	NNS	O	genotype	nsubj	14	SENT_94	[p5l359t2651r717b2723],
3	in	IN	O	in	_	0	SENT_94	[p5l746t2642r814b2703],
4	the	DT	O	the	det	5	SENT_94	[p5l841t2642r947b2704],
5	group	NN	O	group	prep_in	2	SENT_94	[p5l976t2661r1180b2723],
6	of	IN	O	of	_	0	SENT_94	[p5l1209t2642r1286b2704],
7	117	CD	NUMBER	117	num	8	SENT_94	[p5l1316t2642r1436b2704],
8	patients	NNS	O	patient	prep_of	5	SENT_94	[p5l1466t2642r1742b2723],
9	as	IN	O	as	_	0	SENT_94	[p5l1773t2661r1842b2704],
10	a	DT	O	a	det	11	SENT_94	[p5l1873t2661r1909b2704],
11	whole	JJ	O	whole	prep_as	8	SENT_94	[p5l1934t2642r2150b2704],
12	were	VBD	O	be	cop	14	SENT_94	[p5l9t2768r179b2812],
13	50	CD	NUMBER	50	num	14	SENT_94	[p5l233t2749r318b2812],
14	patients	NNS	O	patient	_	0	SENT_94	[p5l370t2749r645b2830],
15	with	IN	O	with	_	0	SENT_94	[p5l699t2749r856b2811],
16	TT	NN	O	tt	prep_with	14	SENT_94	[p5l908t2750r1015b2811],
17	(	CD	PERCENT	(	number	18	SENT_94	[p5l1070t2749r1307b2826],
18	43	CD	PERCENT	43	num	19	SENT_94	[p5l1070t2749r1307b2826],
19	%	NN	PERCENT	%	dep	16	SENT_94	[p5l1070t2749r1307b2826],
20	)	CD	NUMBER	)	dep	16	SENT_94	[p5l1070t2749r1307b2826],
21	,	,	O	,	_	0	SENT_94	[p5l1070t2749r1307b2826],
22	48	CD	NUMBER	48	num	23	SENT_94	[p5l1362t2749r1446b2812],
23	patients	NNS	O	patient	conj_and	16	SENT_94	[p5l1500t2749r1776b2830],
24	with	IN	O	with	_	0	SENT_94	[p5l1830t2749r1987b2811],
25	TC	NN	O	tc	prep_with	23	SENT_94	[p5l2039t2749r2149b2812],
26	(	CD	PERCENT	(	number	27	SENT_94	[p5l11t2857r248b2934],
27	41	CD	PERCENT	41	num	28	SENT_94	[p5l11t2857r248b2934],
28	%	NN	PERCENT	%	dep	23	SENT_94	[p5l11t2857r248b2934],
29	)	CD	NUMBER	)	dep	28	SENT_94	[p5l11t2857r248b2934],
30	,	,	O	,	_	0	SENT_94	[p5l11t2857r248b2934],
31	and	CC	O	and	_	0	SENT_94	[p5l289t2857r414b2919],
32	19	CD	NUMBER	19	conj_and	16	SENT_94	[p5l458t2857r534b2920],
33	with	IN	O	with	_	0	SENT_94	[p5l572t2856r729b2919],
34	CC	NN	O	cc	prep_with	32	SENT_94	[p5l765t2857r879b2919],
35	(	CD	PERCENT	(	number	36	SENT_94	[p5l919t2856r1155b2934],
36	16	CD	PERCENT	16	num	37	SENT_94	[p5l919t2856r1155b2934],
37	%	NN	PERCENT	%	dep	32	SENT_94	[p5l919t2856r1155b2934],
38	)	CD	NUMBER	)	dep	37	SENT_94	[p5l919t2856r1155b2934],
39	.	.	O	.	_	0	SENT_94	[p5l919t2856r1155b2934],

1	The	DT	O	the	det	3	SENT_95	[p5l1195t2857r1331b2919],
2	allele	NN	O	allele	nn	3	SENT_95	[p5l1370t2856r1560b2919],
3	frequencies	NNS	O	frequency	nsubj	5	SENT_95	[p5l1596t2856r2006b2937],
4	are	VBP	O	be	cop	5	SENT_95	[p5l2045t2876r2150b2919],
5	0.63	CD	NUMBER	0.63	_	0	SENT_95	[p5l9t2963r158b3026],
6	and	CC	O	and	_	0	SENT_95	[p5l209t2963r335b3026],
7	0.37	CD	NUMBER	0.37	conj_and	5	SENT_95	[p5l380t2964r530b3026],
8	for	IN	O	for	_	0	SENT_95	[p5l578t2963r681b3026],
9	the	DT	O	the	det	13	SENT_95	[p5l725t2963r832b3026],
10	T	NN	O	t	nn	13	SENT_95	[p5l878t2965r930b3025],
11	and	CC	O	and	_	0	SENT_95	[p5l970t2963r1096b3026],
12	C	NN	O	c	conj_and	10	SENT_95	[p5l1141t2964r1196b3026],
13	allele	NN	O	allele	prep_for	5	SENT_95	[p5l1244t2963r1454b3037],
14	,	,	O	,	_	0	SENT_95	[p5l1244t2963r1454b3037],
15	respectively	RB	O	respectively	advmod	5	SENT_95	[p5l1502t2963r1945b3044],
16	,	,	O	,	_	0	SENT_95	[p5l1502t2963r1945b3044],
17	with	IN	O	with	_	0	SENT_95	[p5l1994t2963r2151b3026],
18	the	DT	O	the	det	20	SENT_95	[p5l8t3070r115b3132],
19	observed	VBN	O	observe	amod	20	SENT_95	[p5l152t3070r472b3133],
20	genotypes	NNS	O	genotype	nsubj	21	SENT_95	[p5l508t3079r866b3151],
21	being	VBG	O	be	prepc_with	5	SENT_95	[p5l903t3070r1100b3151],
22	in	IN	O	in	_	0	SENT_95	[p5l1136t3070r1204b3132],
23	Hardy	NNP	LOCATION	Hardy	prep_in	21	SENT_95	[p5l1240t3070r1838b3151],
24	.	.	O	.	_	0	SENT_95	[p5l1240t3070r1838b3151],

1	—	NN	O	—	_	0	SENT_96	[p5l1240t3070r1838b3151],
2	.	.	O	.	_	0	SENT_96	[p5l1240t3070r1838b3151],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_97	[p5l1240t3070r1838b3151],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_97	[p5l1874t3070r2148b3151, p5l7t3177r176b3239],
3	by	IN	O	by	_	0	SENT_97	[p5l206t3177r294b3258],
4	the	DT	O	the	det	6	SENT_97	[p5l327t3177r434b3239],
5	chi	NN	O	chus	nn	6	SENT_97	[p5l468t3177r838b3258],
6	—	NN	O	—	prep_by	2	SENT_97	[p5l468t3177r838b3258],
7	square	JJ	O	square	amod	10	SENT_97	[p5l468t3177r838b3258],
8	test	NN	O	test	nn	10	SENT_97	[p5l871t3186r995b3239],
9	(	NN	O	(	nn	10	SENT_97	[p5l1029t3177r1109b3254],
10	P	NN	O	p	dep	1	SENT_97	[p5l1029t3177r1109b3254],
11	=	JJ	O	=	amod	13	SENT_97	[p5l1150t3198r1204b3219],
12	.41	CD	NUMBER	.41	tmod	11	SENT_97	[p5l1241t3177r1393b3254],
13	)	NN	O	)	dep	10	SENT_97	[p5l1241t3177r1393b3254],
14	.	.	O	.	_	0	SENT_97	[p5l1241t3177r1393b3254],

1	The	DT	O	the	det	2	SENT_98	[p5l1430t3177r1567b3239],
2	population	NN	O	population	nsubj	6	SENT_98	[p5l1599t3177r1982b3258],
3	was	VBD	O	be	cop	6	SENT_98	[p5l2015t3196r2149b3239],
4	almost	RB	O	almost	advmod	6	SENT_98	[p5l10t3284r246b3347],
5	entirely	RB	O	entirely	advmod	6	SENT_98	[p5l284t3284r555b3365],
6	white	JJ	O	white	_	0	SENT_98	[p5l595t3284r811b3358],
7	,	,	O	,	_	0	SENT_98	[p5l595t3284r811b3358],
8	and	CC	O	and	_	0	SENT_98	[p5l854t3284r980b3347],
9	our	PRP$	O	we	poss	12	SENT_98	[p5l1019t3304r1136b3347],
10	reported	VBN	O	report	amod	12	SENT_98	[p5l1172t3284r1470b3365],
11	allele	NN	O	allele	nn	12	SENT_98	[p5l1510t3284r1700b3347],
12	frequencies	NNS	O	frequency	nsubj	14	SENT_98	[p5l1740t3284r2149b3365],
13	are	VBP	O	be	cop	14	SENT_98	[p5l10t3410r115b3453],
14	consistent	JJ	O	consistent	conj_and	6	SENT_98	[p5l145t3390r502b3453],
15	with	IN	O	with	_	0	SENT_98	[p5l530t3390r687b3453],
16	previous	JJ	O	previous	amod	17	SENT_98	[p5l715t3390r1018b3471],
17	reports	NNS	O	report	prep_with	14	SENT_98	[p5l1048t3400r1294b3471],
18	in	IN	O	in	_	0	SENT_98	[p5l1325t3390r1393b3452],
19	this	DT	O	this	det	23	SENT_98	[p5l1421t3390r1546b3453],
20	racial	JJ	O	racial	amod	23	SENT_98	[p5l1577t3390r1774b3453],
21	group	NN	O	group	nn	23	SENT_98	[p5l1805t3371r2145b3471],
22	.6	CD	NUMBER	.6	num	23	SENT_98	[p5l1805t3371r2145b3471],
23	’“	NN	O	’“	prep_in	17	SENT_98	[p5l1805t3371r2145b3471],

1	Efﬁcacy	NN	O	efﬁcacy	nn	2	SENT_99	[p5l14t3593r328b3686],
2	analysis	NN	O	analysis	_	0	SENT_99	[p5l365t3593r696b3686],

1	The	DT	O	the	det	3	SENT_100	[p6l116t73r252b136],
2	baseline	NN	O	baseline	nn	3	SENT_100	[p6l290t73r581b136],
3	characteristics	NNS	O	characteristic	nsubj	11	SENT_100	[p6l622t73r1132b136],
4	and	CC	O	and	_	0	SENT_100	[p6l1174t73r1299b136],
5	medications	NNS	O	medication	conj_and	3	SENT_100	[p6l1338t73r1768b136],
6	of	IN	O	of	_	0	SENT_100	[p6l1809t73r1886b136],
7	the	DT	O	the	det	10	SENT_100	[p6l1918t73r2025b136],
8	98	CD	NUMBER	98	num	10	SENT_100	[p6l2065t74r2147b137],
9	study	NN	O	study	nn	10	SENT_100	[p6l11t181r199b262],
10	patients	NNS	O	patient	prep_of	3	SENT_100	[p6l232t181r509b262],
11	included	VBD	O	include	_	0	SENT_100	[p6l545t181r854b243],
12	in	IN	O	in	mark	16	SENT_100	[p6l887t181r954b242],
13	this	DT	O	this	det	14	SENT_100	[p6l989t181r1114b243],
14	analysis	NN	O	analysis	nsubjpass	16	SENT_100	[p6l1152t181r1435b262],
15	are	VBP	O	be	auxpass	16	SENT_100	[p6l1472t200r1577b243],
16	summarized	VBN	O	summarize	advcl	11	SENT_100	[p6l1616t181r2049b243],
17	in	IN	O	in	_	0	SENT_100	[p6l2084t181r2151b242],
18	Table	NNP	O	Table	prep_in	16	SENT_100	[p6l8t289r203b351],
19	1	CD	NUMBER	1	num	18	SENT_100	[p6l234t289r285b351],
20	.	.	O	.	_	0	SENT_100	[p6l234t289r285b351],

1	Summary	NN	O	summary	nn	2	SENT_101	[p6l314t289r657b369],
2	statistics	NNS	O	statistics	nsubj	14	SENT_101	[p6l682t288r985b351],
3	for	IN	O	for	_	0	SENT_101	[p6l1008t288r1111b351],
4	the	DT	O	the	det	7	SENT_101	[p6l1131t288r1238b351],
5	baseline	NN	O	baseline	nn	7	SENT_101	[p6l1259t288r1551b351],
6	lipid	NN	O	lipid	nn	7	SENT_101	[p6l1575t288r1737b369],
7	panel	NN	O	panel	prep_for	2	SENT_101	[p6l1757t288r1969b369],
8	,	,	O	,	_	0	SENT_101	[p6l1757t288r1969b369],
9	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	nn	10	SENT_101	[p6l1995t289r2148b351, p6l8t395r704b458],
10	ratio	NN	O	ratio	appos	7	SENT_101	[p6l721t395r902b469],
11	,	,	O	,	_	0	SENT_101	[p6l721t395r902b469],
12	desmosterol	NN	O	desmosterol	appos	10	SENT_101	[p6l923t395r1373b469],
13	,	,	O	,	_	0	SENT_101	[p6l923t395r1373b469],
14	follow	VB	O	follow	_	0	SENT_101	[p6l1393t395r1740b476],
15	—	CD	NUMBER	—	dobj	14	SENT_101	[p6l1393t395r1740b476],
16	up	IN	O	up	_	0	SENT_101	[p6l1393t395r1740b476],
17	lipid	NN	O	lipid	nn	18	SENT_101	[p6l1758t395r1921b476],
18	panel	NN	O	panel	prep_up	14	SENT_101	[p6l1935t395r2147b476],
19	,	,	O	,	_	0	SENT_101	[p6l1935t395r2147b476],
20	and	CC	O	and	_	0	SENT_101	[p6l10t502r136b564],
21	percent	NN	O	percent	nn	22	SENT_101	[p6l178t511r443b583],
22	change	NN	O	change	nsubjpass	29	SENT_101	[p6l488t502r737b583],
23	in	IN	O	in	_	0	SENT_101	[p6l784t502r851b564],
24	lipid	NN	O	lipid	nn	25	SENT_101	[p6l896t502r1059b583],
25	parameters	NNS	O	parameter	prep_in	22	SENT_101	[p6l1102t511r1493b583],
26	by	IN	O	by	_	0	SENT_101	[p6l1539t502r1626b583],
27	genotype	NN	O	genotype	prep_by	25	SENT_101	[p6l1673t511r1998b583],
28	are	VBP	O	be	auxpass	29	SENT_101	[p6l2045t521r2150b564],
29	shown	VBN	O	show	conj_and	14	SENT_101	[p6l11t609r237b671],
30	in	IN	O	in	_	0	SENT_101	[p6l266t609r333b670],
31	Table	NNP	O	Table	prep_in	29	SENT_101	[p6l363t609r557b671],
32	2	CD	NUMBER	2	num	31	SENT_101	[p6l589t609r648b671],
33	.	.	O	.	_	0	SENT_101	[p6l589t609r648b671],

1	The	DT	O	the	det	2	SENT_102	[p6l682t609r818b671],
2	patients	NNS	O	patient	nsubj	7	SENT_102	[p6l848t609r1124b690],
3	with	IN	O	with	_	0	SENT_102	[p6l1156t609r1312b671],
4	the	DT	O	the	det	6	SENT_102	[p6l1341t609r1448b671],
5	CC	NN	O	cc	nn	6	SENT_102	[p6l1480t609r1593b671],
6	genotype	NN	O	genotype	prep_with	2	SENT_102	[p6l1626t618r1950b690],
7	were	VBD	O	be	_	0	SENT_102	[p6l1980t628r2150b671],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_102	[p6l11t716r449b797],
9	younger	JJR	O	younger	dep	25	SENT_102	[p6l471t735r764b797],
10	than	IN	O	than	_	0	SENT_102	[p6l784t716r936b778],
11	the	DT	O	the	det	12	SENT_102	[p6l958t716r1065b778],
12	patients	NNS	O	patient	prep_than	9	SENT_102	[p6l1087t716r1364b797],
13	with	IN	O	with	_	0	SENT_102	[p6l1387t716r1544b779],
14	the	DT	O	the	det	16	SENT_102	[p6l1565t716r1672b778],
15	TT	NN	O	tt	nn	16	SENT_102	[p6l1695t717r1802b778],
16	genotype	NN	O	genotype	prep_with	12	SENT_102	[p6l1825t725r2149b797],
17	or	CC	O	or	_	0	SENT_102	[p6l9t843r82b886],
18	the	DT	O	the	det	22	SENT_102	[p6l101t823r207b886],
19	combined	JJ	O	combined	amod	22	SENT_102	[p6l229t823r581b886],
20	TT/TC	NN	O	tt/tc	nn	22	SENT_102	[p6l601t824r846b886],
21	genotype	NN	O	genotype	nn	22	SENT_102	[p6l870t833r1194b904],
22	group	NN	O	group	conj_or	16	SENT_102	[p6l1216t843r1420b904],
23	(	CD	NUMBER	(	num	24	SENT_102	[p6l1445t824r1525b901],
24	P	NN	O	p	dep	25	SENT_102	[p6l1445t824r1525b901],
25	<	JJR	O	<	dep	7	SENT_102	[p6l1551t830r1611b882],
26	.01	CD	NUMBER	.01	num	27	SENT_102	[p6l1633t824r1785b901],
27	)	NN	O	)	dep	25	SENT_102	[p6l1633t824r1785b901],
28	.	.	O	.	_	0	SENT_102	[p6l1633t824r1785b901],

1	However	RB	O	however	advmod	10	SENT_103	[p6l1810t825r2148b898],
2	,	,	O	,	_	0	SENT_103	[p6l1810t825r2148b898],
3	as	IN	O	as	mark	5	SENT_103	[p6l10t950r78b993],
4	previously	RB	DATE	previously	advmod	5	SENT_103	[p6l97t930r471b1011],
5	reported	VBN	O	report	advcl	10	SENT_103	[p6l489t930r806b1011],
6	,	,	O	,	_	0	SENT_103	[p6l489t930r806b1011],
7	age	NN	O	age	nsubjpass	10	SENT_103	[p6l829t950r949b1011],
8	was	VBD	O	be	auxpass	10	SENT_103	[p6l967t950r1101b993],
9	not	RB	O	not	neg	10	SENT_103	[p6l1120t940r1234b993],
10	shown	VBN	O	show	_	0	SENT_103	[p6l1254t930r1479b993],
11	to	TO	O	to	aux	12	SENT_103	[p6l1497t939r1564b993],
12	inﬂuence	VB	O	inﬂuence	xcomp	10	SENT_103	[p6l1583t930r1909b993],
13	the	DT	O	the	det	14	SENT_103	[p6l1928t930r2035b993],
14	efﬁcacy	NN	O	efﬁcacy	dobj	12	SENT_103	[p6l2055t930r2148b993, p6l9t1036r219b1117],
15	of	IN	O	of	_	0	SENT_103	[p6l242t1036r318b1098],
16	atorvastatin	NN	O	atorvastatin	prep_of	14	SENT_103	[p6l335t1036r749b1098],
17	in	IN	O	in	_	0	SENT_103	[p6l771t1036r838b1098],
18	our	PRP$	O	we	poss	20	SENT_103	[p6l861t1056r978b1098],
19	cohort	NN	O	cohort	nn	20	SENT_103	[p6l999t1017r1281b1098],
20	.2	NN	NUMBER	.2	prep_in	12	SENT_103	[p6l999t1017r1281b1098],
21	The	DT	O	the	det	24	SENT_103	[p6l1302t1036r1439b1098],
22	baseline	NN	O	baseline	nn	24	SENT_103	[p6l1460t1036r1752b1098],
23	lipid	NN	O	lipid	nn	24	SENT_103	[p6l1775t1036r1937b1117],
24	panel	NN	O	panel	nsubj	25	SENT_103	[p6l1957t1036r2150b1117],
25	demonstrated	VBD	O	demonstrate	rcmod	20	SENT_103	[p6l9t1144r490b1207],
26	that	IN	O	that	complm	32	SENT_103	[p6l516t1144r649b1207],
27	patients	NNS	O	patient	nsubj	32	SENT_103	[p6l673t1144r949b1225],
28	with	IN	O	with	_	0	SENT_103	[p6l978t1144r1135b1207],
29	the	DT	O	the	det	31	SENT_103	[p6l1161t1144r1267b1207],
30	CC	NN	O	cc	nn	31	SENT_103	[p6l1296t1145r1409b1207],
31	genotype	NN	O	genotype	prep_with	27	SENT_103	[p6l1438t1154r1763b1225],
32	trended	VBD	O	trend	ccomp	25	SENT_103	[p6l1790t1144r2057b1207],
33	to	TO	O	to	aux	34	SENT_103	[p6l2083t1154r2149b1207],
34	have	VB	O	have	xcomp	32	SENT_103	[p6l8t1251r172b1314],
35	greater	JJR	O	greater	amod	37	SENT_103	[p6l221t1261r469b1332],
36	baseline	NN	O	baseline	nn	37	SENT_103	[p6l514t1251r805b1314],
37	triglyceride	NN	O	triglyceride	dobj	34	SENT_103	[p6l854t1251r1266b1332],
38	than	IN	O	than	_	0	SENT_103	[p6l1314t1251r1466b1314],
39	patients	NNS	O	patient	prep_than	34	SENT_103	[p6l1513t1251r1789b1332],
40	with	IN	O	with	_	0	SENT_103	[p6l1840t1251r1996b1314],
41	the	DT	O	the	prep_with	39	SENT_103	[p6l2043t1251r2150b1314],

1	Table	NNP	O	Table	_	0	SENT_104	[p6l61t1494r240b1554],
2	1	CD	NUMBER	1	num	4	SENT_104	[p6l277t1498r308b1553],
3	Patient	NN	O	patient	nn	4	SENT_104	[p6l425t1495r652b1554],
4	characteristics	NNS	O	characteristic	nsubj	7	SENT_104	[p6l683t1494r1146b1554],
5	of	IN	O	of	_	0	SENT_104	[p6l1180t1494r1245b1554],
6	patients	NNS	O	patient	prep_of	4	SENT_104	[p6l1273t1495r1532b1569],
7	included	VBN	O	include	rcmod	1	SENT_104	[p6l1563t1494r1835b1554],
8	in	IN	O	in	_	0	SENT_104	[p6l1867t1495r1924b1553],
9	the	DT	O	the	det	10	SENT_104	[p6l1958t1494r2062b1554],
10	analysis	NN	O	analysis	prep_in	7	SENT_104	[p6l65t1591r316b1666],

1	Mean	NN	O	mean	_	0	SENT_105	[p6l1419t1783r1576b1839],
2	:	:	O	:	_	0	SENT_105	[p6l1619t1788r1668b1836],
3	SD	NN	O	sd	dep	1	SENT_105	[p6l1705t1782r1782b1839],
4	or	CC	O	or	_	0	SENT_105	[p6l1816t1798r1878b1839],
5	n	NN	O	n	dep	1	SENT_105	[p6l1909t1798r1939b1838],
6	(	CD	NUMBER	(	number	7	SENT_105	[p6l1979t1780r2087b1856],
7	°	CD	NUMBER	°	dep	3	SENT_105	[p6l1979t1780r2087b1856],
8	/	:	O	/	punct	9	SENT_105	[p6l1979t1780r2087b1856],
9	o	NN	O	o	dep	7	SENT_105	[p6l1979t1780r2087b1856],
10	)	CD	NUMBER	)	num	9	SENT_105	[p6l1979t1780r2087b1856],

1	Age	NNP	O	Age	_	0	SENT_106	[p6l67t1971r184b2043],
2	67	CD	NUMBER	67	num	1	SENT_106	[p6l1418t1973r1489b2028],
3	:	:	O	:	_	0	SENT_106	[p6l1530t1976r1578b2025],
4	10	CD	NUMBER	10	num	5	SENT_106	[p6l1621t1973r1692b2028],
5	Males	NNS	O	male	dep	1	SENT_106	[p6l70t2064r241b2123],
6	77	CD	NUMBER	77	number	7	SENT_106	[p6l1419t2070r1489b2123],
7	(	CD	NUMBER	(	dep	5	SENT_106	[p6l1527t2064r1655b2140],
8	79	CD	NUMBER	79	dep	12	SENT_106	[p6l1527t2064r1655b2140],
9	)	CD	NUMBER	)	num	10	SENT_106	[p6l1527t2064r1655b2140],
10	Females	NNS	O	female	dep	8	SENT_106	[p6l72t2161r317b2221],
11	21	CD	NUMBER	21	dep	12	SENT_106	[p6l1419t2166r1488b2220],
12	(	CD	NUMBER	(	dep	1	SENT_106	[p6l1527t2161r1655b2239],
13	21	CD	NUMBER	21	number	14	SENT_106	[p6l1527t2161r1655b2239],
14	)	CD	NUMBER	)	num	22	SENT_106	[p6l1527t2161r1655b2239],
15	White	NNP	O	White	nn	22	SENT_106	[p6l67t2259r249b2320],
16	97	CD	NUMBER	97	num	22	SENT_106	[p6l1417t2264r1489b2320],
17	(	CD	NUMBER	(	number	18	SENT_106	[p6l1527t2259r1655b2337],
18	99	CD	NUMBER	99	amod	22	SENT_106	[p6l1527t2259r1655b2337],
19	)	CD	NUMBER	)	num	21	SENT_106	[p6l1527t2259r1655b2337],
20	Body	NN	O	body	nn	21	SENT_106	[p6l72t2357r225b2432],
21	mass	NN	O	mass	dep	18	SENT_106	[p6l258t2375r407b2416],
22	index	NN	O	index	dep	12	SENT_106	[p6l438t2357r612b2416],
23	27	CD	NUMBER	27	dep	22	SENT_106	[p6l1419t2362r1489b2416],
24	:	:	O	:	_	0	SENT_106	[p6l1530t2365r1578b2413],
25	5	CD	NUMBER	5	num	26	SENT_106	[p6l1621t2363r1650b2416],
26	Medications	NNS	O	medication	dep	22	SENT_106	[p6l70t2454r451b2513],

1	Aspirin	NN	O	aspirin	dep	6	SENT_107	[p6l147t2552r367b2627],
2	85	CD	NUMBER	85	dep	1	SENT_107	[p6l1416t2556r1489b2612],
3	(	NN	O	(	dep	6	SENT_107	[p6l1527t2551r1655b2629],
4	87	CD	NUMBER	87	num	3	SENT_107	[p6l1527t2551r1655b2629],
5	)	CD	NUMBER	)	num	6	SENT_107	[p6l1527t2551r1655b2629],
6	Clopidogrel	NNP	ORGANIZATION	Clopidogrel	dep	18	SENT_107	[p6l149t2648r510b2723],
7	13	CD	NUMBER	13	num	6	SENT_107	[p6l1419t2653r1489b2707],
8	(	CD	NUMBER	(	number	9	SENT_107	[p6l1527t2648r1655b2724],
9	13	CD	NUMBER	13	num	13	SENT_107	[p6l1527t2648r1655b2724],
10	)	NN	O	)	nn	13	SENT_107	[p6l1527t2648r1655b2724],
11	Warfarin	NN	O	warfarin	nn	13	SENT_107	[p6l148t2745r410b2806],
12	1	CD	NUMBER	1	num	13	SENT_107	[p6l1460t2752r1489b2805],
13	(	NN	O	(	dep	6	SENT_107	[p6l1527t2746r1615b2823],
14	1	CD	NUMBER	1	number	15	SENT_107	[p6l1527t2746r1615b2823],
15	)	CD	NUMBER	)	num	16	SENT_107	[p6l1527t2746r1615b2823],
16	Beta-blocker	NN	O	beta-blocker	dep	13	SENT_107	[p6l152t2843r554b2904],
17	26	CD	NUMBER	26	num	18	SENT_107	[p6l1419t2848r1490b2904],
18	(	CD	NUMBER	(	dep	31	SENT_107	[p6l1527t2843r1655b2921],
19	26	CD	NUMBER	26	number	20	SENT_107	[p6l1527t2843r1655b2921],
20	)	CD	NUMBER	)	num	27	SENT_107	[p6l1527t2843r1655b2921],
21	Amlodipine	NNP	ORGANIZATION	Amlodipine	nn	27	SENT_107	[p6l147t2942r510b3017],
22	21	CD	NUMBER	21	number	23	SENT_107	[p6l1419t2947r1488b3001],
23	(	CD	NUMBER	(	num	25	SENT_107	[p6l1527t2942r1655b3019],
24	21	CD	NUMBER	21	number	25	SENT_107	[p6l1527t2942r1655b3019],
25	)	CD	NUMBER	)	npadvmod	26	SENT_107	[p6l1527t2942r1655b3019],
26	Angiotensin-converting	JJ	O	angiotensin-converting	amod	27	SENT_107	[p6l147t3038r909b3113],
27	enzyme	NN	O	enzyme	dep	18	SENT_107	[p6l944t3056r1180b3113],
28	41	CD	NUMBER	41	num	29	SENT_107	[p6l1415t3043r1488b3097],
29	(	CD	NUMBER	(	dep	27	SENT_107	[p6l1527t3038r1655b3114],
30	42	CD	NUMBER	42	num	31	SENT_107	[p6l1527t3038r1655b3114],
31	)	NN	O	)	_	0	SENT_107	[p6l1527t3038r1655b3114],

1	inhibitor	NN	O	inhibitor	_	0	SENT_108	[p6l227t3135r512b3195],

1	Angiotensin	NN	O	angiotensin	nn	3	SENT_109	[p6l147t3233r531b3308],
2	receptor	NN	O	receptor	nn	3	SENT_109	[p6l569t3238r832b3308],
3	blocker	NN	O	blocker	dep	8	SENT_109	[p6l863t3232r1093b3293],
4	17	CD	NUMBER	17	dep	3	SENT_109	[p6l1420t3239r1489b3292],
5	(	NN	O	(	dep	8	SENT_109	[p6l1527t3232r1655b3310],
6	17	CD	NUMBER	17	num	5	SENT_109	[p6l1527t3232r1655b3310],
7	)	CD	NUMBER	)	num	8	SENT_109	[p6l1527t3232r1655b3310],
8	Insulin	NN	ORGANIZATION	insulin	dep	13	SENT_109	[p6l148t3329r368b3388],
9	10	CD	NUMBER	10	number	10	SENT_109	[p6l1419t3334r1491b3388],
10	(	CD	NUMBER	(	dep	8	SENT_109	[p6l1527t3329r1655b3405],
11	10	CD	NUMBER	10	num	12	SENT_109	[p6l1527t3329r1655b3405],
12	)	CD	NUMBER	)	dep	10	SENT_109	[p6l1527t3329r1655b3405],
13	Metformin	NNP	ORGANIZATION	Metformin	dep	20	SENT_109	[p6l151t3426r470b3487],
14	14	CD	NUMBER	14	num	13	SENT_109	[p6l1420t3431r1492b3487],
15	(	CD	NUMBER	(	number	16	SENT_109	[p6l1527t3426r1655b3504],
16	14	CD	NUMBER	14	dep	13	SENT_109	[p6l1527t3426r1655b3504],
17	)	CD	NUMBER	)	num	18	SENT_109	[p6l1527t3426r1655b3504],
18	Sulfonylurea	NNP	ORGANIZATION	Sulfonylurea	dep	16	SENT_109	[p6l147t3524r543b3600],
19	11	CD	NUMBER	11	num	18	SENT_109	[p6l1420t3531r1488b3584],
20	(	CD	NUMBER	(	dep	22	SENT_109	[p6l1527t3524r1655b3602],
21	11	CD	NUMBER	11	num	22	SENT_109	[p6l1527t3524r1655b3602],
22	)	NN	O	)	_	0	SENT_109	[p6l1527t3524r1655b3602],

1	TT/TC	NN	O	tt/tc	nn	2	SENT_110	[p7l8t88r252b151],
2	genotype	NN	O	genotype	_	0	SENT_110	[p7l283t97r607b169],
3	(	CD	NUMBER	(	num	4	SENT_110	[p7l638t89r719b165],
4	P	NN	O	p	dep	2	SENT_110	[p7l638t89r719b165],
5	=	JJ	O	=	amod	7	SENT_110	[p7l754t110r808b130],
6	.051	CD	NUMBER	.051	tmod	5	SENT_110	[p7l840t88r1036b165],
7	)	NN	O	)	dep	4	SENT_110	[p7l840t88r1036b165],
8	.	.	O	.	_	0	SENT_110	[p7l840t88r1036b165],

1	There	EX	O	there	expl	2	SENT_111	[p7l1068t88r1274b150],
2	were	VBD	O	be	_	0	SENT_111	[p7l1301t107r1471b151],
3	no	DT	O	no	det	4	SENT_111	[p7l1499t107r1585b150],
4	differences	NNS	O	difference	nsubj	2	SENT_111	[p7l1614t88r2006b150],
5	between	IN	O	between	_	0	SENT_111	[p7l2034t88r2145b150, p7l8t205r219b258],
6	the	DT	O	the	det	7	SENT_111	[p7l251t196r358b258],
7	genotypes	NNS	O	genotype	prep_between	4	SENT_111	[p7l391t205r748b276],
8	in	IN	O	in	_	0	SENT_111	[p7l782t195r850b257],
9	measures	NNS	O	measure	prep_in	7	SENT_111	[p7l881t215r1210b258],
10	of	IN	O	of	_	0	SENT_111	[p7l1245t195r1322b258],
11	cholesterol	NN	O	cholesterol	nn	12	SENT_111	[p7l1349t196r1738b258],
12	absorption	NN	O	absorption	prep_of	9	SENT_111	[p7l1773t195r2147b276],
13	(	CD	NUMBER	(	num	12	SENT_111	[p7l10t302r144b379],
14	the	DT	O	the	det	16	SENT_111	[p7l10t302r144b379],
15	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	nn	16	SENT_111	[p7l184t302r1008b365],
16	ratio	NN	O	ratio	dep	9	SENT_111	[p7l1048t302r1238b379],
17	)	CD	NUMBER	)	dep	16	SENT_111	[p7l1048t302r1238b379],
18	or	CC	O	or	_	0	SENT_111	[p7l1281t322r1353b365],
19	cholesterol	NN	O	cholesterol	nn	20	SENT_111	[p7l1392t302r1782b365],
20	synthesis	NN	O	synthesis	prep_in	7	SENT_111	[p7l1825t302r2145b383],
21	(	CD	NUMBER	(	num	23	SENT_111	[p7l10t409r517b486],
22	desmosterol	NN	O	desmosterol	nn	23	SENT_111	[p7l10t409r517b486],
23	)	NN	O	)	dep	20	SENT_111	[p7l10t409r517b486],
24	,	,	O	,	_	0	SENT_111	[p7l10t409r517b486],
25	which	WDT	O	which	dobj	29	SENT_111	[p7l560t409r775b471],
26	we	PRP	O	we	nsubj	29	SENT_111	[p7l815t428r916b472],
27	have	VBP	O	have	aux	29	SENT_111	[p7l955t409r1120b472],
28	previously	RB	DATE	previously	advmod	29	SENT_111	[p7l1158t409r1533b490],
29	shown	VBN	O	show	rcmod	7	SENT_111	[p7l1575t409r1801b472],
30	to	TO	O	to	aux	31	SENT_111	[p7l1840t419r1906b471],
31	affect	VB	O	affect	xcomp	29	SENT_111	[p7l1949t409r2148b471],
32	LDL	NN	O	ldl	dobj	31	SENT_111	[p7l7t514r267b577],
33	.	.	O	.	_	0	SENT_111	[p7l7t514r267b577],

1	—	NN	O	—	_	0	SENT_112	[p7l7t514r267b577],
2	.	.	O	.	_	0	SENT_112	[p7l7t514r267b577],

1	C	NN	O	c	nn	2	SENT_113	[p7l7t514r267b577],
2	response	NN	O	response	nsubj	15	SENT_113	[p7l303t534r613b595],
3	to	TO	O	to	_	0	SENT_113	[p7l650t524r716b576],
4	atorvastatin	NN	O	atorvastatin	nn	5	SENT_113	[p7l754t494r1223b576],
5	.2	NN	NUMBER	.2	prep_to	2	SENT_113	[p7l754t494r1223b576],
6	Similarly	RB	O	similarly	advmod	9	SENT_113	[p7l1261t513r1604b594],
7	,	,	O	,	_	0	SENT_113	[p7l1261t513r1604b594],
8	there	EX	O	there	expl	9	SENT_113	[p7l1643t514r1819b576],
9	were	VBD	O	be	rcmod	5	SENT_113	[p7l1854t534r2024b576],
10	no	DT	O	no	det	12	SENT_113	[p7l2060t534r2146b576],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_113	[p7l11t621r380b702],
12	differences	NNS	O	difference	nsubj	9	SENT_113	[p7l405t621r796b683],
13	in	IN	O	in	_	0	SENT_113	[p7l823t621r890b682],
14	the	DT	O	the	prep_in	12	SENT_113	[p7l915t621r1022b683],
15	follow	VBP	O	follow	_	0	SENT_113	[p7l1048t621r1395b702],
16	—	CD	NUMBER	—	dobj	15	SENT_113	[p7l1048t621r1395b702],
17	up	IN	O	up	_	0	SENT_113	[p7l1048t621r1395b702],
18	lipid	NN	O	lipid	nn	19	SENT_113	[p7l1422t621r1584b702],
19	panel	NN	O	panel	prep_up	15	SENT_113	[p7l1607t621r1799b702],
20	after	IN	O	after	_	0	SENT_113	[p7l1827t621r1989b683],
21	a	DT	O	a	det	23	SENT_113	[p7l2014t640r2051b683],
22	6week	JJ	O	6week	amod	23	SENT_113	[p7l2076t620r2144b684, p7l8t729r195b792],
23	course	NN	O	course	prep_after	15	SENT_113	[p7l219t749r448b792],
24	of	IN	O	of	_	0	SENT_113	[p7l474t729r551b792],
25	atorvastatin	NN	O	atorvastatin	nn	27	SENT_113	[p7l570t729r983b792],
26	80	CD	NUMBER	80	num	27	SENT_113	[p7l1011t730r1093b792],
27	mg	NN	O	mg	prep_of	23	SENT_113	[p7l1117t749r1247b810],
28	.	.	O	.	_	0	SENT_113	[p7l1117t749r1247b810],

1	In	IN	O	in	_	0	SENT_114	[p7l1276t731r1348b791],
2	the	DT	O	the	det	3	SENT_114	[p7l1371t729r1478b792],
3	cohort	NN	O	cohort	prep_in	13	SENT_114	[p7l1503t730r1730b792],
4	as	IN	O	as	_	0	SENT_114	[p7l1754t749r1823b792],
5	a	DT	O	a	det	6	SENT_114	[p7l1850t749r1887b792],
6	whole	JJ	O	whole	prep_as	3	SENT_114	[p7l1909t729r2144b803],
7	,	,	O	,	_	0	SENT_114	[p7l1909t729r2144b803],
8	the	DT	O	the	det	10	SENT_114	[p7l8t836r114b899],
9	6-week	JJ	DURATION	6-week	amod	10	SENT_114	[p7l135t836r395b899],
10	course	NN	O	course	nsubj	13	SENT_114	[p7l413t856r643b899],
11	of	IN	O	of	_	0	SENT_114	[p7l663t836r739b899],
12	atorvastatin	NN	O	atorvastatin	prep_of	10	SENT_114	[p7l753t836r1166b899],
13	reduced	VBD	O	reduce	_	0	SENT_114	[p7l1183t836r1467b899],
14	LDL	NN	O	ldl	dobj	13	SENT_114	[p7l1483t836r1744b899],
15	.	.	O	.	_	0	SENT_114	[p7l1483t836r1744b899],

1	—	NN	O	—	_	0	SENT_115	[p7l1483t836r1744b899],
2	.	.	O	.	_	0	SENT_115	[p7l1483t836r1744b899],

1	C	NN	O	c	_	0	SENT_116	[p7l1483t836r1744b899],
2	by	IN	O	by	_	0	SENT_116	[p7l1762t836r1849b917],
3	an	DT	O	a	det	6	SENT_116	[p7l1870t856r1950b899],
4	average	JJ	O	average	amod	6	SENT_116	[p7l1970t856r2146b899, p7l10t962r129b1024],
5	58	CD	PERCENT	58	num	6	SENT_116	[p7l151t943r307b1006],
6	%	NN	PERCENT	%	prep_by	1	SENT_116	[p7l151t943r307b1006],
7	:	:	O	:	_	0	SENT_116	[p7l339t948r393b1002],
8	11	CD	PERCENT	11	num	9	SENT_116	[p7l430t943r579b1006],
9	%	NN	PERCENT	%	dep	1	SENT_116	[p7l430t943r579b1006],
10	(	CD	NUMBER	(	num	11	SENT_116	[p7l605t944r824b1020],
11	mean	NN	O	mean	dep	9	SENT_116	[p7l605t944r824b1020],
12	:	:	O	:	_	0	SENT_116	[p7l853t948r906b1002],
13	SD	NN	O	sd	dep	1	SENT_116	[p7l937t943r1094b1020],
14	)	NN	O	)	dep	13	SENT_116	[p7l937t943r1094b1020],
15	.	.	O	.	_	0	SENT_116	[p7l937t943r1094b1020],

1	There	EX	O	there	expl	2	SENT_117	[p7l1117t943r1323b1005],
2	were	VBD	O	be	_	0	SENT_117	[p7l1342t962r1512b1005],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_117	[p7l1536t943r1905b1024],
4	differences	NNS	O	difference	nsubj	2	SENT_117	[p7l1925t943r2145b1005, p7l9t1070r203b1113],
5	in	IN	O	in	_	0	SENT_117	[p7l226t1050r293b1112],
6	this	DT	O	this	det	7	SENT_117	[p7l313t1050r438b1113],
7	response	NN	O	response	prep_in	4	SENT_117	[p7l461t1070r771b1131],
8	on	IN	O	on	_	0	SENT_117	[p7l794t1070r880b1113],
9	the	DT	O	the	det	10	SENT_117	[p7l900t1050r1007b1113],
10	basis	NN	O	basis	prep_on	7	SENT_117	[p7l1028t1050r1203b1113],
11	of	IN	O	of	_	0	SENT_117	[p7l1227t1050r1304b1113],
12	genotype	NN	O	genotype	prep_of	10	SENT_117	[p7l1321t1060r1663b1131],
13	.	.	O	.	_	0	SENT_117	[p7l1321t1060r1663b1131],

1	Patients	NNS	O	patient	nsubj	6	SENT_118	[p7l1689t1050r1968b1113],
2	with	IN	O	with	_	0	SENT_118	[p7l1991t1050r2148b1113],
3	the	DT	O	the	det	5	SENT_118	[p7l8t1157r114b1220],
4	CC	NN	O	cc	nn	5	SENT_118	[p7l147t1158r260b1220],
5	genotype	NN	O	genotype	prep_with	1	SENT_118	[p7l294t1166r618b1238],
6	showed	VBD	O	show	_	0	SENT_118	[p7l653t1157r919b1220],
7	a	DT	O	a	det	10	SENT_118	[p7l951t1177r988b1220],
8	53	CD	PERCENT	53	num	10	SENT_118	[p7l1019t1157r1174b1220],
9	%	NN	PERCENT	%	nn	10	SENT_118	[p7l1019t1157r1174b1220],
10	reduction	NN	O	reduction	dobj	6	SENT_118	[p7l1208t1157r1545b1220],
11	in	IN	O	in	_	0	SENT_118	[p7l1576t1157r1643b1219],
12	LDL	NN	O	ldl	prep_in	10	SENT_118	[p7l1673t1158r1933b1220],
13	.	.	O	.	_	0	SENT_118	[p7l1673t1158r1933b1220],

1	—	NN	O	—	_	0	SENT_119	[p7l1673t1158r1933b1220],
2	.	.	O	.	_	0	SENT_119	[p7l1673t1158r1933b1220],

1	C	NN	O	c	nsubj	12	SENT_120	[p7l1673t1158r1933b1220],
2	compared	VBN	O	compare	_	0	SENT_120	[p7l1966t1177r2145b1220, p7l7t1264r205b1345],
3	with	IN	O	with	prepc_compared_with	1	SENT_120	[p7l230t1264r387b1327],
4	59	CD	PERCENT	59	num	5	SENT_120	[p7l413t1264r570b1327],
5	%	NN	PERCENT	%	pobj	1	SENT_120	[p7l413t1264r570b1327],
6	in	IN	O	in	_	0	SENT_120	[p7l599t1264r666b1326],
7	patients	NNS	O	patient	prep_in	5	SENT_120	[p7l691t1264r966b1345],
8	with	IN	O	with	_	0	SENT_120	[p7l995t1264r1151b1327],
9	the	DT	O	the	det	11	SENT_120	[p7l1176t1264r1282b1326],
10	TT/TC	NN	O	tt/tc	nn	11	SENT_120	[p7l1309t1264r1554b1327],
11	genotypes	NNS	O	genotype	prep_with	7	SENT_120	[p7l1582t1273r1940b1345],
12	(	VBP	O	(	_	0	SENT_120	[p7l1971t1265r2050b1341],
13	P	NN	O	p	dobj	12	SENT_120	[p7l1971t1265r2050b1341],
14	=	JJ	O	=	advmod	12	SENT_120	[p7l2085t1286r2138b1306],
15	.034	CD	NUMBER	.034	num	16	SENT_120	[p7l12t1370r209b1446],
16	)	NN	O	)	dep	14	SENT_120	[p7l12t1370r209b1446],
17	.	.	O	.	_	0	SENT_120	[p7l12t1370r209b1446],

1	Since	IN	O	since	mark	4	SENT_121	[p7l237t1370r431b1432],
2	we	PRP	O	we	nsubj	4	SENT_121	[p7l452t1389r552b1432],
3	have	VBP	O	have	aux	4	SENT_121	[p7l573t1370r738b1431],
4	shown	VBN	O	show	_	0	SENT_121	[p7l763t1370r989b1432],
5	the	DT	O	the	det	7	SENT_121	[p7l1010t1370r1117b1431],
6	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	nn	7	SENT_121	[p7l1139t1370r1963b1432],
7	ratio	NN	O	ratio	nsubj	11	SENT_121	[p7l1984t1370r2146b1431],
8	and	CC	O	and	_	0	SENT_121	[p7l10t1477r135b1539],
9	desmosterol	NN	O	desmosterol	nsubj	11	SENT_121	[p7l157t1477r586b1539],
10	to	TO	O	to	aux	11	SENT_121	[p7l609t1486r675b1539],
11	predict	VB	O	predict	xcomp	4	SENT_121	[p7l697t1477r946b1558],
12	percent	NN	O	percent	nn	13	SENT_121	[p7l966t1486r1230b1558],
13	LDL	NN	O	ldl	dobj	11	SENT_121	[p7l1250t1477r1510b1540],
14	.	.	O	.	_	0	SENT_121	[p7l1250t1477r1510b1540],

1	—	NN	O	—	_	0	SENT_122	[p7l1250t1477r1510b1540],
2	.	.	O	.	_	0	SENT_122	[p7l1250t1477r1510b1540],

1	C	NN	O	c	nn	2	SENT_123	[p7l1250t1477r1510b1540],
2	reduction	NN	O	reduction	ccomp	9	SENT_123	[p7l1532t1477r1870b1539],
3	to	TO	O	to	_	0	SENT_123	[p7l1892t1486r1958b1539],
4	ator	NN	O	ator	nn	6	SENT_123	[p7l1983t1486r2145b1539],
5	—	NN	O	—	nn	6	SENT_123	[p7l1983t1486r2145b1539],
6	vastatin	NN	O	vastatin	prep_to	2	SENT_123	[p7l8t1584r302b1658],
7	,	,	O	,	_	0	SENT_123	[p7l8t1584r302b1658],
8	we	PRP	O	we	nsubj	9	SENT_123	[p7l326t1604r426b1647],
9	assessed	VBD	O	assess	_	0	SENT_123	[p7l449t1584r748b1647],
10	the	DT	O	the	det	11	SENT_123	[p7l767t1584r874b1647],
11	independence	NN	O	independence	dobj	9	SENT_123	[p7l895t1584r1384b1665],
12	of	IN	O	of	_	0	SENT_123	[p7l1407t1584r1483b1647],
13	this	DT	O	this	det	14	SENT_123	[p7l1497t1584r1622b1647],
14	association	NN	O	association	prep_of	11	SENT_123	[p7l1646t1584r2040b1647],
15	by	IN	O	by	_	0	SENT_123	[p7l2059t1585r2147b1665],
16	adding	VBG	O	add	prepc_by	9	SENT_123	[p7l10t1691r248b1772],
17	these	DT	O	these	det	18	SENT_123	[p7l273t1691r453b1754],
18	variables	NNS	O	variable	dobj	16	SENT_123	[p7l477t1691r794b1754],
19	as	IN	O	as	_	0	SENT_123	[p7l822t1711r890b1754],
20	covariates	NNS	O	covariate	prep_as	16	SENT_123	[p7l917t1691r1273b1754],
21	in	IN	O	in	_	0	SENT_123	[p7l1298t1691r1366b1753],
22	a	DT	O	a	det	24	SENT_123	[p7l1391t1711r1428b1754],
23	multivariate	JJ	O	multivariate	amod	24	SENT_123	[p7l1451t1691r1879b1754],
24	model	NN	O	model	prep_in	20	SENT_123	[p7l1903t1691r2143b1754],
25	.	.	O	.	_	0	SENT_123	[p7l1903t1691r2143b1754],

1	The	DT	O	the	det	2	SENT_124	[p7l8t1798r144b1861],
2	relationship	NN	O	relationship	_	0	SENT_124	[p7l195t1798r616b1879],
3	between	IN	O	between	_	0	SENT_124	[p7l668t1798r965b1861],
4	genotype	NN	O	genotype	nn	7	SENT_124	[p7l1018t1808r1342b1879],
5	and	CC	O	and	_	0	SENT_124	[p7l1396t1798r1522b1861],
6	percent	NN	O	percent	conj_and	4	SENT_124	[p7l1572t1807r1836b1879],
7	LDL	NN	O	ldl	prep_between	2	SENT_124	[p7l1886t1799r2146b1861],
8	.	.	O	.	_	0	SENT_124	[p7l1886t1799r2146b1861],

1	—	NN	O	—	_	0	SENT_125	[p7l1886t1799r2146b1861],
2	.	.	O	.	_	0	SENT_125	[p7l1886t1799r2146b1861],

1	C	NN	O	c	nn	2	SENT_126	[p7l1886t1799r2146b1861],
2	reduction	NN	O	reduction	nsubj	10	SENT_126	[p7l7t1904r344b1966],
3	remained	VBD	O	remain	cop	10	SENT_126	[p7l368t1904r702b1966],
4	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_126	[p7l729t1904r1098b1985],
5	at	IN	O	at	_	0	SENT_126	[p7l1124t1913r1186b1966],
6	the	DT	O	the	det	7	SENT_126	[p7l1209t1904r1316b1966],
7	P	NN	O	p	prep_at	4	SENT_126	[p7l1340t1906r1395b1965],
8	=	JJ	O	=	amod	7	SENT_126	[p7l1428t1925r1481b1946],
9	.045	CD	NUMBER	.045	tmod	8	SENT_126	[p7l1511t1903r1656b1967],
10	level	NN	O	level	_	0	SENT_126	[p7l1685t1904r1873b1966],
11	.	.	O	.	_	0	SENT_126	[p7l1685t1904r1873b1966],

1	Myalgia	NN	O	myalgium	nn	2	SENT_127	[p7l13t2076r322b2168],
2	analysis	NN	O	analysis	_	0	SENT_127	[p7l362t2076r692b2168],

1	Of	IN	O	of	_	0	SENT_128	[p7l116t2300r212b2363],
2	our	PRP$	O	we	poss	4	SENT_128	[p7l256t2319r373b2362],
3	study	NN	O	study	nn	4	SENT_128	[p7l423t2300r610b2381],
4	population	NN	O	population	prep_of	11	SENT_128	[p7l658t2300r1039b2381],
5	of	IN	O	of	_	0	SENT_128	[p7l1089t2300r1166b2362],
6	154	CD	NUMBER	154	num	7	SENT_128	[p7l1216t2300r1339b2363],
7	patients	NNS	O	patient	prep_of	4	SENT_128	[p7l1387t2300r1684b2381],
8	,	,	O	,	_	0	SENT_128	[p7l1387t2300r1684b2381],
9	12	CD	NUMBER	12	num	10	SENT_128	[p7l1744t2300r1821b2362],
10	patients	NNS	O	patient	nsubj	11	SENT_128	[p7l1869t2300r2146b2381],
11	reported	VBD	O	report	_	0	SENT_128	[p7l7t2407r305b2488],
12	muscle	NN	O	muscle	nn	13	SENT_128	[p7l341t2407r592b2469],
13	symptoms	NNS	O	symptom	dobj	11	SENT_128	[p7l633t2416r993b2488],
14	of	IN	O	of	_	0	SENT_128	[p7l1033t2407r1109b2469],
15	muscle	NN	O	muscle	nn	16	SENT_128	[p7l1141t2407r1391b2469],
16	pain	NN	O	pain	prep_of	13	SENT_128	[p7l1428t2407r1600b2488],
17	,	,	O	,	_	0	SENT_128	[p7l1428t2407r1600b2488],
18	tenderness	NN	O	tenderness	prep_of	13	SENT_128	[p7l1641t2407r2034b2481],
19	,	,	O	,	_	0	SENT_128	[p7l1641t2407r2034b2481],
20	or	CC	O	or	_	0	SENT_128	[p7l2076t2426r2149b2469],
21	weakness	NN	O	weakness	prep_of	13	SENT_128	[p7l8t2514r346b2577],
22	during	IN	O	during	_	0	SENT_128	[p7l385t2514r614b2595],
23	the	DT	O	the	det	25	SENT_128	[p7l651t2514r758b2577],
24	treatment	NN	O	treatment	nn	25	SENT_128	[p7l795t2523r1133b2577],
25	period	NN	O	period	prep_during	11	SENT_128	[p7l1168t2514r1412b2595],
26	.	.	O	.	_	0	SENT_128	[p7l1168t2514r1412b2595],

1	Of	IN	O	of	_	0	SENT_129	[p7l1455t2514r1551b2577],
2	the	DT	O	the	det	4	SENT_129	[p7l1581t2514r1688b2577],
3	12	CD	NUMBER	12	num	4	SENT_129	[p7l1733t2515r1810b2576],
4	patients	NNS	O	patient	prep_of	8	SENT_129	[p7l1846t2514r2144b2595],
5	,	,	O	,	_	0	SENT_129	[p7l1846t2514r2144b2595],
6	one	CD	NUMBER	one	num	7	SENT_129	[p7l9t2641r134b2684],
7	patient	NN	O	patient	nsubj	8	SENT_129	[p7l167t2621r410b2702],
8	had	VBD	O	have	_	0	SENT_129	[p7l442t2621r571b2684],
9	frank	JJ	O	frank	amod	10	SENT_129	[p7l604t2621r792b2684],
10	rhabdomyolysis	NN	O	rhabdomyolysis	dobj	8	SENT_129	[p7l822t2621r1391b2702],
11	with	IN	O	with	_	0	SENT_129	[p7l1426t2621r1582b2684],
12	serum	NN	O	serum	nn	14	SENT_129	[p7l1618t2641r1832b2684],
13	creatine	NN	O	creatine	nn	14	SENT_129	[p7l1866t2621r2147b2684],
14	phosphokinase	NN	O	phosphokinase	prep_with	10	SENT_129	[p7l7t2728r536b2809],
15	>	JJR	O	>	dep	14	SENT_129	[p7l577t2729r888b2802],
16	20,000	CD	NUMBER	20,000	num	17	SENT_129	[p7l577t2729r888b2802],
17	U/L	NN	O	u/l	dep	15	SENT_129	[p7l922t2729r1081b2791],
18	.	.	O	.	_	0	SENT_129	[p7l922t2729r1081b2791],

1	This	DT	O	this	det	2	SENT_130	[p7l1120t2728r1274b2791],
2	patient	NN	O	patient	nsubj	5	SENT_130	[p7l1309t2728r1553b2809],
3	did	VBD	O	do	aux	5	SENT_130	[p7l1587t2728r1698b2791],
4	not	RB	O	not	neg	5	SENT_130	[p7l1731t2738r1845b2791],
5	provide	VB	O	provide	_	0	SENT_130	[p7l1875t2728r2147b2809],
6	consent	NN	O	consent	dobj	5	SENT_130	[p7l9t2844r280b2897],
7	for	IN	O	for	_	0	SENT_130	[p7l312t2835r415b2897],
8	genotyping	NN	O	genotyping	prep_for	5	SENT_130	[p7l445t2835r863b2916],
9	.	.	O	.	_	0	SENT_130	[p7l445t2835r863b2916],

1	Of	IN	O	of	_	0	SENT_131	[p7l901t2835r997b2898],
2	the	DT	O	the	det	5	SENT_131	[p7l1024t2835r1130b2897],
3	10	CD	NUMBER	10	num	5	SENT_131	[p7l1172t2835r1250b2898],
4	genotyped	JJ	O	genotyped	amod	5	SENT_131	[p7l1284t2835r1654b2916],
5	patients	NNS	O	patient	prep_of	12	SENT_131	[p7l1686t2835r1961b2916],
6	who	WP	O	who	nsubj	7	SENT_131	[p7l1997t2835r2146b2898],
7	reported	VBD	O	report	rcmod	5	SENT_131	[p7l7t2942r305b3023],
8	myalgia	NN	O	myalgium	dobj	7	SENT_131	[p7l331t2942r637b3023],
9	,	,	O	,	_	0	SENT_131	[p7l331t2942r637b3023],
10	one	CD	NUMBER	one	num	11	SENT_131	[p7l669t2961r793b3004],
11	patient	NN	O	patient	nsubj	12	SENT_131	[p7l820t2942r1064b3023],
12	had	VBD	O	have	dep	28	SENT_131	[p7l1090t2942r1218b3004],
13	a	DT	O	a	det	15	SENT_131	[p7l1245t2961r1282b3004],
14	creatine	NN	O	creatine	nn	15	SENT_131	[p7l1309t2942r1589b3004],
15	phosphokinase	NN	O	phosphokinase	dobj	12	SENT_131	[p7l1616t2942r2146b3023],
16	of	IN	O	of	_	0	SENT_131	[p7l9t3049r86b3112],
17	200	CD	NUMBER	200	num	18	SENT_131	[p7l119t3050r248b3112],
18	U/L	NN	O	u/l	prep_of	15	SENT_131	[p7l286t3050r447b3123],
19	,	,	O	,	_	0	SENT_131	[p7l286t3050r447b3123],
20	and	CC	O	and	_	0	SENT_131	[p7l491t3049r616b3112],
21	the	DT	O	the	det	24	SENT_131	[p7l653t3049r760b3112],
22	remaining	VBG	O	remain	amod	24	SENT_131	[p7l797t3049r1159b3130],
23	9	CD	NUMBER	9	num	24	SENT_131	[p7l1199t3050r1238b3113],
24	patients	NNS	O	patient	nsubj	25	SENT_131	[p7l1276t3049r1552b3130],
25	reported	VBD	O	report	conj_and	12	SENT_131	[p7l1591t3049r1889b3130],
26	symptoms	NNS	O	symptom	dobj	25	SENT_131	[p7l1929t3069r2145b3130, p7l8t3166r177b3219],
27	but	CC	O	but	advmod	25	SENT_131	[p7l238t3156r352b3219],
28	had	VBD	O	have	_	0	SENT_131	[p7l410t3156r538b3219],
29	a	DT	O	a	det	31	SENT_131	[p7l599t3176r636b3219],
30	creatine	NN	O	creatine	nn	31	SENT_131	[p7l696t3156r976b3219],
31	phosphokinase	NN	O	phosphokinase	dobj	28	SENT_131	[p7l1037t3156r1566b3237],
32	less	JJR	O	less	amod	31	SENT_131	[p7l1627t3156r1756b3219],
33	than	IN	O	than	dep	32	SENT_131	[p7l1818t3156r1970b3219],
34	our	PRP$	O	we	poss	35	SENT_131	[p7l2032t3176r2149b3219],
35	laboratory	NN	O	laboratory	poss	38	SENT_131	[p7l8t3263r432b3344],
36	’s	POS	O	’s	_	0	SENT_131	[p7l8t3263r432b3344],
37	upper	JJ	O	upper	amod	38	SENT_131	[p7l457t3282r661b3344],
38	limit	NN	O	limit	npadvmod	42	SENT_131	[p7l684t3263r852b3325],
39	of	IN	O	of	_	0	SENT_131	[p7l877t3263r953b3325],
40	normal	JJ	O	normal	amod	41	SENT_131	[p7l972t3263r1223b3325],
41	(	NN	O	(	prep_of	38	SENT_131	[p7l1251t3264r1344b3340],
42	<	JJR	O	<	dep	32	SENT_131	[p7l1251t3264r1344b3340],
43	170	CD	NUMBER	170	num	45	SENT_131	[p7l1361t3263r1483b3325],
44	U/L	NN	O	u/l	nn	45	SENT_131	[p7l1509t3263r1697b3340],
45	)	NN	O	)	nsubj	28	SENT_131	[p7l1509t3263r1697b3340],
46	.	.	O	.	_	0	SENT_131	[p7l1509t3263r1697b3340],

1	Genotyping	NN	O	genotyping	nn	4	SENT_132	[p7l1728t3263r2146b3344],
2	and	CC	O	and	_	0	SENT_132	[p7l9t3371r135b3433],
3	allele	NN	O	allele	conj_and	1	SENT_132	[p7l168t3370r358b3433],
4	frequencies	NNS	O	frequency	nsubj	18	SENT_132	[p7l393t3370r801b3451],
5	in	IN	O	in	_	0	SENT_132	[p7l835t3370r903b3432],
6	patients	NNS	O	patient	prep_in	4	SENT_132	[p7l933t3370r1210b3451],
7	with	IN	O	with	_	0	SENT_132	[p7l1244t3370r1401b3433],
8	and	CC	O	and	_	0	SENT_132	[p7l1435t3370r1560b3433],
9	without	IN	O	without	_	0	SENT_132	[p7l1592t3370r1864b3433],
10	muscle	NN	O	muscle	nn	11	SENT_132	[p7l1896t3370r2146b3433],
11	symptoms	NNS	O	symptom	prep_without	6	SENT_132	[p7l11t3487r371b3558],
12	are	VBP	O	be	auxpass	13	SENT_132	[p7l398t3497r503b3540],
13	displayed	VBN	O	display	_	0	SENT_132	[p7l528t3477r869b3558],
14	in	IN	O	in	_	0	SENT_132	[p7l892t3477r959b3539],
15	Table	NNP	O	Table	prep_in	13	SENT_132	[p7l983t3477r1178b3540],
16	3	CD	NUMBER	3	num	15	SENT_132	[p7l1205t3478r1240b3540],
17	and	CC	O	and	_	0	SENT_132	[p7l1270t3477r1395b3540],
18	show	VB	O	show	conj_and	13	SENT_132	[p7l1422t3477r1602b3540],
19	a	DT	O	a	det	21	SENT_132	[p7l1628t3497r1664b3540],
20	greater	JJR	O	greater	amod	21	SENT_132	[p7l1688t3477r2144b3558],
21	—	NN	O	—	dobj	18	SENT_132	[p7l1688t3477r2144b3558],
22	than	IN	O	than	_	0	SENT_132	[p7l1688t3477r2144b3558],
23	—	CD	NUMBER	—	prep_than	18	SENT_132	[p7l1688t3477r2144b3558],
24	expected	VBN	O	expect	partmod	23	SENT_132	[p7l8t3584r324b3665],
25	T	NN	O	t	nn	27	SENT_132	[p7l356t3586r408b3646],
26	allele	NN	O	allele	nn	27	SENT_132	[p7l436t3584r626b3647],
27	frequency	NN	O	frequency	dobj	24	SENT_132	[p7l660t3584r1014b3665],
28	in	IN	O	in	_	0	SENT_132	[p7l1048t3584r1115b3646],
29	patients	NNS	O	patient	prep_in	27	SENT_132	[p7l1146t3584r1422b3665],
30	with	IN	O	with	_	0	SENT_132	[p7l1457t3584r1613b3647],
31	myalgia	NN	O	myalgium	prep_with	24	SENT_132	[p7l1646t3584r1934b3665],
32	compared	VBN	O	compare	_	0	SENT_132	[p7l1966t3604r2145b3647, p7l7t3691r205b3772],
33	with	IN	O	with	prepc_compared_with	24	SENT_132	[p7l234t3691r391b3754],
34	patients	NNS	O	patient	pobj	24	SENT_132	[p7l419t3691r695b3772],
35	without	IN	O	without	_	0	SENT_132	[p7l727t3691r999b3754],
36	myalgia	NN	O	myalgium	prep_without	34	SENT_132	[p7l1027t3691r1315b3772],
37	and	CC	O	and	_	0	SENT_132	[p7l1345t3691r1471b3754],
38	a	DT	O	a	det	45	SENT_132	[p7l1502t3711r1539b3754],
39	correspondingly	RB	O	correspondingly	advmod	40	SENT_132	[p7l1568t3691r2146b3772],
40	lower	JJR	O	lower	amod	45	SENT_132	[p8l8t20r208b82],
41	than	IN	O	than	_	0	SENT_132	[p8l239t20r391b82],
42	expected	VBN	O	expect	amod	44	SENT_132	[p8l424t20r740b101],
43	C	NN	O	c	nn	44	SENT_132	[p8l773t20r827b83],
44	allele	NN	O	allele	prep_than	40	SENT_132	[p8l863t20r1054b82],
45	frequency	NN	O	frequency	prep_than	18	SENT_132	[p8l1087t20r1454b101],
46	.	.	O	.	_	0	SENT_132	[p8l1087t20r1454b101],

1	Discussion	NN	O	discussion	_	0	SENT_133	[p8l15t262r484b342],

1	Our	PRP$	O	we	poss	2	SENT_134	[p8l116t467r252b529],
2	results	NNS	O	result	nsubj	3	SENT_134	[p8l280t466r510b529],
3	show	VBP	O	show	dep	43	SENT_134	[p8l545t466r725b529],
4	allele	NN	O	allele	nn	5	SENT_134	[p8l757t466r948b529],
5	frequencies	NNS	O	frequency	dobj	3	SENT_134	[p8l979t466r1388b547],
6	of	IN	O	of	_	0	SENT_134	[p8l1421t466r1497b529],
7	0.63	CD	NUMBER	0.63	prep_of	5	SENT_134	[p8l1522t466r1670b529],
8	and	CC	O	and	_	0	SENT_134	[p8l1707t466r1833b529],
9	0.37	CD	NUMBER	0.37	prep_of	5	SENT_134	[p8l1863t467r2012b529],
10	for	IN	O	for	_	0	SENT_134	[p8l2046t466r2149b529],
11	the	DT	O	the	det	15	SENT_134	[p8l8t573r114b635],
12	T	NN	O	t	nn	15	SENT_134	[p8l133t574r184b635],
13	and	CC	O	and	_	0	SENT_134	[p8l197t573r323b635],
14	C	NN	O	c	nn	15	SENT_134	[p8l341t573r395b636],
15	allele	NN	O	allele	prep_for	3	SENT_134	[p8l416t573r625b647],
16	,	,	O	,	_	0	SENT_134	[p8l416t573r625b647],
17	respectively	RB	O	respectively	advmod	15	SENT_134	[p8l645t573r1089b654],
18	,	,	O	,	_	0	SENT_134	[p8l645t573r1089b654],
19	in	IN	O	in	_	0	SENT_134	[p8l1110t573r1177b635],
20	the	DT	O	the	det	22	SENT_134	[p8l1194t573r1301b635],
21	C3435T	NN	O	c3435t	nn	22	SENT_134	[p8l1320t573r1609b636],
22	polymorphism	NN	O	polymorphism	prep_in	15	SENT_134	[p8l1626t573r2148b654],
23	of	IN	O	of	_	0	SENT_134	[p8l9t680r86b743],
24	ABCBI	NNP	LOCATION	ABCBI	prep_of	22	SENT_134	[p8l114t681r406b754],
25	,	,	O	,	_	0	SENT_134	[p8l114t681r406b754],
26	which	WDT	O	which	nsubj	28	SENT_134	[p8l450t680r666b743],
27	are	VBP	O	be	cop	28	SENT_134	[p8l709t700r813b743],
28	consistent	JJ	O	consistent	rcmod	15	SENT_134	[p8l855t680r1211b743],
29	with	IN	O	with	_	0	SENT_134	[p8l1252t680r1409b743],
30	previous	JJ	O	previous	amod	31	SENT_134	[p8l1447t680r1751b761],
31	reports	NNS	O	report	prep_with	28	SENT_134	[p8l1792t690r2037b761],
32	in	IN	O	in	_	0	SENT_134	[p8l2080t680r2148b742],
33	white	JJ	O	white	amod	34	SENT_134	[p8l8t786r203b849],
34	cohorts	NNS	O	cohort	prep_in	31	SENT_134	[p8l234t767r550b849],
35	.6	CD	NUMBER	.6	tmod	28	SENT_134	[p8l234t767r550b849],
36	A	DT	O	a	det	38	SENT_134	[p8l579t787r641b848],
37	6-week	JJ	DURATION	6-week	amod	38	SENT_134	[p8l672t786r932b849],
38	course	NN	O	course	nsubj	43	SENT_134	[p8l961t806r1190b849],
39	of	IN	O	of	_	0	SENT_134	[p8l1221t786r1298b849],
40	atorvastatin	NN	O	atorvastatin	nn	42	SENT_134	[p8l1323t786r1735b849],
41	80	CD	NUMBER	80	num	42	SENT_134	[p8l1768t787r1851b849],
42	mg/day	NN	O	mg/day	prep_of	38	SENT_134	[p8l1881t786r2146b867],
43	reduced	VBD	O	reduce	_	0	SENT_134	[p8l7t894r290b956],
44	LDL	NN	O	ldl	dobj	43	SENT_134	[p8l321t894r581b957],
45	.	.	O	.	_	0	SENT_134	[p8l321t894r581b957],

1	—	NN	O	—	_	0	SENT_135	[p8l321t894r581b957],
2	.	.	O	.	_	0	SENT_135	[p8l321t894r581b957],

1	C	NN	O	c	_	0	SENT_136	[p8l321t894r581b957],
2	by	IN	O	by	_	0	SENT_136	[p8l613t894r701b975],
3	an	DT	O	a	det	6	SENT_136	[p8l736t913r816b956],
4	average	JJ	O	average	amod	6	SENT_136	[p8l851t913r1122b975],
5	58	CD	PERCENT	58	num	6	SENT_136	[p8l1157t894r1314b957],
6	%	NN	PERCENT	%	prep_by	1	SENT_136	[p8l1157t894r1314b957],
7	:	:	O	:	_	0	SENT_136	[p8l1359t899r1412b953],
8	11	CD	PERCENT	11	num	9	SENT_136	[p8l1462t894r1611b957],
9	%	NN	PERCENT	%	dep	1	SENT_136	[p8l1462t894r1611b957],
10	(	CD	NUMBER	(	num	11	SENT_136	[p8l1651t895r1869b971],
11	mean	NN	O	mean	dep	9	SENT_136	[p8l1651t895r1869b971],
12	:	:	O	:	_	0	SENT_136	[p8l1911t899r1965b953],
13	SD	NN	O	sd	nn	14	SENT_136	[p8l2009t894r2144b971],
14	)	NN	O	)	dep	1	SENT_136	[p8l2009t894r2144b971],
15	in	IN	O	in	_	0	SENT_136	[p8l8t1001r75b1063],
16	the	DT	O	the	det	17	SENT_136	[p8l93t1001r200b1064],
17	cohort	NN	O	cohort	prep_in	14	SENT_136	[p8l219t1002r447b1064],
18	as	IN	O	as	_	0	SENT_136	[p8l465t1021r534b1064],
19	a	DT	O	a	det	20	SENT_136	[p8l555t1021r592b1064],
20	whole	NN	O	whole	prep_as	17	SENT_136	[p8l609t1001r842b1064],
21	.	.	O	.	_	0	SENT_136	[p8l609t1001r842b1064],

1	There	EX	O	there	expl	2	SENT_137	[p8l865t1001r1071b1064],
2	were	VBD	O	be	_	0	SENT_137	[p8l1089t1021r1259b1064],
3	genotype	NN	O	genotype	nn	6	SENT_137	[p8l1278t1001r2003b1082],
4	—	NN	O	—	nn	6	SENT_137	[p8l1278t1001r2003b1082],
5	dependent	JJ	O	dependent	amod	6	SENT_137	[p8l1278t1001r2003b1082],
6	differences	NNS	O	difference	nsubj	2	SENT_137	[p8l2021t1001r2145b1064, p8l8t1108r303b1170],
7	in	IN	O	in	_	0	SENT_137	[p8l329t1108r396b1169],
8	atorvastatin	NN	O	atorvastatin	nn	9	SENT_137	[p8l423t1108r835b1170],
9	efﬁcacy	NN	O	efﬁcacy	prep_in	6	SENT_137	[p8l861t1108r1162b1189],
10	;	:	O	;	_	0	SENT_137	[p8l861t1108r1162b1189],
11	patients	NNS	O	patient	nsubj	16	SENT_137	[p8l1189t1108r1465b1189],
12	with	IN	O	with	_	0	SENT_137	[p8l1492t1108r1648b1170],
13	the	DT	O	the	det	15	SENT_137	[p8l1673t1108r1779b1170],
14	CC	NN	O	cc	nn	15	SENT_137	[p8l1806t1108r1919b1171],
15	genotype	NN	O	genotype	prep_with	11	SENT_137	[p8l1947t1127r2145b1189, p8l8t1225r159b1296],
16	showed	VBD	O	show	parataxis	2	SENT_137	[p8l183t1215r449b1278],
17	a	DT	O	a	det	20	SENT_137	[p8l471t1235r508b1278],
18	53	CD	PERCENT	53	num	20	SENT_137	[p8l529t1215r685b1278],
19	%	NN	PERCENT	%	nn	20	SENT_137	[p8l529t1215r685b1278],
20	reduction	NN	O	reduction	dobj	16	SENT_137	[p8l709t1215r1047b1278],
21	in	IN	O	in	_	0	SENT_137	[p8l1067t1215r1134b1277],
22	LDL	NN	O	ldl	prep_in	20	SENT_137	[p8l1154t1216r1414b1278],
23	.	.	O	.	_	0	SENT_137	[p8l1154t1216r1414b1278],

1	—	NN	O	—	_	0	SENT_138	[p8l1154t1216r1414b1278],
2	.	.	O	.	_	0	SENT_138	[p8l1154t1216r1414b1278],

1	C	NN	O	c	nsubj	13	SENT_139	[p8l1154t1216r1414b1278],
2	compared	VBN	O	compare	_	0	SENT_139	[p8l1438t1215r1789b1296],
3	with	IN	O	with	prepc_compared_with	1	SENT_139	[p8l1809t1215r1965b1278],
4	59	CD	PERCENT	59	num	5	SENT_139	[p8l1987t1215r2144b1279],
5	%	NN	PERCENT	%	pobj	1	SENT_139	[p8l1987t1215r2144b1279],
6	in	IN	O	in	_	0	SENT_139	[p8l8t1322r75b1384],
7	patients	NNS	O	patient	prep_in	5	SENT_139	[p8l95t1322r372b1403],
8	with	IN	O	with	_	0	SENT_139	[p8l396t1322r552b1385],
9	the	DT	O	the	det	12	SENT_139	[p8l574t1322r680b1385],
10	T	NN	O	t	nn	12	SENT_139	[p8l703t1324r756b1384],
11	T/TC	NN	O	t/tc	nn	12	SENT_139	[p8l758t1323r948b1385],
12	genotypes	NNS	O	genotype	prep_with	7	SENT_139	[p8l973t1332r1331b1403],
13	(	VBP	O	(	_	0	SENT_139	[p8l1358t1323r1438b1399],
14	P	NN	O	p	dobj	13	SENT_139	[p8l1358t1323r1438b1399],
15	=	JJ	O	=	advmod	13	SENT_139	[p8l1469t1344r1522b1365],
16	.034	CD	NUMBER	.034	num	17	SENT_139	[p8l1549t1323r1745b1399],
17	)	NN	O	)	dep	15	SENT_139	[p8l1549t1323r1745b1399],
18	.	.	O	.	_	0	SENT_139	[p8l1549t1323r1745b1399],

1	Mechanistically	RB	O	mechanistically	advmod	6	SENT_140	[p8l1771t1322r2145b1385, p8l8t1429r244b1510],
2	,	,	O	,	_	0	SENT_140	[p8l1771t1322r2145b1385, p8l8t1429r244b1510],
3	this	DT	O	this	det	4	SENT_140	[p8l281t1429r406b1491],
4	ﬁnding	NN	O	ﬁnding	nsubj	6	SENT_140	[p8l443t1429r691b1510],
5	is	VBZ	O	be	cop	6	SENT_140	[p8l726t1429r781b1491],
6	consistent	JJ	O	consistent	_	0	SENT_140	[p8l818t1429r1174b1491],
7	with	IN	O	with	_	0	SENT_140	[p8l1208t1429r1364b1492],
8	previous	JJ	O	previous	amod	9	SENT_140	[p8l1396t1429r1699b1510],
9	reports	NNS	O	report	prep_with	6	SENT_140	[p8l1734t1438r1979b1510],
10	that	WDT	O	that	nsubj	11	SENT_140	[p8l2014t1429r2148b1491],
11	showed	VBD	O	show	rcmod	9	SENT_140	[p8l11t1536r277b1598],
12	the	DT	O	the	det	14	SENT_140	[p8l313t1536r419b1598],
13	CC	NN	O	cc	nn	14	SENT_140	[p8l457t1536r571b1598],
14	genotype	NN	O	genotype	dobj	11	SENT_140	[p8l610t1545r934b1617],
15	to	TO	O	to	aux	17	SENT_140	[p8l971t1545r1037b1598],
16	be	VB	O	be	auxpass	17	SENT_140	[p8l1073t1536r1155b1598],
17	associated	VBN	O	associate	xcomp	11	SENT_140	[p8l1194t1536r1560b1598],
18	with	IN	O	with	_	0	SENT_140	[p8l1595t1536r1751b1598],
19	greater	JJR	O	greater	amod	21	SENT_140	[p8l1788t1545r2036b1617],
20	Pglycoprotein	NN	O	pglycoprotein	nn	21	SENT_140	[p8l2070t1537r2145b1597, p8l9t1642r459b1723],
21	levels7	NN	O	levels7	prep_with	17	SENT_140	[p8l496t1624r732b1705],
22	and	CC	O	and	_	0	SENT_140	[p8l773t1642r899b1705],
23	a	DT	O	a	det	26	SENT_140	[p8l937t1662r974b1705],
24	smaller	JJR	O	smaller	amod	26	SENT_140	[p8l1013t1642r1273b1705],
25	atorvastatin	NN	O	atorvastatin	nn	26	SENT_140	[p8l1311t1642r1723b1705],
26	area	NN	O	area	conj_and	21	SENT_140	[p8l1763t1662r1909b1705],
27	under	IN	O	under	_	0	SENT_140	[p8l1945t1642r2149b1705],
28	the	DT	O	the	det	29	SENT_140	[p8l8t1750r114b1812],
29	curve	NN	O	curve	prep_under	17	SENT_140	[p8l141t1770r336b1813],
30	in	IN	O	in	_	0	SENT_140	[p8l363t1750r430b1812],
31	pharmacokinetic	JJ	O	pharmacokinetic	amod	32	SENT_140	[p8l454t1750r1050b1831],
32	studies	NNS	O	study	prep_in	29	SENT_140	[p8l1081t1731r1378b1812],
33	.8	CD	NUMBER	.8	tmod	17	SENT_140	[p8l1081t1731r1378b1812],

1	There	EX	O	there	expl	2	SENT_141	[p8l115t1857r321b1919],
2	were	VBD	O	be	_	0	SENT_141	[p8l348t1877r518b1919],
3	no	DT	O	no	det	4	SENT_141	[p8l546t1877r632b1919],
4	differences	NNS	O	difference	nsubj	2	SENT_141	[p8l662t1857r1053b1919],
5	in	IN	O	in	_	0	SENT_141	[p8l1083t1857r1150b1918],
6	the	DT	O	the	det	9	SENT_141	[p8l1177t1858r1283b1919],
7	cholesterol	NN	O	cholesterol	nn	9	SENT_141	[p8l1312t1857r1703b1919],
8	metabolism	NN	O	metabolism	nn	9	SENT_141	[p8l1730t1857r2149b1919],
9	markers	NNS	O	marker	prep_in	4	SENT_141	[p8l8t1964r292b2026],
10	that	IN	O	that	complm	13	SENT_141	[p8l332t1964r465b2026],
11	we	PRP	O	we	nsubj	13	SENT_141	[p8l503t1983r603b2026],
12	have	VBP	O	have	aux	13	SENT_141	[p8l642t1964r806b2026],
13	shown	VBN	O	show	ccomp	2	SENT_141	[p8l848t1964r1074b2026],
14	to	TO	O	to	aux	15	SENT_141	[p8l1111t1973r1178b2026],
15	determine	VB	O	determine	xcomp	13	SENT_141	[p8l1217t1964r1573b2026],
16	the	DT	O	the	det	17	SENT_141	[p8l1611t1964r1718b2026],
17	efﬁcacy	NN	O	efﬁcacy	dobj	15	SENT_141	[p8l1758t1964r2037b2045],
18	of	IN	O	of	_	0	SENT_141	[p8l2077t1964r2153b2026],
19	atorvastatinz	NN	O	atorvastatinz	prep_of	17	SENT_141	[p8l10t2052r456b2133],
20	according	VBG	O	accord	_	0	SENT_141	[p8l501t2070r848b2151],
21	to	TO	O	to	prepc_according_to	15	SENT_141	[p8l893t2080r959b2133],
22	genotype	NN	O	genotype	pobj	15	SENT_141	[p8l1004t2080r1350b2151],
23	;	:	O	;	_	0	SENT_141	[p8l1004t2080r1350b2151],
24	desmosterol	NN	O	desmosterol	nsubj	31	SENT_141	[p8l1398t2071r1827b2133],
25	and	CC	O	and	_	0	SENT_141	[p8l1872t2071r1998b2133],
26	the	DT	O	the	det	28	SENT_141	[p8l2040t2071r2147b2133],
27	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	nn	28	SENT_141	[p8l9t2178r832b2241],
28	ratio	NN	O	ratio	nsubj	31	SENT_141	[p8l882t2178r1044b2241],
29	did	VBD	O	do	aux	31	SENT_141	[p8l1096t2178r1207b2241],
30	not	RB	O	not	neg	31	SENT_141	[p8l1256t2188r1369b2241],
31	differ	VB	O	differ	parataxis	2	SENT_141	[p8l1419t2178r1615b2241],
32	by	IN	O	by	_	0	SENT_141	[p8l1661t2178r1748b2259],
33	genotype	NN	O	genotype	prep_by	31	SENT_141	[p8l1800t2188r2142b2259],
34	.	.	O	.	_	0	SENT_141	[p8l1800t2188r2142b2259],

1	The	DT	O	the	det	2	SENT_142	[p8l8t2285r144b2347],
2	relationship	NN	O	relationship	_	0	SENT_142	[p8l195t2285r616b2366],
3	between	IN	O	between	_	0	SENT_142	[p8l668t2285r965b2347],
4	genotype	NN	O	genotype	nn	7	SENT_142	[p8l1018t2294r1342b2366],
5	and	CC	O	and	_	0	SENT_142	[p8l1396t2285r1522b2347],
6	percent	NN	O	percent	conj_and	4	SENT_142	[p8l1572t2295r1836b2366],
7	LDL	NN	O	ldl	prep_between	2	SENT_142	[p8l1885t2285r2146b2348],
8	.	.	O	.	_	0	SENT_142	[p8l1885t2285r2146b2348],

1	—	NN	O	—	_	0	SENT_143	[p8l1885t2285r2146b2348],
2	.	.	O	.	_	0	SENT_143	[p8l1885t2285r2146b2348],

1	C	NN	O	c	_	0	SENT_144	[p8l1885t2285r2146b2348],

1	94	CD	NUMBER	94	_	0	SENT_145	[p8l35t2444r74b2472],
2	Journal	NNP	O	Journal	dep	1	SENT_145	[p8l1207t2441r1332b2472],
3	of	IN	O	of	_	0	SENT_145	[p8l1347t2441r1381b2472],
4	clinical	JJ	O	clinical	amod	5	SENT_145	[p8l1395t2441r1516b2472],
5	Lipidology	NNP	O	Lipidology	prep_of	2	SENT_145	[p8l1533t2441r1714b2480],
6	,	,	O	,	_	0	SENT_145	[p8l1533t2441r1714b2480],
7	vol	NN	O	vol	appos	5	SENT_145	[p8l1732t2441r1784b2472],
8	5	CD	NUMBER	5	num	7	SENT_145	[p8l1800t2444r1827b2477],
9	,	,	O	,	_	0	SENT_145	[p8l1800t2444r1827b2477],
10	No	DT	O	no	det	11	SENT_145	[p8l1847t2443r1886b2472],
11	2	CD	NUMBER	2	appos	7	SENT_145	[p8l1905t2444r1932b2476],
12	,	,	O	,	_	0	SENT_145	[p8l1905t2444r1932b2476],
13	April	NNP	DATE	April	tmod	7	SENT_145	[p8l1950t2441r2029b2480],
14	2011	CD	DATE	2011	num	13	SENT_145	[p8l2045t2444r2122b2472],

1	Table	NNP	O	Table	_	0	SENT_146	[p8l59t2562r142b2590],
2	2	CD	NUMBER	2	num	4	SENT_146	[p8l155t2563r171b2589],
3	Patient	NN	O	patient	nn	4	SENT_146	[p8l224t2562r330b2590],
4	characteristics	NNS	O	characteristic	dep	1	SENT_146	[p8l341t2562r566b2594],
5	,	,	O	,	_	0	SENT_146	[p8l341t2562r566b2594],
6	lipid	NN	O	lipid	nn	7	SENT_146	[p8l581t2562r644b2597],
7	concentrations	NNS	O	concentration	appos	4	SENT_146	[p8l658t2562r889b2594],
8	,	,	O	,	_	0	SENT_146	[p8l658t2562r889b2594],
9	and	CC	O	and	_	0	SENT_146	[p8l903t2562r954b2590],
10	percent	NN	O	percent	nn	11	SENT_146	[p8l968t2565r1079b2597],
11	change	NN	O	change	conj_and	1	SENT_146	[p8l1090t2562r1195b2597],
12	in	IN	O	in	_	0	SENT_146	[p8l1206t2562r1233b2589],
13	lipid	NN	O	lipid	nn	14	SENT_146	[p8l1248t2562r1311b2597],
14	parameters	NNS	O	parameter	prep_in	11	SENT_146	[p8l1325t2565r1486b2597],
15	according	VBG	O	accord	_	0	SENT_146	[p8l1498t2562r1641b2597],
16	to	TO	O	to	prepc_according_to	1	SENT_146	[p8l1653t2565r1683b2590],
17	c3435r	VB	O	c3435r	pcomp	1	SENT_146	[p8l1696t2563r1803b2590],
18	Genotype	NN	O	genotype	dobj	17	SENT_146	[p8l1814t2563r1952b2597],
19	in	IN	O	in	_	0	SENT_146	[p8l1964t2562r1990b2589],
20	ABCB1	NN	O	abcb1	prep_in	17	SENT_146	[p8l2003t2563r2098b2590],

1	All	DT	O	all	det	2	SENT_147	[p8l680t2655r720b2683],
2	genotypes	NNS	O	genotype	_	0	SENT_147	[p8l734t2658r894b2690],
3	,	,	O	,	_	0	SENT_147	[p8l734t2658r894b2690],
4	P	NN	O	p	nn	5	SENT_147	[p8l1641t2640r1659b2667],
5	Value	NN	O	value	appos	2	SENT_147	[p8l1672t2639r1749b2667],

1	Variable	JJ	O	variable	amod	2	SENT_148	[p8l61t2714r180b2742],
2	n	NN	O	n	_	0	SENT_148	[p8l682t2722r696b2742],
3	=	JJ	O	=	amod	10	SENT_148	[p8l716t2725r738b2734],
4	98	CD	NUMBER	98	num	5	SENT_148	[p8l757t2716r791b2742],
5	TT	NN	ORGANIZATION	tt	tmod	3	SENT_148	[p8l927t2715r968b2746],
6	,	,	O	,	_	0	SENT_148	[p8l927t2715r968b2746],
7	n	NN	O	n	appos	5	SENT_148	[p8l985t2722r1000b2742],
8	=	JJ	O	=	amod	10	SENT_148	[p8l1019t2725r1042b2734],
9	41	CD	NUMBER	41	tmod	8	SENT_148	[p8l1060t2716r1093b2742],
10	TC	NN	O	tc	dep	2	SENT_148	[p8l1165t2715r1206b2746],
11	,	,	O	,	_	0	SENT_148	[p8l1165t2715r1206b2746],
12	n	NN	O	n	appos	10	SENT_148	[p8l1224t2722r1238b2742],
13	=	JJ	O	=	amod	12	SENT_148	[p8l1258t2725r1280b2734],
14	42	CD	NUMBER	42	num	15	SENT_148	[p8l1298t2716r1332b2742],
15	CC	NN	O	cc	dep	13	SENT_148	[p8l1404t2715r1445b2746],
16	,	,	O	,	_	0	SENT_148	[p8l1404t2715r1445b2746],
17	n	NN	O	n	nn	21	SENT_148	[p8l1462t2722r1476b2742],
18	=	JJ	O	=	amod	21	SENT_148	[p8l1496t2725r1518b2734],
19	15	CD	NUMBER	15	tmod	18	SENT_148	[p8l1538t2717r1570b2742],
20	ANOVA	NNP	ORGANIZATION	ANOVA	nn	21	SENT_148	[p8l1641t2715r1741b2742],
21	TT	NN	O	tt	appos	10	SENT_148	[p8l1772t2715r1804b2742],
22	vs	CC	O	vs	_	0	SENT_148	[p8l1818t2722r1847b2742],
23	CC	NN	O	cc	nn	24	SENT_148	[p8l1862t2715r1894b2742],
24	TT/TC	NN	O	tt/tc	conj_vs	10	SENT_148	[p8l1925t2714r2007b2749],
25	vs	CC	O	vs	_	0	SENT_148	[p8l2021t2722r2051b2742],
26	CC	NN	O	cc	nn	27	SENT_148	[p8l2066t2715r2098b2742],
27	Age	NN	O	age	conj_vs	24	SENT_148	[p8l8t2799r116b2866],
28	67	CD	NUMBER	67	dep	27	SENT_148	[p8l1313t2801r1379b2852],
29	:	:	O	:	_	0	SENT_148	[p8l1417t2804r1462b2849],
30	10	CD	NUMBER	10	number	31	SENT_148	[p8l1501t2801r1568b2852],
31	69.76	CD	NUMBER	69.76	dep	27	SENT_148	[p8l1745t2801r1909b2852],
32	:	:	O	:	_	0	SENT_148	[p8l1946t2804r1991b2849],
33	9	CD	NUMBER	9	num	36	SENT_148	[p8l2028t2801r2057b2852],
34	Body	NN	O	body	nn	36	SENT_148	[p8l13t2886r154b2956],
35	mass	NN	O	mass	nn	36	SENT_148	[p8l185t2903r324b2941],
36	index	NN	O	index	dep	31	SENT_148	[p8l352t2886r514b2941],
37	27	CD	NUMBER	27	dep	36	SENT_148	[p8l1313t2891r1379b2941],
38	:	:	O	:	_	0	SENT_148	[p8l1417t2893r1462b2938],
39	5	CD	NUMBER	5	number	40	SENT_148	[p8l1501t2892r1529b2941],
40	27	CD	NUMBER	27	dep	27	SENT_148	[p8l1842t2891r1908b2941],
41	:	:	O	:	_	0	SENT_148	[p8l1946t2893r1991b2938],
42	5	CD	NUMBER	5	num	45	SENT_148	[p8l2029t2892r2057b2941],
43	Baseline	NN	O	baseline	nn	45	SENT_148	[p8l13t2975r256b3031],
44	lipid	NN	O	lipid	nn	45	SENT_148	[p8l288t2975r416b3045],
45	panel	NN	O	panel	dep	40	SENT_148	[p8l449t2975r626b3045],
46	,	,	O	,	_	0	SENT_148	[p8l449t2975r626b3045],
47	mg/dL	NN	O	mg/dl	appos	45	SENT_148	[p8l660t2975r851b3045],

1	Total	JJ	O	total	amod	2	SENT_149	[p8l82t3065r232b3121],
2	cholesterol	NN	O	cholesterol	_	0	SENT_149	[p8l260t3065r589b3121],
3	207	CD	NUMBER	207	num	2	SENT_149	[p8l1276t3070r1379b3121],
4	i	FW	O	i	dep	2	SENT_149	[p8l1417t3073r1462b3118],
5	30	CD	NUMBER	30	number	6	SENT_149	[p8l1499t3070r1567b3121],
6	204	CD	NUMBER	204	dep	4	SENT_149	[p8l1805t3070r1911b3121],
7	:	:	O	:	_	0	SENT_149	[p8l1946t3073r1991b3118],
8	36	CD	NUMBER	36	num	11	SENT_149	[p8l2028t3070r2095b3121],
9	Low-density	NN	O	low-density	nn	11	SENT_149	[p8l87t3156r444b3226],
10	lipoprotein	NN	O	lipoprotein	nn	11	SENT_149	[p8l475t3156r798b3226],
11	cholesterol	NN	O	cholesterol	dep	4	SENT_149	[p8l833t3156r1162b3211],
12	132	CD	NUMBER	132	dep	11	SENT_149	[p8l1276t3160r1379b3211],
13	:	:	O	:	_	0	SENT_149	[p8l1417t3163r1462b3208],
14	32	CD	NUMBER	32	number	15	SENT_149	[p8l1499t3160r1566b3211],
15	130	CD	NUMBER	130	dep	4	SENT_149	[p8l1805t3160r1909b3211],
16	:	:	O	:	_	0	SENT_149	[p8l1946t3163r1991b3208],
17	30	CD	NUMBER	30	num	20	SENT_149	[p8l2028t3160r2096b3211],
18	High-density	JJ	O	high-density	amod	20	SENT_149	[p8l87t3246r469b3316],
19	lipoprotein	NN	O	lipoprotein	nn	20	SENT_149	[p8l501t3246r824b3316],
20	cholesterol	NN	O	cholesterol	dep	15	SENT_149	[p8l859t3246r1188b3301],
21	45	CD	NUMBER	45	dep	20	SENT_149	[p8l1310t3251r1379b3301],
22	:	:	O	:	_	0	SENT_149	[p8l1417t3254r1462b3298],
23	14	CD	NUMBER	14	number	24	SENT_149	[p8l1501t3251r1568b3301],
24	45	CD	NUMBER	45	dep	4	SENT_149	[p8l1839t3251r1908b3301],
25	:	:	O	:	_	0	SENT_149	[p8l1946t3254r1991b3298],
26	16	CD	NUMBER	16	num	27	SENT_149	[p8l2030t3251r2095b3301],
27	Triglycerides	NNPS	O	Triglycerides	dep	24	SENT_149	[p8l81t3335r457b3405],
28	149	CD	NUMBER	149	dep	27	SENT_149	[p8l1276t3340r1379b3391],
29	:	:	O	:	_	0	SENT_149	[p8l1416t3343r1462b3388],
30	83	CD	NUMBER	83	number	31	SENT_149	[p8l1498t3340r1565b3391],
31	148	CD	NUMBER	148	dep	4	SENT_149	[p8l1805t3340r1910b3391],
32	:	:	O	:	_	0	SENT_149	[p8l1945t3343r1991b3388],
33	69	CD	NUMBER	69	num	36	SENT_149	[p8l2029t3340r2094b3391],
34	Baseline	NN	O	baseline	nn	36	SENT_149	[p8l12t3426r255b3481],
35	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	nn	36	SENT_149	[p8l286t3425r996b3495],
36	ratio	NN	O	ratio	dep	31	SENT_149	[p8l1025t3426r1180b3489],
37	,	,	O	,	_	0	SENT_149	[p8l1025t3426r1180b3489],
38	125	CD	NUMBER	125	appos	36	SENT_149	[p8l1276t3431r1379b3481],
39	i	FW	O	i	dep	38	SENT_149	[p8l1416t3433r1461b3478],
40	38	CD	NUMBER	38	number	41	SENT_149	[p8l1499t3430r1567b3481],
41	125	CD	NUMBER	125	dep	39	SENT_149	[p8l1805t3431r1908b3481],
42	:	:	O	:	_	0	SENT_149	[p8l1945t3433r1990b3478],
43	44	CD	NUMBER	44	dep	39	SENT_149	[p8l2026t3431r2097b3481],

1	umol	NN	O	umol	nn	3	SENT_150	[p8l85t3516r234b3584],
2	cholestanol/mmol	NN	O	cholestanol/mmol	nn	3	SENT_150	[p8l261t3516r804b3585],
3	cholesterol	NN	O	cholesterol	_	0	SENT_150	[p8l832t3516r1161b3571],
4	>	JJR	O	>	dep	3	SENT_150	[p8l93t3610r264b3662],
5	<	JJR	O	<	dep	4	SENT_150	[p8l93t3610r264b3662],
6	1OO	CD	NUMBER	1oo	dep	3	SENT_150	[p8l93t3610r264b3662],

1	Baseline	NN	O	baseline	nn	2	SENT_151	[p8l12t3696r255b3751],
2	desmosterol	NN	O	desmosterol	_	0	SENT_151	[p8l286t3696r661b3759],
3	,	,	O	,	_	0	SENT_151	[p8l286t3696r661b3759],
4	umol/L	NN	O	umol/l	appos	2	SENT_151	[p8l696t3695r911b3765],
5	2.32	CD	NUMBER	2.32	num	4	SENT_151	[p8l1253t3700r1378b3751],
6	:	:	O	:	_	0	SENT_151	[p8l1416t3703r1461b3748],
7	0.86	CD	NUMBER	0.86	num	8	SENT_151	[p8l1498t3700r1625b3751],
8	2.26	CD	NUMBER	2.26	dep	2	SENT_151	[p8l1782t3700r1908b3751],
9	:	:	O	:	_	0	SENT_151	[p8l1945t3703r1990b3748],
10	0.83	CD	NUMBER	0.83	dep	8	SENT_151	[p8l2027t3700r2153b3751],

1	Treatment	NN	O	treatment	_	0	SENT_152	[p9l6t18r311b71],

1	Total	JJ	O	total	amod	2	SENT_153	[p9l81t105r232b161],
2	cholesterol	NN	O	cholesterol	_	0	SENT_153	[p9l259t105r589b161],
3	116	CD	NUMBER	116	num	2	SENT_153	[p9l1276t110r1379b161],
4	:	:	O	:	_	0	SENT_153	[p9l1416t113r1461b158],
5	24	CD	NUMBER	24	num	8	SENT_153	[p9l1500t110r1568b161],
6	Low-density	NN	O	low-density	nn	8	SENT_153	[p9l87t196r444b266],
7	lipoprotein	NN	O	lipoprotein	nn	8	SENT_153	[p9l475t196r799b266],
8	cholesterol	NN	O	cholesterol	dep	2	SENT_153	[p9l833t196r1162b251],
9	55	CD	NUMBER	55	dep	8	SENT_153	[p9l1314t202r1379b251],
10	:	:	O	:	_	0	SENT_153	[p9l1417t203r1462b248],
11	18	CD	NUMBER	18	num	14	SENT_153	[p9l1501t200r1568b251],
12	High-density	JJ	O	high-density	amod	14	SENT_153	[p9l87t286r470b356],
13	lipoprotein	NN	O	lipoprotein	nn	14	SENT_153	[p9l501t286r824b356],
14	cholesterol	NN	O	cholesterol	dep	8	SENT_153	[p9l859t286r1188b341],
15	43	CD	NUMBER	43	dep	14	SENT_153	[p9l1310t291r1379b341],
16	:	:	O	:	_	0	SENT_153	[p9l1417t294r1462b338],
17	1	CD	NUMBER	1	num	18	SENT_153	[p9l1501t292r1528b340],
18	Triglycerides	NNPS	O	Triglycerides	dep	8	SENT_153	[p9l82t375r457b445],
19	93	CD	NUMBER	93	num	21	SENT_153	[p9l1312t380r1379b431],
20	:	:	O	:	_	0	SENT_153	[p9l1417t383r1462b428],
21	40	CD	NUMBER	40	dep	18	SENT_153	[p9l1498t380r1567b431],

1	Percent	NN	O	percent	_	0	SENT_154	[p9l12t468r233b521],
2	change	NN	O	change	dep	1	SENT_154	[p9l261t466r490b536],
3	,	,	O	,	_	0	SENT_154	[p9l261t466r490b536],
4	°	CD	NUMBER	°	appos	2	SENT_154	[p9l523t470r574b521],
5	/	:	O	/	punct	6	SENT_154	[p9l523t470r574b521],
6	o	NN	O	o	dep	4	SENT_154	[p9l523t470r574b521],

1	Total	JJ	O	total	amod	2	SENT_155	[p9l82t556r232b611],
2	cholesterol	NN	O	cholesterol	_	0	SENT_155	[p9l260t556r589b611],
3	-43	CD	NUMBER	-43	num	5	SENT_155	[p9l1255t561r1378b611],
4	:	:	O	:	_	0	SENT_155	[p9l1417t564r1462b608],
5	10	CD	NUMBER	10	dep	15	SENT_155	[p9l1501t561r1567b611],
6	Low	JJ	O	low	amod	9	SENT_155	[p9l87t646r444b716],
7	—	NN	O	—	nn	9	SENT_155	[p9l87t646r444b716],
8	density	NN	O	density	nn	9	SENT_155	[p9l87t646r444b716],
9	lipoprotein	NN	O	lipoprotein	dep	5	SENT_155	[p9l475t646r798b716],
10	cholesterol	NN	O	cholesterol	dep	15	SENT_155	[p9l833t646r1162b701],
11	-58	CD	NUMBER	-58	num	10	SENT_155	[p9l1255t651r1381b701],
12	:11	CD	NUMBER	:11	num	15	SENT_155	[p9l1416t652r1540b700],
13	High-density	JJ	O	high-density	amod	15	SENT_155	[p9l87t736r470b806],
14	lipoprotein	NN	O	lipoprotein	nn	15	SENT_155	[p9l501t736r824b806],
15	cholesterol	NN	O	cholesterol	dep	2	SENT_155	[p9l859t736r1188b791],
16	+2	CD	NUMBER	+2	dep	15	SENT_155	[p9l1292t741r1379b790],
17	:	:	O	:	_	0	SENT_155	[p9l1417t743r1462b788],
18	18	CD	NUMBER	18	num	19	SENT_155	[p9l1501t740r1568b791],
19	Triglycerides	NNPS	ORGANIZATION	Triglycerides	dep	2	SENT_155	[p9l82t826r457b896],
20	31	CD	NUMBER	31	num	22	SENT_155	[p9l1312t831r1378b881],
21	:	:	O	:	_	0	SENT_155	[p9l1417t834r1462b878],
22	24	CD	NUMBER	24	dep	19	SENT_155	[p9l1501t831r1568b881],

1	-45	CD	NUMBER	-45	_	0	SENT_156	[p9l55t3004r217b3069],
2	:	:	O	:	_	0	SENT_156	[p9l267t3007r325b3065],
3	8	CD	NUMBER	8	num	4	SENT_156	[p9l372t3004r414b3069],
4	-40	CD	NUMBER	-40	dep	1	SENT_156	[p9l676t3004r839b3069],
5	:	:	O	:	_	0	SENT_156	[p9l887t3008r945b3065],
6	10	CD	NUMBER	10	number	7	SENT_156	[p9l996t3004r1083b3069],
7	.19	CD	NUMBER	.19	dep	1	SENT_156	[p9l1247t3004r1359b3069],
8	-60	CD	NUMBER	-60	dep	7	SENT_156	[p9l55t3121r219b3186],
9	:	:	O	:	_	0	SENT_156	[p9l267t3125r325b3182],
10	9	CD	NUMBER	9	num	11	SENT_156	[p9l373t3121r411b3186],
11	-53	CD	NUMBER	-53	dep	1	SENT_156	[p9l676t3121r837b3186],
12	:	:	O	:	_	0	SENT_156	[p9l887t3125r945b3182],
13	11	CD	NUMBER	11	number	14	SENT_156	[p9l996t3122r1079b3185],
14	.07	CD	NUMBER	.07	dep	11	SENT_156	[p9l1247t3121r1360b3186],
15	+3	CD	NUMBER	+3	dep	18	SENT_156	[p9l104t3238r216b3304],
16	i	FW	O	i	dep	15	SENT_156	[p9l267t3242r325b3300],
17	18	CD	NUMBER	18	dep	18	SENT_156	[p9l376t3238r462b3304],
18	+1	CD	NUMBER	+1	dep	11	SENT_156	[p9l724t3240r836b3303],
19	i	FW	O	i	dep	18	SENT_156	[p9l887t3242r946b3300],
20	14	CD	NUMBER	14	number	21	SENT_156	[p9l996t3239r1084b3304],
21	.76	CD	NUMBER	.76	num	22	SENT_156	[p9l1247t3238r1361b3304],
22	31	CD	NUMBER	31	dep	19	SENT_156	[p9l131t3356r216b3421],
23	:	:	O	:	_	0	SENT_156	[p9l267t3359r325b3417],
24	21	CD	NUMBER	21	number	25	SENT_156	[p9l375t3356r459b3420],
25	33	CD	NUMBER	33	dep	11	SENT_156	[p9l750t3356r837b3421],
26	:	:	O	:	_	0	SENT_156	[p9l887t3360r946b3417],
27	25	CD	NUMBER	25	number	28	SENT_156	[p9l995t3356r1080b3421],
28	.95	CD	NUMBER	.95	dep	1	SENT_156	[p9l1247t3356r1361b3421],
29	ANOVA	NNP	ORGANIZATION	ANOVA	dep	28	SENT_156	[p9l169t3476r378b3536],
30	,	,	O	,	_	0	SENT_156	[p9l169t3476r378b3536],
31	analysis	NN	O	analysis	appos	1	SENT_156	[p9l409t3474r632b3542],
32	of	IN	O	of	_	0	SENT_156	[p9l661t3474r719b3528],
33	variance	NN	O	variance	prep_of	31	SENT_156	[p9l741t3475r995b3528],
34	.	.	O	.	_	0	SENT_156	[p9l741t3475r995b3528],

1	reduction	NN	O	reduction	nsubj	15	SENT_157	[p9l7t3703r344b3766],
2	in	IN	O	in	_	0	SENT_157	[p9l370t3703r437b3765],
3	response	NN	O	response	prep_in	1	SENT_157	[p9l461t3723r772b3784],
4	to	TO	O	to	_	0	SENT_157	[p9l798t3713r865b3766],
5	atorvastatin	NN	O	atorvastatin	prep_to	3	SENT_157	[p9l893t3703r1306b3766],
6	remained	VBD	O	remain	cop	15	SENT_157	[p9l1330t3703r1663b3766],
7	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_157	[p9l1692t3703r2061b3784],
8	at	IN	O	at	_	0	SENT_157	[p9l2087t3713r2149b3766],
9	the	DT	O	the	det	10	SENT_157	[p10l8t19r114b80],
10	P	NN	O	p	prep_at	7	SENT_157	[p10l145t21r200b80],
11	=	JJ	O	=	advmod	14	SENT_157	[p10l240t40r294b61],
12	.045	CD	NUMBER	.045	num	13	SENT_157	[p10l330t19r475b81],
13	level	NN	O	level	dep	11	SENT_157	[p10l511t19r681b81],
14	when	WRB	O	when	dep	10	SENT_157	[p10l713t19r904b81],
15	desmosterol	NN	O	desmosterol	_	0	SENT_157	[p10l937t19r1365b80],
16	and	CC	O	and	_	0	SENT_157	[p10l1399t19r1525b80],
17	cholestanol/cholesterol	NN	O	cholestanol/cholesterol	conj_and	15	SENT_157	[p10l1557t19r2145b81, p10l8t125r269b186],

1	ratio	NN	O	ratio	nsubjpass	3	SENT_158	[p10l309t125r471b186],
2	were	VBD	O	be	auxpass	3	SENT_158	[p10l510t144r680b186],
3	entered	VBN	O	enter	_	0	SENT_158	[p10l723t125r984b186],
4	as	IN	O	as	_	0	SENT_158	[p10l1025t144r1093b186],
5	covariates	NNS	O	covariate	prep_as	3	SENT_158	[p10l1136t125r1492b186],
6	in	IN	O	in	_	0	SENT_158	[p10l1534t125r1602b186],
7	a	DT	O	a	det	9	SENT_158	[p10l1643t144r1680b186],
8	multivariate	JJ	O	multivariate	amod	9	SENT_158	[p10l1719t125r2147b186],
9	model	NN	O	model	prep_in	5	SENT_158	[p10l8t232r249b306],
10	,	,	O	,	_	0	SENT_158	[p10l8t232r249b306],
11	suggesting	VBG	O	suggest	xcomp	3	SENT_158	[p10l287t232r664b313],
12	an	DT	O	a	det	13	SENT_158	[p10l699t252r780b295],
13	effect	NN	O	effect	dobj	11	SENT_158	[p10l813t232r1014b295],
14	on	IN	O	on	_	0	SENT_158	[p10l1046t252r1132b295],
15	atorvastatin	NN	O	atorvastatin	nn	16	SENT_158	[p10l1167t232r1579b295],
16	efﬁcacy	NN	O	efﬁcacy	prep_on	13	SENT_158	[p10l1613t232r1892b313],
17	that	WDT	O	that	nsubj	19	SENT_158	[p10l1925t232r2059b295],
18	is	VBZ	O	be	cop	19	SENT_158	[p10l2091t232r2146b295],
19	independent	JJ	O	independent	rcmod	13	SENT_158	[p10l8t339r445b420],
20	of	IN	O	of	_	0	SENT_158	[p10l472t339r549b402],
21	altered	JJ	O	altered	amod	23	SENT_158	[p10l572t339r813b402],
22	cholesterol	NN	O	cholesterol	nn	23	SENT_158	[p10l840t339r1230b402],
23	metabolism	NN	O	metabolism	prep_of	19	SENT_158	[p10l1257t339r1692b402],
24	.	.	O	.	_	0	SENT_158	[p10l1257t339r1692b402],

1	In	IN	O	in	_	0	SENT_159	[p10l1724t341r1795b401],
2	the	DT	O	the	det	4	SENT_159	[p10l1822t339r1928b402],
3	tolerability	NN	O	tolerability	nn	4	SENT_159	[p10l1956t339r2145b402, p10l9t446r235b527],
4	analysis	NN	O	analysis	prep_in	7	SENT_159	[p10l269t446r572b527],
5	,	,	O	,	_	0	SENT_159	[p10l269t446r572b527],
6	we	PRP	O	we	nsubj	7	SENT_159	[p10l608t465r708b508],
7	found	VBD	O	find	_	0	SENT_159	[p10l742t446r949b508],
8	the	DT	O	the	det	10	SENT_159	[p10l980t446r1087b508],
9	T	NN	O	t	nn	10	SENT_159	[p10l1120t447r1172b507],
10	allele	NN	O	allele	dobj	7	SENT_159	[p10l1199t446r1390b508],
11	to	TO	O	to	aux	14	SENT_159	[p10l1423t455r1489b508],
12	be	VB	O	be	cop	14	SENT_159	[p10l1522t446r1604b508],
13	more	RBR	O	more	advmod	14	SENT_159	[p10l1637t465r1818b508],
14	frequent	JJ	O	frequent	xcomp	7	SENT_159	[p10l1852t446r2149b527],
15	in	IN	O	in	_	0	SENT_159	[p10l8t553r75b615],
16	patients	NNS	O	patient	prep_in	14	SENT_159	[p10l121t553r396b634],
17	with	IN	O	with	_	0	SENT_159	[p10l446t553r602b616],
18	muscle	NN	O	muscle	nn	19	SENT_159	[p10l649t553r900b616],
19	symptoms	NNS	O	symptom	prep_with	16	SENT_159	[p10l951t563r1310b634],
20	compared	VBN	O	compare	_	0	SENT_159	[p10l1360t553r1711b634],
21	with	IN	O	with	prepc_compared_with	14	SENT_159	[p10l1758t553r1914b616],
22	those	DT	O	those	dobj	37	SENT_159	[p10l1960t553r2147b616],
23	without	IN	O	without	_	0	SENT_159	[p10l8t659r280b721],
24	(	CD	NUMBER	(	num	25	SENT_159	[p10l314t659r495b736],
25	0.80	CD	NUMBER	0.80	prep_without	22	SENT_159	[p10l314t659r495b736],
26	vs	CC	O	vs	_	0	SENT_159	[p10l529t678r604b721],
27	0.62	CD	NUMBER	0.62	num	28	SENT_159	[p10l639t659r819b736],
28	)	NN	O	)	nsubj	37	SENT_159	[p10l639t659r819b736],
29	and	CC	O	and	_	0	SENT_159	[p10l856t659r982b721],
30	the	DT	O	the	det	32	SENT_159	[p10l1015t659r1121b721],
31	C	NN	O	c	nn	32	SENT_159	[p10l1156t659r1210b721],
32	allele	NN	O	allele	conj_and	28	SENT_159	[p10l1247t659r1436b721],
33	to	TO	O	to	aux	37	SENT_159	[p10l1471t668r1537b721],
34	be	VB	O	be	cop	37	SENT_159	[p10l1570t659r1652b721],
35	less	JJR	O	less	amod	37	SENT_159	[p10l1686t659r1816b721],
36	frequent	JJ	O	frequent	amod	37	SENT_159	[p10l1852t659r2148b739],
37	(	NN	O	(	pcomp	14	SENT_159	[p10l10t768r190b844],
38	0.20	CD	NUMBER	0.20	dep	37	SENT_159	[p10l10t768r190b844],
39	vs	CC	O	vs	_	0	SENT_159	[p10l236t787r311b830],
40	0.38	CD	NUMBER	0.38	conj_vs	37	SENT_159	[p10l358t768r532b841],
41	;	:	O	;	_	0	SENT_159	[p10l358t768r532b841],
42	P	NN	O	p	dep	40	SENT_159	[p10l580t770r635b829],
43	=	JJ	O	=	amod	45	SENT_159	[p10l688t789r742b810],
44	.043	CD	NUMBER	.043	tmod	43	SENT_159	[p10l791t768r988b844],
45	)	NN	O	)	dep	42	SENT_159	[p10l791t768r988b844],
46	.	.	O	.	_	0	SENT_159	[p10l791t768r988b844],

1	Again	RB	O	again	advmod	7	SENT_160	[p10l1037t767r1272b848],
2	,	,	O	,	_	0	SENT_160	[p10l1037t767r1272b848],
3	this	DT	O	this	det	4	SENT_160	[p10l1320t767r1446b830],
4	observation	NN	O	observation	nsubjpass	7	SENT_160	[p10l1493t767r1905b830],
5	could	MD	O	could	aux	7	SENT_160	[p10l1951t767r2148b830],
6	be	VB	O	be	auxpass	7	SENT_160	[p10l7t874r89b937],
7	explained	VBN	O	explain	_	0	SENT_160	[p10l121t874r467b955],
8	by	IN	O	by	_	0	SENT_160	[p10l495t874r582b955],
9	the	DT	O	the	det	11	SENT_160	[p10l613t874r719b937],
10	TT	NN	O	tt	nn	11	SENT_160	[p10l751t876r858b936],
11	genotype	NN	O	genotype	agent	7	SENT_160	[p10l890t884r1213b955],
12	being	VBG	O	be	auxpass	13	SENT_160	[p10l1243t874r1440b955],
13	associated	VBN	O	associate	partmod	11	SENT_160	[p10l1473t874r1838b937],
14	with	IN	O	with	_	0	SENT_160	[p10l1869t874r2025b937],
15	altered	JJ	O	altered	amod	17	SENT_160	[p10l2057t874r2145b937, p10l8t981r185b1043],
16	atorvastatin	NN	O	atorvastatin	nn	17	SENT_160	[p10l217t981r630b1043],
17	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	13	SENT_160	[p10l659t981r1289b1062],
18	and	CC	O	and	_	0	SENT_160	[p10l1323t981r1448b1043],
19	increased	VBN	O	increase	partmod	11	SENT_160	[p10l1478t981r1815b1043],
20	drug	NN	O	drug	nn	21	SENT_160	[p10l1845t981r2005b1062],
21	exposure	NN	O	exposure	iobj	19	SENT_160	[p10l2037t1000r2145b1043, p10l7t1069r298b1168],
22	.8	CD	NUMBER	.8	dobj	19	SENT_160	[p10l2037t1000r2145b1043, p10l7t1069r298b1168],
23	These	DT	O	these	det	24	SENT_160	[p10l334t1087r545b1150],
24	results	NNS	O	result	nsubjpass	27	SENT_160	[p10l579t1087r809b1150],
25	are	VBP	O	be	auxpass	27	SENT_160	[p10l848t1107r952b1150],
26	best	RB	O	best	advmod	27	SENT_160	[p10l986t1087r1130b1150],
27	put	VBN	O	put	rcmod	22	SENT_160	[p10l1163t1097r1277b1168],
28	into	IN	O	into	_	0	SENT_160	[p10l1310t1087r1446b1150],
29	context	NN	O	context	prep_into	27	SENT_160	[p10l1482t1097r1744b1150],
30	in	IN	O	in	_	0	SENT_160	[p10l1777t1087r1845b1149],
31	light	NN	O	light	prep_in	13	SENT_160	[p10l1879t1087r2042b1168],
32	of	IN	O	of	_	0	SENT_160	[p10l2077t1087r2153b1150],
33	our	PRP$	O	we	poss	35	SENT_160	[p10l9t1214r126b1257],
34	recent	JJ	O	recent	amod	35	SENT_160	[p10l151t1204r371b1257],
35	ﬁndings	NNS	O	ﬁndings	prep_of	31	SENT_160	[p10l398t1195r680b1276],
36	that	WDT	O	that	dobj	40	SENT_160	[p10l709t1195r843b1257],
37	cholesterol	NN	O	cholesterol	nn	39	SENT_160	[p10l870t1195r1260b1257],
38	absorption	NN	O	absorption	nn	39	SENT_160	[p10l1291t1195r1664b1276],
39	markers	NNS	O	marker	nsubj	40	SENT_160	[p10l1692t1195r1977b1257],
40	predict	VBP	O	predict	rcmod	31	SENT_160	[p10l2004t1214r2145b1276, p10l9t1303r141b1365],
41	percent	NN	O	percent	nn	42	SENT_160	[p10l171t1312r435b1384],
42	LDL	NN	O	ldl	dobj	40	SENT_160	[p10l467t1303r726b1366],
43	.	.	O	.	_	0	SENT_160	[p10l467t1303r726b1366],

1	—	NN	O	—	_	0	SENT_161	[p10l467t1303r726b1366],
2	.	.	O	.	_	0	SENT_161	[p10l467t1303r726b1366],

1	C	NN	O	c	nn	2	SENT_162	[p10l467t1303r726b1366],
2	reduction	NN	O	reduction	nsubj	19	SENT_162	[p10l759t1303r1097b1365],
3	in	IN	O	in	_	0	SENT_162	[p10l1129t1303r1196b1364],
4	response	NN	O	response	prep_in	2	SENT_162	[p10l1228t1323r1538b1384],
5	to	TO	O	to	_	0	SENT_162	[p10l1571t1312r1638b1365],
6	atorvastatin	NN	O	atorvastatin	nn	7	SENT_162	[p10l1673t1284r2141b1365],
7	.2	NN	NUMBER	.2	prep_to	19	SENT_162	[p10l1673t1284r2141b1365],
8	Our	PRP$	O	we	poss	9	SENT_162	[p10l117t1411r252b1473],
9	approach	NN	O	approach	nsubj	19	SENT_162	[p10l289t1410r613b1491],
10	of	IN	O	of	_	0	SENT_162	[p10l649t1410r726b1473],
11	using	VBG	O	use	prepc_of	9	SENT_162	[p10l755t1410r946b1491],
12	cholesterol	NN	O	cholesterol	nn	14	SENT_162	[p10l983t1410r1373b1473],
13	metabolism	NN	O	metabolism	nn	14	SENT_162	[p10l1409t1410r1826b1473],
14	markers	NNS	O	marker	dobj	11	SENT_162	[p10l1861t1410r2146b1473],
15	to	TO	O	to	aux	16	SENT_162	[p10l8t1527r74b1580],
16	predict	VB	O	predict	xcomp	11	SENT_162	[p10l137t1517r387b1598],
17	atorvastatin	NN	O	atorvastatin	nn	18	SENT_162	[p10l451t1517r863b1580],
18	response	NN	O	response	dobj	16	SENT_162	[p10l926t1537r1236b1598],
19	explains	VBZ	O	explain	_	0	SENT_162	[p10l1301t1517r1595b1598],
20	more	JJR	O	more	dobj	19	SENT_162	[p10l1659t1537r1841b1580],
21	of	IN	O	of	_	0	SENT_162	[p10l1906t1517r1982b1580],
22	the	DT	O	the	det	23	SENT_162	[p10l2040t1517r2146b1580],
23	variation	NN	O	variation	prep_of	20	SENT_162	[p10l8t1624r322b1687],
24	in	IN	O	in	_	0	SENT_162	[p10l389t1624r457b1686],
25	percent	NN	O	percent	nn	26	SENT_162	[p10l521t1634r786b1705],
26	LDL	NN	O	ldl	prep_in	23	SENT_162	[p10l850t1625r1109b1687],
27	.	.	O	.	_	0	SENT_162	[p10l850t1625r1109b1687],

1	—	NN	O	—	_	0	SENT_163	[p10l850t1625r1109b1687],
2	.	.	O	.	_	0	SENT_163	[p10l850t1625r1109b1687],

1	C	NN	O	c	nn	2	SENT_164	[p10l850t1625r1109b1687],
2	reduction	NN	O	reduction	nsubjpass	6	SENT_164	[p10l1177t1624r1513b1687],
3	than	IN	O	than	advmod	6	SENT_164	[p10l1580t1624r1732b1687],
4	has	VBZ	O	have	aux	6	SENT_164	[p10l1797t1624r1912b1687],
5	been	VBN	O	be	auxpass	6	SENT_164	[p10l1979t1624r2147b1687],
6	reported	VBN	O	report	_	0	SENT_164	[p10l7t1730r305b1811],
7	with	IN	O	with	_	0	SENT_164	[p10l335t1730r491b1793],
8	pharmacogenomic	JJ	O	pharmacogenomic	amod	9	SENT_164	[p10l521t1730r1180b1811],
9	strategies	NNS	O	strategy	prep_with	6	SENT_164	[p10l1215t1711r1604b1811],
10	?	.	O	?	_	0	SENT_164	[p10l1215t1711r1604b1811],

1	This	DT	O	this	det	2	SENT_165	[p10l1634t1730r1789b1792],
2	approach	NN	O	approach	nsubj	3	SENT_165	[p10l1824t1730r2147b1811],
3	integrates	VBZ	O	integrate	_	0	SENT_165	[p10l8t1838r351b1919],
4	the	DT	O	the	det	5	SENT_165	[p10l404t1839r510b1901],
5	effects	NNS	O	effect	dobj	3	SENT_165	[p10l564t1838r795b1901],
6	of	IN	O	of	_	0	SENT_165	[p10l849t1838r926b1901],
7	known	JJ	O	known	amod	10	SENT_165	[p10l970t1839r1209b1901],
8	and	CC	O	and	_	0	SENT_165	[p10l1263t1839r1388b1901],
9	unknown	JJ	O	unknown	amod	10	SENT_165	[p10l1438t1838r1766b1901],
10	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_165	[p10l1816t1838r2145b1919, p10l7t1945r257b2026],
11	that	WDT	O	that	nsubj	13	SENT_165	[p10l295t1945r429b2008],
12	individually	RB	O	individually	advmod	13	SENT_165	[p10l464t1945r893b2026],
13	have	VBP	O	have	rcmod	5	SENT_165	[p10l930t1945r1094b2008],
14	small	JJ	O	small	amod	15	SENT_165	[p10l1135t1945r1323b2008],
15	effects	NNS	O	effect	dobj	13	SENT_165	[p10l1361t1945r1593b2008],
16	on	IN	O	on	_	0	SENT_165	[p10l1634t1965r1719b2008],
17	cholesterol	NN	O	cholesterol	nn	18	SENT_165	[p10l1757t1945r2147b2008],
18	metabolism	NN	O	metabolism	prep_on	13	SENT_165	[p10l8t2052r425b2115],
19	and	CC	O	and	_	0	SENT_165	[p10l463t2052r589b2115],
20	statin	NN	O	statin	nn	21	SENT_165	[p10l628t2052r817b2115],
21	efﬁcacy	NN	O	efﬁcacy	conj_and	18	SENT_165	[p10l855t2052r1147b2133],
22	.	.	O	.	_	0	SENT_165	[p10l855t2052r1147b2133],

1	For	IN	O	for	_	0	SENT_166	[p10l1188t2054r1310b2115],
2	example	NN	O	example	prep_for	10	SENT_166	[p10l1346t2052r1666b2133],
3	,	,	O	,	_	0	SENT_166	[p10l1346t2052r1666b2133],
4	the	DT	O	the	det	6	SENT_166	[p10l1706t2052r1812b2115],
5	apoE4/4	NN	O	apoe4/4	nn	6	SENT_166	[p10l1852t2053r2146b2133],
6	genotype	NN	O	genotype	appos	2	SENT_166	[p10l9t2168r352b2240],
7	,	,	O	,	_	0	SENT_166	[p10l9t2168r352b2240],
8	which	WDT	O	which	nsubjpass	10	SENT_166	[p10l395t2159r611b2221],
9	is	VBZ	O	be	auxpass	10	SENT_166	[p10l650t2159r705b2221],
10	associated	VBN	O	associate	_	0	SENT_166	[p10l747t2159r1112b2221],
11	with	IN	O	with	_	0	SENT_166	[p10l1151t2159r1307b2222],
12	lesser	JJR	O	lesser	amod	14	SENT_166	[p10l1346t2159r1548b2221],
13	percent	NN	O	percent	nn	14	SENT_166	[p10l1584t2169r1849b2240],
14	LDL	NN	O	ldl	prep_with	10	SENT_166	[p10l1886t2159r2146b2222],
15	.	.	O	.	_	0	SENT_166	[p10l1886t2159r2146b2222],

1	—	NN	O	—	_	0	SENT_167	[p10l1886t2159r2146b2222],
2	.	.	O	.	_	0	SENT_167	[p10l1886t2159r2146b2222],

1	C	NN	O	c	nn	2	SENT_168	[p10l1886t2159r2146b2222],
2	reduction	NN	O	reduction	nsubj	45	SENT_168	[p10l7t2266r337b2328],
3	with	IN	O	with	_	0	SENT_168	[p10l372t2266r525b2328],
4	atorvastatin	NN	O	atorvastatin	prep_with	2	SENT_168	[p10l563t2266r966b2328],
5	compared	VBN	O	compare	_	0	SENT_168	[p10l1002t2266r1346b2347],
6	to	TO	O	to	prepc_compared_to	4	SENT_168	[p10l1381t2275r1447b2328],
7	the	DT	O	the	det	9	SENT_168	[p10l1483t2266r1588b2328],
8	apoE3/3	NN	O	apoe3/3	nn	9	SENT_168	[p10l1626t2266r1910b2347],
9	genotype	NN	O	genotype	pobj	4	SENT_168	[p10l1951t2285r2145b2347, p10l8t2353r244b2453],
10	,	,	O	,	_	0	SENT_168	[p10l1951t2285r2145b2347, p10l8t2353r244b2453],
11	”	NN	O	”	nsubjpass	14	SENT_168	[p10l1951t2285r2145b2347, p10l8t2353r244b2453],
12	is	VBZ	O	be	auxpass	14	SENT_168	[p10l273t2372r328b2435],
13	also	RB	O	also	advmod	14	SENT_168	[p10l361t2372r497b2435],
14	associated	VBN	O	associate	dep	9	SENT_168	[p10l529t2372r887b2435],
15	with	IN	O	with	_	0	SENT_168	[p10l915t2372r1069b2435],
16	greater	JJR	O	greater	amod	18	SENT_168	[p10l1099t2382r1341b2453],
17	cholesterol	NN	O	cholesterol	nn	18	SENT_168	[p10l1370t2372r1751b2435],
18	absorption	NN	O	absorption	prep_with	14	SENT_168	[p10l1782t2372r2147b2453],
19	and	CC	O	and	_	0	SENT_168	[p10l10t2479r133b2541],
20	lower	JJR	O	lower	amod	22	SENT_168	[p10l182t2479r379b2541],
21	cholesterol	NN	O	cholesterol	nn	22	SENT_168	[p10l427t2479r808b2541],
22	synthesis	NN	O	synthesis	conj_and	18	SENT_168	[p10l861t2460r1341b2560],
23	.15	CD	NUMBER	.15	number	24	SENT_168	[p10l861t2460r1341b2560],
24	’16	CD	NUMBER	’16	dep	22	SENT_168	[p10l861t2460r1341b2560],
25	Similarly	RB	O	similarly	advmod	14	SENT_168	[p10l1394t2479r1728b2560],
26	,	,	O	,	_	0	SENT_168	[p10l1394t2479r1728b2560],
27	the	DT	O	the	det	29	SENT_168	[p10l1780t2479r1884b2541],
28	Dl9H	NN	O	dl9h	nn	29	SENT_168	[p10l1935t2479r2147b2542],
29	polymorphism	NN	O	polymorphism	dep	9	SENT_168	[p10l7t2587r518b2668],
30	in	IN	O	in	_	0	SENT_168	[p10l559t2587r626b2648],
31	ABCG8	NN	O	abcg8	prep_in	29	SENT_168	[p10l662t2587r958b2661],
32	,	,	O	,	_	0	SENT_168	[p10l662t2587r958b2661],
33	which	WDT	O	which	nsubjpass	35	SENT_168	[p10l1004t2587r1217b2649],
34	is	VBZ	O	be	auxpass	35	SENT_168	[p10l1258t2587r1311b2649],
35	associated	VBN	O	associate	rcmod	31	SENT_168	[p10l1357t2587r1714b2649],
36	with	IN	O	with	_	0	SENT_168	[p10l1756t2587r1910b2649],
37	lower	JJR	O	lower	amod	39	SENT_168	[p10l1952t2587r2149b2649],
38	cholesterol	NN	O	cholesterol	nn	39	SENT_168	[p10l9t2693r389b2756],
39	absorption	NN	O	absorption	prep_with	35	SENT_168	[p10l437t2674r888b2774],
40	,	,	O	,	_	0	SENT_168	[p10l437t2674r888b2774],
41	”	NN	O	”	appos	39	SENT_168	[p10l437t2674r888b2774],
42	may	MD	O	may	aux	45	SENT_168	[p10l935t2714r1085b2774],
43	be	VB	O	be	cop	45	SENT_168	[p10l1130t2693r1212b2756],
44	a	DT	O	a	det	45	SENT_168	[p10l1261t2714r1297b2756],
45	predictor	NN	O	predictor	_	0	SENT_168	[p10l1341t2693r1659b2774],
46	of	IN	O	of	_	0	SENT_168	[p10l1703t2693r1780b2756],
47	increased	VBN	O	increase	prep_of	45	SENT_168	[p10l1818t2693r2148b2756],

1	LDL	NN	O	ldl	_	0	SENT_169	[p10l7t2851r264b2913],
2	.	.	O	.	_	0	SENT_169	[p10l7t2851r264b2913],

1	—	NN	O	—	_	0	SENT_170	[p10l7t2851r264b2913],
2	.	.	O	.	_	0	SENT_170	[p10l7t2851r264b2913],

1	C	NN	O	c	nn	2	SENT_171	[p10l7t2851r264b2913],
2	response	NN	O	response	_	0	SENT_171	[p10l295t2870r599b2931],
3	to	TO	O	to	_	0	SENT_171	[p10l630t2860r697b2913],
4	atorvastatin	NN	O	atorvastatin	prep_to	2	SENT_171	[p10l730t2832r1218b2913],
5	.	.	O	.	_	0	SENT_171	[p10l730t2832r1218b2913],

1	”	NN	O	”	_	0	SENT_172	[p10l730t2832r1218b2913],

1	However	RB	O	however	advmod	14	SENT_173	[p10l115t2960r451b3032],
2	,	,	O	,	_	0	SENT_173	[p10l115t2960r451b3032],
3	a	DT	O	a	det	4	SENT_173	[p10l496t2978r533b3021],
4	limitation	NN	O	limitation	nsubj	14	SENT_173	[p10l571t2958r919b3021],
5	of	IN	O	of	_	0	SENT_173	[p10l959t2958r1036b3021],
6	using	VBG	O	use	prepc_of	4	SENT_173	[p10l1069t2958r1259b3039],
7	cholesterol	NN	O	cholesterol	nn	9	SENT_173	[p10l1300t2958r1690b3021],
8	metabolism	NN	O	metabolism	nn	9	SENT_173	[p10l1730t2958r2148b3021],
9	markers	NNS	O	marker	dobj	6	SENT_173	[p10l8t3065r291b3127],
10	to	TO	O	to	aux	11	SENT_173	[p10l321t3074r387b3127],
11	predict	VB	O	predict	xcomp	6	SENT_173	[p10l414t3065r663b3146],
12	atorvastatin	NN	O	atorvastatin	nn	13	SENT_173	[p10l691t3065r1104b3128],
13	response	NN	O	response	dobj	11	SENT_173	[p10l1130t3084r1441b3146],
14	is	VBZ	O	be	_	0	SENT_173	[p10l1469t3065r1524b3127],
15	that	IN	O	that	complm	20	SENT_173	[p10l1553t3065r1686b3127],
16	this	DT	O	this	det	17	SENT_173	[p10l1712t3065r1838b3127],
17	strategy	NN	O	strategy	nsubj	20	SENT_173	[p10l1870t3074r2147b3146],
18	does	VBZ	O	do	aux	20	SENT_173	[p10l9t3172r167b3234],
19	not	RB	O	not	neg	20	SENT_173	[p10l193t3181r306b3234],
20	take	VB	O	take	ccomp	14	SENT_173	[p10l329t3172r476b3234],
21	into	IN	O	into	_	0	SENT_173	[p10l501t3172r637b3234],
22	account	NN	O	account	nn	23	SENT_173	[p10l664t3181r940b3234],
23	variation	NN	O	variation	prep_into	20	SENT_173	[p10l964t3172r1278b3234],
24	in	IN	O	in	_	0	SENT_173	[p10l1302t3172r1369b3233],
25	drug	NN	O	drug	nn	26	SENT_173	[p10l1395t3172r1554b3253],
26	metabolism	NN	O	metabolism	prep_in	23	SENT_173	[p10l1579t3172r1996b3234],
27	and	CC	O	and	_	0	SENT_173	[p10l2022t3172r2148b3234],
28	drug	NN	O	drug	nn	30	SENT_173	[p10l9t3278r168b3359],
29	disposition	NN	O	disposition	nn	30	SENT_173	[p10l225t3260r667b3359],
30	.3	NN	NUMBER	.3	conj_and	20	SENT_173	[p10l225t3260r667b3359],
31	In	IN	O	in	dep	30	SENT_173	[p10l726t3280r798b3340],
32	this	DT	O	this	det	33	SENT_173	[p10l853t3278r978b3341],
33	context	NN	O	context	pobj	31	SENT_173	[p10l1036t3288r1316b3352],
34	,	,	O	,	_	0	SENT_173	[p10l1036t3288r1316b3352],
35	our	PRP$	O	we	poss	36	SENT_173	[p10l1375t3298r1493b3341],
36	ﬁnding	NN	O	ﬁnding	nsubj	66	SENT_173	[p10l1547t3278r1796b3359],
37	that	IN	O	that	complm	54	SENT_173	[p10l1852t3278r1986b3341],
38	the	DT	O	the	det	40	SENT_173	[p10l2040t3278r2146b3341],
39	C3435T	NN	O	c3435t	nn	40	SENT_173	[p10l9t3386r298b3449],
40	polymorphisms	NNS	O	polymorphism	nsubjpass	54	SENT_173	[p10l325t3386r878b3467],
41	in	IN	O	in	_	0	SENT_173	[p10l908t3386r975b3448],
42	ABCBI	NNP	LOCATION	ABCBI	prep_in	40	SENT_173	[p10l996t3386r1262b3449],
43	,	,	O	,	_	0	SENT_173	[p10l1275t3438r1288b3460],
44	which	WDT	O	which	nsubjpass	47	SENT_173	[p10l1320t3386r1535b3449],
45	has	VBZ	O	have	aux	47	SENT_173	[p10l1562t3386r1677b3448],
46	been	VBN	O	be	auxpass	47	SENT_173	[p10l1706t3386r1874b3448],
47	associated	VBN	O	associate	rcmod	42	SENT_173	[p10l1903t3386r2144b3448, p10l10t3494r156b3556],
48	with	IN	O	with	_	0	SENT_173	[p10l187t3494r343b3556],
49	altered	JJ	O	altered	amod	51	SENT_173	[p10l376t3494r618b3556],
50	atorvastatin	NN	O	atorvastatin	nn	51	SENT_173	[p10l650t3494r1063b3556],
51	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	47	SENT_173	[p10l1094t3475r1779b3575],
52	,8	CD	NUMBER	,8	tmod	47	SENT_173	[p10l1094t3475r1779b3575],
53	is	VBZ	O	be	auxpass	54	SENT_173	[p10l1813t3494r1867b3556],
54	associated	VBN	O	associate	dep	36	SENT_173	[p10l1903t3494r2144b3556, p10l10t3601r156b3664],
55	with	IN	O	with	_	0	SENT_173	[p10l181t3601r338b3664],
56	variation	NN	O	variation	prep_with	54	SENT_173	[p10l364t3601r678b3664],
57	in	IN	O	in	_	0	SENT_173	[p10l704t3601r771b3663],
58	atorvastatin	NN	O	atorvastatin	nn	59	SENT_173	[p10l798t3601r1211b3664],
59	efﬁcacy	NN	O	efﬁcacy	prep_in	54	SENT_173	[p10l1238t3601r1518b3682],
60	independently	RB	O	independently	advmod	59	SENT_173	[p10l1544t3601r2049b3682],
61	of	IN	O	of	_	0	SENT_173	[p10l2076t3601r2153b3664],
62	variation	NN	O	variation	prep_of	59	SENT_173	[p10l8t3708r323b3771],
63	in	IN	O	in	_	0	SENT_173	[p10l367t3708r435b3770],
64	cholesterol	NN	O	cholesterol	nn	65	SENT_173	[p10l481t3708r870b3771],
65	metabolism	NN	O	metabolism	prep_in	62	SENT_173	[p10l916t3708r1334b3771],
66	raises	VBZ	O	raise	ccomp	14	SENT_173	[p10l1377t3708r1577b3771],
67	the	DT	O	the	det	68	SENT_173	[p10l1624t3708r1731b3771],
68	possibility	NN	O	possibility	dobj	66	SENT_173	[p10l1775t3708r2146b3789],
69	that	IN	O	that	complm	73	SENT_173	[p11l8t20r141b83],
70	it	PRP	O	it	nsubj	73	SENT_173	[p11l172t20r221b83],
71	may	MD	O	may	aux	73	SENT_173	[p11l252t40r403b101],
72	be	VB	O	be	cop	73	SENT_173	[p11l434t20r516b83],
73	possible	JJ	O	possible	ccomp	66	SENT_173	[p11l548t20r839b101],
74	to	TO	O	to	aux	75	SENT_173	[p11l871t30r938b83],
75	use	VB	O	use	xcomp	73	SENT_173	[p11l970t40r1087b83],
76	pharmacogenomic	JJ	O	pharmacogenomic	amod	77	SENT_173	[p11l1118t20r1778b101],
77	strategies	NNS	O	strategy	dobj	75	SENT_173	[p11l1814t20r2145b101],
78	to	TO	O	to	aux	79	SENT_173	[p11l8t136r74b189],
79	complement	VB	O	complement	xcomp	75	SENT_173	[p11l115t127r557b208],
80	a	DT	O	a	det	84	SENT_173	[p11l597t146r634b189],
81	cholesterol	NN	O	cholesterol	nn	84	SENT_173	[p11l673t127r1063b189],
82	metabolism	NN	O	metabolism	nn	84	SENT_173	[p11l1103t127r1520b189],
83	marker	NN	O	marker	nn	84	SENT_173	[p11l1559t127r1812b189],
84	strategy	NN	O	strategy	dobj	79	SENT_173	[p11l1853t136r2142b208],
85	.	.	O	.	_	0	SENT_173	[p11l1853t136r2142b208],

1	Such	PDT	O	such	predet	4	SENT_174	[p11l10t234r184b296],
2	a	DT	O	a	det	4	SENT_174	[p11l216t253r252b296],
3	combined	JJ	O	combined	amod	4	SENT_174	[p11l282t234r634b296],
4	approach	NN	O	approach	nsubj	6	SENT_174	[p11l665t234r990b315],
5	may	MD	O	may	aux	6	SENT_174	[p11l1020t253r1170b315],
6	explain	VB	O	explain	_	0	SENT_174	[p11l1202t234r1463b315],
7	more	JJR	O	more	dobj	6	SENT_174	[p11l1493t253r1674b296],
8	of	IN	O	of	_	0	SENT_174	[p11l1706t234r1782b296],
9	the	DT	O	the	det	10	SENT_174	[p11l1806t234r1912b296],
10	variation	NN	O	variation	prep_of	7	SENT_174	[p11l1942t234r2145b296, p11l8t341r145b404],
11	in	IN	O	in	_	0	SENT_174	[p11l177t341r244b403],
12	drug	NN	O	drug	nn	13	SENT_174	[p11l278t341r437b422],
13	efﬁcacy	NN	O	efﬁcacy	prep_in	6	SENT_174	[p11l471t341r750b422],
14	than	IN	O	than	prep	6	SENT_174	[p11l783t341r935b404],
15	with	IN	O	with	pcomp	14	SENT_174	[p11l968t341r1124b404],
16	either	CC	O	either	dep	15	SENT_174	[p11l1157t341r1360b404],
17	approach	NN	O	approach	conj	15	SENT_174	[p11l1393t341r1718b422],
18	alone	RB	O	alone	advmod	6	SENT_174	[p11l1752t341r1960b404],
19	.	.	O	.	_	0	SENT_174	[p11l1752t341r1960b404],

1	Table	NNP	O	Table	_	0	SENT_175	[p11l59t497r142b525],
2	3	CD	NUMBER	3	num	1	SENT_175	[p11l158t498r174b525],
3	Genotypes	NNP	O	Genotypes	dep	1	SENT_175	[p11l226t498r379b532],
4	and	CC	O	and	_	0	SENT_175	[p11l394t497r446b525],
5	allele	NN	O	allele	nn	6	SENT_175	[p11l462t497r540b525],
6	frequency	NN	O	frequency	dep	1	SENT_175	[p11l554t497r699b532],
7	in	IN	O	in	_	0	SENT_175	[p11l713t497r739b524],
8	patients	NNS	O	patient	conj_and	8	SENT_175	[p11l757t497r877b532],
9	with	IN	O	with	_	0	SENT_175	[p11l892t497r954b525],
10	and	CC	O	and	_	0	SENT_175	[p11l971t497r1023b525],
11	without	IN	O	without	_	0	SENT_175	[p11l1039t497r1155b525],
12	muscle	NN	O	muscle	nn	13	SENT_175	[p11l1170t497r1269b525],
13	symptoms	NNS	O	symptom	prep_with	8	SENT_175	[p11l1283t500r1431b532],

1	Genotype	NN	O	genotype	nsubj	25	SENT_176	[p11l805t575r953b609],
2	,	,	O	,	_	0	SENT_176	[p11l805t575r953b609],
3	n	NN	O	n	dep	1	SENT_176	[p11l970t583r984b602],
4	(	CD	NUMBER	(	num	5	SENT_176	[p11l1003t574r1012b610],
5	°	CD	NUMBER	°	dep	3	SENT_176	[p11l1027t574r1065b610],
6	/	:	O	/	punct	3	SENT_176	[p11l1027t574r1065b610],
7	o	NN	O	o	nn	10	SENT_176	[p11l1027t574r1065b610],
8	)	CD	NUMBER	)	num	10	SENT_176	[p11l1027t574r1065b610],
9	Allele	NN	O	allele	nn	10	SENT_176	[p11l1789t574r1871b602],
10	frequency	NN	O	frequency	dep	3	SENT_176	[p11l1885t574r2030b609],
11	(	CD	NUMBER	(	number	12	SENT_176	[p11l2046t574r2096b610],
12	°	CD	NUMBER	°	num	24	SENT_176	[p11l2046t574r2096b610],
13	/	:	O	/	punct	14	SENT_176	[p11l2046t574r2096b610],
14	n	NN	O	n	dep	24	SENT_176	[p11l2046t574r2096b610],
15	)	CD	NUMBER	)	num	16	SENT_176	[p11l2046t574r2096b610],
16	Symptoms	NNS	O	symptom	dep	14	SENT_176	[p11l62t636r212b670],
17	group	NN	O	group	nn	24	SENT_176	[p11l227t643r311b670],
18	TT	NN	ORGANIZATION	tt	nn	24	SENT_176	[p11l804t636r837b662],
19	TC	NN	ORGANIZATION	tc	nn	24	SENT_176	[p11l1132t636r1165b663],
20	CC	NN	ORGANIZATION	cc	nn	24	SENT_176	[p11l1461t636r1493b663],
21	T	NN	ORGANIZATION	t	nn	24	SENT_176	[p11l1789t636r1805b662],
22	C	NN	ORGANIZATION	c	nn	24	SENT_176	[p11l2064t636r2079b663],
23	Muscle	NN	ORGANIZATION	muscle	nn	24	SENT_176	[p11l63t702r161b730],
24	symptoms	NNS	O	symptom	dep	10	SENT_176	[p11l175t705r323b737],
25	(	VBP	O	(	_	0	SENT_176	[p11l339t702r367b738],
26	n	NN	O	n	nsubj	47	SENT_176	[p11l339t702r367b738],
27	=	JJ	O	=	dep	47	SENT_176	[p11l386t712r409b722],
28	10	CD	NUMBER	10	num	29	SENT_176	[p11l429t702r474b738],
29	)	NN	O	)	dep	35	SENT_176	[p11l429t702r474b738],
30	7	CD	NUMBER	7	num	31	SENT_176	[p11l824t705r838b730],
31	(	NN	O	(	dep	29	SENT_176	[p11l856t702r915b738],
32	70	CD	NUMBER	70	num	33	SENT_176	[p11l856t702r915b738],
33	)	NN	O	)	dep	35	SENT_176	[p11l856t702r915b738],
34	2	CD	NUMBER	2	num	35	SENT_176	[p11l1153t704r1167b730],
35	(	CD	NUMBER	(	dep	41	SENT_176	[p11l1184t702r1244b738],
36	20	CD	NUMBER	20	num	37	SENT_176	[p11l1184t702r1244b738],
37	)	NN	O	)	dep	35	SENT_176	[p11l1184t702r1244b738],
38	1	CD	NUMBER	1	number	39	SENT_176	[p11l1481t705r1495b730],
39	(	CD	NUMBER	(	dep	37	SENT_176	[p11l1512t702r1572b738],
40	10	CD	NUMBER	10	num	41	SENT_176	[p11l1512t702r1572b738],
41	)	NN	O	)	dep	47	SENT_176	[p11l1512t702r1572b738],
42	80	CD	NUMBER	80	number	43	SENT_176	[p11l1789t704r1824b730],
43	20	CD	NUMBER	20	dep	41	SENT_176	[p11l2065t704r2098b730],
44	No	DT	O	no	det	45	SENT_176	[p11l64t758r99b785],
45	muscle	NN	O	muscle	dep	43	SENT_176	[p11l116t757r215b785],
46	symptoms	NNS	O	symptom	nsubj	47	SENT_176	[p11l230t760r377b792],
47	(	VBP	O	(	xcomp	25	SENT_176	[p11l394t757r421b793],
48	n	NN	O	n	dobj	47	SENT_176	[p11l394t757r421b793],
49	=	JJ	O	=	dep	48	SENT_176	[p11l441t767r464b777],
50	107	CD	NUMBER	107	num	51	SENT_176	[p11l483t757r547b793],
51	)	CD	NUMBER	)	iobj	49	SENT_176	[p11l483t757r547b793],
52	43	CD	NUMBER	43	num	53	SENT_176	[p11l804t759r838b785],
53	(	CD	NUMBER	(	dobj	49	SENT_176	[p11l856t757r915b793],
54	40	CD	NUMBER	40	num	55	SENT_176	[p11l856t757r915b793],
55	)	NN	O	)	dep	63	SENT_176	[p11l856t757r915b793],
56	46	CD	NUMBER	46	number	57	SENT_176	[p11l1132t759r1167b785],
57	(	CD	NUMBER	(	dep	55	SENT_176	[p11l1184t757r1244b793],
58	43	CD	NUMBER	43	num	59	SENT_176	[p11l1184t757r1244b793],
59	)	NN	O	)	dep	57	SENT_176	[p11l1184t757r1244b793],
60	18	CD	NUMBER	18	num	61	SENT_176	[p11l1462t759r1496b785],
61	(	NN	O	(	dep	63	SENT_176	[p11l1512t757r1572b793],
62	17	CD	NUMBER	17	num	63	SENT_176	[p11l1512t757r1572b793],
63	)	CD	NUMBER	)	dep	73	SENT_176	[p11l1512t757r1572b793],
64	62	CD	NUMBER	62	num	68	SENT_176	[p11l1790t759r1823b785],
65	38	CD	NUMBER	38	num	68	SENT_176	[p11l2064t759r2098b785],
66	P	NN	O	p	nn	68	SENT_176	[p11l62t806r80b833],
67	value	NN	O	value	nn	68	SENT_176	[p11l92t805r170b833],
68	symptoms	NNS	O	symptom	dep	63	SENT_176	[p11l185t808r332b840],
69	vs	CC	O	vs	_	0	SENT_176	[p11l347t814r376b833],
70	no	DT	O	no	det	71	SENT_176	[p11l392t814r426b833],
71	symptoms	NNS	O	symptom	dep	63	SENT_176	[p11l441t808r589b840],
72	.19	CD	NUMBER	.19	num	73	SENT_176	[p11l1168t808r1211b833],
73	.043	CD	NUMBER	.043	dep	47	SENT_176	[p11l1913t808r1975b833],

1	Hoenig	NNP	PERSON	Hoenig	_	0	SENT_177	[p11l37t928r151b967],
2	et	FW	O	et	nn	5	SENT_177	[p11l168t931r200b959],
3	al	FW	O	al	nn	5	SENT_177	[p11l216t928r245b959],
4	C3435T	NN	O	c3435t	nn	5	SENT_177	[p11l292t929r410b959],
5	polymorphism	NN	O	polymorphism	dep	1	SENT_177	[p11l427t928r656b967],
6	in	IN	O	in	_	0	SENT_177	[p11l674t928r703b959],
7	ABCB1	NN	O	abcb1	nn	10	SENT_177	[p11l722t929r827b959],
8	and	CC	O	and	_	0	SENT_177	[p11l845t928r902b959],
9	atorvastatin	NN	O	atorvastatin	nn	10	SENT_177	[p11l920t928r1118b959],
10	efﬁcacy	NN	O	efﬁcacy	prep_in	5	SENT_177	[p11l1137t928r1263b967],
11	95	CD	NUMBER	95	dep	1	SENT_177	[p11l2086t931r2123b959],

1	Our	PRP$	O	we	poss	2	SENT_178	[p11l120t1081r256b1144],
2	study	NN	O	study	nsubj	4	SENT_178	[p11l291t1081r478b1162],
3	has	VBZ	O	have	aux	4	SENT_178	[p11l511t1081r627b1143],
4	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_178	[p11l663t1081r1023b1143],
5	a	DT	O	a	det	7	SENT_178	[p11l1058t1100r1095b1143],
6	previous	JJ	O	previous	amod	7	SENT_178	[p11l1126t1081r1429b1162],
7	report	NN	O	report	dobj	4	SENT_178	[p11l1463t1090r1677b1162],
8	showing	VBG	O	show	partmod	7	SENT_178	[p11l1712t1081r2006b1162],
9	the	DT	O	the	det	11	SENT_178	[p11l2040t1081r2147b1143],
10	CC	NN	O	cc	nn	11	SENT_178	[p11l12t1189r126b1251],
11	genotype	NN	O	genotype	dobj	8	SENT_178	[p11l170t1198r495b1269],
12	of	IN	O	of	_	0	SENT_178	[p11l539t1188r616b1251],
13	the	DT	O	the	det	14	SENT_178	[p11l651t1188r758b1251],
14	C3435T	NN	O	c3435t	prep_of	11	SENT_178	[p11l802t1188r1090b1251],
15	in	IN	O	in	_	0	SENT_178	[p11l1131t1188r1198b1250],
16	ABCBI	NNP	ORGANIZATION	ABCBI	prep_in	8	SENT_178	[p11l1234t1189r1499b1252],
17	to	TO	O	to	aux	19	SENT_178	[p11l1548t1198r1614b1251],
18	be	VB	O	be	auxpass	19	SENT_178	[p11l1657t1188r1739b1251],
19	associated	VBN	O	associate	xcomp	8	SENT_178	[p11l1784t1188r2148b1251],
20	with	IN	O	with	_	0	SENT_178	[p11l12t1296r168b1359],
21	a	DT	O	a	det	23	SENT_178	[p11l211t1316r248b1359],
22	lower	JJR	O	lower	amod	23	SENT_178	[p11l287t1296r488b1359],
23	response	NN	O	response	prep_with	19	SENT_178	[p11l527t1316r837b1377],
24	to	TO	O	to	_	0	SENT_178	[p11l878t1306r945b1359],
25	atorvastatin	NN	O	atorvastatin	prep_to	23	SENT_178	[p11l989t1277r1491b1359],
26	.	.	O	.	_	0	SENT_178	[p11l989t1277r1491b1359],

1	”	NN	O	”	dep	112	SENT_179	[p11l989t1277r1491b1359],
2	However	RB	O	however	dep	112	SENT_179	[p11l1532t1298r1868b1370],
3	,	,	O	,	_	0	SENT_179	[p11l1532t1298r1868b1370],
4	in	IN	O	in	dep	112	SENT_179	[p11l1912t1296r1979b1358],
5	this	DT	O	this	dep	112	SENT_179	[p11l2021t1296r2146b1359],
6	report	NN	O	report	dep	112	SENT_179	[p11l10t1413r241b1485],
7	,	,	O	,	_	0	SENT_179	[p11l10t1413r241b1485],
8	the	DT	O	the	dep	112	SENT_179	[p11l274t1404r381b1466],
9	effect	NN	O	effect	dep	112	SENT_179	[p11l411t1404r611b1466],
10	was	VBD	O	be	dep	112	SENT_179	[p11l640t1423r773b1467],
11	limited	VBN	O	limit	dep	112	SENT_179	[p11l805t1404r1057b1466],
12	to	TO	O	to	dep	112	SENT_179	[p11l1086t1413r1152b1466],
13	women	NNS	O	woman	dep	112	SENT_179	[p11l1181t1423r1441b1467],
14	and	CC	O	and	dep	112	SENT_179	[p11l1472t1404r1597b1466],
15	was	VBD	O	be	dep	112	SENT_179	[p11l1626t1423r1759b1466],
16	not	RB	O	not	dep	112	SENT_179	[p11l1790t1413r1903b1466],
17	reproduced	VBN	O	reproduce	dep	112	SENT_179	[p11l1931t1423r2145b1485, p11l12t1510r223b1573],
18	in	IN	O	in	dep	112	SENT_179	[p11l269t1510r337b1572],
19	a	DT	O	a	dep	112	SENT_179	[p11l385t1531r422b1573],
20	subsequent	JJ	O	subsequent	dep	112	SENT_179	[p11l471t1511r862b1591],
21	study	NN	O	study	dep	112	SENT_179	[p11l912t1491r1182b1591],
22	.19	CD	NUMBER	.19	dep	112	SENT_179	[p11l912t1491r1182b1591],
23	Simvastatin	NNP	MISC	Simvastatin	dep	112	SENT_179	[p11l1232t1510r1648b1573],
24	is	VBZ	O	be	dep	112	SENT_179	[p11l1695t1510r1751b1573],
25	also	RB	O	also	dep	112	SENT_179	[p11l1801t1511r1939b1573],
26	a	DT	O	a	dep	112	SENT_179	[p11l1989t1531r2025b1573],
27	Pglycoprotein	NN	MISC	pglycoprotein	dep	112	SENT_179	[p11l2071t1512r2145b1572, p11l12t1617r462b1698],
28	substrates	NNS	O	substrate	dep	112	SENT_179	[p11l502t1598r845b1679],
29	and	CC	O	and	dep	112	SENT_179	[p11l886t1617r1012b1679],
30	the	DT	O	the	dep	112	SENT_179	[p11l1048t1617r1154b1679],
31	C3435T	NN	O	c3435t	dep	112	SENT_179	[p11l1193t1616r1482b1680],
32	polymorphism	NN	O	polymorphism	dep	112	SENT_179	[p11l1518t1617r2039b1698],
33	or	CC	O	or	dep	112	SENT_179	[p11l2077t1637r2149b1679],
34	nearby	JJ	O	nearby	dep	112	SENT_179	[p11l11t1725r251b1806],
35	polymorphisms	NNS	O	polymorphism	dep	112	SENT_179	[p11l305t1725r858b1806],
36	in	IN	O	in	dep	112	SENT_179	[p11l915t1725r982b1787],
37	strong	JJ	O	strong	dep	112	SENT_179	[p11l1040t1735r1256b1806],
38	linkage	NN	O	linkage	dep	112	SENT_179	[p11l1311t1725r1571b1806],
39	disequilibrium	NN	O	disequilibrium	dep	112	SENT_179	[p11l1628t1725r2148b1806],
40	with	IN	O	with	dep	112	SENT_179	[p11l12t1832r168b1895],
41	it	PRP	O	it	dep	112	SENT_179	[p11l200t1832r249b1895],
42	have	VBP	O	have	dep	112	SENT_179	[p11l280t1832r444b1895],
43	been	VBN	O	be	dep	112	SENT_179	[p11l476t1832r644b1895],
44	shown	VBN	O	show	dep	112	SENT_179	[p11l679t1832r905b1895],
45	to	TO	O	to	dep	112	SENT_179	[p11l937t1842r1003b1895],
46	similarly	RB	O	similarly	dep	112	SENT_179	[p11l1040t1832r1352b1913],
47	inﬂuence	VB	O	inﬂuence	dep	112	SENT_179	[p11l1385t1832r1710b1895],
48	simvastatin	NN	O	simvastatin	dep	112	SENT_179	[p11l1747t1832r2147b1895],
49	efﬁcacy	NN	O	efﬁcacy	dep	112	SENT_179	[p11l12t1919r375b2019],
50	.2	NN	NUMBER	.2	dep	112	SENT_179	[p11l12t1919r375b2019],
51	O	NN	O	o	dep	112	SENT_179	[p11l12t1919r375b2019],
52	However	RB	O	however	dep	112	SENT_179	[p11l399t1939r735b2012],
53	,	,	O	,	_	0	SENT_179	[p11l399t1939r735b2012],
54	other	JJ	O	other	dep	112	SENT_179	[p11l763t1938r945b2000],
55	investigators	NNS	O	investigator	dep	112	SENT_179	[p11l967t1938r1417b2019],
56	have	VBP	O	have	dep	112	SENT_179	[p11l1441t1938r1606b2000],
57	shown	VBN	O	show	dep	112	SENT_179	[p11l1633t1938r1858b2000],
58	ABCBI	NNP	O	ABCBI	dep	112	SENT_179	[p11l1875t1938r2140b2001],
59	polymorphisms	NNS	O	polymorphism	dep	112	SENT_179	[p11l10t2045r563b2126],
60	to	TO	O	to	dep	112	SENT_179	[p11l589t2055r655b2108],
61	inﬂuence	VB	O	inﬂuence	dep	112	SENT_179	[p11l680t2045r1005b2108],
62	the	DT	O	the	dep	112	SENT_179	[p11l1030t2046r1136b2108],
63	efﬁcacy	NN	O	efﬁcacy	dep	112	SENT_179	[p11l1162t2045r1442b2126],
64	of	IN	O	of	dep	112	SENT_179	[p11l1467t2045r1543b2108],
65	ﬂuvastatinzl	NN	O	ﬂuvastatinzl	dep	112	SENT_179	[p11l1562t2027r1991b2108],
66	and	CC	O	and	dep	112	SENT_179	[p11l2023t2046r2148b2108],
67	pravastatin	NN	O	pravastatin	dep	112	SENT_179	[p11l10t2133r488b2233],
68	,22	CD	NUMBER	,22	dep	112	SENT_179	[p11l10t2133r488b2233],
69	neither	DT	O	neither	dep	112	SENT_179	[p11l545t2152r793b2215],
70	of	IN	O	of	dep	112	SENT_179	[p11l849t2152r925b2215],
71	which	WDT	O	which	dep	112	SENT_179	[p11l976t2152r1191b2215],
72	are	VBP	O	be	dep	112	SENT_179	[p11l1250t2172r1354b2215],
73	P	NN	O	p	dep	112	SENT_179	[p11l1411t2152r1940b2233],
74	—	CD	NUMBER	—	dep	112	SENT_179	[p11l1411t2152r1940b2233],
75	glycoprotein	NN	O	glycoprotein	dep	112	SENT_179	[p11l1411t2152r1940b2233],
76	substrates	NNS	O	substrate	dep	112	SENT_179	[p11l1999t2152r2145b2215, p11l14t2240r424b2333],
77	,5	CD	NUMBER	,5	dep	112	SENT_179	[p11l1999t2152r2145b2215, p11l14t2240r424b2333],
78	’	CD	NUMBER	’	dep	112	SENT_179	[p11l1999t2152r2145b2215, p11l14t2240r424b2333],
79	9	CD	NUMBER	9	dep	112	SENT_179	[p11l1999t2152r2145b2215, p11l14t2240r424b2333],
80	’23	CD	NUMBER	’23	dep	112	SENT_179	[p11l1999t2152r2145b2215, p11l14t2240r424b2333],
81	suggesting	VBG	O	suggest	dep	112	SENT_179	[p11l456t2259r831b2340],
82	that	IN	O	that	dep	112	SENT_179	[p11l858t2259r992b2321],
83	other	JJ	O	other	dep	112	SENT_179	[p11l1018t2259r1200b2321],
84	mechanisms	NNS	O	mechanism	dep	112	SENT_179	[p11l1224t2259r1662b2321],
85	are	VBP	O	be	dep	112	SENT_179	[p11l1691t2279r1796b2321],
86	responsible	JJ	O	responsible	dep	112	SENT_179	[p11l1822t2259r2145b2340, p11l10t2366r118b2429],
87	for	IN	O	for	dep	112	SENT_179	[p11l170t2366r273b2429],
88	the	DT	O	the	dep	112	SENT_179	[p11l323t2366r429b2429],
89	variation	NN	O	variation	dep	112	SENT_179	[p11l480t2366r794b2429],
90	in	IN	O	in	dep	112	SENT_179	[p11l847t2366r914b2428],
91	drug	NN	O	drug	dep	112	SENT_179	[p11l966t2366r1125b2447],
92	efﬁcacy	NN	O	efﬁcacy	dep	112	SENT_179	[p11l1178t2366r1458b2447],
93	or	CC	O	or	dep	112	SENT_179	[p11l1511t2386r1583b2429],
94	that	IN	O	that	dep	112	SENT_179	[p11l1633t2366r1767b2429],
95	a	DT	O	a	dep	112	SENT_179	[p11l1819t2386r1856b2429],
96	nearby	JJ	O	nearby	dep	112	SENT_179	[p11l1906t2366r2147b2447],
97	functional	JJ	O	functional	dep	112	SENT_179	[p11l12t2471r371b2534],
98	polymorphism	NN	O	polymorphism	dep	112	SENT_179	[p11l408t2472r929b2553],
99	in	IN	O	in	dep	112	SENT_179	[p11l965t2472r1032b2533],
100	another	DT	O	another	dep	112	SENT_179	[p11l1071t2472r1336b2534],
101	gene	NN	O	gene	dep	112	SENT_179	[p11l1372t2491r1536b2553],
102	in	IN	O	in	dep	112	SENT_179	[p11l1574t2472r1641b2533],
103	linkage	NN	O	linkage	dep	112	SENT_179	[p11l1678t2472r1938b2553],
104	disequilibrium	NN	O	disequilibrium	dep	112	SENT_179	[p11l1977t2472r2145b2534, p11l12t2580r388b2661],
105	with	IN	O	with	dep	112	SENT_179	[p11l424t2580r581b2643],
106	ABCBI	NN	O	abcbus	dep	112	SENT_179	[p11l611t2581r877b2644],
107	polymorphisms	NNS	O	polymorphism	dep	112	SENT_179	[p11l919t2580r1472b2661],
108	is	VBZ	O	be	dep	112	SENT_179	[p11l1511t2580r1566b2643],
109	responsible	JJ	O	responsible	dep	112	SENT_179	[p11l1603t2580r2008b2661],
110	for	IN	O	for	dep	112	SENT_179	[p11l2047t2580r2149b2643],
111	the	DT	O	the	dep	112	SENT_179	[p11l11t2687r118b2750],
112	effect	NN	O	effect	_	0	SENT_179	[p11l152t2687r368b2750],
113	.	.	O	.	_	0	SENT_179	[p11l152t2687r368b2750],

1	Alternatively	RB	O	alternatively	advmod	7	SENT_180	[p11l405t2687r887b2768],
2	,	,	O	,	_	0	SENT_180	[p11l405t2687r887b2768],
3	these	DT	O	these	nsubj	7	SENT_180	[p11l923t2687r1103b2750],
4	could	MD	O	could	aux	7	SENT_180	[p11l1137t2687r1334b2750],
5	be	VB	O	be	cop	7	SENT_180	[p11l1364t2687r1446b2750],
6	chance	NN	O	chance	nn	7	SENT_180	[p11l1480t2687r1726b2750],
7	ﬁndings	NNS	O	ﬁndings	_	0	SENT_180	[p11l1760t2687r2061b2768],
8	.	.	O	.	_	0	SENT_180	[p11l1760t2687r2061b2768],

1	Our	PRP$	O	we	poss	2	SENT_181	[p11l120t2794r256b2857],
2	study	NN	O	study	nsubj	3	SENT_181	[p11l298t2794r485b2875],
3	has	VBZ	O	have	_	0	SENT_181	[p11l525t2794r641b2856],
4	important	JJ	O	important	amod	5	SENT_181	[p11l683t2794r1031b2875],
5	limitations	NNS	O	limitation	dobj	3	SENT_181	[p11l1071t2794r1469b2856],
6	.	.	O	.	_	0	SENT_181	[p11l1071t2794r1469b2856],

1	First	RB	ORDINAL	first	advmod	7	SENT_182	[p11l1514t2794r1695b2868],
2	,	,	O	,	_	0	SENT_182	[p11l1514t2794r1695b2868],
3	our	PRP$	O	we	poss	5	SENT_182	[p11l1740t2813r1857b2856],
4	sample	NN	O	sample	nn	5	SENT_182	[p11l1899t2794r2147b2875],
5	size	NN	O	size	nsubj	7	SENT_182	[p11l14t2901r147b2964],
6	is	VBZ	O	be	cop	7	SENT_182	[p11l192t2901r247b2964],
7	small	JJ	O	small	_	0	SENT_182	[p11l296t2901r501b2964],
8	.	.	O	.	_	0	SENT_182	[p11l296t2901r501b2964],

1	This	DT	O	this	nsubj	3	SENT_183	[p11l550t2901r704b2964],
2	could	MD	O	could	aux	3	SENT_183	[p11l751t2901r947b2964],
3	mean	VB	O	mean	_	0	SENT_183	[p11l990t2921r1182b2964],
4	that	IN	O	that	complm	9	SENT_183	[p11l1225t2901r1359b2964],
5	our	PRP$	O	we	poss	6	SENT_183	[p11l1402t2921r1519b2964],
6	ﬁndings	NNS	O	ﬁndings	nsubj	9	SENT_183	[p11l1562t2901r1844b2982],
7	are	VBP	O	be	cop	9	SENT_183	[p11l1891t2921r1996b2964],
8	the	DT	O	the	det	9	SENT_183	[p11l2040t2901r2147b2964],
9	result	NN	O	result	ccomp	3	SENT_183	[p11l10t3008r209b3071],
10	of	IN	O	of	_	0	SENT_183	[p11l245t3008r322b3071],
11	chance	NN	O	chance	prep_of	9	SENT_183	[p11l352t3008r617b3082],
12	,	,	O	,	_	0	SENT_183	[p11l352t3008r617b3082],
13	and	CC	O	and	_	0	SENT_183	[p11l659t3008r784b3071],
14	they	PRP	O	they	nsubj	15	SENT_183	[p11l819t3008r970b3089],
15	require	VBP	O	require	conj_and	3	SENT_183	[p11l1006t3008r1257b3089],
16	independent	JJ	O	independent	amod	17	SENT_183	[p11l1294t3008r1731b3089],
17	replication	NN	O	replication	dobj	15	SENT_183	[p11l1765t3008r2148b3089],
18	in	IN	O	in	_	0	SENT_183	[p11l11t3115r79b3177],
19	larger	JJR	O	larger	amod	20	SENT_183	[p11l114t3115r322b3196],
20	cohorts	NNS	O	cohort	prep_in	17	SENT_183	[p11l357t3115r634b3177],
21	.	.	O	.	_	0	SENT_183	[p11l357t3115r634b3177],

1	We	PRP	O	we	nsubj	5	SENT_184	[p11l674t3116r790b3177],
2	also	RB	O	also	advmod	5	SENT_184	[p11l828t3115r967b3177],
3	did	VBD	O	do	aux	5	SENT_184	[p11l1005t3115r1116b3177],
4	not	RB	O	not	neg	5	SENT_184	[p11l1151t3124r1264b3177],
5	stratify	VB	O	stratify	_	0	SENT_184	[p11l1303t3115r1550b3196],
6	our	PRP$	O	we	poss	7	SENT_184	[p11l1588t3134r1704b3177],
7	analysis	NN	O	analysis	dobj	5	SENT_184	[p11l1741t3115r2022b3196],
8	on	IN	O	on	_	0	SENT_184	[p11l2062t3134r2148b3177],
9	the	DT	O	the	det	10	SENT_184	[p11l11t3221r118b3283],
10	basis	NN	O	basis	prep_on	5	SENT_184	[p11l151t3221r326b3283],
11	of	IN	O	of	_	0	SENT_184	[p11l362t3220r439b3283],
12	gender	NN	O	gender	prep_of	10	SENT_184	[p11l467t3221r708b3302],
13	despite	IN	O	despite	_	0	SENT_184	[p11l741t3221r991b3302],
14	women	NNS	O	woman	prep_despite	5	SENT_184	[p11l1024t3240r1284b3283],
15	showing	VBG	O	show	partmod	14	SENT_184	[p11l1320t3221r1614b3302],
16	lower	JJR	O	lower	amod	18	SENT_184	[p11l1648t3221r1849b3284],
17	ABCBI	NN	O	abcbus	nn	18	SENT_184	[p11l1876t3221r2140b3284],
18	expression	NN	O	expression	dobj	15	SENT_184	[p11l12t3328r390b3409],
19	than	IN	O	than	_	0	SENT_184	[p11l415t3328r567b3390],
20	men	NNS	O	man	prep_than	15	SENT_184	[p11l593t3309r800b3390],
21	.4	CD	NUMBER	.4	npadvmod	22	SENT_184	[p11l593t3309r800b3390],
22	Further	JJ	O	further	amod	20	SENT_184	[p11l825t3328r1102b3402],
23	,	,	O	,	_	0	SENT_184	[p11l825t3328r1102b3402],
24	our	PRP$	O	we	poss	26	SENT_184	[p11l1133t3348r1250b3390],
25	study	NN	O	study	nn	26	SENT_184	[p11l1277t3328r1464b3409],
26	design	NN	O	design	nsubj	27	SENT_184	[p11l1491t3328r1721b3409],
27	used	VBD	O	use	dep	5	SENT_184	[p11l1746t3328r1908b3390],
28	a	DT	O	a	det	31	SENT_184	[p11l1935t3348r1972b3390],
29	candidate	NN	O	candidate	nn	31	SENT_184	[p11l1997t3348r2145b3390, p11l12t3436r227b3499],
30	gene	NN	O	gene	nn	31	SENT_184	[p11l254t3456r419b3517],
31	approach	NN	O	approach	dobj	27	SENT_184	[p11l448t3436r791b3517],
32	,	,	O	,	_	0	SENT_184	[p11l448t3436r791b3517],
33	and	CC	O	and	_	0	SENT_184	[p11l822t3436r948b3499],
34	we	PRP	O	we	nsubj	35	SENT_184	[p11l973t3456r1073b3499],
35	chose	VBD	O	choose	conj_and	5	SENT_184	[p11l1102t3436r1301b3499],
36	a	DT	O	a	det	40	SENT_184	[p11l1330t3456r1366b3499],
37	speciﬁc	JJ	O	speciﬁc	amod	40	SENT_184	[p11l1394t3436r1661b3517],
38	single	JJ	O	single	amod	40	SENT_184	[p11l1691t3436r1899b3517],
39	nucleotide	NN	O	nucleotide	nn	40	SENT_184	[p11l1925t3436r2145b3499, p11l12t3543r187b3606],
40	polymorphism	NN	O	polymorphism	dobj	35	SENT_184	[p11l248t3543r769b3624],
41	for	IN	O	for	_	0	SENT_184	[p11l830t3543r933b3606],
42	analysis	NN	O	analysis	prep_for	40	SENT_184	[p11l994t3543r1296b3624],
43	.	.	O	.	_	0	SENT_184	[p11l994t3543r1296b3624],

1	Genotyping	VBG	O	genotype	dep	30	SENT_185	[p11l1363t3543r1780b3624],
2	at	IN	O	at	_	0	SENT_185	[p11l1844t3553r1906b3606],
3	other	JJ	O	other	amod	5	SENT_185	[p11l1967t3543r2149b3606],
4	ABCBI	NNP	O	ABCBI	nn	5	SENT_185	[p11l6t3650r270b3713],
5	polymorphisms	NNS	O	polymorphism	prep_at	1	SENT_185	[p11l310t3650r863b3731],
6	and	CC	O	and	_	0	SENT_185	[p11l900t3650r1026b3712],
7	haplotype	NN	O	haplotype	nn	8	SENT_185	[p11l1059t3650r1409b3731],
8	comparisons	NNS	O	comparison	nsubj	11	SENT_185	[p11l1444t3650r1891b3731],
9	would	MD	O	would	aux	11	SENT_185	[p11l1927t3650r2148b3713],
10	have	VB	O	have	aux	11	SENT_185	[p12l11t20r176b83],
11	resulted	VBN	O	result	conj_and	1	SENT_185	[p12l200t20r483b83],
12	in	IN	O	in	_	0	SENT_185	[p12l506t20r574b82],
13	comparisons	NNS	O	comparison	prep_in	11	SENT_185	[p12l599t20r1045b101],
14	between	IN	O	between	_	0	SENT_185	[p12l1071t20r1369b83],
15	small	JJ	O	small	amod	16	SENT_185	[p12l1396t20r1583b83],
16	numbers	NNS	O	number	prep_between	13	SENT_185	[p12l1609t20r1913b83],
17	of	IN	O	of	_	0	SENT_185	[p12l1940t20r2017b83],
18	patients	NNS	O	patient	prep_of	16	SENT_185	[p12l2035t40r2145b101, p12l11t127r222b201],
19	,	,	O	,	_	0	SENT_185	[p12l2035t40r2145b101, p12l11t127r222b201],
20	and	CC	O	and	_	0	SENT_185	[p12l254t127r380b190],
21	hence	RB	O	hence	advmod	24	SENT_185	[p12l405t127r632b201],
22	,	,	O	,	_	0	SENT_185	[p12l405t127r632b201],
23	we	PRP	O	we	nsubj	24	SENT_185	[p12l663t147r763b190],
24	chose	VBD	O	choose	conj_and	11	SENT_185	[p12l791t127r990b190],
25	to	TO	O	to	aux	26	SENT_185	[p12l1018t137r1085b190],
26	study	VB	O	study	xcomp	24	SENT_185	[p12l1116t127r1303b208],
27	the	DT	O	the	det	29	SENT_185	[p12l1330t127r1437b190],
28	best	JJS	O	best	amod	29	SENT_185	[p12l1463t127r1979b190],
29	—	NN	O	—	dobj	26	SENT_185	[p12l1463t127r1979b190],
30	described	VBD	O	describe	_	0	SENT_185	[p12l1463t127r1979b190],
31	polymorphism	NN	O	polymorphism	dobj	30	SENT_185	[p12l2005t127r2145b208, p12l11t235r417b316],
32	in	IN	O	in	_	0	SENT_185	[p12l468t235r536b297],
33	ABCBI	NNP	O	ABCBI	prep_in	30	SENT_185	[p12l581t236r847b298],
34	.6	CD	NUMBER	.6	num	33	SENT_185	[p12l861t216r909b297],
35	Further	JJ	O	further	nsubj	30	SENT_185	[p12l961t235r1239b309],
36	,	,	O	,	_	0	SENT_185	[p12l961t235r1239b309],
37	our	PRP$	O	we	poss	40	SENT_185	[p12l1296t255r1412b297],
38	small	JJ	O	small	amod	40	SENT_185	[p12l1466t235r1654b297],
39	sample	NN	O	sample	nn	40	SENT_185	[p12l1710t235r1958b316],
40	size	NN	O	size	appos	35	SENT_185	[p12l2014t235r2147b297],
41	precluded	VBD	O	preclude	rcmod	40	SENT_185	[p12l10t342r363b423],
42	the	DT	O	the	det	43	SENT_185	[p12l416t342r522b405],
43	consideration	NN	O	consideration	dobj	41	SENT_185	[p12l578t342r1057b405],
44	of	IN	O	of	_	0	SENT_185	[p12l1113t342r1189b405],
45	polymorphisms	NNS	O	polymorphism	prep_of	43	SENT_185	[p12l1236t342r1788b423],
46	in	IN	O	in	_	0	SENT_185	[p12l1845t342r1912b404],
47	other	JJ	O	other	amod	48	SENT_185	[p12l1967t342r2149b405],
48	genes	NNS	O	gene	prep_in	41	SENT_185	[p12l12t467r210b529],
49	related	VBN	O	relate	partmod	48	SENT_185	[p12l246t448r489b510],
50	to	TO	O	to	_	0	SENT_185	[p12l523t457r589b510],
51	atorvastatin	NN	O	atorvastatin	nn	52	SENT_185	[p12l626t448r1039b510],
52	metabolism	NN	O	metabolism	prep_to	49	SENT_185	[p12l1073t448r1490b510],
53	such	JJ	O	such	_	0	SENT_185	[p12l1527t448r1685b510],
54	as	IN	O	as	_	0	SENT_185	[p12l1721t467r1789b510],
55	the	DT	O	the	det	58	SENT_185	[p12l1825t448r1932b510],
56	cytochrome	NN	O	cytochrome	nn	58	SENT_185	[p12l1968t457r2145b529, p12l12t555r277b618],
57	P450	NN	O	p450	nn	58	SENT_185	[p12l303t555r484b618],
58	3A4	NN	O	3a4	prep_such_as	52	SENT_185	[p12l514t556r661b618],
59	to	TO	O	to	aux	60	SENT_185	[p12l688t565r754b618],
60	construct	VB	O	construct	xcomp	49	SENT_185	[p12l782t565r1108b618],
61	more	RBR	O	more	advmod	62	SENT_185	[p12l1134t576r1314b618],
62	complex	JJ	O	complex	amod	63	SENT_185	[p12l1342t555r1647b636],
63	haplotypes	NNS	O	haplotype	dobj	60	SENT_185	[p12l1672t537r2147b636],
64	.24	CD	NUMBER	.24	nsubj	70	SENT_185	[p12l1672t537r2147b636],
65	However	RB	O	however	advmod	70	SENT_185	[p12l119t665r454b737],
66	,	,	O	,	_	0	SENT_185	[p12l119t665r454b737],
67	our	PRP$	O	we	poss	69	SENT_185	[p12l488t683r605b726],
68	study	NN	O	study	nn	69	SENT_185	[p12l635t663r822b744],
69	design	NN	O	design	nsubj	70	SENT_185	[p12l853t663r1082b744],
70	differs	VBZ	O	differ	rcmod	63	SENT_185	[p12l1112t663r1338b726],
71	from	IN	O	from	_	0	SENT_185	[p12l1370t663r1541b726],
72	previous	JJ	O	previous	amod	73	SENT_185	[p12l1568t663r1871b744],
73	reports	NNS	O	report	prep_from	70	SENT_185	[p12l1900t673r2146b744],
74	in	IN	O	in	_	0	SENT_185	[p12l11t770r79b832],
75	several	JJ	O	several	amod	77	SENT_185	[p12l102t770r346b833],
76	important	JJ	O	important	amod	77	SENT_185	[p12l368t770r716b851],
77	aspects	NNS	O	aspect	prep_in	73	SENT_185	[p12l737t779r1008b851],
78	.	.	O	.	_	0	SENT_185	[p12l737t779r1008b851],

1	First	RB	ORDINAL	first	advmod	6	SENT_186	[p12l1033t770r1214b844],
2	,	,	O	,	_	0	SENT_186	[p12l1033t770r1214b844],
3	our	PRP$	O	we	poss	5	SENT_186	[p12l1239t789r1356b832],
4	study	NN	O	study	nn	5	SENT_186	[p12l1378t770r1565b851],
5	design	NN	O	design	nsubj	6	SENT_186	[p12l1587t770r1817b851],
6	excludes	VBZ	O	exclude	_	0	SENT_186	[p12l1838t770r2146b832],
7	patients	NNS	O	patient	dobj	6	SENT_186	[p12l10t877r285b958],
8	taking	VBG	O	take	partmod	7	SENT_186	[p12l343t877r563b958],
9	many	JJ	O	many	amod	10	SENT_186	[p12l620t897r815b958],
10	drugs	NNS	O	drug	dobj	8	SENT_186	[p12l871t877r1064b958],
11	that	WDT	O	that	nsubj	12	SENT_186	[p12l1121t877r1254b940],
12	inhibit	VBP	O	inhibit	rcmod	10	SENT_186	[p12l1309t877r1542b940],
13	P	NN	O	p	nn	15	SENT_186	[p12l1596t877r2142b958],
14	—	CD	NUMBER	—	num	15	SENT_186	[p12l1596t877r2142b958],
15	glycoprotein	NN	O	glycoprotein	dobj	12	SENT_186	[p12l1596t877r2142b958],
16	.	.	O	.	_	0	SENT_186	[p12l1596t877r2142b958],

1	Previous	JJ	O	previous	amod	2	SENT_187	[p12l11t984r317b1047],
2	investigators	NNS	O	investigator	nsubj	13	SENT_187	[p12l347t984r796b1065],
3	do	VBP	O	do	aux	5	SENT_187	[p12l826t984r910b1047],
4	not	RB	O	not	neg	5	SENT_187	[p12l939t994r1052b1047],
5	describe	VB	O	describe	_	0	SENT_187	[p12l1078t984r1373b1047],
6	such	JJ	O	such	amod	9	SENT_187	[p12l1404t984r1562b1047],
7	stringent	JJ	O	stringent	amod	9	SENT_187	[p12l1592t984r1901b1065],
8	exclusion	NN	O	exclusion	nn	9	SENT_187	[p12l1928t984r2145b1047, p12l14t1091r158b1153],
9	criteria	NNS	O	criterion	dobj	5	SENT_187	[p12l198t1091r450b1153],
10	and	CC	O	and	_	0	SENT_187	[p12l491t1091r616b1153],
11	do	VBP	O	do	aux	13	SENT_187	[p12l656t1091r740b1153],
12	not	RB	O	not	neg	13	SENT_187	[p12l781t1100r894b1153],
13	report	VB	O	report	conj_and	5	SENT_187	[p12l931t1100r1145b1172],
14	patient	NN	O	patient	nn	15	SENT_187	[p12l1182t1091r1425b1172],
15	medications	NNS	O	medication	dobj	13	SENT_187	[p12l1465t1091r1893b1153],
16	as	IN	O	as	mark	18	SENT_187	[p12l1936t1110r2004b1153],
17	we	PRP	O	we	nsubj	18	SENT_187	[p12l2047t1110r2147b1154],
18	have	VBP	O	have	advcl	13	SENT_187	[p12l11t1178r348b1260],
19	.10	CD	NUMBER	.10	number	20	SENT_187	[p12l11t1178r348b1260],
20	’19	CD	NUMBER	’19	dobj	18	SENT_187	[p12l11t1178r348b1260],
21	It	PRP	O	it	nsubj	23	SENT_187	[p12l376t1199r429b1260],
22	is	VBZ	O	be	cop	23	SENT_187	[p12l456t1197r511b1260],
23	possible	JJ	O	possible	rcmod	20	SENT_187	[p12l538t1197r829b1278],
24	that	IN	O	that	complm	28	SENT_187	[p12l856t1198r990b1260],
25	concomitant	JJ	O	concomitant	amod	26	SENT_187	[p12l1017t1197r1459b1260],
26	medications	NNS	O	medication	nsubj	28	SENT_187	[p12l1484t1197r1914b1260],
27	effectively	RB	O	effectively	advmod	28	SENT_187	[p12l1943t1197r2145b1260, p12l11t1304r210b1385],
28	nullify	VBP	O	nullify	ccomp	23	SENT_187	[p12l250t1304r486b1385],
29	the	DT	O	the	det	30	SENT_187	[p12l526t1304r632b1366],
30	effect	NN	O	effect	dobj	28	SENT_187	[p12l674t1304r874b1366],
31	of	IN	O	of	_	0	SENT_187	[p12l914t1304r991b1366],
32	the	DT	O	the	det	34	SENT_187	[p12l1025t1304r1131b1366],
33	C3435T	NN	O	c3435t	nn	34	SENT_187	[p12l1173t1303r1461b1367],
34	polymorphism	NN	O	polymorphism	prep_of	30	SENT_187	[p12l1501t1303r2022b1385],
35	on	IN	O	on	_	0	SENT_187	[p12l2062t1323r2148b1366],
36	Atorvastatin	NNP	O	Atorvastatin	nn	37	SENT_187	[p12l11t1412r449b1475],
37	efﬁcacy	NN	O	efﬁcacy	nsubj	39	SENT_187	[p12l473t1412r752b1493],
38	thereby	RB	O	thereby	advmod	39	SENT_187	[p12l775t1412r1041b1493],
39	explaining	VBG	O	explain	prepc_on	28	SENT_187	[p12l1065t1412r1438b1493],
40	why	WRB	O	why	advmod	47	SENT_187	[p12l1463t1412r1612b1493],
41	the	DT	O	the	det	44	SENT_187	[p12l1636t1412r1743b1475],
42	initial	JJ	O	initial	amod	44	SENT_187	[p12l1766t1412r1973b1475],
43	positive	JJ	O	positive	amod	44	SENT_187	[p12l1996t1432r2145b1493, p12l11t1518r166b1581],
44	studylo	NN	O	studylo	nsubjpass	47	SENT_187	[p12l197t1499r452b1599],
45	was	VBD	O	be	auxpass	47	SENT_187	[p12l479t1538r613b1581],
46	not	RB	O	not	neg	47	SENT_187	[p12l643t1528r756b1581],
47	reproduced	VBN	O	reproduce	advcl	39	SENT_187	[p12l782t1499r1271b1599],
48	.	.	O	.	_	0	SENT_187	[p12l782t1499r1271b1599],

1	”	NN	O	”	nn	3	SENT_188	[p12l782t1499r1271b1599],
2	Another	DT	O	another	det	3	SENT_188	[p12l1299t1518r1591b1581],
3	strength	NN	O	strength	nsubj	12	SENT_188	[p12l1621t1518r1904b1599],
4	of	IN	O	of	_	0	SENT_188	[p12l1933t1518r2009b1581],
5	our	PRP$	O	we	poss	7	SENT_188	[p12l2032t1538r2149b1581],
6	study	NN	O	study	nn	7	SENT_188	[p12l14t1626r201b1707],
7	design	NN	O	design	prep_of	3	SENT_188	[p12l236t1626r465b1707],
8	is	VBZ	O	be	cop	12	SENT_188	[p12l499t1626r554b1688],
9	our	PRP$	O	we	poss	12	SENT_188	[p12l589t1645r706b1688],
10	stringent	JJ	O	stringent	amod	12	SENT_188	[p12l740t1626r1048b1707],
11	adherence	NN	O	adherence	nn	12	SENT_188	[p12l1082t1626r1439b1688],
12	criterion	NN	O	criterion	_	0	SENT_188	[p12l1474t1626r1775b1688],
13	of	IN	O	of	_	0	SENT_188	[p12l1809t1626r1886b1688],
14	>	JJR	O	>	amod	17	SENT_188	[p12l1918t1626r2143b1689],
15	90	CD	PERCENT	90	number	16	SENT_188	[p12l1918t1626r2143b1689],
16	%	NN	PERCENT	%	amod	17	SENT_188	[p12l1918t1626r2143b1689],
17	compliance	NN	O	compliance	prep_of	12	SENT_188	[p12l12t1733r422b1814],
18	for	IN	O	for	_	0	SENT_188	[p12l440t1733r543b1796],
19	inclusion	NN	O	inclusion	prep_for	12	SENT_188	[p12l559t1733r885b1796],
20	in	IN	O	in	_	0	SENT_188	[p12l902t1733r969b1795],
21	the	DT	O	the	det	24	SENT_188	[p12l986t1733r1093b1796],
22	atorvastatin	NN	O	atorvastatin	nn	24	SENT_188	[p12l1113t1733r1525b1796],
23	efﬁcacy	NN	O	efﬁcacy	nn	24	SENT_188	[p12l1543t1733r1823b1814],
24	analysis	NN	O	analysis	prep_in	19	SENT_188	[p12l1842t1733r2142b1814],
25	.	.	O	.	_	0	SENT_188	[p12l1842t1733r2142b1814],

1	It	PRP	O	it	nsubj	3	SENT_189	[p12l11t1842r65b1903],
2	is	VBZ	O	be	cop	3	SENT_189	[p12l90t1840r145b1903],
3	possible	JJ	O	possible	_	0	SENT_189	[p12l172t1840r463b1921],
4	that	IN	O	that	complm	13	SENT_189	[p12l490t1840r624b1903],
5	studies	NNS	O	study	nsubj	13	SENT_189	[p12l652t1840r893b1903],
6	that	WDT	O	that	nsubj	9	SENT_189	[p12l921t1840r1055b1903],
7	did	VBD	O	do	aux	9	SENT_189	[p12l1081t1840r1192b1903],
8	not	RB	O	not	neg	9	SENT_189	[p12l1218t1850r1331b1903],
9	employ	VB	O	employ	rcmod	5	SENT_189	[p12l1357t1840r1622b1921],
10	such	JJ	O	such	amod	12	SENT_189	[p12l1652t1840r1810b1903],
11	stringent	JJ	O	stringent	amod	12	SENT_189	[p12l1840t1840r2148b1921],
12	criteria	NNS	O	criterion	dobj	9	SENT_189	[p12l12t1947r264b2009],
13	have	VBP	O	have	ccomp	3	SENT_189	[p12l281t1947r446b2010],
14	a	DT	O	a	det	15	SENT_189	[p12l466t1966r503b2009],
15	dilution	NN	O	dilution	dobj	13	SENT_189	[p12l520t1947r796b2009],
16	of	IN	O	of	_	0	SENT_189	[p12l815t1947r892b2009],
17	statistical	JJ	O	statistical	amod	18	SENT_189	[p12l907t1947r1240b2009],
18	power	NN	O	power	prep_of	15	SENT_189	[p12l1258t1966r1479b2028],
19	in	IN	O	in	_	0	SENT_189	[p12l1496t1947r1563b2009],
20	detecting	VBG	O	detect	prepc_in	13	SENT_189	[p12l1582t1947r1906b2028],
21	the	DT	O	the	det	22	SENT_189	[p12l1925t1947r2032b2009],
22	effect	NN	O	effect	dobj	20	SENT_189	[p12l2051t1947r2145b2009, p12l12t2052r145b2115],
23	of	IN	O	of	_	0	SENT_189	[p12l174t2052r251b2115],
24	a	DT	O	a	det	25	SENT_189	[p12l277t2072r314b2115],
25	polymorphism	NN	O	polymorphism	prep_of	22	SENT_189	[p12l341t2053r863b2134],
26	due	JJ	O	due	_	0	SENT_189	[p12l892t2053r1017b2115],
27	to	TO	O	to	_	0	SENT_189	[p12l1048t2062r1114b2115],
28	non	JJ	O	non	amod	31	SENT_189	[p12l1145t2053r1615b2115],
29	—	NN	O	—	nn	31	SENT_189	[p12l1145t2053r1615b2115],
30	adherent	JJ	O	adherent	amod	31	SENT_189	[p12l1145t2053r1615b2115],
31	patients	NNS	O	patient	prep_due_to	25	SENT_189	[p12l1644t2053r1919b2134],
32	being	VBG	O	be	auxpass	33	SENT_189	[p12l1950t2053r2146b2134],
33	grouped	VBN	O	group	partmod	31	SENT_189	[p12l12t2161r302b2242],
34	with	IN	O	with	_	0	SENT_189	[p12l328t2161r484b2224],
35	the	DT	O	the	det	39	SENT_189	[p12l509t2161r616b2223],
36	true	JJ	O	true	amod	39	SENT_189	[p12l642t2170r779b2223],
37	hypo	NN	O	hypo	nn	39	SENT_189	[p12l805t2161r1416b2242],
38	—	NN	O	—	nn	39	SENT_189	[p12l805t2161r1416b2242],
39	responders	NNS	O	responder	prep_with	33	SENT_189	[p12l805t2161r1416b2242],
40	.	.	O	.	_	0	SENT_189	[p12l805t2161r1416b2242],

1	An	DT	O	a	det	5	SENT_190	[p12l118t2269r225b2330],
2	important	JJ	O	important	amod	5	SENT_190	[p12l262t2268r608b2349],
3	and	CC	O	and	_	0	SENT_190	[p12l646t2268r772b2331],
4	novel	JJ	O	novel	conj_and	2	SENT_190	[p12l808t2268r1002b2331],
5	ﬁnding	NN	O	ﬁnding	nsubj	12	SENT_190	[p12l1041t2268r1289b2349],
6	from	IN	O	from	_	0	SENT_190	[p12l1327t2268r1499b2331],
7	our	PRP$	O	we	poss	8	SENT_190	[p12l1537t2288r1654b2331],
8	analysis	NN	O	analysis	prep_from	5	SENT_190	[p12l1691t2268r1973b2349],
9	was	VBD	O	be	cop	12	SENT_190	[p12l2012t2288r2146b2331],
10	the	DT	O	the	det	12	SENT_190	[p12l11t2375r118b2438],
11	increased	VBN	O	increase	amod	12	SENT_190	[p12l166t2375r502b2438],
12	frequency	NN	O	frequency	_	0	SENT_190	[p12l549t2375r904b2456],
13	of	IN	O	of	_	0	SENT_190	[p12l952t2375r1029b2438],
14	the	DT	O	the	det	16	SENT_190	[p12l1070t2375r1176b2438],
15	T	NN	O	t	nn	16	SENT_190	[p12l1225t2377r1277b2437],
16	allele	NN	O	allele	prep_of	12	SENT_190	[p12l1320t2375r1510b2438],
17	in	IN	O	in	_	0	SENT_190	[p12l1558t2375r1626b2437],
18	patients	NNS	O	patient	prep_in	16	SENT_190	[p12l1672t2375r1947b2456],
19	who	WP	O	who	nsubj	20	SENT_190	[p12l1997t2375r2147b2438],
20	reported	VBD	O	report	rcmod	12	SENT_190	[p12l10t2482r308b2563],
21	muscle	NN	O	muscle	nn	22	SENT_190	[p12l342t2482r592b2544],
22	symptoms	NNS	O	symptom	dobj	20	SENT_190	[p12l631t2491r1010b2563],
23	.	.	O	.	_	0	SENT_190	[p12l631t2491r1010b2563],

1	One	CD	NUMBER	one	num	2	SENT_191	[p12l1051t2482r1195b2545],
2	patient	NN	O	patient	nsubj	6	SENT_191	[p12l1230t2482r1473b2563],
3	in	IN	O	in	_	0	SENT_191	[p12l1507t2482r1574b2544],
4	our	PRP$	O	we	poss	5	SENT_191	[p12l1610t2501r1727b2544],
5	cohort	NN	O	cohort	prep_in	2	SENT_191	[p12l1761t2482r1988b2544],
6	had	VBD	O	have	_	0	SENT_191	[p12l2020t2482r2148b2544],
7	rhabdomyolysis	NN	O	rhabdomyolysis	dobj	6	SENT_191	[p12l10t2587r601b2669],
8	;	:	O	;	_	0	SENT_191	[p12l10t2587r601b2669],
9	this	DT	O	this	det	10	SENT_191	[p12l643t2587r768b2650],
10	patient	NN	O	patient	nsubj	11	SENT_191	[p12l806t2588r1050b2669],
11	refused	VBD	O	refuse	parataxis	6	SENT_191	[p12l1086t2588r1348b2650],
12	consent	NN	O	consent	dobj	11	SENT_191	[p12l1386t2597r1657b2650],
13	for	IN	O	for	_	0	SENT_191	[p12l1694t2588r1797b2650],
14	genotyping	NN	O	genotyping	prep_for	11	SENT_191	[p12l1833t2597r2145b2669, p12l11t2696r141b2777],
15	.	.	O	.	_	0	SENT_191	[p12l1833t2597r2145b2669, p12l11t2696r141b2777],

1	Although	IN	O	although	mark	9	SENT_192	[p12l171t2696r507b2777],
2	this	DT	O	this	nsubj	9	SENT_192	[p12l532t2696r657b2759],
3	is	VBZ	O	be	cop	9	SENT_192	[p12l685t2696r740b2759],
4	the	DT	O	the	det	9	SENT_192	[p12l767t2696r874b2759],
5	most	RBS	O	most	advmod	6	SENT_192	[p12l901t2706r1073b2759],
6	serious	JJ	O	serious	amod	9	SENT_192	[p12l1101t2696r1347b2759],
7	muscle	NN	O	muscle	nn	9	SENT_192	[p12l1374t2696r1625b2759],
8	adverse	JJ	O	adverse	amod	9	SENT_192	[p12l1654t2696r1921b2759],
9	effect	NN	O	effect	advcl	43	SENT_192	[p12l1948t2696r2149b2759],
10	related	JJ	O	related	amod	9	SENT_192	[p12l10t2803r254b2866],
11	to	TO	O	to	_	0	SENT_192	[p12l308t2813r374b2866],
12	statin	NN	O	statin	nn	13	SENT_192	[p12l433t2803r621b2866],
13	use	NN	O	use	prep_to	10	SENT_192	[p12l676t2823r811b2877],
14	,	,	O	,	_	0	SENT_192	[p12l676t2823r811b2877],
15	myalgia	NN	O	myalgium	nsubj	43	SENT_192	[p12l870t2803r1157b2884],
16	and	CC	O	and	_	0	SENT_192	[p12l1213t2803r1338b2866],
17	myositis	NN	O	myositis	nsubj	43	SENT_192	[p12l1393t2803r1711b2884],
18	,	,	O	,	_	0	SENT_192	[p12l1393t2803r1711b2884],
19	which	WDT	O	which	nsubjpass	21	SENT_192	[p12l1771t2803r1986b2866],
20	are	VBP	O	be	auxpass	21	SENT_192	[p12l2042t2823r2147b2866],
21	characterized	VBN	O	characterize	rcmod	15	SENT_192	[p12l12t2910r488b2972],
22	by	IN	O	by	_	0	SENT_192	[p12l521t2910r608b2991],
23	normal	JJ	O	normal	amod	25	SENT_192	[p12l644t2910r894b2972],
24	creatine	NN	O	creatine	nn	25	SENT_192	[p12l930t2910r1211b2972],
25	phosphokinase	NN	O	phosphokinase	agent	21	SENT_192	[p12l1245t2910r1773b2991],
26	and	CC	O	and	_	0	SENT_192	[p12l1811t2910r1936b2972],
27	creatine	NN	O	creatine	nn	28	SENT_192	[p12l1971t2929r2144b2972, p12l11t3017r143b3080],
28	phosphokinase	NN	O	phosphokinase	agent	21	SENT_192	[p12l176t3017r704b3098],
29	lower	JJR	O	lower	advmod	21	SENT_192	[p12l738t3017r939b3080],
30	than	IN	O	than	_	0	SENT_192	[p12l970t3017r1122b3080],
31	10	CD	NUMBER	10	number	32	SENT_192	[p12l1164t3018r1242b3080],
32	times	NNS	O	time	num	35	SENT_192	[p12l1275t3017r1465b3080],
33	the	DT	O	the	det	35	SENT_192	[p12l1500t3017r1607b3080],
34	upper	JJ	O	upper	amod	35	SENT_192	[p12l1640t3037r1843b3098],
35	limit	NN	O	limit	prep_than	21	SENT_192	[p12l1875t3017r2044b3080],
36	of	IN	O	of	_	0	SENT_192	[p12l2077t3017r2153b3080],
37	normal	JJ	O	normal	prep_of	35	SENT_192	[p12l11t3125r258b3187],
38	respectively	RB	O	respectively	advmod	37	SENT_192	[p12l304t3125r735b3206],
39	,	,	O	,	_	0	SENT_192	[p12l304t3125r735b3206],
40	are	VBP	O	be	cop	43	SENT_192	[p12l787t3145r890b3187],
41	more	RBR	O	more	advmod	42	SENT_192	[p12l938t3145r1116b3187],
42	common	JJ	O	common	amod	43	SENT_192	[p12l1165t3145r1470b3187],
43	complaints	NNS	O	complaint	_	0	SENT_192	[p12l1518t3106r1986b3206],
44	.	.	O	.	_	0	SENT_192	[p12l1518t3106r1986b3206],

1	”	NN	O	”	nsubj	28	SENT_193	[p12l1518t3106r1986b3206],
2	Although	IN	O	although	mark	10	SENT_193	[p12l2033t3124r2145b3186, p12l11t3232r253b3313],
3	the	DT	O	the	det	5	SENT_193	[p12l315t3232r421b3295],
4	rs4363657	NN	O	rs4363657	nn	5	SENT_193	[p12l483t3232r849b3295],
5	polymorphism	NN	O	polymorphism	nsubjpass	10	SENT_193	[p12l913t3232r1424b3313],
6	in	IN	O	in	_	0	SENT_193	[p12l1486t3232r1553b3294],
7	SLCOIBI	NNP	ORGANIZATION	SLCOIBI	prep_in	5	SENT_193	[p12l1616t3233r1963b3295],
8	has	VBZ	O	have	aux	10	SENT_193	[p12l2033t3232r2146b3295],
9	been	VBN	O	be	auxpass	10	SENT_193	[p12l10t3339r176b3401],
10	associated	VBN	O	associate	dep	28	SENT_193	[p12l213t3339r570b3401],
11	with	IN	O	with	_	0	SENT_193	[p12l604t3339r758b3401],
12	rhabdomyolysis	NN	O	rhabdomyolysis	prep_with	10	SENT_193	[p12l792t3339r1348b3420],
13	in	IN	O	in	prep	12	SENT_193	[p12l1384t3339r1452b3401],
14	users	NNS	O	user	dep	24	SENT_193	[p12l1486t3358r1661b3401],
15	of	IN	O	of	_	0	SENT_193	[p12l1700t3339r1776b3401],
16	high	JJ	O	high	amod	18	SENT_193	[p12l1805t3339r2147b3420],
17	—	NN	O	—	nn	18	SENT_193	[p12l1805t3339r2147b3420],
18	dose	NN	O	dose	prep_of	14	SENT_193	[p12l1805t3339r2147b3420],
19	simvastatin	NN	O	simvastatin	dep	24	SENT_193	[p12l11t3430r499b3523],
20	,25	CD	NUMBER	,25	num	19	SENT_193	[p12l11t3430r499b3523],
21	the	DT	O	the	det	24	SENT_193	[p12l556t3449r663b3511],
22	more	RBR	O	more	advmod	23	SENT_193	[p12l719t3469r900b3511],
23	common	JJ	O	common	amod	24	SENT_193	[p12l956t3469r1267b3511],
24	complaint	NN	O	complaint	dep	13	SENT_193	[p12l1322t3449r1679b3530],
25	of	IN	O	of	_	0	SENT_193	[p12l1734t3449r1811b3511],
26	myalgia	NN	O	myalgium	prep_of	24	SENT_193	[p12l1860t3449r2148b3530],
27	arguably	RB	O	arguably	advmod	26	SENT_193	[p12l10t3557r318b3638],
28	has	VBZ	O	have	_	0	SENT_193	[p12l353t3557r468b3620],
29	a	DT	O	a	det	31	SENT_193	[p12l508t3577r545b3620],
30	greater	JJR	O	greater	amod	31	SENT_193	[p12l580t3567r828b3638],
31	impact	NN	O	impact	dobj	28	SENT_193	[p12l862t3557r1105b3638],
32	on	IN	O	on	_	0	SENT_193	[p12l1141t3577r1227b3620],
33	patient	NN	O	patient	nn	34	SENT_193	[p12l1261t3557r1506b3638],
34	adherence	NN	O	adherence	prep_on	28	SENT_193	[p12l1543t3557r1922b3632],
35	,	,	O	,	_	0	SENT_193	[p12l1543t3557r1922b3632],
36	especially	RB	O	especially	advmod	28	SENT_193	[p12l1961t3577r2144b3638, p12l9t3664r204b3745],
37	in	IN	O	in	_	0	SENT_193	[p12l238t3664r305b3726],
38	the	DT	O	the	det	40	SENT_193	[p12l337t3664r444b3727],
39	long	JJ	O	long	amod	40	SENT_193	[p12l477t3664r633b3745],
40	term	NN	O	term	prep_in	28	SENT_193	[p12l666t3674r846b3727],
41	.	.	O	.	_	0	SENT_193	[p12l666t3674r846b3727],

1	In	IN	O	in	_	0	SENT_194	[p13l115t21r187b82],
2	the	DT	O	the	det	3	SENT_194	[p13l236t20r342b82],
3	Treat	NN	O	treat	prep_in	18	SENT_194	[p13l392t21r577b82],
4	to	TO	O	to	_	0	SENT_194	[p13l625t29r692b82],
5	New	NNP	O	New	nn	8	SENT_194	[p13l741t21r905b83],
6	Targets	NNP	O	Targets	nn	8	SENT_194	[p13l954t21r1212b101],
7	(	CD	NUMBER	(	num	8	SENT_194	[p13l1266t21r1492b97],
8	TNT	NNP	O	TNT	prep_to	3	SENT_194	[p13l1266t21r1492b97],
9	)	CD	NUMBER	)	num	10	SENT_194	[p13l1266t21r1492b97],
10	study	NN	O	study	dep	8	SENT_194	[p13l1546t20r1733b101],
11	of	IN	O	of	_	0	SENT_194	[p13l1784t20r1861b82],
12	10,000	CD	NUMBER	10,000	num	13	SENT_194	[p13l1912t20r2146b94],
13	patients	NNS	O	patient	prep_of	10	SENT_194	[p13l7t127r282b208],
14	prescribed	VBN	O	prescribe	partmod	13	SENT_194	[p13l314t127r686b208],
15	atorvastatin	NN	O	atorvastatin	dobj	14	SENT_194	[p13l718t127r1150b202],
16	,	,	O	,	_	0	SENT_194	[p13l718t127r1150b202],
17	there	EX	O	there	expl	18	SENT_194	[p13l1183t127r1360b190],
18	were	VBD	O	be	dep	21	SENT_194	[p13l1390t147r1560b190],
19	only	RB	O	only	quantmod	20	SENT_194	[p13l1593t127r1747b208],
20	5	CD	NUMBER	5	nsubj	18	SENT_194	[p13l1780t127r1817b190],
21	reported	VBD	O	report	_	0	SENT_194	[p13l1850t127r2148b208],
22	cases	NNS	O	case	dobj	21	SENT_194	[p13l9t252r192b295],
23	of	IN	O	of	_	0	SENT_194	[p13l246t233r322b295],
24	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	22	SENT_194	[p13l366t233r935b314],
25	(	CD	PERCENT	(	num	24	SENT_194	[p13l989t232r1294b310],
26	0.05	CD	PERCENT	0.05	dep	27	SENT_194	[p13l989t232r1294b310],
27	%	NN	PERCENT	%	advmod	24	SENT_194	[p13l989t232r1294b310],
28	)	CD	NUMBER	)	nsubj	21	SENT_194	[p13l989t232r1294b310],
29	,	,	O	,	_	0	SENT_194	[p13l989t232r1294b310],
30	whereas	IN	O	whereas	mark	33	SENT_194	[p13l1348t233r1636b295],
31	475	CD	NUMBER	475	num	32	SENT_194	[p13l1688t232r1816b295],
32	patients	NNS	O	patient	nsubj	33	SENT_194	[p13l1869t233r2146b314],
33	reported	VBD	O	report	dep	28	SENT_194	[p13l7t341r305b421],
34	myalgia	JJ	O	myalgia	amod	35	SENT_194	[p13l330t340r618b421],
35	(	NN	O	(	dobj	33	SENT_194	[p13l646t321r976b418],
36	4.8	CD	PERCENT	4.8	num	37	SENT_194	[p13l646t321r976b418],
37	%	NN	PERCENT	%	nsubj	67	SENT_194	[p13l646t321r976b418],
38	)	CD	NUMBER	)	number	39	SENT_194	[p13l646t321r976b418],
39	.26	CD	NUMBER	.26	num	37	SENT_194	[p13l646t321r976b418],
40	In	IN	O	in	_	0	SENT_194	[p13l1002t342r1074b402],
41	our	PRP$	O	we	poss	42	SENT_194	[p13l1101t360r1219b403],
42	cohort	NN	O	cohort	prep_in	52	SENT_194	[p13l1243t340r1489b414],
43	,	,	O	,	_	0	SENT_194	[p13l1243t340r1489b414],
44	the	DT	O	the	det	46	SENT_194	[p13l1517t340r1624b403],
45	T	NN	O	t	nn	46	SENT_194	[p13l1651t342r1703b402],
46	allele	NN	O	allele	nsubjpass	52	SENT_194	[p13l1725t340r1915b403],
47	of	IN	O	of	_	0	SENT_194	[p13l1943t340r2020b403],
48	the	DT	O	the	det	50	SENT_194	[p13l2040t340r2147b403],
49	C3435T	NN	O	c3435t	nn	50	SENT_194	[p13l9t448r298b511],
50	polymorphism	NN	O	polymorphism	prep_of	46	SENT_194	[p13l334t448r856b529],
51	was	VBD	O	be	auxpass	52	SENT_194	[p13l892t468r1026b511],
52	found	VBN	O	find	rcmod	37	SENT_194	[p13l1065t448r1271b511],
53	to	TO	O	to	aux	56	SENT_194	[p13l1306t458r1373b511],
54	be	VB	O	be	cop	56	SENT_194	[p13l1409t448r1492b511],
55	more	RBR	O	more	advmod	56	SENT_194	[p13l1529t468r1710b511],
56	frequent	JJ	O	frequent	xcomp	52	SENT_194	[p13l1747t448r2045b529],
57	in	IN	O	in	_	0	SENT_194	[p13l2080t448r2148b510],
58	patients	NNS	O	patient	prep_in	56	SENT_194	[p13l7t555r282b636],
59	with	IN	O	with	_	0	SENT_194	[p13l309t555r465b618],
60	muscle	NN	O	muscle	nn	61	SENT_194	[p13l490t555r740b617],
61	symptoms	NNS	O	symptom	prep_with	58	SENT_194	[p13l768t564r1129b636],
62	than	IN	O	than	dep	56	SENT_194	[p13l1155t555r1307b617],
63	in	IN	O	in	_	0	SENT_194	[p13l1331t555r1398b617],
64	those	DT	O	those	prep_in	56	SENT_194	[p13l1422t555r1608b617],
65	without	IN	O	without	_	0	SENT_194	[p13l1632t555r1903b618],
66	symptoms	NNS	O	symptom	prep_without	64	SENT_194	[p13l1929t574r2145b636, p13l8t672r177b725],
67	(	VBP	O	(	rcmod	35	SENT_194	[p13l224t663r404b740],
68	0.80	CD	NUMBER	0.80	dobj	67	SENT_194	[p13l224t663r404b740],
69	vs	CC	O	vs	_	0	SENT_194	[p13l447t682r522b725],
70	0.62	CD	NUMBER	0.62	num	71	SENT_194	[p13l566t662r747b740],
71	)	NN	O	)	conj_vs	68	SENT_194	[p13l566t662r747b740],
72	and	CC	O	and	_	0	SENT_194	[p13l793t662r919b725],
73	the	DT	O	the	det	75	SENT_194	[p13l960t662r1066b725],
74	C	NN	O	c	nn	75	SENT_194	[p13l1111t663r1165b725],
75	allele	NN	O	allele	conj_vs	68	SENT_194	[p13l1211t662r1401b725],
76	to	TO	O	to	aux	80	SENT_194	[p13l1443t672r1510b725],
77	be	VB	O	be	cop	80	SENT_194	[p13l1552t662r1634b725],
78	less	JJR	O	less	amod	80	SENT_194	[p13l1678t662r1807b725],
79	frequent	JJ	O	frequent	amod	80	SENT_194	[p13l1851t662r2148b743],
80	(	NN	O	(	xcomp	67	SENT_194	[p13l10t769r191b845],
81	0.20	CD	NUMBER	0.20	dep	80	SENT_194	[p13l10t769r191b845],
82	vs	CC	O	vs	_	0	SENT_194	[p13l224t788r299b830],
83	0.38	CD	NUMBER	0.38	conj_vs	80	SENT_194	[p13l334t769r508b841],
84	;	:	O	;	_	0	SENT_194	[p13l334t769r508b841],
85	P	NN	O	p	dep	83	SENT_194	[p13l543t771r598b829],
86	=	JJ	O	=	amod	88	SENT_194	[p13l639t790r692b811],
87	.043	CD	NUMBER	.043	tmod	86	SENT_194	[p13l729t769r926b845],
88	)	NN	O	)	dep	85	SENT_194	[p13l729t769r926b845],
89	.	.	O	.	_	0	SENT_194	[p13l729t769r926b845],

1	However	RB	O	however	advmod	6	SENT_195	[p13l963t770r1300b841],
2	,	,	O	,	_	0	SENT_195	[p13l963t770r1300b841],
3	this	DT	O	this	det	4	SENT_195	[p13l1335t768r1460b830],
4	observation	NN	O	observation	nsubj	6	SENT_195	[p13l1496t768r1909b830],
5	is	VBZ	O	be	cop	6	SENT_195	[p13l1941t768r1996b830],
6	unlikely	JJ	O	unlikely	_	0	SENT_195	[p13l2030t788r2144b830, p13l8t875r209b956],
7	to	TO	O	to	aux	10	SENT_195	[p13l256t884r322b937],
8	be	VB	O	be	cop	10	SENT_195	[p13l368t875r451b937],
9	clinically	RB	O	clinically	advmod	10	SENT_195	[p13l498t875r829b956],
10	useful	JJ	O	useful	xcomp	6	SENT_195	[p13l876t875r1092b937],
11	because	IN	O	because	mark	28	SENT_195	[p13l1138t875r1419b937],
12	of	IN	O	of	_	0	SENT_195	[p13l1467t875r1544b937],
13	the	DT	O	the	det	15	SENT_195	[p13l1584t875r1691b937],
14	50	CD	NUMBER	50	num	15	SENT_195	[p13l1739t875r1824b938],
15	patients	NNS	O	patient	prep_of	28	SENT_195	[p13l1869t875r2145b956],
16	with	IN	O	with	_	0	SENT_195	[p13l8t981r164b1043],
17	the	DT	O	the	det	19	SENT_195	[p13l194t981r301b1043],
18	TT	NN	O	tt	nn	19	SENT_195	[p13l331t982r438b1042],
19	genotype	NN	O	genotype	prep_with	15	SENT_195	[p13l469t990r814b1062],
20	,	,	O	,	_	0	SENT_195	[p13l469t990r814b1062],
21	43	CD	PERCENT	43	number	22	SENT_195	[p13l846t981r929b1044],
22	(	CD	PERCENT	(	amod	25	SENT_195	[p13l966t980r1182b1058],
23	86	CD	PERCENT	86	num	24	SENT_195	[p13l966t980r1182b1058],
24	%	NN	PERCENT	%	dep	22	SENT_195	[p13l966t980r1182b1058],
25	)	NN	O	)	nsubj	28	SENT_195	[p13l966t980r1182b1058],
26	did	VBD	O	do	aux	28	SENT_195	[p13l1215t981r1327b1043],
27	not	RB	O	not	neg	28	SENT_195	[p13l1356t990r1469b1043],
28	report	VB	O	report	advcl	10	SENT_195	[p13l1497t990r1711b1062],
29	any	DT	O	any	det	31	SENT_195	[p13l1741t1000r1866b1062],
30	muscle	NN	O	muscle	nn	31	SENT_195	[p13l1896t981r2146b1043],
31	symptoms	NNS	O	symptom	dobj	28	SENT_195	[p13l11t1098r390b1170],
32	.	.	O	.	_	0	SENT_195	[p13l11t1098r390b1170],

1	In	IN	O	in	_	0	SENT_196	[p13l437t1090r508b1151],
2	clinical	JJ	O	clinical	amod	3	SENT_196	[p13l550t1089r811b1151],
3	practice	NN	O	practice	prep_in	15	SENT_196	[p13l852t1089r1153b1170],
4	,	,	O	,	_	0	SENT_196	[p13l852t1089r1153b1170],
5	concomitant	JJ	O	concomitant	amod	6	SENT_196	[p13l1199t1089r1641b1151],
6	use	NN	O	use	nsubj	15	SENT_196	[p13l1680t1108r1796b1151],
7	of	IN	O	of	_	0	SENT_196	[p13l1839t1089r1917b1151],
8	drugs	NNS	O	drug	prep_of	6	SENT_196	[p13l1952t1089r2145b1170],
9	that	WDT	O	that	nsubj	10	SENT_196	[p13l8t1196r141b1259],
10	inhibit	VBP	O	inhibit	rcmod	8	SENT_196	[p13l179t1196r412b1259],
11	P	NN	O	p	nn	13	SENT_196	[p13l449t1196r979b1277],
12	—	CD	NUMBER	—	num	13	SENT_196	[p13l449t1196r979b1277],
13	glycoprotein	NN	O	glycoprotein	dobj	10	SENT_196	[p13l449t1196r979b1277],
14	may	MD	O	may	aux	15	SENT_196	[p13l1017t1216r1168b1277],
15	have	VB	O	have	_	0	SENT_196	[p13l1207t1196r1372b1259],
16	more	JJR	O	more	amod	17	SENT_196	[p13l1411t1216r1591b1259],
17	inﬂuence	NN	O	inﬂuence	dobj	15	SENT_196	[p13l1630t1196r1956b1259],
18	than	IN	O	than	_	0	SENT_196	[p13l1995t1196r2147b1259],
19	genotype	NN	O	genotype	prep_than	15	SENT_196	[p13l9t1312r333b1384],
20	and	CC	O	and	_	0	SENT_196	[p13l366t1303r491b1366],
21	may	MD	O	may	aux	22	SENT_196	[p13l521t1323r672b1384],
22	have	VB	O	have	conj_and	15	SENT_196	[p13l702t1303r866b1366],
23	an	DT	O	a	det	25	SENT_196	[p13l899t1323r980b1366],
24	additive	JJ	O	additive	amod	25	SENT_196	[p13l1012t1303r1294b1366],
25	effect	NN	O	effect	dobj	22	SENT_196	[p13l1325t1303r1525b1366],
26	on	IN	O	on	_	0	SENT_196	[p13l1555t1323r1641b1366],
27	the	DT	O	the	det	29	SENT_196	[p13l1671t1303r1778b1366],
28	TT	NN	O	tt	nn	29	SENT_196	[p13l1809t1305r1916b1365],
29	genotype	NN	O	genotype	prep_on	25	SENT_196	[p13l1947t1323r2144b1384, p13l8t1419r159b1491],
30	by	IN	O	by	_	0	SENT_196	[p13l221t1410r308b1491],
31	further	JJ	O	further	prep_by	29	SENT_196	[p13l371t1410r614b1472],
32	increasing	VBG	O	increase	partmod	31	SENT_196	[p13l674t1410r1039b1491],
33	Atorvastatin	NN	O	atorvastatin	nn	34	SENT_196	[p13l1103t1410r1541b1472],
34	concentrations	NNS	O	concentration	dobj	32	SENT_196	[p13l1604t1410r2142b1472],
35	.	.	O	.	_	0	SENT_196	[p13l1604t1410r2142b1472],

1	Although	IN	O	although	mark	6	SENT_197	[p13l8t1516r344b1597],
2	many	JJ	O	many	nsubj	6	SENT_197	[p13l377t1535r573b1597],
3	of	IN	O	of	_	0	SENT_197	[p13l608t1516r685b1578],
4	the	DT	O	the	det	5	SENT_197	[p13l712t1516r819b1578],
5	drugs	NNS	O	drug	prep_of	2	SENT_197	[p13l854t1516r1047b1597],
6	reported	VBD	O	report	advcl	56	SENT_197	[p13l1082t1516r1380b1597],
7	to	TO	O	to	aux	8	SENT_197	[p13l1413t1525r1479b1578],
8	interact	VB	O	interact	xcomp	6	SENT_197	[p13l1514t1516r1783b1578],
9	with	IN	O	with	mark	13	SENT_197	[p13l1816t1516r1973b1578],
10	aorvastatin	NN	O	aorvastatin	nsubjpass	13	SENT_197	[p13l2008t1535r2145b1578, p13l8t1624r283b1687],
11	have	VBP	O	have	aux	13	SENT_197	[p13l324t1624r488b1687],
12	been	VBN	O	be	auxpass	13	SENT_197	[p13l530t1624r698b1687],
13	identiﬁed	VBN	O	identiﬁed	advcl	8	SENT_197	[p13l739t1624r1076b1687],
14	as	IN	O	as	mark	38	SENT_197	[p13l1120t1644r1188b1687],
15	inhibitors	NNS	O	inhibitor	nsubj	38	SENT_197	[p13l1231t1624r1570b1687],
16	of	IN	O	of	_	0	SENT_197	[p13l1614t1624r1691b1687],
17	cytochrome	NN	O	cytochrome	nn	19	SENT_197	[p13l1728t1624r2147b1705],
18	P450	NN	O	p450	nn	19	SENT_197	[p13l8t1731r188b1794],
19	3AA4	NN	O	3aa4	prep_of	15	SENT_197	[p13l232t1731r463b1805],
20	,	,	O	,	_	0	SENT_197	[p13l232t1731r463b1805],
21	many	JJ	O	many	appos	15	SENT_197	[p13l508t1751r704b1812],
22	of	IN	O	of	_	0	SENT_197	[p13l745t1731r822b1794],
23	these	DT	O	these	det	24	SENT_197	[p13l857t1731r1037b1794],
24	drugs	NNS	O	drug	prep_of	21	SENT_197	[p13l1080t1731r1294b1812],
25	,	,	O	,	_	0	SENT_197	[p13l1080t1731r1294b1812],
26	such	JJ	O	such	_	0	SENT_197	[p13l1342t1731r1500b1794],
27	as	IN	O	as	_	0	SENT_197	[p13l1542t1751r1610b1794],
28	ketoconazole	NN	O	ketoconazole	nn	30	SENT_197	[p13l1653t1731r2144b1805],
29	,	,	O	,	_	0	SENT_197	[p13l1653t1731r2144b1805],
30	cyclosporine	NN	O	cyclosporine	prep_such_as	15	SENT_197	[p13l9t1838r481b1919],
31	,	,	O	,	_	0	SENT_197	[p13l9t1838r481b1919],
32	and	CC	O	and	_	0	SENT_197	[p13l525t1838r651b1900],
33	grapefruit	NN	O	grapefruit	nn	34	SENT_197	[p13l689t1838r1040b1919],
34	juice	NN	O	juice	prep_such_as	15	SENT_197	[p13l1070t1838r1269b1919],
35	,	,	O	,	_	0	SENT_197	[p13l1070t1838r1269b1919],
36	are	VBP	O	be	cop	38	SENT_197	[p13l1313t1857r1417b1900],
37	also	RB	O	also	advmod	38	SENT_197	[p13l1458t1838r1597b1900],
38	modulators	NNS	O	modulator	advcl	13	SENT_197	[p13l1636t1838r2035b1900],
39	of	IN	O	of	_	0	SENT_197	[p13l2077t1838r2153b1900],
40	P-glycoprotein	NN	O	p-glycoprotein	prep_of	38	SENT_197	[p13l8t1925r593b2025],
41	.9	CD	NUMBER	.9	num	40	SENT_197	[p13l8t1925r593b2025],
42	Hence	RB	O	hence	advmod	6	SENT_197	[p13l626t1945r871b2017],
43	,	,	O	,	_	0	SENT_197	[p13l626t1945r871b2017],
44	the	DT	O	the	det	45	SENT_197	[p13l907t1944r1013b2006],
45	role	NN	O	role	nsubj	59	SENT_197	[p13l1045t1944r1182b2006],
46	of	IN	O	of	_	0	SENT_197	[p13l1217t1944r1294b2006],
47	P	NN	O	p	nn	49	SENT_197	[p13l1320t1944r1850b2025],
48	—	CD	NUMBER	—	num	49	SENT_197	[p13l1320t1944r1850b2025],
49	glycoprotein	NN	O	glycoprotein	prep_of	45	SENT_197	[p13l1320t1944r1850b2025],
50	in	IN	O	in	_	0	SENT_197	[p13l1882t1944r1950b2006],
51	atorvastatin	NN	O	atorvastatin	nn	52	SENT_197	[p13l1983t1953r2145b2006, p13l8t2052r283b2115],
52	tolerability	NN	O	tolerability	prep_in	49	SENT_197	[p13l309t2052r701b2133],
53	may	MD	O	may	aux	56	SENT_197	[p13l729t2072r880b2133],
54	have	VB	O	have	aux	56	SENT_197	[p13l907t2052r1072b2115],
55	been	VBN	O	be	auxpass	56	SENT_197	[p13l1099t2052r1266b2115],
56	underappreciated	VBN	O	underappreciate	_	0	SENT_197	[p13l1293t2052r1910b2133],
57	and	CC	O	and	_	0	SENT_197	[p13l1938t2052r2064b2115],
58	is	VBZ	O	be	cop	59	SENT_197	[p13l2090t2052r2146b2115],
59	worthy	JJ	O	worthy	conj_and	56	SENT_197	[p13l8t2159r257b2240],
60	of	IN	O	of	_	0	SENT_197	[p13l292t2159r369b2222],
61	further	JJ	O	further	amod	62	SENT_197	[p13l394t2159r636b2222],
62	study	NN	O	study	prep_of	59	SENT_197	[p13l670t2159r871b2240],
63	.	.	O	.	_	0	SENT_197	[p13l670t2159r871b2240],

1	In	IN	O	in	_	0	SENT_198	[p13l115t2267r187b2328],
2	summary	NN	O	summary	prep_in	6	SENT_198	[p13l231t2285r572b2347],
3	,	,	O	,	_	0	SENT_198	[p13l231t2285r572b2347],
4	we	PRP	O	we	nsubj	6	SENT_198	[p13l618t2285r718b2329],
5	have	VBP	O	have	aux	6	SENT_198	[p13l759t2266r925b2329],
6	shown	VBN	O	show	_	0	SENT_198	[p13l970t2266r1195b2329],
7	genotype	NN	O	genotype	dobj	6	SENT_198	[p13l1238t2275r1562b2347],
8	at	IN	O	at	_	0	SENT_198	[p13l1606t2275r1667b2328],
9	the	DT	O	the	det	11	SENT_198	[p13l1708t2266r1814b2328],
10	C3435T	NN	O	c3435t	nn	11	SENT_198	[p13l1858t2266r2147b2329],
11	polymorphism	NN	O	polymorphism	prep_at	6	SENT_198	[p13l7t2373r528b2454],
12	in	IN	O	in	_	0	SENT_198	[p13l558t2373r625b2435],
13	ABCBI	NNP	ORGANIZATION	ABCBI	prep_in	11	SENT_198	[p13l649t2374r915b2437],
14	to	TO	O	to	aux	15	SENT_198	[p13l951t2383r1018b2436],
15	inﬂuence	VB	O	inﬂuence	xcomp	6	SENT_198	[p13l1049t2373r1374b2436],
16	the	DT	O	the	det	17	SENT_198	[p13l1405t2373r1511b2436],
17	LDL	NN	O	ldl	dobj	15	SENT_198	[p13l1542t2374r1802b2436],
18	.	.	O	.	_	0	SENT_198	[p13l1542t2374r1802b2436],

1	—	NN	O	—	_	0	SENT_199	[p13l1542t2374r1802b2436],
2	.	.	O	.	_	0	SENT_199	[p13l1542t2374r1802b2436],

1	C	NN	O	c	nn	3	SENT_200	[p13l1542t2374r1802b2436],
2	lowering	NN	O	lowering	nn	3	SENT_200	[p13l1834t2373r2146b2454],
3	effect	NN	O	effect	nsubj	11	SENT_200	[p13l9t2480r209b2543],
4	and	CC	O	and	_	0	SENT_200	[p13l247t2480r372b2543],
5	incidence	NN	O	incidence	conj_and	3	SENT_200	[p13l409t2480r750b2543],
6	of	IN	O	of	_	0	SENT_200	[p13l789t2480r866b2543],
7	muscle	NN	O	muscle	nn	8	SENT_200	[p13l897t2480r1147b2543],
8	symptoms	NNS	O	symptom	prep_of	5	SENT_200	[p13l1188t2490r1549b2561],
9	in	IN	O	in	_	0	SENT_200	[p13l1587t2480r1655b2542],
10	patients	NNS	O	patient	prep_in	8	SENT_200	[p13l1690t2480r1967b2561],
11	prescribed	VBN	O	prescribe	_	0	SENT_200	[p13l2004t2500r2145b2561, p13l11t2587r264b2649],
12	atorvastatin	NN	O	atorvastatin	nn	14	SENT_200	[p13l297t2587r709b2650],
13	80	CD	NUMBER	80	num	14	SENT_200	[p13l743t2587r826b2650],
14	mg	NN	O	mg	dobj	11	SENT_200	[p13l857t2606r987b2668],
15	.	.	O	.	_	0	SENT_200	[p13l857t2606r987b2668],

1	The	DT	O	the	det	3	SENT_201	[p13l1022t2587r1158b2649],
2	CC	NN	O	cc	nn	3	SENT_201	[p13l1191t2587r1305b2650],
3	genotype	NN	O	genotype	nsubjpass	5	SENT_201	[p13l1338t2596r1662b2668],
4	is	VBZ	O	be	auxpass	5	SENT_201	[p13l1694t2587r1749b2649],
5	associated	VBN	O	associate	_	0	SENT_201	[p13l1783t2587r2148b2649],
6	with	IN	O	with	_	0	SENT_201	[p13l8t2693r165b2754],
7	a	DT	O	a	det	9	SENT_201	[p13l207t2712r244b2754],
8	lesser	JJR	O	lesser	amod	9	SENT_201	[p13l283t2693r486b2754],
9	LDL	NN	O	ldl	prep_with	5	SENT_201	[p13l524t2693r784b2755],
10	.	.	O	.	_	0	SENT_201	[p13l524t2693r784b2755],

1	—	NN	O	—	_	0	SENT_202	[p13l524t2693r784b2755],
2	.	.	O	.	_	0	SENT_202	[p13l524t2693r784b2755],

1	C	NN	O	c	nn	2	SENT_203	[p13l524t2693r784b2755],
2	reduction	NN	O	reduction	_	0	SENT_203	[p13l825t2693r1163b2754],
3	with	IN	O	with	_	0	SENT_203	[p13l1205t2693r1361b2755],
4	atorvastatin	NN	O	atorvastatin	prep_with	2	SENT_203	[p13l1403t2693r1816b2755],
5	whereas	IN	O	whereas	mark	10	SENT_203	[p13l1857t2693r2145b2754],
6	the	DT	O	the	det	8	SENT_203	[p13l8t2800r114b2862],
7	T	NN	O	t	nn	8	SENT_203	[p13l144t2801r196b2862],
8	allele	NN	O	allele	nsubjpass	10	SENT_203	[p13l220t2800r411b2862],
9	was	VBD	O	be	auxpass	10	SENT_203	[p13l439t2819r573b2863],
10	found	VBN	O	find	dep	4	SENT_203	[p13l605t2800r810b2862],
11	with	IN	O	with	_	0	SENT_203	[p13l840t2800r996b2863],
12	increased	VBN	O	increase	amod	13	SENT_203	[p13l1025t2800r1362b2862],
13	frequency	NN	O	frequency	prep_with	10	SENT_203	[p13l1391t2800r1745b2881],
14	in	IN	O	in	_	0	SENT_203	[p13l1774t2800r1842b2862],
15	patients	NNS	O	patient	prep_in	13	SENT_203	[p13l1869t2800r2146b2881],
16	reporting	VBG	O	report	partmod	15	SENT_203	[p13l7t2907r332b2988],
17	myalgia	NN	O	myalgium	dobj	16	SENT_203	[p13l358t2907r662b2988],
18	.	.	O	.	_	0	SENT_203	[p13l358t2907r662b2988],

1	The	DT	O	the	det	2	SENT_204	[p13l692t2907r828b2970],
2	association	NN	O	association	nsubjpass	13	SENT_204	[p13l855t2907r1249b2970],
3	of	IN	O	of	_	0	SENT_204	[p13l1275t2907r1351b2970],
4	the	DT	O	the	det	6	SENT_204	[p13l1369t2907r1476b2970],
5	CC	NN	O	cc	nn	6	SENT_204	[p13l1502t2908r1616b2970],
6	genotype	NN	O	genotype	prep_of	2	SENT_204	[p13l1643t2917r1967b2988],
7	with	IN	O	with	_	0	SENT_204	[p13l1991t2907r2148b2970],
8	reduced	VBN	O	reduce	amod	10	SENT_204	[p13l7t3014r289b3077],
9	atorvastatin	NN	O	atorvastatin	nn	10	SENT_204	[p13l321t3014r734b3077],
10	efﬁcacy	NN	O	efﬁcacy	prep_with	6	SENT_204	[p13l765t3014r1045b3095],
11	was	VBD	O	be	auxpass	13	SENT_204	[p13l1075t3034r1209b3077],
12	not	RB	O	not	neg	13	SENT_204	[p13l1241t3024r1354b3077],
13	related	VBN	O	relate	_	0	SENT_204	[p13l1382t3014r1626b3077],
14	to	TO	O	to	_	0	SENT_204	[p13l1655t3023r1722b3077],
15	differences	NNS	O	difference	prep_to	13	SENT_204	[p13l1754t3014r2146b3077],
16	in	IN	O	in	_	0	SENT_204	[p13l8t3121r75b3183],
17	cholesterol	NN	O	cholesterol	nn	18	SENT_204	[p13l110t3121r499b3184],
18	metabolism	NN	O	metabolism	prep_in	15	SENT_204	[p13l534t3121r969b3184],
19	.	.	O	.	_	0	SENT_204	[p13l534t3121r969b3184],

1	These	DT	O	these	det	2	SENT_205	[p13l1007t3121r1218b3184],
2	observations	NNS	O	observation	nsubj	5	SENT_205	[p13l1254t3121r1699b3184],
3	are	VBP	O	be	cop	5	SENT_205	[p13l1737t3141r1841b3184],
4	broadly	RB	O	broadly	advmod	5	SENT_205	[p13l1875t3121r2147b3202],
5	consistent	JJ	O	consistent	_	0	SENT_205	[p13l9t3227r365b3289],
6	with	IN	O	with	_	0	SENT_205	[p13l405t3227r562b3289],
7	the	DT	O	the	det	9	SENT_205	[p13l603t3227r709b3289],
8	previous	JJ	O	previous	amod	9	SENT_205	[p13l751t3227r1054b3308],
9	report	NN	O	report	prep_with	5	SENT_205	[p13l1096t3236r1310b3308],
10	that	IN	O	that	complm	15	SENT_205	[p13l1350t3227r1483b3289],
11	the	DT	O	the	det	13	SENT_205	[p13l1524t3227r1630b3289],
12	TT	NN	O	tt	nn	13	SENT_205	[p13l1672t3228r1779b3288],
13	genotype	NN	O	genotype	nsubjpass	15	SENT_205	[p13l1822t3236r2147b3308],
14	is	VBZ	O	be	auxpass	15	SENT_205	[p13l8t3335r63b3398],
15	associated	VBN	O	associate	ccomp	5	SENT_205	[p13l95t3335r460b3398],
16	with	IN	O	with	_	0	SENT_205	[p13l486t3335r643b3398],
17	a	DT	O	a	det	20	SENT_205	[p13l672t3355r709b3398],
18	larger	JJR	O	larger	amod	20	SENT_205	[p13l736t3335r945b3416],
19	atorvastatin	NN	O	atorvastatin	nn	20	SENT_205	[p13l971t3335r1384b3398],
20	area	NN	O	area	prep_with	15	SENT_205	[p13l1414t3355r1561b3398],
21	under	IN	O	under	_	0	SENT_205	[p13l1587t3335r1790b3398],
22	the	DT	O	the	det	26	SENT_205	[p13l1816t3335r1923b3398],
23	curve	NN	O	curve	nn	26	SENT_205	[p13l1952t3355r2147b3398],
24	and	CC	O	and	_	0	SENT_205	[p13l10t3441r135b3504],
25	half	NN	O	half	nn	26	SENT_205	[p13l159t3441r303b3504],
26	life	NN	O	life	prep_under	20	SENT_205	[p13l322t3441r438b3504],
27	compared	VBN	O	compare	_	0	SENT_205	[p13l465t3441r816b3522],
28	with	IN	O	with	prepc_compared_with	15	SENT_205	[p13l840t3441r996b3504],
29	the	DT	O	the	det	31	SENT_205	[p13l1021t3441r1128b3504],
30	CC	NN	O	cc	nn	31	SENT_205	[p13l1155t3442r1268b3504],
31	genotype	NN	O	genotype	pobj	15	SENT_205	[p13l1296t3422r1676b3522],
32	,8	CD	NUMBER	,8	dep	31	SENT_205	[p13l1296t3422r1676b3522],
33	which	WDT	O	which	nsubj	34	SENT_205	[p13l1702t3441r1919b3504],
34	offers	VBZ	O	offer	rcmod	32	SENT_205	[p13l1944t3441r2146b3503],
35	a	DT	O	a	det	37	SENT_205	[p13l10t3569r46b3612],
36	pharmacokinetic	JJ	O	pharmacokinetic	amod	37	SENT_205	[p13l86t3549r681b3630],
37	explanation	NN	O	explanation	dobj	34	SENT_205	[p13l726t3549r1141b3630],
38	for	IN	O	for	_	0	SENT_205	[p13l1184t3549r1287b3612],
39	our	PRP$	O	we	poss	40	SENT_205	[p13l1329t3569r1446b3612],
40	ﬁndings	NNS	O	ﬁndings	prep_for	37	SENT_205	[p13l1487t3549r1789b3630],
41	.	.	O	.	_	0	SENT_205	[p13l1487t3549r1789b3630],

1	In	IN	O	in	_	0	SENT_206	[p13l1836t3551r1908b3611],
2	white	JJ	O	white	amod	3	SENT_206	[p13l1951t3549r2146b3612],
3	subjects	NNS	O	subject	prep_in	10	SENT_206	[p13l11t3655r313b3736],
4	,	,	O	,	_	0	SENT_206	[p13l11t3655r313b3736],
5	the	DT	O	the	det	9	SENT_206	[p13l353t3655r460b3717],
6	T	NN	O	t	nn	9	SENT_206	[p13l498t3656r550b3716],
7	and	CC	O	and	_	0	SENT_206	[p13l583t3655r709b3717],
8	C	NN	O	c	nn	9	SENT_206	[p13l746t3655r801b3718],
9	alleles	NNS	O	allele	nsubj	10	SENT_206	[p13l841t3655r1064b3717],
10	occur	VBP	O	occur	_	0	SENT_206	[p13l1105t3674r1302b3717],
11	with	IN	O	with	_	0	SENT_206	[p13l1338t3655r1495b3717],
12	nearly	RB	O	nearly	advmod	13	SENT_206	[p13l1532t3655r1753b3736],
13	equal	JJ	O	equal	amod	14	SENT_206	[p13l1792t3655r1982b3736],
14	frequency	NN	O	frequency	prep_with	10	SENT_206	[p13l2021t3655r2144b3717, p14l8t40r285b101],
15	;	:	O	;	_	0	SENT_206	[p13l2021t3655r2144b3717, p14l8t40r285b101],

1	however	RB	O	however	advmod	8	SENT_207	[p14l326t20r643b95],
2	,	,	O	,	_	0	SENT_207	[p14l326t20r643b95],
3	the	DT	O	the	det	5	SENT_207	[p14l685t20r791b83],
4	C	NN	O	c	nn	5	SENT_207	[p14l831t21r885b83],
5	allele	NN	O	allele	nsubj	8	SENT_207	[p14l927t20r1117b83],
6	is	VBZ	O	be	cop	8	SENT_207	[p14l1156t20r1211b83],
7	more	RBR	O	more	advmod	8	SENT_207	[p14l1251t40r1432b83],
8	frequent	JJ	O	frequent	_	0	SENT_207	[p14l1471t20r1768b101],
9	in	IN	O	in	_	0	SENT_207	[p14l1805t20r1873b82],
10	people	NNS	O	people	prep_in	8	SENT_207	[p14l1909t20r2147b101],
11	of	IN	O	of	_	0	SENT_207	[p14l9t127r86b190],
12	African	JJ	MISC	african	amod	13	SENT_207	[p14l114t127r385b190],
13	origin	NN	O	origin	prep_of	10	SENT_207	[p14l421t127r632b208],
14	whereas	IN	O	whereas	mark	20	SENT_207	[p14l666t127r955b190],
15	the	DT	O	the	det	17	SENT_207	[p14l991t127r1098b190],
16	T	NN	O	t	nn	17	SENT_207	[p14l1133t129r1185b189],
17	allele	NN	O	allele	nsubj	20	SENT_207	[p14l1215t127r1405b190],
18	is	VBZ	O	be	cop	20	SENT_207	[p14l1441t127r1496b190],
19	more	RBR	O	more	advmod	20	SENT_207	[p14l1532t147r1714b190],
20	frequent	JJ	O	frequent	advcl	8	SENT_207	[p14l1749t127r2047b208],
21	in	IN	O	in	_	0	SENT_207	[p14l2080t127r2148b189],
22	Asians	NNPS	MISC	Asians	prep_in	20	SENT_207	[p14l8t233r246b295],
23	and	CC	O	and	_	0	SENT_207	[p14l285t233r410b295],
24	Indian	JJ	MISC	indian	amod	25	SENT_207	[p14l445t233r671b295],
25	subjects	NNS	O	subject	prep_in	20	SENT_207	[p14l710t214r1048b314],
26	.6	CD	NUMBER	.6	num	27	SENT_207	[p14l710t214r1048b314],
27	One	CD	NUMBER	one	nsubj	29	SENT_207	[p14l1085t233r1229b296],
28	may	MD	O	may	aux	29	SENT_207	[p14l1265t253r1416b314],
29	speculate	VB	O	speculate	ccomp	20	SENT_207	[p14l1455t233r1783b314],
30	that	IN	O	that	complm	34	SENT_207	[p14l1818t233r1952b295],
31	such	JJ	O	such	amod	32	SENT_207	[p14l1989t233r2147b295],
32	differences	NNS	O	difference	nsubj	34	SENT_207	[p14l9t341r400b404],
33	could	MD	O	could	aux	34	SENT_207	[p14l446t341r643b404],
34	lead	VB	O	lead	ccomp	29	SENT_207	[p14l686t341r834b404],
35	to	TO	O	to	_	0	SENT_207	[p14l877t351r943b404],
36	variations	NNS	O	variation	prep_to	34	SENT_207	[p14l987t341r1335b404],
37	in	IN	O	in	_	0	SENT_207	[p14l1380t341r1448b403],
38	drug	NN	O	drug	nn	39	SENT_207	[p14l1492t341r1651b422],
39	efﬁcacy	NN	O	efﬁcacy	prep_in	36	SENT_207	[p14l1697t341r1976b422],
40	and	CC	O	and	_	0	SENT_207	[p14l2022t341r2148b404],
41	muscle	NN	O	muscle	nn	42	SENT_207	[p14l8t448r258b511],
42	symptoms	NNS	O	symptom	conj_and	39	SENT_207	[p14l297t458r657b529],
43	in	IN	O	in	_	0	SENT_207	[p14l693t448r760b510],
44	different	JJ	O	different	amod	46	SENT_207	[p14l795t448r1100b511],
45	patient	NN	O	patient	nn	46	SENT_207	[p14l1132t448r1376b529],
46	populations	NNS	O	population	prep_in	36	SENT_207	[p14l1409t448r1823b529],
47	and	CC	O	and	_	0	SENT_207	[p14l1862t448r1987b511],
48	this	DT	O	this	det	49	SENT_207	[p14l2020t448r2146b511],
49	warrants	NNS	O	warrant	conj_and	36	SENT_207	[p14l8t564r312b618],
50	further	RB	O	further	advmod	51	SENT_207	[p14l346t555r589b617],
51	investigation	NN	O	investigation	dep	49	SENT_207	[p14l620t555r1095b636],
52	.	.	O	.	_	0	SENT_207	[p14l620t555r1095b636],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_208	[p14l9t797r828b898],

1	M.R.H.	NNP	O	M.R.H.	nn	2	SENT_209	[p14l114t1003r378b1064],
2	thanks	NNS	O	thanks	nsubj	7	SENT_209	[p14l406t1001r635b1064],
3	all	PDT	O	all	predet	7	SENT_209	[p14l663t1001r748b1064],
4	the	DT	O	the	det	7	SENT_209	[p14l773t1001r880b1064],
5	Vascular	JJ	O	vascular	amod	7	SENT_209	[p14l905t1001r1212b1064],
6	Surgery	NN	O	surgery	nn	7	SENT_209	[p14l1238t1002r1515b1082],
7	staff	NN	O	staff	_	0	SENT_209	[p14l1542t1001r1700b1064],
8	at	IN	O	at	_	0	SENT_209	[p14l1720t1011r1782b1064],
9	the	DT	O	the	det	15	SENT_209	[p14l1804t1001r1911b1064],
10	Royal	NNP	ORGANIZATION	Royal	nn	11	SENT_209	[p14l1936t1001r2147b1082],
11	Brisbane	NNP	ORGANIZATION	Brisbane	poss	15	SENT_209	[p14l8t1108r322b1171],
12	&	CC	ORGANIZATION	&	_	0	SENT_209	[p14l388t1109r451b1171],
13	Women	NNP	ORGANIZATION	Women	conj_and	11	SENT_209	[p14l513t1109r848b1171],
14	’s	POS	O	’s	_	0	SENT_209	[p14l513t1109r848b1171],
15	Hospital	NN	O	hospital	prep_at	7	SENT_209	[p14l911t1108r1211b1189],
16	for	IN	O	for	_	0	SENT_209	[p14l1274t1108r1377b1171],
17	their	PRP$	O	they	poss	18	SENT_209	[p14l1438t1108r1602b1171],
18	assistance	NN	O	assistance	prep_for	15	SENT_209	[p14l1664t1108r2016b1171],
19	in	IN	O	in	_	0	SENT_209	[p14l2080t1108r2148b1170],
20	identifying	VBG	O	identify	prepc_in	18	SENT_209	[p14l8t1215r398b1296],
21	eligible	JJ	O	eligible	amod	22	SENT_209	[p14l432t1215r698b1296],
22	patients	NNS	O	patient	dobj	20	SENT_209	[p14l730t1215r1025b1296],
23	.	.	O	.	_	0	SENT_209	[p14l730t1215r1025b1296],

1	Financial	NNP	O	Financial	nn	2	SENT_210	[p14l15t1457r418b1538],
2	disclosures	NNS	O	disclosure	_	0	SENT_210	[p14l458t1458r959b1538],

1	This	DT	O	this	det	2	SENT_211	[p14l115t1661r270b1724],
2	work	NN	O	work	nsubjpass	4	SENT_211	[p14l293t1661r475b1724],
3	is	VBZ	O	be	auxpass	4	SENT_211	[p14l494t1661r549b1724],
4	supported	VBN	O	support	_	0	SENT_211	[p14l575t1661r923b1742],
5	by	IN	O	by	_	0	SENT_211	[p14l942t1661r1029b1742],
6	Pﬁzer	NNP	O	Pﬁzer	nn	8	SENT_211	[p14l1051t1661r1258b1724],
7	Australia	NNP	LOCATION	Australia	nn	8	SENT_211	[p14l1278t1661r1604b1724],
8	AUS	NNP	O	AUS	agent	4	SENT_211	[p14l1624t1661r2145b1724, p14l8t1768r138b1831],
9	.	.	O	.	_	0	SENT_211	[p14l1624t1661r2145b1724, p14l8t1768r138b1831],

1	—	NN	O	—	_	0	SENT_212	[p14l1624t1661r2145b1724, p14l8t1768r138b1831],
2	.	.	O	.	_	0	SENT_212	[p14l1624t1661r2145b1724, p14l8t1768r138b1831],

1	ATO06002	NN	O	ato06002	_	0	SENT_213	[p14l1624t1661r2145b1724, p14l8t1768r138b1831],
2	(	CD	NUMBER	(	num	4	SENT_213	[p14l170t1769r424b1845],
3	MRH	NN	O	mrh	nn	4	SENT_213	[p14l170t1769r424b1845],
4	)	NN	O	)	dep	1	SENT_213	[p14l170t1769r424b1845],
5	and	CC	O	and	_	0	SENT_213	[p14l457t1768r583b1831],
6	the	DT	O	the	det	8	SENT_213	[p14l610t1768r717b1831],
7	Royal	NNP	ORGANIZATION	Royal	nn	8	SENT_213	[p14l745t1768r956b1849],
8	Brisbane	NNP	ORGANIZATION	Brisbane	conj_and	4	SENT_213	[p14l985t1768r1299b1831],
9	and	CC	ORGANIZATION	and	_	0	SENT_213	[p14l1331t1768r1456b1831],
10	Women	NNP	ORGANIZATION	Women	poss	13	SENT_213	[p14l1483t1769r1817b1831],
11	’s	POS	ORGANIZATION	’s	_	0	SENT_213	[p14l1483t1769r1817b1831],
12	Hospital	NNP	ORGANIZATION	Hospital	nn	13	SENT_213	[p14l1846t1768r2146b1849],
13	Foundation	NNP	ORGANIZATION	Foundation	dep	1	SENT_213	[p14l7t1875r412b1937],
14	(	CD	NUMBER	(	num	15	SENT_213	[p14l435t1876r709b1952],
15	MRH	NNP	O	MRH	dep	13	SENT_213	[p14l435t1876r709b1952],
16	)	CD	NUMBER	)	num	15	SENT_213	[p14l435t1876r709b1952],
17	.	.	O	.	_	0	SENT_213	[p14l435t1876r709b1952],

1	M.R.H.	NNP	O	M.R.H.	nsubj	2	SENT_214	[p14l734t1876r998b1937],
2	receives	VBZ	O	receive	_	0	SENT_214	[p14l1021t1875r1310b1937],
3	salary	NN	O	salary	nn	4	SENT_214	[p14l1334t1875r1542b1956],
4	support	NN	O	support	dobj	2	SENT_214	[p14l1566t1884r1830b1956],
5	from	IN	O	from	_	0	SENT_214	[p14l1849t1875r2021b1937],
6	the	DT	O	the	det	8	SENT_214	[p14l2040t1875r2146b1937],
7	96	CD	NUMBER	96	num	8	SENT_214	[p14l35t2034r72b2062],
8	Journal	NNP	O	Journal	prep_from	4	SENT_214	[p14l1207t2031r1332b2062],
9	of	IN	O	of	_	0	SENT_214	[p14l1347t2031r1381b2062],
10	Clinical	JJ	O	clinical	amod	11	SENT_214	[p14l1395t2031r1516b2062],
11	Lipidology	NNP	O	Lipidology	prep_of	8	SENT_214	[p14l1533t2031r1714b2070],
12	,	,	O	,	_	0	SENT_214	[p14l1533t2031r1714b2070],
13	Vol	NNP	O	Vol	appos	8	SENT_214	[p14l1732t2031r1784b2062],
14	5	CD	NUMBER	5	num	13	SENT_214	[p14l1800t2034r1827b2067],
15	,	,	O	,	_	0	SENT_214	[p14l1800t2034r1827b2067],
16	No	DT	O	no	det	17	SENT_214	[p14l1847t2033r1886b2062],
17	2	CD	NUMBER	2	appos	8	SENT_214	[p14l1905t2034r1932b2066],
18	,	,	O	,	_	0	SENT_214	[p14l1905t2034r1932b2066],
19	April	NNP	DATE	April	tmod	2	SENT_214	[p14l1950t2031r2029b2070],
20	2011	CD	DATE	2011	num	19	SENT_214	[p14l2045t2034r2122b2062],

1	National	NNP	ORGANIZATION	National	nn	2	SENT_215	[p14l7t2184r314b2245],
2	Health	NNP	ORGANIZATION	Health	_	0	SENT_215	[p14l339t2184r576b2245],
3	and	CC	ORGANIZATION	and	_	0	SENT_215	[p14l602t2184r728b2245],
4	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_215	[p14l751t2184r1043b2245],
5	Research	NNP	ORGANIZATION	Research	nn	6	SENT_215	[p14l1068t2184r1394b2245],
6	Council	NNP	ORGANIZATION	Council	conj_and	2	SENT_215	[p14l1420t2184r1700b2246],
7	of	IN	ORGANIZATION	of	_	0	SENT_215	[p14l1726t2184r1803b2245],
8	Australia	NNP	ORGANIZATION	Australia	prep_of	6	SENT_215	[p14l1821t2184r2148b2245],
9	(	CD	NUMBER	(	num	8	SENT_215	[p14l10t2290r395b2367],
10	#	#	MONEY	#	dep	11	SENT_215	[p14l10t2290r395b2367],
11	409936	CD	MONEY	409936	dep	2	SENT_215	[p14l10t2290r395b2367],
12	)	NN	O	)	dep	11	SENT_215	[p14l10t2290r395b2367],
13	.	.	O	.	_	0	SENT_215	[p14l10t2290r395b2367],

1	References	NNS	O	reference	_	0	SENT_216	[p14l14t2528r504b2608],

1	1	LS	NUMBER	1	_	0	SENT_217	[p14l50t2770r91b2819],
2	.	.	O	.	_	0	SENT_217	[p14l50t2770r91b2819],

1	Robinson	NNP	PERSON	Robinson	nn	2	SENT_218	[p14l132t2769r404b2819],
2	JG	NNP	O	JG	_	0	SENT_218	[p14l428t2770r521b2829],
3	,	,	O	,	_	0	SENT_218	[p14l428t2770r521b2829],
4	Smith	NNP	PERSON	Smith	nn	5	SENT_218	[p14l551t2769r718b2820],
5	B	NNP	O	B	appos	2	SENT_218	[p14l743t2770r804b2829],
6	,	,	O	,	_	0	SENT_218	[p14l743t2770r804b2829],
7	Maheshwari	NNP	ORGANIZATION	Maheshwari	nn	8	SENT_218	[p14l832t2769r1181b2819],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_218	[p14l1208t2770r1273b2829],
9	,	,	O	,	_	0	SENT_218	[p14l1208t2770r1273b2829],
10	Schrott	NNP	PERSON	Schrott	nn	13	SENT_218	[p14l1302t2769r1506b2820],
11	H.	NNP	PERSON	H.	nn	13	SENT_218	[p14l1530t2770r1594b2819],
12	Pleiotropic	JJ	PERSON	pleiotropic	amod	13	SENT_218	[p14l1623t2769r1934b2834],
13	effects	NNS	O	effect	appos	2	SENT_218	[p14l1961t2769r2147b2819],
14	of	IN	O	of	_	0	SENT_218	[p14l133t2858r194b2908],
15	statins	NNS	O	statin	prep_of	13	SENT_218	[p14l227t2858r420b2908],
16	:	:	O	:	_	0	SENT_218	[p14l227t2858r420b2908],
17	beneﬁt	NN	O	beneﬁt	dep	2	SENT_218	[p14l459t2858r653b2908],
18	beyond	IN	O	beyond	_	0	SENT_218	[p14l686t2858r895b2923],
19	cholesterol	NN	O	cholesterol	nn	20	SENT_218	[p14l929t2858r1240b2908],
20	reduction	NN	O	reduction	prep_beyond	17	SENT_218	[p14l1275t2858r1574b2908],
21	?	.	O	?	_	0	SENT_218	[p14l1275t2858r1574b2908],

1	A	DT	O	a	det	2	SENT_219	[p14l1610t2859r1660b2908],
2	meta-regression	NN	O	meta-regression	_	0	SENT_219	[p14l1694t2858r2148b2923],
3	analysis	NN	O	analysis	dep	2	SENT_219	[p14l134t2947r372b3012],
4	.	.	O	.	_	0	SENT_219	[p14l134t2947r372b3012],

1	J	NNP	O	J	nn	4	SENT_220	[p14l402t2949r438b2998],
2	Am	NNP	O	Am	nn	4	SENT_220	[p14l453t2948r550b2997],
3	Coll	NNP	PERSON	Coll	nn	4	SENT_220	[p14l579t2947r698b2998],
4	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_220	[p14l726t2947r954b2998],
5	.	.	O	.	_	0	SENT_220	[p14l726t2947r954b2998],

1	2005	CD	DATE	2005	_	0	SENT_221	[p14l985t2947r1571b3007],
2	;	:	O	;	_	0	SENT_221	[p14l985t2947r1571b3007],
3	46	CD	NUMBER	46	num	5	SENT_221	[p14l985t2947r1571b3007],
4	:	:	O	:	_	0	SENT_221	[p14l985t2947r1571b3007],
5	l855	CD	NUMBER	l855	dep	1	SENT_221	[p14l985t2947r1571b3007],
6	—	CD	NUMBER	—	number	7	SENT_221	[p14l985t2947r1571b3007],
7	1862	CD	DATE	1862	dep	5	SENT_221	[p14l985t2947r1571b3007],
8	.	.	O	.	_	0	SENT_221	[p14l985t2947r1571b3007],

1	2	LS	NUMBER	2	_	0	SENT_222	[p14l44t3037r91b3087],
2	.	.	O	.	_	0	SENT_222	[p14l44t3037r91b3087],

1	Hoenig	NNP	PERSON	Hoenig	nn	2	SENT_223	[p14l132t3037r340b3102],
2	MR	NN	PERSON	mr	nsubj	21	SENT_223	[p14l362t3038r486b3096],
3	,	,	O	,	_	0	SENT_223	[p14l362t3038r486b3096],
4	Walker	NNP	PERSON	Walker	nn	5	SENT_223	[p14l510t3037r717b3087],
5	PJ	NNP	PERSON	PJ	appos	2	SENT_223	[p14l737t3038r818b3096],
6	,	,	O	,	_	0	SENT_223	[p14l737t3038r818b3096],
7	Gurnsey	NNP	ORGANIZATION	Gurnsey	nn	8	SENT_223	[p14l843t3037r1080b3102],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_223	[p14l1104t3037r1164b3096],
9	,	,	O	,	_	0	SENT_223	[p14l1104t3037r1164b3096],
10	Beadle	NNP	PERSON	Beadle	nn	11	SENT_223	[p14l1188t3037r1385b3087],
11	K	NNP	PERSON	K	appos	2	SENT_223	[p14l1409t3038r1472b3096],
12	,	,	O	,	_	0	SENT_223	[p14l1409t3038r1472b3096],
13	Johnson	NNP	PERSON	Johnson	nn	15	SENT_223	[p14l1497t3037r1729b3087],
14	L.	NNP	PERSON	L.	nn	15	SENT_223	[p14l1750t3038r1806b3087],
15	Markers	NNPS	PERSON	Markers	appos	2	SENT_223	[p14l1832t3037r2067b3087],
16	of	IN	O	of	_	0	SENT_223	[p14l2091t3036r2153b3087],
17	cholesterol	NN	O	cholesterol	nn	18	SENT_223	[p14l133t3125r444b3175],
18	absorption	NN	O	absorption	prep_of	15	SENT_223	[p14l473t3125r772b3190],
19	and	CC	O	and	_	0	SENT_223	[p14l801t3125r902b3175],
20	synthesis	NN	O	synthesis	conj_and	18	SENT_223	[p14l931t3125r1188b3190],
21	predict	VBP	O	predict	_	0	SENT_223	[p14l1215t3125r1415b3190],
22	the	DT	O	the	det	27	SENT_223	[p14l1442t3125r1527b3175],
23	low	JJ	O	low	amod	27	SENT_223	[p14l1556t3125r1659b3175],
24	density	NN	O	density	nn	27	SENT_223	[p14l1688t3125r1891b3190],
25	lipoprotein	NN	O	lipoprotein	nn	27	SENT_223	[p14l1920t3125r2146b3190, p14l132t3214r238b3265],
26	cholesterol	NN	O	cholesterol	nn	27	SENT_223	[p14l276t3214r587b3265],
27	response	NN	O	response	dobj	21	SENT_223	[p14l624t3230r872b3279],
28	to	TO	O	to	_	0	SENT_223	[p14l909t3222r963b3265],
29	atorvastatin	NN	O	atorvastatin	prep_to	21	SENT_223	[p14l1002t3214r1342b3265],
30	.	.	O	.	_	0	SENT_223	[p14l1002t3214r1342b3265],

1	J	NNP	O	J	nn	3	SENT_224	[p14l1384t3216r1420b3265],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_224	[p14l1457t3214r1778b3265],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_224	[p14l1814t3214r2144b3265],
4	.	.	O	.	_	0	SENT_224	[p14l1814t3214r2144b3265],

1	2010	CD	DATE	2010	_	0	SENT_225	[p14l133t3303r648b3362],
2	;	:	O	;	_	0	SENT_225	[p14l133t3303r648b3362],
3	56:396	CD	NUMBER	56:396	number	4	SENT_225	[p14l133t3303r648b3362],
4	-401	CD	NUMBER	-401	dep	1	SENT_225	[p14l133t3303r648b3362],
5	.	.	O	.	_	0	SENT_225	[p14l133t3303r648b3362],

1	3	LS	NUMBER	3	_	0	SENT_226	[p14l45t3392r91b3442],
2	.	.	O	.	_	0	SENT_226	[p14l45t3392r91b3442],

1	Hoenig	NNP	PERSON	Hoenig	nn	2	SENT_227	[p14l132t3392r340b3457],
2	MR	NN	PERSON	mr	_	0	SENT_227	[p14l363t3393r488b3451],
3	,	,	O	,	_	0	SENT_227	[p14l363t3393r488b3451],
4	Rolfe	NNP	PERSON	Rolfe	nsubj	5	SENT_227	[p14l512t3392r669b3442],
5	BE	VBP	O	be	dep	2	SENT_227	[p14l693t3393r797b3451],
6	,	,	O	,	_	0	SENT_227	[p14l693t3393r797b3451],
7	Campbell	NNP	PERSON	Campbell	nn	10	SENT_227	[p14l823t3392r1099b3457],
8	J	NNP	PERSON	J	nn	10	SENT_227	[p14l1122t3393r1148b3442],
9	H.	NNP	PERSON	H.	nn	10	SENT_227	[p14l1150t3393r1213b3442],
10	Cholestanol	NNP	PERSON	Cholestanol	appos	2	SENT_227	[p14l1240t3392r1594b3442],
11	:	:	O	:	_	0	SENT_227	[p14l1240t3392r1594b3442],
12	a	DT	O	a	det	14	SENT_227	[p14l1623t3408r1653b3442],
13	serum	NN	O	serum	nn	14	SENT_227	[p14l1677t3408r1849b3442],
14	marker	NN	O	marker	dep	2	SENT_227	[p14l1870t3392r2073b3442],
15	to	TO	O	to	dep	14	SENT_227	[p14l2094t3400r2147b3442],
16	guide	NN	O	guide	nn	21	SENT_227	[p14l133t3480r289b3545],
17	LDL	NN	O	ldl	nn	21	SENT_227	[p14l322t3482r459b3530],
18	cholesterol	NN	O	cholesterol	nn	21	SENT_227	[p14l493t3480r1080b3545],
19	—	CD	NUMBER	—	num	21	SENT_227	[p14l493t3480r1080b3545],
20	lowering	NN	O	lowering	nn	21	SENT_227	[p14l493t3480r1080b3545],
21	therapy	NN	O	therapy	dep	14	SENT_227	[p14l1113t3480r1334b3545],
22	.	.	O	.	_	0	SENT_227	[p14l1113t3480r1334b3545],

1	Atherosclerosis	NN	O	atherosclerosis	_	0	SENT_228	[p14l1369t3480r1823b3531],
2	.	.	O	.	_	0	SENT_228	[p14l1369t3480r1823b3531],

1	2006	CD	DATE	2006	_	0	SENT_229	[p14l1861t3480r2143b3540],
2	;	:	O	;	_	0	SENT_229	[p14l1861t3480r2143b3540],
3	184	CD	NUMBER	184	num	5	SENT_229	[p14l1861t3480r2143b3540],
4	:	:	O	:	_	0	SENT_229	[p14l1861t3480r2143b3540],
5	247-254	CD	NUMBER	247-254	dep	1	SENT_229	[p14l133t3569r393b3620],
6	.	.	O	.	_	0	SENT_229	[p14l133t3569r393b3620],

1	4	LS	NUMBER	4	_	0	SENT_230	[p14l42t3659r91b3709],
2	.	.	O	.	_	0	SENT_230	[p14l42t3659r91b3709],

1	Pauli	NNP	PERSON	Pauli	_	0	SENT_231	[p14l132t3659r529b3724],
2	.	.	O	.	_	0	SENT_231	[p14l132t3659r529b3724],

1	—	NN	O	—	_	0	SENT_232	[p14l132t3659r529b3724],
2	.	.	O	.	_	0	SENT_232	[p14l132t3659r529b3724],

1	Magnus	NNP	PERSON	Magnus	nn	2	SENT_233	[p14l132t3659r529b3724],
2	C	NNP	PERSON	C	_	0	SENT_233	[p14l553t3659r613b3718],
3	,	,	O	,	_	0	SENT_233	[p14l553t3659r613b3718],
4	Kroetz	NNP	PERSON	Kroetz	nn	5	SENT_233	[p14l640t3660r831b3709],
5	DL	NNP	O	DL	appos	2	SENT_233	[p14l854t3660r962b3709],
6	.	.	O	.	_	0	SENT_233	[p14l854t3660r962b3709],

1	Functional	JJ	O	functional	amod	2	SENT_234	[p14l988t3659r1293b3709],
2	implications	NNS	O	implication	_	0	SENT_234	[p14l1315t3659r1666b3724],
3	of	IN	O	of	_	0	SENT_234	[p14l1692t3659r1753b3709],
4	genetic	JJ	O	genetic	amod	5	SENT_234	[p14l1771t3659r1975b3724],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_234	[p14l1998t3659r2147b3724, p14l132t3747r446b3812],
6	in	IN	O	in	_	0	SENT_234	[p14l470t3747r524b3797],
7	the	DT	O	the	det	10	SENT_234	[p14l548t3747r634b3798],
8	multidrug	JJ	O	multidrug	amod	10	SENT_234	[p14l657t3747r937b3812],
9	resistance	NN	O	resistance	nn	10	SENT_234	[p14l960t3747r1241b3798],
10	gene	NN	O	gene	prep_in	2	SENT_234	[p14l1265t3763r1396b3812],
11	MDR1	NN	O	mdr1	nn	14	SENT_234	[p14l1421t3748r1610b3797],
12	(	CD	NUMBER	(	num	14	SENT_234	[p14l1642t3748r1926b3809],
13	ABCB1	NN	O	abcb1	nn	14	SENT_234	[p14l1642t3748r1926b3809],
14	)	NN	O	)	dep	10	SENT_234	[p14l1642t3748r1926b3809],
15	.	.	O	.	_	0	SENT_234	[p14l1642t3748r1926b3809],

1	Pharm	NNP	O	Pharm	_	0	SENT_235	[p14l1955t3747r2148b3798],
2	ll	NN	O	ll	dep	1	SENT_235	[p15l14t1883r91b1933],
3	.	.	O	.	_	0	SENT_235	[p15l14t1883r91b1933],

1	Res	NNP	O	Res	_	0	SENT_236	[p15l130t22r248b70],
2	.	.	O	.	_	0	SENT_236	[p15l130t22r248b70],

1	2004	CD	DATE	2004	_	0	SENT_237	[p15l278t21r793b79],
2	;	:	O	;	_	0	SENT_237	[p15l278t21r793b79],
3	21:904	CD	NUMBER	21:904	number	4	SENT_237	[p15l278t21r793b79],
4	-913	CD	NUMBER	-913	dep	1	SENT_237	[p15l278t21r793b79],
5	.	.	O	.	_	0	SENT_237	[p15l278t21r793b79],

1	.	.	O	.	_	0	SENT_238	[p15l82t150r91b159],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_239	[p15l131t110r295b174],
2	E	NNP	PERSON	E	_	0	SENT_239	[p15l308t110r366b168],
3	,	,	O	,	_	0	SENT_239	[p15l308t110r366b168],
4	Casciano	NNP	O	Casciano	nn	5	SENT_239	[p15l382t109r640b159],
5	CN	NN	O	cn	appos	2	SENT_239	[p15l655t109r766b168],
6	,	,	O	,	_	0	SENT_239	[p15l655t109r766b168],
7	Clement	NNP	ORGANIZATION	Clement	nn	8	SENT_239	[p15l782t109r1023b159],
8	RP	NNP	ORGANIZATION	RP	appos	2	SENT_239	[p15l1035t110r1128b168],
9	,	,	O	,	_	0	SENT_239	[p15l1035t110r1128b168],
10	Johnson	NNP	PERSON	Johnson	nn	11	SENT_239	[p15l1143t109r1375b159],
11	WW	NNP	O	WW	appos	2	SENT_239	[p15l1386t110r1529b159],
12	.	.	O	.	_	0	SENT_239	[p15l1386t110r1529b159],

1	HMG-CoA	JJ	O	hmg-coa	amod	3	SENT_240	[p15l1545t109r1868b159],
2	reductase	NN	O	reductase	nn	3	SENT_240	[p15l1879t109r2148b159],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_240	[p15l132t198r403b248],
4	(	VBP	O	(	_	0	SENT_240	[p15l427t198r651b260],
5	statins	NNS	O	statin	nsubj	7	SENT_240	[p15l427t198r651b260],
6	)	JJ	O	)	dep	7	SENT_240	[p15l427t198r651b260],
7	characterized	VBN	O	characterize	xcomp	4	SENT_240	[p15l675t198r1055b248],
8	as	IN	O	as	_	0	SENT_240	[p15l1077t214r1132b248],
9	direct	JJ	O	direct	amod	10	SENT_240	[p15l1154t198r1316b248],
10	inhibitors	NNS	O	inhibitor	prep_as	7	SENT_240	[p15l1336t198r1607b248],
11	of	IN	O	of	_	0	SENT_240	[p15l1630t198r1691b248],
12	P-glycoprotein	NN	O	p-glycoprotein	prep_of	10	SENT_240	[p15l1707t198r2141b263],
13	.	.	O	.	_	0	SENT_240	[p15l1707t198r2141b263],

1	Pharm	NNP	O	Pharm	nn	2	SENT_241	[p15l131t287r324b336],
2	Res	NNP	O	Res	_	0	SENT_241	[p15l341t288r459b337],
3	.	.	O	.	_	0	SENT_241	[p15l341t288r459b337],

1	2001	CD	DATE	2001	_	0	SENT_242	[p15l483t286r998b345],
2	;	:	O	;	_	0	SENT_242	[p15l483t286r998b345],
3	18:800	CD	NUMBER	18:800	number	4	SENT_242	[p15l483t286r998b345],
4	-806	CD	NUMBER	-806	dep	1	SENT_242	[p15l483t286r998b345],
5	.	.	O	.	_	0	SENT_242	[p15l483t286r998b345],

1	.	.	O	.	_	0	SENT_243	[p15l82t416r91b425],

1	Fung	NNP	ORGANIZATION	Fung	nn	2	SENT_244	[p15l132t376r276b440],
2	KL	NNP	ORGANIZATION	KL	_	0	SENT_244	[p15l307t376r414b434],
3	,	,	O	,	_	0	SENT_244	[p15l307t376r414b434],
4	Gottesman	NNP	PERSON	Gottesman	nn	5	SENT_244	[p15l447t375r753b425],
5	MM	NN	O	mm	appos	2	SENT_244	[p15l781t376r920b425],
6	.	.	O	.	_	0	SENT_244	[p15l781t376r920b425],

1	A	DT	O	a	det	3	SENT_245	[p15l953t375r1003b424],
2	synonymous	JJ	O	synonymous	amod	3	SENT_245	[p15l1034t391r1388b440],
3	polymorphism	NN	O	polymorphism	_	0	SENT_245	[p15l1417t375r1833b440],
4	in	IN	O	in	_	0	SENT_245	[p15l1860t375r1915b424],
5	a	DT	O	a	det	9	SENT_245	[p15l1945t391r1975b425],
6	common	JJ	O	common	amod	9	SENT_245	[p15l2003t390r2146b425, p15l132t480r258b514],
7	MDR1	NN	O	mdr1	nn	9	SENT_245	[p15l294t464r484b513],
8	(	CD	NUMBER	(	num	9	SENT_245	[p15l529t464r801b526],
9	ABCB1	NN	O	abcb1	prep_in	3	SENT_245	[p15l529t464r801b526],
10	)	CD	NUMBER	)	num	12	SENT_245	[p15l529t464r801b526],
11	haplotype	NN	O	haplotype	nn	12	SENT_245	[p15l839t464r1120b529],
12	shapes	NNS	O	shape	dep	3	SENT_245	[p15l1160t464r1344b529],
13	protein	NN	O	protein	nn	14	SENT_245	[p15l1382t464r1584b529],
14	function	NN	O	function	dep	12	SENT_245	[p15l1621t464r1868b514],
15	.	.	O	.	_	0	SENT_245	[p15l1621t464r1868b514],

1	Biochim	NNP	PERSON	Biochim	nn	3	SENT_246	[p15l1910t464r2148b514],
2	Biophys	NNP	PERSON	Biophys	nn	3	SENT_246	[p15l130t552r361b615],
3	Acta	NNP	PERSON	Acta	_	0	SENT_246	[p15l381t553r530b601],
4	.	.	O	.	_	0	SENT_246	[p15l381t553r530b601],

1	2009	CD	DATE	2009	_	0	SENT_247	[p15l560t552r1146b611],
2	;	:	O	;	_	0	SENT_247	[p15l560t552r1146b611],
3	l794	CD	NUMBER	l794	number	4	SENT_247	[p15l560t552r1146b611],
4	:860	CD	NUMBER	:860	num	6	SENT_247	[p15l560t552r1146b611],
5	—	NN	O	—	nn	6	SENT_247	[p15l560t552r1146b611],
6	87l	NN	O	87l	dep	1	SENT_247	[p15l560t552r1146b611],
7	.	.	O	.	_	0	SENT_247	[p15l560t552r1146b611],

1	.	.	O	.	_	0	SENT_248	[p15l82t682r91b691],

1	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	2	SENT_249	[p15l132t641r444b706],
2	S	NNP	O	S	_	0	SENT_249	[p15l463t641r514b700],
3	,	,	O	,	_	0	SENT_249	[p15l463t641r514b700],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_249	[p15l537t641r679b691],
5	o	NN	O	o	appos	2	SENT_249	[p15l698t641r762b700],
6	,	,	O	,	_	0	SENT_249	[p15l698t641r762b700],
7	Von	NNP	PERSON	Von	nn	9	SENT_249	[p15l784t657r889b691],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_249	[p15l909t641r1119b691],
9	O	NNP	PERSON	O	appos	2	SENT_249	[p15l1139t641r1202b700],
10	,	,	O	,	_	0	SENT_249	[p15l1139t641r1202b700],
11	et	FW	O	et	nn	12	SENT_249	[p15l1225t648r1275b691],
12	al.	FW	O	al.	appos	2	SENT_249	[p15l1296t641r1359b691],
13	.	.	O	.	_	0	SENT_249	[p15l1296t641r1359b691],

1	Functional	JJ	O	functional	amod	2	SENT_250	[p15l1382t641r1686b691],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_250	[p15l1706t641r2147b706],
3	of	IN	O	of	_	0	SENT_250	[p15l133t729r194b779],
4	the	DT	O	the	det	7	SENT_250	[p15l213t729r299b779],
5	human	JJ	O	human	amod	7	SENT_250	[p15l323t729r516b779],
6	multidrug-resistance	JJ	O	multidrug-resistance	amod	7	SENT_250	[p15l540t729r1125b794],
7	gene	NN	O	gene	prep_of	2	SENT_250	[p15l1150t745r1297b794],
8	:	:	O	:	_	0	SENT_250	[p15l1150t745r1297b794],
9	multiple	JJ	O	multiple	amod	11	SENT_250	[p15l1326t729r1563b794],
10	sequence	NN	O	sequence	nn	11	SENT_250	[p15l1589t745r1847b794],
11	Variations	NNS	O	variation	dep	2	SENT_250	[p15l1869t729r2147b779],
12	and	CC	O	and	_	0	SENT_250	[p15l134t818r234b868],
13	correlation	NN	O	correlation	conj_and	11	SENT_250	[p15l255t818r562b868],
14	of	IN	O	of	_	0	SENT_250	[p15l583t818r645b868],
15	one	CD	NUMBER	one	num	16	SENT_250	[p15l661t834r762b868],
16	allele	NN	O	allele	prep_of	13	SENT_250	[p15l784t818r936b868],
17	with	IN	O	with	_	0	SENT_250	[p15l955t818r1080b868],
18	P-glycoprotein	NN	MISC	p-glycoprotein	nn	19	SENT_250	[p15l1100t818r1523b883],
19	expression	NN	O	expression	prep_with	16	SENT_250	[p15l1544t818r1846b883],
20	and	CC	O	and	_	0	SENT_250	[p15l1868t818r1968b868],
21	activity	NN	O	activity	conj_and	19	SENT_250	[p15l1989t818r2146b868, p15l132t907r206b972],
22	in	FW	O	in	prep	13	SENT_250	[p15l232t907r286b957],
23	vivo	FW	O	vivo	pobj	22	SENT_250	[p15l309t907r443b957],
24	.	.	O	.	_	0	SENT_250	[p15l309t907r443b957],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_251	[p15l474t909r608b957],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_251	[p15l632t907r757b958],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_251	[p15l777t907r930b957],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_251	[p15l952t908r1038b958],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_251	[p15l1069t909r1117b958],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_251	[p15l1139t908r1174b958],
7	A.	NNP	O	A.	_	0	SENT_251	[p15l1193t908r1254b957],
8	2000	CD	DATE	2000	num	7	SENT_251	[p15l1284t907r1870b967],
9	;	:	O	;	_	0	SENT_251	[p15l1284t907r1870b967],
10	97:3473	CD	NUMBER	97:3473	number	11	SENT_251	[p15l1284t907r1870b967],
11	—	CD	NUMBER	—	dep	7	SENT_251	[p15l1284t907r1870b967],
12	3478	CD	NUMBER	3478	dep	11	SENT_251	[p15l1284t907r1870b967],
13	.	.	O	.	_	0	SENT_251	[p15l1284t907r1870b967],

1	.	.	O	.	_	0	SENT_252	[p15l82t1038r91b1046],

1	Keskitalo	NNP	O	Keskitalo	nn	2	SENT_253	[p15l134t996r402b1046],
2	JE	NNP	O	JE	nsubj	15	SENT_253	[p15l429t997r514b1055],
3	,	,	O	,	_	0	SENT_253	[p15l429t997r514b1055],
4	Kurkinen	NNP	PERSON	Kurkinen	nn	5	SENT_253	[p15l544t996r810b1046],
5	KJ	NNP	PERSON	KJ	appos	2	SENT_253	[p15l837t997r928b1056],
6	,	,	O	,	_	0	SENT_253	[p15l837t997r928b1056],
7	Neuvoneni	NNP	ORGANIZATION	Neuvoneni	nn	8	SENT_253	[p15l957t996r1267b1046],
8	PJ	NNP	ORGANIZATION	PJ	appos	2	SENT_253	[p15l1294t997r1375b1056],
9	,	,	O	,	_	0	SENT_253	[p15l1294t997r1375b1056],
10	Niemi	NNP	PERSON	Niemi	nn	13	SENT_253	[p15l1404t996r1580b1046],
11	M.	NNP	O	M.	nn	13	SENT_253	[p15l1607t997r1683b1046],
12	ABCB1	NNP	O	ABCB1	nn	13	SENT_253	[p15l1713t996r1934b1046],
13	haplotypes	NNS	O	haplotype	appos	2	SENT_253	[p15l1967t996r2146b1061, p15l132t1093r280b1150],
14	differentially	RB	O	differentially	advmod	15	SENT_253	[p15l301t1085r671b1150],
15	affect	VBP	O	affect	_	0	SENT_253	[p15l693t1085r852b1135],
16	the	DT	O	the	det	17	SENT_253	[p15l872t1085r957b1135],
17	pharmacokinetics	NNS	O	pharmacokinetic	dobj	15	SENT_253	[p15l977t1085r1478b1150],
18	of	IN	O	of	_	0	SENT_253	[p15l1501t1085r1562b1135],
19	the	DT	O	the	det	23	SENT_253	[p15l1578t1085r1663b1135],
20	acid	NN	O	acid	nn	23	SENT_253	[p15l1685t1085r1802b1135],
21	and	CC	O	and	_	0	SENT_253	[p15l1823t1085r1923b1135],
22	lactone	NN	O	lactone	nn	23	SENT_253	[p15l1943t1085r2148b1135],
23	forms	NNS	O	form	prep_of	17	SENT_253	[p15l133t1174r295b1224],
24	of	IN	O	of	_	0	SENT_253	[p15l321t1174r382b1224],
25	simvastatin	NN	O	simvastatin	prep_of	23	SENT_253	[p15l404t1174r723b1224],
26	and	CC	O	and	_	0	SENT_253	[p15l748t1174r849b1224],
27	atorvastatin	NN	O	atorvastatin	prep_of	23	SENT_253	[p15l873t1174r1213b1224],
28	.	.	O	.	_	0	SENT_253	[p15l873t1174r1213b1224],

1	Clin	NNP	O	Clin	nn	3	SENT_254	[p15l1247t1174r1364b1225],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_254	[p15l1387t1174r1705b1224],
3	Ther	NNP	O	Ther	_	0	SENT_254	[p15l1729t1174r1869b1224],
4	.	.	O	.	_	0	SENT_254	[p15l1729t1174r1869b1224],

1	2008	CD	DATE	2008	_	0	SENT_255	[p15l1898t1174r2143b1233],
2	;	:	O	;	_	0	SENT_255	[p15l1898t1174r2143b1233],
3	84	CD	NUMBER	84	num	5	SENT_255	[p15l1898t1174r2143b1233],
4	:	:	O	:	_	0	SENT_255	[p15l1898t1174r2143b1233],
5	457-461	CD	NUMBER	457-461	dep	1	SENT_255	[p15l132t1262r393b1311],
6	.	.	O	.	_	0	SENT_255	[p15l132t1262r393b1311],

1	.	.	O	.	_	0	SENT_256	[p15l82t1391r91b1399],

1	Holtzman	NNP	ORGANIZATION	Holtzman	nn	2	SENT_257	[p15l133t1349r413b1399],
2	CW	NNP	ORGANIZATION	CW	_	0	SENT_257	[p15l432t1349r553b1408],
3	,	,	O	,	_	0	SENT_257	[p15l432t1349r553b1408],
4	Wiggins	NNP	PERSON	Wiggins	nn	5	SENT_257	[p15l575t1349r812b1414],
5	BS	NNP	O	BS	appos	2	SENT_257	[p15l832t1349r933b1409],
6	,	,	O	,	_	0	SENT_257	[p15l832t1349r933b1409],
7	Spinler	NNP	O	Spinler	nn	8	SENT_257	[p15l956t1349r1160b1414],
8	SA	NNP	O	SA	appos	5	SENT_257	[p15l1179t1349r1280b1399],
9	.	.	O	.	_	0	SENT_257	[p15l1179t1349r1280b1399],

1	Role	NN	O	role	_	0	SENT_258	[p15l1303t1349r1436b1399],
2	of	IN	O	of	_	0	SENT_258	[p15l1456t1349r1518b1399],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_258	[p15l1532t1349r1954b1414],
4	in	IN	O	in	_	0	SENT_258	[p15l1973t1349r2027b1399],
5	statin	NN	O	statin	prep_in	1	SENT_258	[p15l2049t1356r2146b1399, p15l133t1438r206b1488],

1	drug	NN	O	drug	nn	2	SENT_259	[p15l233t1438r360b1503],
2	interactions	NNS	O	interaction	_	0	SENT_259	[p15l386t1438r729b1488],
3	.	.	O	.	_	0	SENT_259	[p15l386t1438r729b1488],

1	Pharmacotherapy	NNP	O	Pharmacotherapy	_	0	SENT_260	[p15l760t1438r1283b1502],
2	.	.	O	.	_	0	SENT_260	[p15l760t1438r1283b1502],

1	2006	CD	DATE	2006	_	0	SENT_261	[p15l1314t1438r1900b1498],
2	;	:	O	;	_	0	SENT_261	[p15l1314t1438r1900b1498],
3	26:1601	CD	NUMBER	26:1601	number	4	SENT_261	[p15l1314t1438r1900b1498],
4	—	CD	NUMBER	—	dep	1	SENT_261	[p15l1314t1438r1900b1498],
5	1607	CD	DATE	1607	dep	4	SENT_261	[p15l1314t1438r1900b1498],
6	.	.	O	.	_	0	SENT_261	[p15l1314t1438r1900b1498],

1	Kajinami	NNP	LOCATION	Kajinami	nn	2	SENT_262	[p15l134t1527r396b1592],
2	K	NNP	LOCATION	K	_	0	SENT_262	[p15l416t1529r479b1587],
3	,	,	O	,	_	0	SENT_262	[p15l416t1529r479b1587],
4	Brousseau	NNP	PERSON	Brousseau	nn	5	SENT_262	[p15l499t1529r794b1578],
5	ME	NNP	O	ME	appos	2	SENT_262	[p15l811t1529r932b1587],
6	,	,	O	,	_	0	SENT_262	[p15l811t1529r932b1587],
7	Ordovas	NNP	O	Ordovas	nn	9	SENT_262	[p15l954t1527r1188b1578],
8	J	NNP	O	J	nn	9	SENT_262	[p15l1207t1529r1233b1578],
9	M	NN	O	m	appos	2	SENT_262	[p15l1235t1529r1311b1587],
10	,	,	O	,	_	0	SENT_262	[p15l1235t1529r1311b1587],
11	Schaefer	NNP	PERSON	Schaefer	nn	12	SENT_262	[p15l1333t1527r1581b1578],
12	EJ	NNP	O	EJ	appos	2	SENT_262	[p15l1597t1529r1681b1578],
13	.	.	O	.	_	0	SENT_262	[p15l1597t1529r1681b1578],

1	Polymorphisms	NNS	O	polymorphism	nsubj	22	SENT_263	[p15l1702t1527r2147b1592],
2	in	IN	O	in	_	0	SENT_263	[p15l133t1616r186b1666],
3	the	DT	O	the	det	8	SENT_263	[p15l212t1616r297b1666],
4	multidrug	JJ	O	multidrug	amod	8	SENT_263	[p15l324t1616r604b1681],
5	resistance-1	NN	O	resistance-1	nn	8	SENT_263	[p15l629t1616r963b1666],
6	(	CD	NUMBER	(	num	8	SENT_263	[p15l997t1617r1236b1678],
7	MDR1	NN	O	mdr1	nn	8	SENT_263	[p15l997t1617r1236b1678],
8	)	NN	O	)	prep_in	1	SENT_263	[p15l997t1617r1236b1678],
9	gene	NN	O	gene	nn	10	SENT_263	[p15l1265t1632r1397b1681],
10	inﬂuence	NN	O	inﬂuence	dep	8	SENT_263	[p15l1423t1616r1683b1666],
11	the	DT	O	the	det	12	SENT_263	[p15l1709t1616r1794b1666],
12	response	NN	O	response	dep	10	SENT_263	[p15l1820t1632r2068b1681],
13	to	TO	O	to	_	0	SENT_263	[p15l2094t1624r2147b1666],
14	atorvastatin	NN	O	atorvastatin	nn	15	SENT_263	[p15l134t1705r463b1756],
15	treatment	NN	O	treatment	prep_to	1	SENT_263	[p15l503t1712r773b1755],
16	in	IN	O	in	_	0	SENT_263	[p15l811t1705r865b1755],
17	a	DT	O	a	det	19	SENT_263	[p15l906t1721r935b1755],
18	gender-speciﬁc	JJ	O	gender-speciﬁc	amod	19	SENT_263	[p15l975t1705r1406b1770],
19	manner	NN	O	manner	prep_in	15	SENT_263	[p15l1448t1721r1663b1755],
20	Am	VBP	O	be	cop	22	SENT_263	[p15l1706t1706r1803b1755],
21	J	NN	O	j	nn	22	SENT_263	[p15l1841t1707r1877b1756],
22	Cardiol	NN	O	cardiol	_	0	SENT_263	[p15l1916t1705r2145b1756],
23	.	.	O	.	_	0	SENT_263	[p15l1916t1705r2145b1756],

1	2004	CD	DATE	2004	_	0	SENT_264	[p15l134t1795r379b1853],
2	;	:	O	;	_	0	SENT_264	[p15l134t1795r379b1853],
3	93	CD	NUMBER	93	num	5	SENT_264	[p15l134t1795r379b1853],
4	:	:	O	:	_	0	SENT_264	[p15l134t1795r379b1853],
5	1046-1050	CD	DATE	1046-1050	dep	1	SENT_264	[p15l394t1794r719b1844],
6	.	.	O	.	_	0	SENT_264	[p15l394t1794r719b1844],

1	From	IN	O	from	_	0	SENT_265	[p15l132t1884r342b1933],
2	MF	NN	O	mf	pobj	1	SENT_265	[p15l368t1884r478b1933],
3	.	.	O	.	_	0	SENT_265	[p15l368t1884r478b1933],

1	The	DT	O	the	det	2	SENT_266	[p15l509t1883r618b1933],
2	inﬂuence	NN	O	inﬂuence	_	0	SENT_266	[p15l646t1882r906b1933],
3	of	IN	O	of	_	0	SENT_266	[p15l935t1882r996b1933],
4	MDR1	NN	O	mdr1	nn	5	SENT_266	[p15l1019t1883r1209b1932],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_266	[p15l1242t1883r1683b1948],
6	on	IN	O	on	_	0	SENT_266	[p15l1713t1898r1782b1933],
7	Pglycoprotein	NN	O	pglycoprotein	nn	8	SENT_266	[p15l1809t1883r2146b1948, p15l132t1971r238b2021],
8	expression	NN	O	expression	prep_on	2	SENT_266	[p15l268t1971r569b2036],
9	and	CC	O	and	_	0	SENT_266	[p15l599t1971r700b2021],
10	function	NN	O	function	prep_on	2	SENT_266	[p15l728t1971r965b2021],
11	in	IN	O	in	_	0	SENT_266	[p15l994t1971r1047b2021],
12	humans	NNS	O	human	prep_in	2	SENT_266	[p15l1076t1971r1307b2021],
13	.	.	O	.	_	0	SENT_266	[p15l1076t1971r1307b2021],

1	Adv	NNP	MISC	Adv	nn	4	SENT_267	[p15l1338t1971r1452b2022],
2	Drug	NNP	MISC	Drug	nn	4	SENT_267	[p15l1480t1973r1629b2035],
3	Deliv	NNP	MISC	Deliv	nn	4	SENT_267	[p15l1657t1971r1811b2022],
4	Rev.	NNP	O	Rev.	_	0	SENT_267	[p15l1838t1973r1955b2022],
5	2002	CD	DATE	2002	num	4	SENT_267	[p15l1988t1972r2145b2031],
6	;	:	O	;	_	0	SENT_267	[p15l1988t1972r2145b2031],
7	54:1295	CD	NUMBER	54:1295	number	8	SENT_267	[p15l134t2060r556b2111],
8	—	CD	NUMBER	—	dep	4	SENT_267	[p15l134t2060r556b2111],
9	1310	CD	DATE	1310	dep	8	SENT_267	[p15l134t2060r556b2111],
10	.	.	O	.	_	0	SENT_267	[p15l134t2060r556b2111],

1	Pasternak	NNP	PERSON	Pasternak	nn	2	SENT_268	[p15l132t2150r409b2200],
2	RC	NNP	O	RC	_	0	SENT_268	[p15l423t2150r532b2209],
3	,	,	O	,	_	0	SENT_268	[p15l423t2150r532b2209],
4	Smith	NNP	PERSON	Smith	nn	6	SENT_268	[p15l553t2150r720b2200],
5	SC	NNP	PERSON	SC	nn	6	SENT_268	[p15l738t2150r820b2200],
6	Jr.	NNP	PERSON	Jr.	appos	2	SENT_268	[p15l837t2151r916b2209],
7	,	,	O	,	_	0	SENT_268	[p15l837t2151r916b2209],
8	Bairey	NNP	LOCATION	Bairey	appos	6	SENT_268	[p15l935t2149r1297b2215],
9	.	.	O	.	_	0	SENT_268	[p15l935t2149r1297b2215],

1	—	NN	O	—	_	0	SENT_269	[p15l935t2149r1297b2215],
2	.	.	O	.	_	0	SENT_269	[p15l935t2149r1297b2215],

1	Merz	NNP	PERSON	Merz	nn	2	SENT_270	[p15l935t2149r1297b2215],
2	CN	NN	O	cn	dep	15	SENT_270	[p15l1314t2150r1426b2209],
3	,	,	O	,	_	0	SENT_270	[p15l1314t2150r1426b2209],
4	Grundy	NNP	PERSON	Grundy	nn	5	SENT_270	[p15l1446t2150r1661b2215],
5	SM	NNP	O	SM	appos	2	SENT_270	[p15l1679t2150r1793b2209],
6	,	,	O	,	_	0	SENT_270	[p15l1679t2150r1793b2209],
7	Cleeman	NNP	PERSON	Cleeman	nn	8	SENT_270	[p15l1813t2150r2064b2200],
8	J	NNP	O	J	appos	2	SENT_270	[p15l2080t2151r2107b2200],
9	I	PRP	O	I	dep	8	SENT_270	[p15l2108t2151r2145b2209],
10	,	,	O	,	_	0	SENT_270	[p15l2108t2151r2145b2209],
11	Lenfant	NNP	PERSON	Lenfant	nn	13	SENT_270	[p15l132t2238r354b2288],
12	C.	NNP	O	C.	nn	13	SENT_270	[p15l370t2239r429b2289],
13	ACC/AHA/NHLBI	NNP	O	ACC/AHA/NHLBI	appos	2	SENT_270	[p15l449t2238r1002b2289],
14	Clinical	JJ	O	clinical	amod	15	SENT_270	[p15l1019t2238r1243b2289],
15	Advisory	NNP	O	Advisory	_	0	SENT_270	[p15l1259t2238r1522b2303],
16	on	IN	O	on	_	0	SENT_270	[p15l1539t2254r1608b2288],
17	the	DT	O	the	det	18	SENT_270	[p15l1624t2238r1709b2288],
18	Use	NN	O	use	prep_on	15	SENT_270	[p15l1725t2239r1834b2289],
19	and	CC	O	and	_	0	SENT_270	[p15l1852t2238r1952b2288],
20	Safety	NN	O	safety	prep_on	15	SENT_270	[p15l1970t2238r2148b2303],
21	of	IN	O	of	_	0	SENT_270	[p15l133t2327r195b2377],
22	Statins	NNS	O	statin	prep_of	18	SENT_270	[p15l211t2327r413b2378],
23	.	.	O	.	_	0	SENT_270	[p15l211t2327r413b2378],

1	Circulation	NN	O	circulation	_	0	SENT_271	[p15l443t2327r779b2378],
2	.	.	O	.	_	0	SENT_271	[p15l443t2327r779b2378],

1	2002	CD	DATE	2002	_	0	SENT_272	[p15l803t2327r1425b2385],
2	;	:	O	;	_	0	SENT_272	[p15l803t2327r1425b2385],
3	106:1024	CD	DURATION	106:1024	number	4	SENT_272	[p15l803t2327r1425b2385],
4	-1028	CD	DURATION	-1028	dep	1	SENT_272	[p15l803t2327r1425b2385],
5	.	.	O	.	_	0	SENT_272	[p15l803t2327r1425b2385],

1	Cox	NN	ORGANIZATION	cox	nn	2	SENT_273	[p15l131t2416r247b2466],
2	A	NN	ORGANIZATION	a	_	0	SENT_273	[p15l271t2416r335b2475],
3	,	,	O	,	_	0	SENT_273	[p15l271t2416r335b2475],
4	Dunning	NNP	ORGANIZATION	Dunning	nn	5	SENT_273	[p15l360t2415r608b2480],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_273	[p15l631t2416r760b2475],
6	,	,	O	,	_	0	SENT_273	[p15l631t2416r760b2475],
7	Garcia	NNP	PERSON	Garcia	appos	5	SENT_273	[p15l786t2415r1186b2466],
8	.	.	O	.	_	0	SENT_273	[p15l786t2415r1186b2466],

1	—	NN	O	—	_	0	SENT_274	[p15l786t2415r1186b2466],
2	.	.	O	.	_	0	SENT_274	[p15l786t2415r1186b2466],

1	Closas	NNP	O	Closas	nn	2	SENT_275	[p15l786t2415r1186b2466],
2	M	NNP	O	M	_	0	SENT_275	[p15l1211t2417r1287b2475],
3	,	,	O	,	_	0	SENT_275	[p15l1211t2417r1287b2475],
4	et	FW	O	et	nn	5	SENT_275	[p15l1314t2423r1364b2466],
5	al.	FW	O	al.	appos	2	SENT_275	[p15l1388t2415r1451b2466],
6	.	.	O	.	_	0	SENT_275	[p15l1388t2415r1451b2466],

1	A	DT	O	a	det	4	SENT_276	[p15l1478t2416r1527b2465],
2	common	JJ	O	common	amod	4	SENT_276	[p15l1551t2431r1800b2466],
3	coding	NN	O	coding	nn	4	SENT_276	[p15l1822t2415r2014b2480],
4	variant	NN	O	variant	nsubjpass	8	SENT_276	[p15l2038t2431r2147b2466, p15l130t2505r237b2554],
5	in	IN	O	in	_	0	SENT_276	[p15l259t2505r314b2554],
6	CASP8	NN	O	casp8	prep_in	4	SENT_276	[p15l337t2505r546b2555],
7	is	VBZ	O	be	auxpass	8	SENT_276	[p15l572t2505r616b2554],
8	associated	VBN	O	associate	_	0	SENT_276	[p15l642t2505r934b2554],
9	with	IN	O	with	_	0	SENT_276	[p15l957t2504r1083b2555],
10	breast	NN	O	breast	nn	14	SENT_276	[p15l1104t2504r1276b2554],
11	cancer	NN	O	cancer	nn	14	SENT_276	[p15l1298t2520r1484b2554],
12	risk	NN	O	risk	nn	14	SENT_276	[p15l1506t2504r1623b2554],
13	Nat	NNP	PERSON	Nat	nn	14	SENT_276	[p15l1651t2506r1757b2555],
14	Genet	NNP	PERSON	Genet	prep_with	8	SENT_276	[p15l1780t2506r1961b2555],
15	.	.	O	.	_	0	SENT_276	[p15l1780t2506r1961b2555],

1	2007	CD	DATE	2007	_	0	SENT_277	[p15l1989t2505r2146b2563],
2	;	:	O	;	_	0	SENT_277	[p15l1989t2505r2146b2563],
3	39:352	CD	NUMBER	39:352	number	4	SENT_277	[p15l132t2591r483b2643],
4	-358	CD	NUMBER	-358	dep	1	SENT_277	[p15l132t2591r483b2643],
5	.	.	O	.	_	0	SENT_277	[p15l132t2591r483b2643],

1	Thompson	NNP	PERSON	Thompson	nn	2	SENT_278	[p15l130t2682r435b2747],
2	JF	NNP	O	JF	_	0	SENT_278	[p15l462t2683r538b2741],
3	,	,	O	,	_	0	SENT_278	[p15l462t2683r538b2741],
4	Hyde	NNP	ORGANIZATION	Hyde	nn	5	SENT_278	[p15l569t2682r721b2747],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_278	[p15l751t2682r855b2741],
6	,	,	O	,	_	0	SENT_278	[p15l751t2682r855b2741],
7	Wood	NNP	O	Wood	nn	8	SENT_278	[p15l886t2682r1055b2732],
8	LS	NN	O	l	appos	2	SENT_278	[p15l1083t2682r1180b2741],
9	,	,	O	,	_	0	SENT_278	[p15l1083t2682r1180b2741],
10	et	FW	O	et	nn	11	SENT_278	[p15l1211t2689r1262b2732],
11	al.	FW	O	al.	appos	2	SENT_278	[p15l1291t2682r1354b2732],
12	.	.	O	.	_	0	SENT_278	[p15l1291t2682r1354b2732],

1	Comprehensive	NNP	O	Comprehensive	_	0	SENT_279	[p15l1387t2682r1831b2747],
2	whole	JJ	O	whole	amod	3	SENT_279	[p15l1859t2682r2031b2732],
3	genome	NN	O	genome	dep	1	SENT_279	[p15l2060t2697r2147b2747, p15l130t2786r287b2821],
4	and	CC	O	and	_	0	SENT_279	[p15l321t2771r422b2821],
5	candidate	NN	O	candidate	nn	7	SENT_279	[p15l454t2770r726b2821],
6	gene	NN	O	gene	nn	7	SENT_279	[p15l759t2786r891b2836],
7	analysis	NN	O	analysis	conj_and	3	SENT_279	[p15l925t2770r1151b2836],
8	for	IN	O	for	_	0	SENT_279	[p15l1184t2770r1267b2821],
9	response	NN	O	response	prep_for	3	SENT_279	[p15l1297t2786r1546b2836],
10	to	TO	O	to	_	0	SENT_279	[p15l1578t2778r1631b2821],
11	statin	NN	O	statin	nn	12	SENT_279	[p15l1667t2770r1818b2821],
12	therapy	NN	O	therapy	prep_to	9	SENT_279	[p15l1850t2771r2063b2836],
13	in	IN	O	in	_	0	SENT_279	[p15l2095t2771r2150b2820],
14	TNT	NNP	O	TNT	nn	15	SENT_279	[p15l130t2861r267b2910],
15	Cohort	NNP	O	Cohort	prep_in	12	SENT_279	[p15l294t2860r500b2910],
16	.	.	O	.	_	0	SENT_279	[p15l294t2860r500b2910],

1	Circ	NNP	PERSON	Circ	nn	3	SENT_280	[p15l537t2861r655b2910],
2	Cardiovasc	NNP	PERSON	Cardiovasc	nn	3	SENT_280	[p15l685t2860r1006b2910],
3	Genet	NNP	PERSON	Genet	_	0	SENT_280	[p15l1034t2861r1215b2910],
4	.	.	O	.	_	0	SENT_280	[p15l1034t2861r1215b2910],

1	2009	CD	DATE	2009	_	0	SENT_281	[p15l1246t2860r1725b2918],
2	;	:	O	;	_	0	SENT_281	[p15l1246t2860r1725b2918],
3	2:173	CD	NUMBER	2:173	num	4	SENT_281	[p15l1246t2860r1725b2918],
4	—	NN	O	—	dep	1	SENT_281	[p15l1246t2860r1725b2918],
5	181	CD	NUMBER	181	dep	4	SENT_281	[p15l1246t2860r1725b2918],
6	.	.	O	.	_	0	SENT_281	[p15l1246t2860r1725b2918],

1	Sarkkinen	NNP	PERSON	Sarkkinen	nn	2	SENT_282	[p15l132t2948r419b2998],
2	E	NNP	PERSON	E	_	0	SENT_282	[p15l443t2949r500b3007],
3	,	,	O	,	_	0	SENT_282	[p15l443t2949r500b3007],
4	Korhonen	NNP	O	Korhonen	nn	5	SENT_282	[p15l529t2948r810b2998],
5	M	NNP	O	M	appos	2	SENT_282	[p15l834t2949r911b3007],
6	,	,	O	,	_	0	SENT_282	[p15l834t2949r911b3007],
7	Erkkila	NNP	O	Erkkila	nn	8	SENT_282	[p15l938t2948r1150b2998],
8	A	NNP	O	A	appos	2	SENT_282	[p15l1173t2948r1238b3007],
9	,	,	O	,	_	0	SENT_282	[p15l1173t2948r1238b3007],
10	Ebeling	NNP	ORGANIZATION	Ebeling	nn	11	SENT_282	[p15l1265t2948r1486b3013],
11	T	NN	ORGANIZATION	t	conj_and	5	SENT_282	[p15l1512t2949r1564b3007],
12	,	,	O	,	_	0	SENT_282	[p15l1512t2949r1564b3007],
13	Uusitupa	NNP	O	Uusitupa	nn	15	SENT_282	[p15l1592t2948r1849b3013],
14	M.	NNP	O	M.	nn	15	SENT_282	[p15l1872t2949r1948b2998],
15	Effect	NN	O	effect	conj_and	5	SENT_282	[p15l1977t2948r2150b2998],
16	of	IN	O	of	_	0	SENT_282	[p15l131t3036r193b3087],
17	apolipoprotein	NN	O	apolipoprotein	nn	19	SENT_282	[p15l210t3037r625b3102],
18	E	NN	O	e	nn	19	SENT_282	[p15l645t3038r688b3086],
19	polymorphism	NN	O	polymorphism	prep_of	15	SENT_282	[p15l708t3036r1126b3102],
20	on	IN	O	on	_	0	SENT_282	[p15l1146t3052r1215b3087],
21	serum	NN	O	serum	nn	23	SENT_282	[p15l1239t3052r1410b3087],
22	lipid	NN	O	lipid	nn	23	SENT_282	[p15l1430t3037r1560b3102],
23	response	NN	O	response	prep_on	19	SENT_282	[p15l1580t3052r1828b3102],
24	to	TO	O	to	_	0	SENT_282	[p15l1849t3044r1902b3087],
25	the	DT	O	the	det	27	SENT_282	[p15l1925t3037r2010b3087],
26	separate	JJ	O	separate	amod	27	SENT_282	[p15l2034t3052r2147b3102, p15l132t3133r268b3176],
27	modiﬁcation	NN	O	modiﬁcation	prep_to	23	SENT_282	[p15l300t3126r660b3176],
28	of	IN	O	of	_	0	SENT_282	[p15l693t3126r754b3176],
29	dietary	JJ	O	dietary	amod	30	SENT_282	[p15l782t3126r978b3191],
30	fat	NN	O	fat	prep_of	27	SENT_282	[p15l1010t3126r1085b3176],
31	and	CC	O	and	_	0	SENT_282	[p15l1118t3126r1218b3176],
32	dietary	JJ	O	dietary	amod	33	SENT_282	[p15l1250t3126r1446b3191],
33	cholesterol	NN	O	cholesterol	conj_and	5	SENT_282	[p15l1479t3126r1802b3176],
34	.	.	O	.	_	0	SENT_282	[p15l1479t3126r1802b3176],

1	Am	VBP	O	be	cop	4	SENT_283	[p15l1836t3127r1934b3176],
2	J	NN	O	j	nn	4	SENT_283	[p15l1964t3128r2000b3176],
3	Clin	NN	O	clin	nn	4	SENT_283	[p15l2031t3126r2149b3176],
4	Nutr	NN	O	nutr	_	0	SENT_283	[p15l128t3216r270b3264],
5	.	.	O	.	_	0	SENT_283	[p15l128t3216r270b3264],

1	1998	CD	DATE	1998	_	0	SENT_284	[p15l306t3214r887b3273],
2	;	:	O	;	_	0	SENT_284	[p15l306t3214r887b3273],
3	68:1215	CD	NUMBER	68:1215	number	4	SENT_284	[p15l306t3214r887b3273],
4	—	CD	NUMBER	—	dep	1	SENT_284	[p15l306t3214r887b3273],
5	1222	CD	DATE	1222	dep	4	SENT_284	[p15l306t3214r887b3273],
6	.	.	O	.	_	0	SENT_284	[p15l306t3214r887b3273],

1	Kesaniemi	NNP	ORGANIZATION	Kesaniemi	nn	2	SENT_285	[p15l132t3302r432b3352],
2	YA	NNP	ORGANIZATION	YA	_	0	SENT_285	[p15l447t3302r554b3361],
3	,	,	O	,	_	0	SENT_285	[p15l447t3302r554b3361],
4	Ehnholm	NNP	O	Ehnholm	nn	5	SENT_285	[p15l571t3302r832b3352],
5	C	NNP	O	C	appos	2	SENT_285	[p15l846t3302r906b3361],
6	,	,	O	,	_	0	SENT_285	[p15l846t3302r906b3361],
7	Miettinen	NNP	PERSON	Miettinen	nn	8	SENT_285	[p15l922t3302r1200b3352],
8	TA	NNP	O	TA	appos	5	SENT_285	[p15l1213t3302r1314b3352],
9	.	.	O	.	_	0	SENT_285	[p15l1213t3302r1314b3352],

1	Intestinal	JJ	O	intestinal	amod	4	SENT_286	[p15l1332t3302r1596b3352],
2	cholesterol	NN	O	cholesterol	nn	4	SENT_286	[p15l1611t3302r1923b3352],
3	absorption	NN	O	absorption	nn	4	SENT_286	[p15l1938t3302r2148b3367, p15l130t3392r240b3442],
4	efﬁciency	NN	O	efﬁciency	nsubj	8	SENT_286	[p15l255t3392r533b3457],
5	in	IN	O	in	_	0	SENT_286	[p15l547t3392r602b3441],
6	man	NN	O	man	prep_in	4	SENT_286	[p15l615t3408r737b3442],
7	is	VBZ	O	be	cop	8	SENT_286	[p15l750t3392r794b3442],
8	related	JJ	O	related	_	0	SENT_286	[p15l809t3392r1004b3442],
9	to	TO	O	to	_	0	SENT_286	[p15l1017t3399r1070b3442],
10	apoprotein	NN	O	apoprotein	nn	12	SENT_286	[p15l1086t3392r1390b3457],
11	E	NN	O	e	nn	12	SENT_286	[p15l1402t3393r1444b3441],
12	phenotype	NN	O	phenotype	prep_to	8	SENT_286	[p15l1457t3392r1764b3457],
13	.	.	O	.	_	0	SENT_286	[p15l1457t3392r1764b3457],

1	J	NNP	O	J	nn	3	SENT_287	[p15l1783t3394r1819b3442],
2	Clin	NNP	O	Clin	nn	3	SENT_287	[p15l1833t3392r1950b3442],
3	Invest	NNP	O	Invest	_	0	SENT_287	[p15l1963t3394r2145b3442],
4	.	.	O	.	_	0	SENT_287	[p15l1963t3394r2145b3442],

1	1987	CD	DATE	1987	_	0	SENT_288	[p15l137t3480r647b3539],
2	;	:	O	;	_	0	SENT_288	[p15l137t3480r647b3539],
3	80:578	CD	NUMBER	80:578	number	4	SENT_288	[p15l137t3480r647b3539],
4	-581	CD	NUMBER	-581	dep	1	SENT_288	[p15l137t3480r647b3539],
5	.	.	O	.	_	0	SENT_288	[p15l137t3480r647b3539],

1	Gylling	VBG	O	gylle	_	0	SENT_289	[p15l132t3568r346b3633],
2	H	NN	O	h	dobj	1	SENT_289	[p15l371t3569r435b3627],
3	,	,	O	,	_	0	SENT_289	[p15l371t3569r435b3627],
4	Hallikainen	NNP	O	Hallikainen	nn	5	SENT_289	[p15l461t3568r794b3618],
5	M	NNP	O	M	appos	2	SENT_289	[p15l817t3569r893b3627],
6	,	,	O	,	_	0	SENT_289	[p15l817t3569r893b3627],
7	Pihlajamaki	NNP	PERSON	Pihlajamaki	nn	8	SENT_289	[p15l920t3568r1260b3633],
8	J	NNP	PERSON	J	appos	2	SENT_289	[p15l1284t3569r1325b3627],
9	,	,	O	,	_	0	SENT_289	[p15l1284t3569r1325b3627],
10	et	FW	O	et	nn	11	SENT_289	[p15l1352t3576r1402b3618],
11	al.	FW	O	al.	appos	2	SENT_289	[p15l1426t3568r1489b3618],
12	.	.	O	.	_	0	SENT_289	[p15l1426t3568r1489b3618],

1	Polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_290	[p15l1516t3568r1961b3633],
2	in	IN	O	in	_	0	SENT_290	[p15l1986t3568r2040b3618],
3	the	DT	O	the	det	7	SENT_290	[p15l2063t3568r2149b3618],
4	ABCG5	NN	O	abcg5	nn	7	SENT_290	[p15l130t3657r359b3708],
5	and	CC	O	and	_	0	SENT_290	[p15l388t3657r489b3707],
6	ABCG8	NN	O	abcg8	conj_and	4	SENT_290	[p15l513t3658r743b3708],
7	genes	NNS	O	gene	prep_in	1	SENT_290	[p15l770t3673r929b3722],
8	associate	VBP	O	associate	_	0	SENT_290	[p15l957t3657r1212b3707],
9	with	IN	O	with	_	0	SENT_290	[p15l1236t3657r1361b3708],
10	cholesterol	NN	O	cholesterol	nn	11	SENT_290	[p15l1386t3657r1698b3707],
11	absorption	NN	O	absorption	prep_with	8	SENT_290	[p15l1724t3657r2023b3722],
12	and	CC	O	and	_	0	SENT_290	[p15l2049t3657r2150b3707],
13	insulin	NN	O	insulin	nn	14	SENT_290	[p15l131t3746r324b3796],
14	sensitivity	NN	O	sensitivity	prep_with	8	SENT_290	[p15l351t3746r647b3811],
15	.	.	O	.	_	0	SENT_290	[p15l351t3746r647b3811],

1	J	NN	O	j	nn	2	SENT_291	[p15l678t3748r714b3797],
2	Lipid	NN	O	lipid	_	0	SENT_291	[p15l733t3746r888b3810],
3	Res	NNP	O	Res	dep	2	SENT_291	[p15l908t3748r1025b3796],
4	.	.	O	.	_	0	SENT_291	[p15l908t3748r1025b3796],

1	2004	CD	DATE	2004	_	0	SENT_292	[p15l1056t3746r1284b3805],
2	;	:	O	;	_	0	SENT_292	[p15l1056t3746r1284b3805],
3	45	CD	NUMBER	45	number	4	SENT_292	[p15l1056t3746r1284b3805],
4	21660-1665	CD	NUMBER	21660-1665	dep	1	SENT_292	[p15l1294t3746r1643b3796],
5	.	.	O	.	_	0	SENT_292	[p15l1294t3746r1643b3796],

1	Kajinami	NNP	LOCATION	Kajinami	nn	2	SENT_293	[p16l132t19r395b84],
2	K	NNP	LOCATION	K	_	0	SENT_293	[p16l422t20r486b78],
3	,	,	O	,	_	0	SENT_293	[p16l422t20r486b78],
4	Brousseau	NNP	PERSON	Brousseau	nn	5	SENT_293	[p16l514t20r810b69],
5	ME	NNP	O	ME	appos	2	SENT_293	[p16l835t20r956b79],
6	,	,	O	,	_	0	SENT_293	[p16l835t20r956b79],
7	Nartsupha	NNP	ORGANIZATION	Nartsupha	nn	8	SENT_293	[p16l984t19r1278b84],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_293	[p16l1302t19r1363b79],
9	,	,	O	,	_	0	SENT_293	[p16l1302t19r1363b79],
10	Ordovas	NNP	O	Ordovas	nn	11	SENT_293	[p16l1392t19r1628b69],
11	JM	NN	O	jm	appos	2	SENT_293	[p16l1654t20r1759b78],
12	,	,	O	,	_	0	SENT_293	[p16l1654t20r1759b78],
13	Schaefer	NNP	PERSON	Schaefer	nn	14	SENT_293	[p16l1789t19r2037b69],
14	EJ	NNP	O	EJ	appos	2	SENT_293	[p16l2061t20r2145b69],
15	.	.	O	.	_	0	SENT_293	[p16l2061t20r2145b69],

1	ATP	NN	O	atp	nsubj	5	SENT_294	[p16l130t109r256b158],
2	binding	NN	O	binding	dep	5	SENT_294	[p16l273t108r491b173],
3	cassette	NN	O	cassette	nn	5	SENT_294	[p16l510t116r731b158],
4	transporter	NN	O	transporter	nn	5	SENT_294	[p16l750t116r1060b173],
5	G5	NN	O	g5	conj_and	5	SENT_294	[p16l1077t108r1158b159],
6	and	CC	O	and	_	0	SENT_294	[p16l1182t108r1282b158],
7	G8	NN	O	g8	nn	8	SENT_294	[p16l1302t108r1383b159],
8	genotypes	NNS	O	genotype	conj_and	5	SENT_294	[p16l1405t116r1691b173],
9	and	CC	O	and	_	0	SENT_294	[p16l1712t108r1813b158],
10	plasma	NN	O	plasma	nn	12	SENT_294	[p16l1830t108r2033b173],
11	lipoprotein	NN	O	lipoprotein	nn	12	SENT_294	[p16l2052t108r2147b173, p16l131t197r368b262],
12	levels	NNS	O	level	conj_and	5	SENT_294	[p16l399t197r560b247],
13	before	IN	O	before	_	0	SENT_294	[p16l592t197r774b247],
14	and	CC	O	and	_	0	SENT_294	[p16l807t197r908b247],
15	after	IN	O	after	_	0	SENT_294	[p16l940t197r1070b247],
16	treatment	NN	O	treatment	prep_before	5	SENT_294	[p16l1100t204r1371b247],
17	with	IN	O	with	_	0	SENT_294	[p16l1401t197r1527b247],
18	atorvastatin	NN	O	atorvastatin	prep_with	16	SENT_294	[p16l1559t197r1900b247],
19	.	.	O	.	_	0	SENT_294	[p16l1559t197r1900b247],

1	J	NN	O	j	nn	2	SENT_295	[p16l1936t199r1972b248],
2	Lipid	NN	O	lipid	_	0	SENT_295	[p16l1998t197r2152b261],
3	Res	NNP	O	Res	dep	2	SENT_295	[p16l128t288r246b336],
4	.	.	O	.	_	0	SENT_295	[p16l128t288r246b336],

1	2004	CD	DATE	2004	_	0	SENT_296	[p16l276t286r792b345],
2	;	:	O	;	_	0	SENT_296	[p16l276t286r792b345],
3	45:653	CD	NUMBER	45:653	number	4	SENT_296	[p16l276t286r792b345],
4	-656	CD	NUMBER	-656	dep	1	SENT_296	[p16l276t286r792b345],
5	.	.	O	.	_	0	SENT_296	[p16l276t286r792b345],

1	Thompson	NNP	PERSON	Thompson	nn	2	SENT_297	[p16l130t374r434b439],
2	JF	NNP	O	JF	_	0	SENT_297	[p16l459t375r534b434],
3	,	,	O	,	_	0	SENT_297	[p16l459t375r534b434],
4	Man	NNP	O	Man	nn	5	SENT_297	[p16l562t375r691b424],
5	M	NNP	O	M	appos	2	SENT_297	[p16l716t375r793b434],
6	,	,	O	,	_	0	SENT_297	[p16l716t375r793b434],
7	Johnson	NNP	PERSON	Johnson	nn	9	SENT_297	[p16l821t374r1053b425],
8	K	NNP	O	K	nn	9	SENT_297	[p16l1079t375r1170b434],
9	]	NNP	O	]	appos	2	SENT_297	[p16l1079t375r1170b434],
10	,	,	O	,	_	0	SENT_297	[p16l1079t375r1170b434],
11	et	FW	O	et	nn	12	SENT_297	[p16l1199t382r1249b424],
12	al.	FW	O	al.	appos	2	SENT_297	[p16l1275t374r1338b424],
13	.	.	O	.	_	0	SENT_297	[p16l1275t374r1338b424],

1	An	DT	O	a	det	3	SENT_298	[p16l1367t375r1452b424],
2	association	NN	O	association	nn	3	SENT_298	[p16l1479t374r1794b424],
3	study	NN	O	study	_	0	SENT_298	[p16l1821t374r1971b439],
4	of	IN	O	of	_	0	SENT_298	[p16l1998t374r2059b424],
5	43	CD	NUMBER	43	num	6	SENT_298	[p16l2079t374r2146b425],
6	SNPs	NNS	O	snp	prep_of	3	SENT_298	[p16l132t464r285b514],
7	in	IN	O	in	_	0	SENT_298	[p16l311t463r365b513],
8	16	CD	NUMBER	16	num	10	SENT_298	[p16l397t463r458b514],
9	candidate	NN	O	candidate	nn	10	SENT_298	[p16l484t463r757b514],
10	genes	NNS	O	gene	prep_in	6	SENT_298	[p16l782t479r941b528],
11	with	IN	O	with	_	0	SENT_298	[p16l967t463r1093b514],
12	atorvastatin	NN	O	atorvastatin	nn	13	SENT_298	[p16l1118t463r1448b514],
13	response	NN	O	response	prep_with	3	SENT_298	[p16l1471t479r1731b528],
14	.	.	O	.	_	0	SENT_298	[p16l1471t479r1731b528],

1	Pharmacoge	NNP	O	Pharmacoge	nn	3	SENT_299	[p16l1761t463r2147b528],
2	—	CD	NUMBER	—	num	3	SENT_299	[p16l1761t463r2147b528],
3	nomics	NNS	O	nomic	_	0	SENT_299	[p16l131t554r331b602],
4	J.	NNP	O	J.	dep	3	SENT_299	[p16l355t554r400b602],
5	2005	CD	DATE	2005	num	4	SENT_299	[p16l431t552r910b611],
6	;	:	O	;	_	0	SENT_299	[p16l431t552r910b611],
7	5:352	CD	NUMBER	5:352	num	8	SENT_299	[p16l431t552r910b611],
8	—	NN	O	—	dep	3	SENT_299	[p16l431t552r910b611],
9	358	CD	NUMBER	358	dep	8	SENT_299	[p16l431t552r910b611],
10	.	.	O	.	_	0	SENT_299	[p16l431t552r910b611],

1	Fiegenbaum	NNP	PERSON	Fiegenbaum	nn	2	SENT_300	[p16l130t640r483b705],
2	M	NN	O	m	_	0	SENT_300	[p16l509t641r585b700],
3	,	,	O	,	_	0	SENT_300	[p16l509t641r585b700],
4	da	NN	PERSON	da	nn	6	SENT_300	[p16l616t640r682b690],
5	Silveira	NNP	PERSON	Silveira	nn	6	SENT_300	[p16l710t640r929b691],
6	FR	NN	O	fr	appos	2	SENT_300	[p16l955t641r1056b700],
7	,	,	O	,	_	0	SENT_300	[p16l955t641r1056b700],
8	Van	NNP	PERSON	Van	nn	10	SENT_300	[p16l1086t641r1195b690],
9	der	NNP	O	der	nn	10	SENT_300	[p16l1223t640r1313b690],
10	Sand	NNP	O	Sand	appos	2	SENT_300	[p16l1341t640r1480b691],
11	CR	NN	O	cr	dep	10	SENT_300	[p16l1508t640r1616b700],
12	,	,	O	,	_	0	SENT_300	[p16l1508t640r1616b700],
13	et	FW	O	et	nn	14	SENT_300	[p16l1646t648r1696b690],
14	al.	FW	O	al.	appos	2	SENT_300	[p16l1724t640r1787b690],
15	.	.	O	.	_	0	SENT_300	[p16l1724t640r1787b690],

1	The	DT	O	the	det	2	SENT_301	[p16l1818t640r1927b690],
2	role	NN	O	role	_	0	SENT_301	[p16l1954t640r2064b690],
3	of	IN	O	of	_	0	SENT_301	[p16l2092t640r2154b690],
4	common	JJ	O	common	amod	5	SENT_301	[p16l131t745r380b780],
5	Variants	NNS	O	variant	prep_of	2	SENT_301	[p16l404t729r625b780],
6	of	IN	O	of	_	0	SENT_301	[p16l654t729r716b780],
7	ABCB1	NN	O	abcb1	nn	9	SENT_301	[p16l738t730r981b789],
8	,	,	O	,	_	0	SENT_301	[p16l738t730r981b789],
9	CYP3A4	NN	O	cyp3a4	prep_of	2	SENT_301	[p16l1010t730r1284b789],
10	,	,	O	,	_	0	SENT_301	[p16l1010t730r1284b789],
11	and	CC	O	and	_	0	SENT_301	[p16l1315t729r1416b780],
12	CYP3A5	NN	O	cyp3a5	nn	13	SENT_301	[p16l1442t729r1698b780],
13	genes	NNS	O	gene	conj_and	9	SENT_301	[p16l1728t745r1887b794],
14	in	IN	O	in	_	0	SENT_301	[p16l1915t729r1969b779],
15	lipidlowering	VBG	O	lipidlower	prepc_in	2	SENT_301	[p16l1996t729r2147b794, p16l131t819r381b884],
16	efﬁcacy	NN	O	efﬁcacy	dobj	15	SENT_301	[p16l403t818r625b884],
17	and	CC	O	and	_	0	SENT_301	[p16l649t819r750b869],
18	safety	NN	O	safety	conj_and	16	SENT_301	[p16l772t818r939b884],
19	of	IN	O	of	_	0	SENT_301	[p16l961t818r1022b869],
20	simvastatin	NN	O	simvastatin	nn	21	SENT_301	[p16l1041t818r1362b869],
21	treatment	NN	O	treatment	prep_of	16	SENT_301	[p16l1383t826r1663b869],
22	.	.	O	.	_	0	SENT_301	[p16l1383t826r1663b869],

1	Clin	NNP	O	Clin	nn	3	SENT_302	[p16l1694t819r1812b869],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_302	[p16l1833t819r2151b869],
3	Ther	NNP	O	Ther	_	0	SENT_302	[p16l134t907r273b957],
4	.	.	O	.	_	0	SENT_302	[p16l134t907r273b957],

1	2005	CD	DATE	2005	_	0	SENT_303	[p16l304t907r819b966],
2	;	:	O	;	_	0	SENT_303	[p16l304t907r819b966],
3	78:551	CD	NUMBER	78:551	number	4	SENT_303	[p16l304t907r819b966],
4	-558	CD	NUMBER	-558	dep	1	SENT_303	[p16l304t907r819b966],
5	.	.	O	.	_	0	SENT_303	[p16l304t907r819b966],

1	Bercovich	NN	PERSON	bercovich	nn	2	SENT_304	[p16l130t995r423b1045],
2	D	NN	PERSON	d	_	0	SENT_304	[p16l447t997r512b1054],
3	,	,	O	,	_	0	SENT_304	[p16l447t997r512b1054],
4	Friedlander	NNP	PERSON	Friedlander	nn	5	SENT_304	[p16l540t995r869b1045],
5	Y	NN	PERSON	y	appos	2	SENT_304	[p16l893t997r948b1054],
6	,	,	O	,	_	0	SENT_304	[p16l893t997r948b1054],
7	Korem	NNP	LOCATION	Korem	nn	8	SENT_304	[p16l977t997r1172b1045],
8	S	NNP	O	S	appos	2	SENT_304	[p16l1198t996r1249b1054],
9	,	,	O	,	_	0	SENT_304	[p16l1198t996r1249b1054],
10	et	FW	O	et	nn	11	SENT_304	[p16l1277t1003r1327b1045],
11	al.	FW	O	al.	appos	2	SENT_304	[p16l1353t995r1416b1045],
12	.	.	O	.	_	0	SENT_304	[p16l1353t995r1416b1045],

1	The	DT	O	the	det	2	SENT_305	[p16l1445t995r1554b1045],
2	association	NN	O	association	_	0	SENT_305	[p16l1581t995r1896b1045],
3	of	IN	O	of	_	0	SENT_305	[p16l1922t995r1983b1045],
4	common	JJ	O	common	amod	5	SENT_305	[p16l2004t1011r2147b1045, p16l130t1099r256b1134],
5	SNPs	NNS	O	snp	prep_of	2	SENT_305	[p16l283t1083r435b1133],
6	and	CC	O	and	_	0	SENT_305	[p16l462t1083r563b1133],
7	haplotypes	NNS	O	haplotype	prep_of	2	SENT_305	[p16l587t1083r895b1148],
8	in	IN	O	in	_	0	SENT_305	[p16l921t1083r975b1133],
9	the	DT	O	the	det	13	SENT_305	[p16l1000t1083r1085b1133],
10	CETP	NN	O	cetp	nn	13	SENT_305	[p16l1112t1083r1284b1133],
11	and	CC	O	and	_	0	SENT_305	[p16l1310t1083r1410b1133],
12	MDR1	NN	O	mdr1	conj_and	10	SENT_305	[p16l1434t1083r1624b1133],
13	genes	NNS	O	gene	prep_in	2	SENT_305	[p16l1656t1099r1815b1148],
14	with	IN	O	with	_	0	SENT_305	[p16l1842t1083r1967b1133],
15	lipids	NNS	O	lipid	nn	16	SENT_305	[p16l1992t1083r2148b1148],
16	response	NN	O	response	prep_with	2	SENT_305	[p16l129t1189r378b1238],
17	to	TO	O	to	_	0	SENT_305	[p16l400t1180r453b1223],
18	ﬂuvastatin	NN	O	ﬂuvastatin	prep_to	16	SENT_305	[p16l476t1173r769b1223],
19	in	IN	O	in	_	0	SENT_305	[p16l791t1173r845b1222],
20	familial	JJ	O	familial	amod	21	SENT_305	[p16l866t1173r1088b1223],
21	hypercholesterolemia	NN	O	hypercholesterolemia	prep_in	18	SENT_305	[p16l1109t1173r1735b1238],
22	.	.	O	.	_	0	SENT_305	[p16l1109t1173r1735b1238],

1	Atherosclerosis	NN	O	atherosclerosis	_	0	SENT_306	[p16l1759t1173r2146b1223, p16l130t1264r217b1312],
2	.	.	O	.	_	0	SENT_306	[p16l1759t1173r2146b1223, p16l130t1264r217b1312],

1	2006	CD	DATE	2006	_	0	SENT_307	[p16l248t1261r763b1320],
2	;	:	O	;	_	0	SENT_307	[p16l248t1261r763b1320],
3	185:97	CD	NUMBER	185:97	num	4	SENT_307	[p16l248t1261r763b1320],
4	—	NN	O	—	dep	1	SENT_307	[p16l248t1261r763b1320],
5	107	CD	NUMBER	107	dep	4	SENT_307	[p16l248t1261r763b1320],
6	.	.	O	.	_	0	SENT_307	[p16l248t1261r763b1320],

1	Mega	JJ	O	mega	amod	2	SENT_308	[p16l130t1350r292b1414],
2	JL	NN	O	jl	_	0	SENT_308	[p16l316t1350r401b1408],
3	,	,	O	,	_	0	SENT_308	[p16l316t1350r401b1408],
4	Morrow	NNP	PERSON	Morrow	nn	5	SENT_308	[p16l429t1350r659b1399],
5	DA	NNP	PERSON	DA	appos	2	SENT_308	[p16l685t1349r799b1408],
6	,	,	O	,	_	0	SENT_308	[p16l685t1349r799b1408],
7	Brown	NNP	PERSON	Brown	nn	8	SENT_308	[p16l827t1350r1018b1399],
8	A	NNP	O	A	appos	2	SENT_308	[p16l1044t1349r1109b1408],
9	,	,	O	,	_	0	SENT_308	[p16l1044t1349r1109b1408],
10	Cannon	NNP	ORGANIZATION	Cannon	nn	11	SENT_308	[p16l1138t1349r1358b1399],
11	CP	NNP	ORGANIZATION	CP	appos	2	SENT_308	[p16l1384t1349r1477b1408],
12	,	,	O	,	_	0	SENT_308	[p16l1384t1349r1477b1408],
13	Sabatine	NNP	PERSON	Sabatine	nn	15	SENT_308	[p16l1507t1349r1750b1399],
14	MS.	NNP	PERSON	MS.	nn	15	SENT_308	[p16l1775t1349r1890b1399],
15	Identiﬁcation	NNP	PERSON	Identiﬁcation	appos	2	SENT_308	[p16l1920t1349r2147b1399, p16l131t1438r304b1488],
16	of	IN	O	of	_	0	SENT_308	[p16l333t1438r395b1488],
17	genetic	JJ	O	genetic	amod	18	SENT_308	[p16l420t1438r623b1503],
18	Variants	NNS	O	variant	prep_of	15	SENT_308	[p16l653t1438r875b1488],
19	associated	VBN	O	associate	partmod	18	SENT_308	[p16l907t1438r1198b1488],
20	with	IN	O	with	_	0	SENT_308	[p16l1227t1438r1352b1488],
21	response	NN	O	response	prep_with	19	SENT_308	[p16l1380t1454r1628b1503],
22	to	TO	O	to	_	0	SENT_308	[p16l1656t1446r1709b1488],
23	statin	NN	O	statin	nn	24	SENT_308	[p16l1742t1438r1893b1488],
24	therapy	NN	O	therapy	prep_to	19	SENT_308	[p16l1921t1438r2142b1503],
25	.	.	O	.	_	0	SENT_308	[p16l1921t1438r2142b1503],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_309	[p16l125t1528r477b1578],
2	Thromb	NNP	O	Thromb	nn	4	SENT_309	[p16l502t1528r719b1578],
3	Vasc	NNP	O	Vasc	nn	4	SENT_309	[p16l750t1530r874b1578],
4	Biol	NNP	O	Biol	_	0	SENT_309	[p16l899t1528r1032b1578],
5	.	.	O	.	_	0	SENT_309	[p16l899t1528r1032b1578],

1	2009	CD	DATE	2009	_	0	SENT_310	[p16l1063t1527r1649b1586],
2	;	:	O	;	_	0	SENT_310	[p16l1063t1527r1649b1586],
3	29:1310	CD	NUMBER	29:1310	number	4	SENT_310	[p16l1063t1527r1649b1586],
4	—	CD	NUMBER	—	dep	1	SENT_310	[p16l1063t1527r1649b1586],
5	1315	CD	DATE	1315	dep	4	SENT_310	[p16l1063t1527r1649b1586],
6	.	.	O	.	_	0	SENT_310	[p16l1063t1527r1649b1586],

1	Bogman	NNP	PERSON	Bogman	nn	2	SENT_311	[p16l130t1616r371b1680],
2	K	NNP	PERSON	K	_	0	SENT_311	[p16l397t1616r461b1674],
3	,	,	O	,	_	0	SENT_311	[p16l397t1616r461b1674],
4	Peyer	NNP	ORGANIZATION	Peyer	nn	5	SENT_311	[p16l488t1616r651b1680],
5	AK	NNP	ORGANIZATION	AK	appos	2	SENT_311	[p16l674t1615r790b1674],
6	,	,	O	,	_	0	SENT_311	[p16l674t1615r790b1674],
7	Torok	NNP	PERSON	Torok	nn	8	SENT_311	[p16l818t1615r988b1665],
8	M	NNP	O	M	appos	2	SENT_311	[p16l1011t1616r1088b1674],
9	,	,	O	,	_	0	SENT_311	[p16l1011t1616r1088b1674],
10	Kusters	NNP	O	Kusters	nn	11	SENT_311	[p16l1117t1616r1330b1665],
11	E	NNP	O	E	appos	2	SENT_311	[p16l1356t1616r1414b1674],
12	,	,	O	,	_	0	SENT_311	[p16l1356t1616r1414b1674],
13	Drewe	NNP	PERSON	Drewe	nn	14	SENT_311	[p16l1442t1616r1629b1665],
14	J	NNP	PERSON	J	appos	2	SENT_311	[p16l1654t1616r1680b1665],
15	.	.	O	.	_	0	SENT_311	[p16l1686t1657r1694b1665],

1	HMG-CoA	JJ	O	hmg-coa	amod	2	SENT_312	[p16l1724t1615r2047b1665],
2	reductase	NN	O	reductase	_	0	SENT_312	[p16l2070t1631r2147b1665, p16l131t1704r343b1754],
3	inhibitors	NNS	O	inhibitor	dep	2	SENT_312	[p16l376t1704r648b1754],
4	and	CC	O	and	_	0	SENT_312	[p16l683t1704r784b1754],
5	P-glycoprotein	NN	O	p-glycoprotein	nn	6	SENT_312	[p16l817t1704r1241b1769],
6	modulation	NN	O	modulation	dep	2	SENT_312	[p16l1274t1704r1609b1754],
7	.	.	O	.	_	0	SENT_312	[p16l1274t1704r1609b1754],

1	Br	NN	O	br	_	0	SENT_313	[p16l1647t1706r1721b1754],
2	J	NN	O	j	nn	3	SENT_313	[p16l1750t1706r1786b1755],
3	Pharmacol	NN	O	pharmacol	dep	1	SENT_313	[p16l1814t1704r2145b1754],
4	.	.	O	.	_	0	SENT_313	[p16l1814t1704r2145b1754],

1	2001	CD	DATE	2001	_	0	SENT_314	[p16l131t1794r754b1852],
2	;	:	O	;	_	0	SENT_314	[p16l131t1794r754b1852],
3	132:1183	CD	DURATION	132:1183	number	4	SENT_314	[p16l131t1794r754b1852],
4	-1192	CD	DURATION	-1192	dep	1	SENT_314	[p16l131t1794r754b1852],
5	.	.	O	.	_	0	SENT_314	[p16l131t1794r754b1852],

1	Becker	NNP	PERSON	Becker	nn	2	SENT_315	[p16l130t1881r333b1931],
2	ML	NNP	O	ML	_	0	SENT_315	[p16l356t1882r477b1940],
3	,	,	O	,	_	0	SENT_315	[p16l356t1882r477b1940],
4	Visser	NNP	PERSON	Visser	nn	5	SENT_315	[p16l503t1881r681b1931],
5	LE	NNP	PERSON	LE	appos	2	SENT_315	[p16l705t1882r806b1940],
6	,	,	O	,	_	0	SENT_315	[p16l705t1882r806b1940],
7	Van	NNP	PERSON	Van	nn	9	SENT_315	[p16l833t1897r933b1931],
8	Schaik	NNP	PERSON	Schaik	nn	9	SENT_315	[p16l960t1881r1152b1931],
9	RH	NNP	O	RH	appos	5	SENT_315	[p16l1175t1882r1288b1940],
10	,	,	O	,	_	0	SENT_315	[p16l1175t1882r1288b1940],
11	Hofman	NNP	PERSON	Hofman	nn	12	SENT_315	[p16l1315t1881r1547b1931],
12	A	NNP	O	A	appos	5	SENT_315	[p16l1571t1881r1636b1940],
13	,	,	O	,	_	0	SENT_315	[p16l1571t1881r1636b1940],
14	Uitterlinden	NNP	ORGANIZATION	Uitterlinden	nn	15	SENT_315	[p16l1664t1881r2008b1931],
15	AG	NNP	ORGANIZATION	AG	appos	5	SENT_315	[p16l2032t1881r2146b1940],
16	,	,	O	,	_	0	SENT_315	[p16l2032t1881r2146b1940],
17	Stricker	NNP	PERSON	Stricker	nn	18	SENT_315	[p16l132t1969r356b2020],
18	BH	NNP	O	BH	appos	5	SENT_315	[p16l374t1970r485b2019],
19	.	.	O	.	_	0	SENT_315	[p16l374t1970r485b2019],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_316	[p16l508t1969r772b2019],
2	of	IN	O	of	_	0	SENT_316	[p16l791t1969r853b2019],
3	genetic	JJ	O	genetic	amod	4	SENT_316	[p16l868t1969r1071b2034],
4	Variation	NN	O	variation	prep_of	1	SENT_316	[p16l1092t1969r1343b2019],
5	in	IN	O	in	_	0	SENT_316	[p16l1362t1969r1415b2019],
6	CYP3A4	NN	O	cyp3a4	prep_in	4	SENT_316	[p16l1435t1969r1693b2020],
7	and	CC	O	and	_	0	SENT_316	[p16l1714t1969r1815b2019],
8	ABCB1	NN	O	abcb1	prep_in	4	SENT_316	[p16l1832t1969r2054b2020],
9	on	IN	O	on	_	0	SENT_316	[p16l2080t1985r2149b2019],
10	dose	NN	O	dose	nn	11	SENT_316	[p16l131t2058r259b2109],
11	decrease	NN	O	decrease	prep_on	1	SENT_316	[p16l289t2058r533b2109],
12	or	CC	O	or	_	0	SENT_316	[p16l564t2074r622b2109],
13	switching	NN	O	switching	prep_on	1	SENT_316	[p16l653t2058r927b2123],
14	during	IN	O	during	_	0	SENT_316	[p16l958t2058r1141b2123],
15	simvastatin	NN	O	simvastatin	nn	18	SENT_316	[p16l1174t2058r1494b2109],
16	and	CC	O	and	_	0	SENT_316	[p16l1525t2058r1626b2109],
17	atorvastatin	NN	O	atorvastatin	nn	18	SENT_316	[p16l1657t2058r1987b2109],
18	therapy	NN	O	therapy	prep_during	1	SENT_316	[p16l2016t2058r2146b2109, p16l132t2163r239b2212],
19	.	.	O	.	_	0	SENT_316	[p16l2016t2058r2146b2109, p16l132t2163r239b2212],

1	Pharmacoepidemiol	NNP	O	Pharmacoepidemiol	nn	3	SENT_317	[p16l271t2147r850b2212],
2	Drug	NNP	O	Drug	nn	3	SENT_317	[p16l873t2149r1023b2212],
3	Saf	NNP	O	Saf	_	0	SENT_317	[p16l1048t2148r1152b2212],
4	.	.	O	.	_	0	SENT_317	[p16l1048t2148r1152b2212],

1	2010	CD	DATE	2010	_	0	SENT_318	[p16l1182t2147r1626b2207],
2	;	:	O	;	_	0	SENT_318	[p16l1182t2147r1626b2207],
3	19:75	CD	NUMBER	19:75	number	4	SENT_318	[p16l1182t2147r1626b2207],
4	-81	CD	NUMBER	-81	dep	1	SENT_318	[p16l1182t2147r1626b2207],
5	.	.	O	.	_	0	SENT_318	[p16l1182t2147r1626b2207],

1	Link	NN	O	link	nn	2	SENT_319	[p16l130t2236r262b2286],
2	E	NN	O	e	_	0	SENT_319	[p16l277t2237r334b2296],
3	,	,	O	,	_	0	SENT_319	[p16l277t2237r334b2296],
4	Parish	NNP	O	Parish	nn	5	SENT_319	[p16l353t2236r524b2286],
5	S	NNP	O	S	appos	2	SENT_319	[p16l542t2236r593b2295],
6	,	,	O	,	_	0	SENT_319	[p16l542t2236r593b2295],
7	Armitage	NNP	PERSON	Armitage	nn	8	SENT_319	[p16l611t2236r873b2301],
8	J	NNP	PERSON	J	appos	2	SENT_319	[p16l890t2237r916b2287],
9	,	,	O	,	_	0	SENT_319	[p16l920t2278r930b2296],
10	et	FW	O	et	nn	11	SENT_319	[p16l950t2244r1000b2286],
11	al.	FW	O	al.	appos	2	SENT_319	[p16l1017t2236r1078b2286],
12	.	.	O	.	_	0	SENT_319	[p16l1017t2236r1078b2286],

1	SLCOlBl	NNP	O	SLCOlBl	nn	2	SENT_320	[p16l1100t2236r1386b2287],
2	Variants	NNS	O	variant	nsubj	6	SENT_320	[p16l1409t2236r1623b2287],
3	and	CC	O	and	_	0	SENT_320	[p16l1643t2236r1742b2286],
4	statin-induced	JJ	O	statin-induced	amod	5	SENT_320	[p16l1760t2236r2149b2286],
5	myopathy	NN	O	myopathy	nsubj	6	SENT_320	[p16l130t2325r510b2390],
6	—	VBD	O	—	_	0	SENT_320	[p16l130t2325r510b2390],
7	a	DT	O	a	det	9	SENT_320	[p16l130t2325r510b2390],
8	genomewide	JJ	O	genomewide	amod	9	SENT_320	[p16l528t2325r880b2390],
9	study	NN	O	study	dobj	6	SENT_320	[p16l902t2325r1055b2390],
10	.	.	O	.	_	0	SENT_320	[p16l902t2325r1055b2390],

1	N	NN	O	n	_	0	SENT_321	[p16l1077t2327r1131b2376],
2	Engl	NNP	O	Engl	nn	4	SENT_321	[p16l1143t2325r1277b2390],
3	J	NNP	O	J	nn	4	SENT_321	[p16l1292t2327r1328b2376],
4	Med	NNP	O	Med	dep	1	SENT_321	[p16l1340t2325r1479b2376],
5	.	.	O	.	_	0	SENT_321	[p16l1340t2325r1479b2376],

1	2008	CD	DATE	2008	_	0	SENT_322	[p16l1502t2325r2038b2385],
2	;	:	O	;	_	0	SENT_322	[p16l1502t2325r2038b2385],
3	359:789	CD	NUMBER	359:789	number	4	SENT_322	[p16l1502t2325r2038b2385],
4	-799	CD	NUMBER	-799	dep	1	SENT_322	[p16l1502t2325r2038b2385],
5	.	.	O	.	_	0	SENT_322	[p16l1502t2325r2038b2385],

1	LaRosa	NNP	ORGANIZATION	LaRosa	nn	2	SENT_323	[p16l130t2416r348b2465],
2	JC	NNP	ORGANIZATION	JC	_	0	SENT_323	[p16l377t2415r466b2474],
3	,	,	O	,	_	0	SENT_323	[p16l377t2415r466b2474],
4	Grundy	NNP	PERSON	Grundy	nn	5	SENT_323	[p16l500t2414r715b2479],
5	SM	NNP	O	SM	appos	2	SENT_323	[p16l747t2415r861b2474],
6	,	,	O	,	_	0	SENT_323	[p16l747t2415r861b2474],
7	Waters	NNP	O	Waters	nn	8	SENT_323	[p16l894t2416r1089b2465],
8	DD	NNP	O	DD	appos	2	SENT_323	[p16l1120t2416r1237b2474],
9	,	,	O	,	_	0	SENT_323	[p16l1120t2416r1237b2474],
10	et	FW	O	et	nn	11	SENT_323	[p16l1271t2422r1321b2465],
11	al.	FW	O	al.	appos	2	SENT_323	[p16l1352t2414r1415b2465],
12	.	.	O	.	_	0	SENT_323	[p16l1352t2414r1415b2465],

1	Intensive	JJ	O	intensive	amod	2	SENT_324	[p16l1449t2414r1706b2465],
2	lipid	NN	O	lipid	_	0	SENT_324	[p16l1738t2414r1869b2479],
3	lowering	VBG	O	lower	partmod	2	SENT_324	[p16l1899t2414r2148b2479],
4	with	IN	O	with	_	0	SENT_324	[p16l131t2503r256b2553],
5	atorvastatin	NN	O	atorvastatin	prep_with	3	SENT_324	[p16l288t2503r618b2554],
6	in	IN	O	in	_	0	SENT_324	[p16l649t2503r703b2553],
7	patients	NNS	O	patient	prep_in	3	SENT_324	[p16l734t2503r954b2568],
8	with	IN	O	with	_	0	SENT_324	[p16l987t2503r1112b2554],
9	stable	JJ	O	stable	amod	11	SENT_324	[p16l1146t2503r1309b2553],
10	coronary	JJ	O	coronary	amod	11	SENT_324	[p16l1341t2519r1592b2568],
11	disease	NN	O	disease	prep_with	7	SENT_324	[p16l1624t2503r1839b2553],
12	.	.	O	.	_	0	SENT_324	[p16l1624t2503r1839b2553],

1	N	NN	O	n	_	0	SENT_325	[p16l1874t2505r1928b2554],
2	Engl	NNP	O	Engl	nn	4	SENT_325	[p16l1953t2503r2088b2567],
3	J	NNP	O	J	nn	4	SENT_325	[p16l2117t2505r2153b2554],
4	Med	NNP	O	Med	dep	1	SENT_325	[p16l128t2592r270b2643],
5	.	.	O	.	_	0	SENT_325	[p16l128t2592r270b2643],

1	2005	CD	DATE	2005	_	0	SENT_326	[p16l300t2592r922b2649],
2	;	:	O	;	_	0	SENT_326	[p16l300t2592r922b2649],
3	352:1425	CD	DURATION	352:1425	number	4	SENT_326	[p16l300t2592r922b2649],
4	-1435	CD	DURATION	-1435	dep	1	SENT_326	[p16l300t2592r922b2649],
5	.	.	O	.	_	0	SENT_326	[p16l300t2592r922b2649],

